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The process of ovulation is critical for successful fertilisation and pregnancy. Of utmost 
importance is the progesterone receptor (PGR), which regulates various biological processes 
preceding pregnancy including ovulation, oviductal oocyte/embryo transportation and embryo 
implantation. How PGR can achieve divergent reproductive roles is still poorly understood. 
This thesis aims to explore the molecular mechanisms that allow for highly specialised PGR 
ovulatory functions through describing the PGR cistrome and transcriptome in mouse peri-
ovulatory granulosa cells when PGR is highly induced and active. In addition, the relationship 
between PGR and other transcription factors, especially RUNX1, as well as isoform-specific 
actions were also determined. 
 
As PGR acts through direct binding to the PGR response element (PRE), differences in PGR 
chromatin targets can influence PGR actions. Characterisation of the PGR cistrome using 
chromatin immunoprecipitation – sequencing (ChIP-seq) showed striking distinctions in 
preferential PGR targets in peri-ovulatory granulosa cells compared to the uterus. Granulosa 
PGR favourably interacted with transcriptionally active promoters and had few mutual 
chromatin targets with uterine PGR. Interestingly, motif analysis of PGR peaks identified 
specific patterns in the degree of PRE occupancy and the enrichment of distinct non-canonical 
motifs, suggesting that PGR interacts with other transcription factors in a context-specific 
manner. 
 
Motif analysis of PGR peaks in granulosa cells implied a number of potential protein partners 
such as the JUN/FOS, LRH1, and RUNX families. The physical interaction of these proteins 
with PGR in mouse peri-ovulatory granulosa cells was confirmed through proximity ligation 
assay. Among these, RUNX was a granulosa-specific factor and thus potentially important in 
granulosa-specific PGR roles. RUNX1 displayed context-specific chromatin binding 
properties as shown through RUNX1 ChIP-seq of mouse foetal and adult granulosa cells before 
and after the LH surge. In peri-ovulatory granulosa cells, PGR/RUNX1 interaction was 
specifically hCG-induced, RUNX1 shared mutual targets and non-canonical binding motifs 
with PGR that resulted in the regulation of mutual ovulatory genes. This indicates a close 
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interplay between PGR and RUNX1 in granulosa cells during ovulation, likely in conjunction 
with other modulators. 
 
The PGR-A and PGR-B isoforms play distinct roles in different biological contexts, with PGR-
A being prominent in peri-ovulatory granulosa cells. To further assess the specific roles of 
PGR-A and PGR-B during ovulation, transcriptomes of peri-ovulatory granulosa cells from 
mice lacking both isoforms (PGRKO), PGR-A (AKO) or PGR-B (BKO) were obtained through 
RNA-seq. More than 600 differentially expressed genes were identified in PGRKO and AKO 
with few identified in BKO. Mutual PGR/RUNX1 direct binding was important in the 
regulation of these genes. PGRKO and AKO transcriptomes shared nearly half of their genes 
with little similarities with the BKO transcriptome. The transcriptomic data supports the key 
physiological roles of PGR-A in ovulation. 
 
Altogether, this study provides the first description of the PGR cistrome, interactome and 
transcriptome in granulosa cells. A unique cooperation between PGR, especially PGR-A, and 
specific transcription factors, especially RUNX1, in a mutual transcription complex leads to 
the specification of PGR ovulatory action in granulosa cells. Such understanding in tissue-
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PI3K/AKT/PKB Phosphoinositide 3-kinase / Protein Kinase B 
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PRE / NR3C Progesterone receptor Response Element 
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PTGS1 / PTGS2 Prostaglandin-Endoperoxide Synthase 1 / 2 
PTX3 Pentraxin 3 
RCOR1 REST Corepressor 1 
REST RE1/-Silencing Transcription factor 
RGCC Regulator Of Cell Cycle 
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RHOX5 Reproductive Homeobox 5 
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RMST Rhabdomyosarcoma 2 Associated Transcript 
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RUNX Runt-related transcription factor 
SERPINA1 Serpin Family A Member 1 
SF-1 Steroidogenic Factor 1 
SGK Serum/Glucocorticoid Regulated Kinase 
siRNA small interfering RNA 
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SLP Sex-Limited Protein 
SNAI2 Snail Family Transcriptional Repressor 2 
SNAP25 Synaptosome Associated Protein 25 
snoRNA Small Nucleolar RNA 
snRNA Small Nuclear RNA 
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XXVI 
 
SOX2 / SOX9 / SOX12 SRY-Box Transcription Factor 2 / 9 / 12 
SP1 / SP3 Specificity Protein 1 / 3 
SRA1 / SRAP Steroid receptor RNA Activator 1 (Protein) 
SRC1 / SRC2 / SRC3 Steroid Receptor Coactivator 1 / 2 / 3 
StAR Steroidogenic Acute Regulatory Protein 
STAT3 / STAT5 Signal Transducer And Activator Of Transcription 3 / 5 
SUMO-1 Small Ubiquitin-related MOdifier 1 
SWI/SNF SWItch/Sucrose Non-Fermentable 
TAD Topologically Associating Domain 
TCR T-cell Receptor 
TEL (ETS6) ETS Variant Transcription Factor 6 
TES Transcription End Site 
TGFβ Transforming Growth Factor β 1 
TIMP Metallopeptidase Inhibitor 1 
TLR2 / TLR4 Toll-Like Receptor 2 / 4 
TMEM100 Transmembrane Protein 100 
TNFAIP6 TNF Alpha Induced Protein 6 
TNFSF11 (RANKL) TNF Superfamily Member 11 (Receptor Activator of 
Nuclear factor-κB ligand) 
TSS Transcription Start Site 
TWIST1 Twist-related protein 1 
UBC Ubiquitin C 
UBE2F / UBE2M Ubiquitin Conjugating Enzyme E2F / E2M 
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XIST X Inactive Specific Transcript 
YAP1 Yes Associated Protein 1 
ZBTB1 / ZBTB16 (PLZF) Zinc Finger And BTB Domain Containing 1 / 16 
(Promyelocytic Leukaemia Zinc Finger) 








CHAPTER 1 Literature review 
 
 
Unique among all systems within the female body, the ovary is the only organ in which germ 
cells are developed and is thus aptly responsible for ensuring female reproductive success. In 
support of oocyte development are a host of ovarian somatic cells that cooperate with one 
another and with the oocyte to drive various ovarian functions. Among many critical ovarian 
functions is oocyte maturation and ovulation, during which mature oocytes are released from 
the confinement of the follicle (and the ovary) into the oviduct where fertilisation can occur. A 
number of biological processes, mediated by a complex network of signalling pathways and 
their resultant target genes, contribute to the success of ovulation. Chief among these factors is 
progesterone receptor (PGR), a steroid nuclear receptor of undisputable importance in 
determining ovulation. Outside of the ovary, PGR is also highly involved in distinct biological 
processes throughout the female reproductive tract prior to pregnancy. Exactly how these 
diverse roles are achieved remains to be answered. 
 
1.1 THE OVARY 
The ovarian follicle is composed of female germ cells (oocytes) and somatic cells (mural 
granulosa cells, cumulus cells and theca cells), with the complex interactions between each of 
these compartment being vital for ovarian functions. The main purposes of the ovary are to 
generate viable oocytes and reproductive hormones, with the ultimate goal to enable 
fertilisation and development as well as supporting potential pregnancy. A number of 
biological events occur within the ovary in preparation for these goals, including the formation 
of follicles each containing an oocyte and its supporting network of somatic cells, oocyte 
development and maturation, ovulation and the formation of the corpus luteum (CL) (Figure 
1.1A). Events happening in the ovary are orchestrated by hormones produced by the 
hypothalamus and pituitary that in turn receive feedback from ovarian signals. All of these are 









Figure 1.1 Ovarian structure and the hypothalamic-pituitary-ovarian axis.  
(A) Schematic of follicular development in the ovary in an oestrous cycle. From bottom left, 
anti-clockwise: follicle activation (primordial to primary follicle), folliculogenesis (primary – 
secondary – antral follicle progression), oocyte maturation (pre-ovulatory follicle), ovulation 
and corpus luteum formation (B) Structure of the pre-ovulatory follicle, including oocyte and 
somatic cell components (C) The hypothalamic-pituitary-ovarian axis and effects on the 
oestrous cycle. During pro-oestrus, FSH released from the anterior pituitary in response to 
hypothalamus-secreted GnRH promotes follicle development in the ovary, which in turn 
produces oestradiol acting as a negative feedback to GnRH at low level and positive feedback 
to GnRH when oestradiol level peaks. This also triggers the spike in LH production which 





1.1.1 The oocyte 
The most important cell in the ovary, and arguably the entire female body, is the female germ 
cell or oocyte, for it bears the genetic material required for the creation of the next generation. 
It is one of the largest cells in the body and contains nutrients as well as other factors in support 
of its growth, maturation and development prior to embryo implantation. 
 
Oocytes are created during oogenesis from primordial germ cells 1. This process involves the 
migration of germ cells to the genital ridge and the proliferation of these germ cells by mitosis 
in the foetal ovary.  In the developing ovary, unlike in testis, cell division is arrested early in 
prenatal development when the oocyte enters meiosis which is then arrested at the diplotene 
stage of the first meiotic prophase, as illustrated in Bury et al., 2016 2. During this arrested 
phase the oocyte still generates abundant mRNA that is required for later stages of oocyte 
maturation and early embryo development, during which the oocyte is transcriptionally quiet 
3. Meiotic arrest is sustained by the high level of cAMP in the oocyte, which is maintained by 
endogenous and exogenous cAMP production in the surrounding granulosa and cumulus cells 
4 and can last for up to 40 years in humans. Oocyte development is sporadically initiated in a 
small number of oocytes each day and the resumption of meiosis I in the oocyte is triggered by 
the LH surge 5. This involves the progression to meiosis II in oocyte, during which germinal 
vesicle breakdown (GVBD) and the formation of the first polar body also occur. By the time 
of ovulation, the oocyte is arrested at metaphase of the second meiotic division, a secondary 
arrest which is sustained until fertilisation triggers the extrusion of the second polar body and 
formation of the female pronucleus 6. 
1.1.2 Somatic cells 
In the ovary, each oocyte is normally packaged into a multicellular structure called the ovarian 
follicle in which the oocyte is enclosed in somatic cells (Figure 1.1B). At birth in humans or 
shortly after birth in mice, oocytes are contained within primordial follicles in which oocytes 
are surrounded by a layer of flat un-differentiated pre-granulosa cells, the differentiation of 
which produces granulosa cells that proliferate rapidly 7. Concurrently, the follicle grows, the 
oocyte increases in size and an additional layer of cells known as theca cells are recruited and 
differentiated from the ovarian stromal compartment. Within the peri-ovulatory follicle, 
granulosa cells can be categorised as either cumulus cells, which are immediately surrounding 




wall (hence the term mural) of the follicle. While both cell types share the same origin, each is 
under the control of different paracrine factors that result in different gene expression profiles 
as well as ovarian functions that are disparate essential roles in ovulation 8. 
 
Granulosa cells start out as progenitor somatic cells that are recruited to surround the oocyte 
during early follicle formation in the first 4 days postnatal in the mouse 9. These cells are  
derived from either the mesonephros or the ovarian cortex 1. During the early stage of follicle 
development, granulosa cells display morphological changes and turn more cuboidal 10. This 
is followed by proliferation, resulting in multiple layers of granulosa cells which is then defined 
as the secondary follicle stage. The divergence of granulosa-cumulus cell specification occurs 
in the third stage, where the fluid-filled space known as the antrum is formed within the follicle, 
creating a physical separation between cumulus cells and mural granulosa cells. During 
folliculogenesis and ovulation, the two granulosa cell lineages have shared as well as distinct 
functions. Granulosa cells are responsible for the production of oestradiol and progesterone in 
response to follicle-stimulation hormone (FSH) and luteinising hormone (LH) signalling 11. 
Cumulus cells, on the other hand, are essential for supplying the oocyte with nutrients and 
signalling molecules via specialised gap junctions, thereby promoting oocyte growth and 
developmental competence 10. During ovulation, cumulus expansion, a process of rapid 
extensive extracellular matrix production, is important for ovulation. These two somatic cell 
lineages are also important in maintaining meiotic I arrest in oocytes prior to the LH surge 
through sustaining the cAMP build-up within the oocyte 4. 
 
Throughout all stages of development, the oocyte and somatic cells maintain interaction 
through a network of paracrine factors which is vital for follicular development, oocyte 
maturation and ovulation. The most important oocyte signalling factors are members of the 
TGFβ family, notably GDF9 and BMP15, which work in synergy to promote cumulus-specific 
gene expression, including genes controlling metabolic pathways and cumulus expansion 12. 
Knockout (KO) mouse models of these factors show compromised ovarian functions, including 
developmental arrest at the primary follicle stage (GDF9 KO), impaired ovulation and 
fertilisation (BMP15 KO or double GDF9/BMP15 KO) 10. Reciprocally, somatic-secreted 
factors are also vital for oocyte functions, especially oocyte maturation 4. Prior to the LH surge, 
cGMP and cAMP synthesised in granulosa and cumulus cells are diffused into the oocyte via 
gap junctions where they maintain high cAMP concentration, which inactivates oocyte 




epidermal growth factor-like (EGF-like) factors including amphiregulin (AREG), epiregulin 
(EREG) and BTC are produced by granulosa cells through various signalling pathways and 
inhibits the production of cGMP and cAMP. The resulting drop in cAMP in the oocyte releases 
the block on meiotic progression, ultimately resulting in GVBD and oocytes completing the 
final stage of maturation. 
 
Aside from granulosa cells, theca cells also support oocyte development principally through 
steroidogenesis. During follicle development, progenitor theca cells are recruited to the 
external side of the follicle basement membrane, upon which these cells differentiate and 
proliferate, resulting in the theca layer surrounding the externa of the follicle. During 
folliculogenesis, LH-responsive theca cells produce androgens, which are then taken up by 
granulosa cells as the precursor for oestradiol and progesterone synthesis 1. The production of 
oestradiol in the ovary is thus dependent on granulosa cells and theca cells (the two-cell two-
gonadotrophin model) and is illustrated in Patel et al., 2015 13. 
1.1.3 The oestrous cycle 
The oestrous cycle (or menstrual cycle in human) is under the control of the hypothalamic-
pituitary-ovarian axis. This involves the stringent cross-control of reproductive hormones 
produced at these organs in a dose-dependent manner, which leads to distinct ovarian functions 
at different time points, such as folliculogenesis, oocyte maturation, ovulation and CL 
formation. The coordination of these processes is critical for fertilisation and pregnancy 
success. A schematic of the cycling hormone pathways in the female reproductive cycle is 
shown in Figure 1.1C.  
 
Gonadotropin-releasing hormone (GnRH) neurons in the hypothalamus secretes GnRH in a 
pulsative manner under the influence of other reproductive hormones 14. In turn, circulating 
GnRH stimulates the release of two pituitary hormones, FSH and LH, from gonadotropic cells 
in the anterior pituitary. Such hormone productions are dependent on the frequency of the 
GnRH pulse, with FSH being continuously released whereas LH production is rapidly induced 
by the GnRH surge and thus contributes to differences in the effect of FSH and LH on granulosa 
and theca cells in the ovary. Specifically, prior to the ovulation-inducing LH surge, FSH is the 
main factor to influence ovarian functions through the activation of protein kinase pathways in 




pituitary hormone signalling, the ovary, itself an endocrine organ, produces oestradiol and 
inhibins to regulate GnRH, FSH and LH in feedback loops. Prior to the LH surge, oestradiol 
synthesis in granulosa cells is directly triggered by FSH 14. Similarly, FSH also promotes the 
expression of inhibin A and inhibin B 16. As granulosa cells lack the receptor for LH (LHR) at 
this point, circulating LH indirectly promotes granulosa oestradiol synthesis through inducing 
androgen production in LHR-expressed theca cells which is then converted into oestradiol in 
granulosa cells. The resultant oestradiol and inhibin act in a negative feedback loop on the 
hypothalamus to regulate GnRH and consequentially LH production, while at the same time 
promotes the expression of LHR on the surface of granulosa cell, making them LH-responsive. 
Eventually, the build-up of ovarian oestradiol production switches on the positive feedback 
loop that promotes GnRH secretion, which acts on the pituitary to induce LH production (LH 
surge). Consequently, this leads to various parallel events culminating in the release of the 
mature oocyte into the oviduct, or ovulation. 
 
1.2 OVULATION 
The events of ovulation begin with the LH surge originating from the pituitary gland as a result 
of oestradiol production by the ovary, which acts to increase GnRH expression in the 
hypothalamus and sensitise the pituitary to GnRH action. Together these processes lead to the 
rising release of LH culminating in the LH surge. This results in a number of physiological 
responses in the ovary in preparation for the release of the mature oocyte into the oviduct and 
potential fertilisation, embryo development and implantation, as illustrated in Russell & 
Robker, 2019 17. In the ovary, a multifaceted interplay between different components of the 
pre-ovulatory follicle has to be coordinated as meiotic resumption in oocyte and preparation 
for follicle rupture are initiated following the LH surge. The result is the release of the mature 
oocyte into the oviduct, where further oocyte development and fertilisation can occur, as well 
as the formation of the CL which maintains progesterone production during pregnancy. 
1.2.1 Molecular regulation of ovulation 
1.2.1.1 The LH-induced signalling cascade 
A signalling cascade begins with the LH surge in the ovary (Figure 1.2). LH binding to 
membrane LHR on granulosa and theca cells leads to the activation of the G-protein coupled 




second messenger that activates protein kinase A (PKA). The LH surge also leads to the 
activation of the Serine/Threonine Kinase 1 / 2 (ERK1/2) signalling pathway 18. The disruption 
of any of these components is detrimental to ovulation, as shown in various KO models in 
which the elimination of LHR, PKA or ERK1/2 results in the complete abolition of LH effect 
on oocyte maturation, cumulus-oocyte complex (COC) expansion, ovulation and luteinisation 
19,20. A number of transcription factors are subsequently induced by this pathway, including 
CBP-CITED4 and CEBPβ, which act as master transcription factors in regulating downstream 
processes 21,22. Notable among the genes responding to LH is PGR, a key ovulatory 
transcription factor that by its own merit is responsible for the expression of various ovarian 
functions, including tissue remodelling, muscle contraction and steroidogenesis, all of which 
are vital for ovulation 23. Details on the role of PGR in ovulation as well as other reproductive 
functions are discussed in detail in section 1.3. At the same time, LHR-associated 
phospholipase C (PLC) is also activated which in turn activates other protein kinases, such as 
PKB and PKC 4, that has also been linked to the induction of downstream transcription factors 
crucial for the regulation of ovulatory genes, namely PGR 24 and JUN/FOS transcription factors 
25. 
1.2.1.2 Key master transcription factors 
A consequence of the LH surge is the activation of a number transcriptional pathways through 
different signalling cascades. These are activated in parallel to each other with considerable 
convergence in target genes. Throughout the peri-ovulatory window myriads of transcription 
factors are initiated and are crucial for the regulation of various biological responses to the LH 
surge, ultimately leading to ovulation. The majority of these transcription factors are 
downstream of three known master transcription factors: cAMP Response Element-Binding 
Protein (CREB), CCAAT-enhancer-binding proteins β (CEBPβ) and CREB-Binding Protein 
(CBP)-CITED4. Discussed below are these key transcription factors and their importance in 
the regulation of downstream ovulatory processes, with a focus on studies in mice where most 
research has been done: 
(a) CREB 
CREB is one of the first transcription factors to be activated by the LH surge and plays a vital 
role in transcriptional regulation during ovulation. In granulosa cells, CREB phosphorylation 




activation leads to defects in reproduction, as shown in a transgenic mouse model with a 
mutation in CREB phosphorylation site that renders it inactive 27. Female mice with this 
mutation are subfertile due to the disruption of the oestrous cycle, especially affecting LH 
peaking, suggesting a role of CREB in the positive feedback loop responsible for sustaining 
LH production. CREB also regulates the expression of a suite of downstream target genes that 
are important in various biological events in granulosa cells, including steroidogenesis (StAR 
28, Inhba 29), COC expansion (EGF-like factors 26 and Egf1 30) and circadian clock (Per1 31). 
Importantly, CREB is also involved in the regulation of other transcription factors that are LH-
induced such as c-FOS 32, a member of the JUN/FOS family also with diverse roles in ovulation 
(reviewed in section 1.3.7.3). Another important role of CREB is in the regulation of 
prostaglandin-endoperoxide synthase 2 (PTGS2) and prostaglandin E2 (PGE2) which are 
inflammatory factors important for COC expansion and ovulation 33. The activity of CREB in 
gene regulation often requires interaction with other transcription factors, such as SF-1 in 
regulating Giot1 and Cyp19 34, SP1/SP3 in the expression of Ctsl 35 and CBP/p300 in regulating 
Inhba 29. 
(b) CEBPβ 
CEBPβ, together with CEBPα, are two transcription factors that are induced by LH through 
the PKA/ERK1/2 pathway in granulosa cells, as shown through a lack of CEBPα/β expression 
in ERK1/2 KO mice 22. Both proteins are expressed in granulosa and cumulus cells of antral 
follicles and are highly upregulated in granulosa cells by 4-8 h after stimulation with human 
chorionic gonadotropin (hCG). Not only are CEBPα/β induced by the LH surge, it has been 
shown that the expression of CEBPα/β in human breast cancer cell is also influenced by the 
PGR agonist R5020 and interestingly, an interaction between PGR and CEBPα/β has been 
described in progestin-treated breast cancer cell line, suggesting potential mutual actions 
between these two transcription factors in peri-ovulatory granulosa cells 36. However, while 
there is a regression of CEBPα expression in post-ovulatory granulosa cells, CEBPβ level 
remains high in the luteal phase and may also contribute to CL function 22.  
 
In granulosa cells, the role of CEBPβ is deemed more important than CEBPα in ovulatory 
processes, as shown through granulosa-specific single KO models of either CEBPα or CEBPβ 
22. CEBPα KO female mice display no abnormal reproductive phenotypes; however, the 




complete sterility. This indicates that while CEBPβ is the more prominently functional 
transcription factor in granulosa cells, CEBPα does have additional roles on granulosa 
functions. In these mice, while there are no defects observed in oocyte maturation, there is a 
loss of cumulus cell integrity and a lack of vascularisation, follicle rupture and luteal formation. 
As one of the first transcription factors to be initiated by the LH surge, CEBPβ is involved in 
a number of biological events in granulosa cells in preparation for ovulation and luteinisation 
through regulating the expression of luteal cell genes (Abcb1b, Prlr, StAR, Bhmt) and genes 
involved in vascularisation (Apln) and COC expansion (Has2). Interestingly, other ovulatory 
transcription factors, such as Runx2, is also found to be regulated by CEBPβ in granulosa cells, 
illustrating the role of CEBPβ as an upstream regulator of the subsequent transcriptional 
cascade in response to the LH surge.  
(c) CBP/p300-CITED4 
CBP/p300 refers to the CBP/p300 coactivator family composed of two members, CBP and 
p300, with similar protein structures and functions. While the nomenclature for these two 
proteins are often used interchangeably or in combination, CBP and p300 in fact possess unique 
acetylation properties 37. However, due to the ambiguous nature of publications on CBP/p300, 
here the term CBP/p300 is used to address both proteins. CBP/p300 is a generic transcription 
modulator that regulates gene expression through various means. CBP/p300 possesses histone 
acetyltransferase (HAT) enzymatic activity and can act on different classes of histones, 
including H2A, H2B, H3 and H4, as well as other transcriptional activators such as steroid 
receptor coactivator (SRC) proteins which themselves have additional HAT activity 38. 
CBP/p300 does not possess a DNA binding domain (DBD) and cannot directly interact with 
DNA, instead it is tethered to specific target sites through interactions with other transcription 
factors. In breast cancer, the recruitment of CBP/p300 and other HAT proteins to target 
chromatin sites is driven by PGR, which subsequently leads to histone/protein acetylation and 
thereby creates open chromatin regions to which RNA Polymerase II (Pol II) and the basal 
transcriptional machinery bind in preparation for transcription 39. Additionally, CBP/p300 can 
also facilitate transcriptional elongation by Pol II beyond the first nucleosome and the TSS 40. 
 
CBP/p300 plays a role in various aspects of ovarian functions, including pre- and post-LH 
roles. In granulosa cells, CBP/p300 is involved in the ERK1/2 signalling pathway activated in 




conjunction with its binding partner CITED4, is responsible for the transcriptional regulation 
of extracellular matrix genes that are critical for cumulus expansion, such as Has2, Ptx3 and 
Tnfaip6 17. CBP/p300 also acts in conjunction with other co-factors in steroidogenesis, 
including CEBPβ and GATA4 with implications in the regulation of StAR 41 and with 
Specificity Protein 1 (SP1) in regulating Cyp11a1 expression 42. CBP/p300 also plays a role in 
follicular growth in which it is involved in the nuclear receptor subfamily 5 group A (NR5A) 








Figure 1.2 Molecular pathways in the peri-ovulatory follicle before and after the LH 
surge. 
Before the LH surge occurs, NPPC-triggered cGMP and cAMP production in granulosa and 
cumulus cells leads to the inhibition of PDE3A and a build-up of cAMP level in the oocyte, 
which maintains high cAMP concentration and thus meiotic arrest in the oocyte. Upon the LH 
surge, cAMP/PKA/ERK1/2 and other protein kinase signalling pathways are activated in 
granulosa and cumulus cells, which lead to the induction of various transcription factors (CBP-
CITED4, CEBPβ, CREB, etc.). Subsequently, downstream target genes are upregulated and 
have roles in COC expansion, steroidogenesis, muscle contraction, inflammation and tissue 
remodelling in the follicle. EGF-like factors produced from these pathways also block the 
production of cGMP and cAMP in somatic cells and promote the degradation of cAMP in the 







1.2.1.3 The role of non-coding RNA 
Previously regarded as ‘junk RNA’ due to the lack of an encoded protein sequence and their 
low level of expression, within the past two decades studies demonstrating the roles of non-
coding RNA (ncRNA) in gene regulation have exploded with the development of modern 
transcriptomic techniques that allow for detailed dissection of low-abundant ncRNA. These 
include short ncRNA like micro RNA (miRNA), which bind complementary mRNA sequence 
and facilitate mRNA degradation, thereby acting as a post-transcriptional suppressor 44; as well 
as long non-coding (lncRNA), which can interact with various protein, DNA and RNA targets 
and have extensive roles in protein modification, transcriptional and translational regulation 45. 
One of the first discovered lncRNA, Steroid receptor RNA Activator (Sra1), is a classic 
example of a ncRNA that forms complexes with the transcriptional machinery including steroid 
receptors and is discussed in more detail in section 1.3.7.3. These ncRNA have now been linked 
to diverse roles which are just beginning to be unravelled in the context of reproduction and 
particularly in ovulation.  
 
Studies on the ovarian transcriptome using different methods have indicated a number of 
ncRNA that are associated with poor oocyte development and pregnancy outcome 46-48, with 
different lncRNA profiles associated to different follicular components 49. In contrast, other 
lncRNA play a supportive role in female reproduction, such as promoting ovulation 50 and 
luteinisation of granulosa cells after ovulation 51. Of particular interest is Gas5, a lncRNA that 
is induced in stress or nutrient deprivation conditions through the inhibition of the mTOR 
pathway 52. Recently Gas5 has been highlighted as a suppressor of glucocorticoid receptor 
(GR) transactivation functions, achieved through the RNA hairpin structure of the Gas5 exon 
11-12 that competes with the canonical DNA target of GR in binding the GR DBD 53. Similarly, 
Gas5 can also regulate other steroid receptors (SR), including PGR, androgen receptor (AR) 
and mineralocorticoid receptor (MR), although the impact of such interactions has not been 
studied in detail. Gas5 is present in various parts of the ovary, including granulosa cells at 
various stages of follicle development 54, cumulus cells in associating with pregnancy outcomes 
55 as well as COCs in response to lipotoxic conditions (Russell lab, unpublished observation), 
which suggests potential roles of Gas5 in oocyte maturation and possibly in response to stress.   
 
Not only are lncRNA involved in ovarian functions but the presence of specific miRNA is also 




through a reproductive tissue-specific KO mouse model that targets DICER, the enzyme 
required for miRNA biogenesis 57. Female DICER KO mice display multiple reproductive 
defects, including impaired ovulation, decreased oocyte and embryo integrity and defective 
development of the Müllerian duct, ultimately resulting in sterility. In particular, oocyte-
specific DICER KO leads to abnormal chromosomal and spindle morphologies, cell 
fragmentation and defective cell division. In granulosa cells, the expression of a specific subset 
of miRNA is regulated by the LH surge and studies on an alternative KO model conclude that 
steroidogenesis and luteal vascularisation are abrogated when miRNA/siRNA biogenesis is 
abolished. The efficacy of LH action in granulosa cells can also be modulated by miRNA, such 
as miRNA-200b and miRNA-429, which promote the expression of LHR 58. While miRNA can 
theoretically target multiple mRNA sequences, miRNA activities in the ovary are highly 
specialised, with specific miRNA having discreet roles at its cellular targets. In granulosa cells, 
for instance, miRNA-224 and miRNA-383 are involved in various granulosa functions, 
including cell proliferation, differentiation and steroidogenesis; whereas in the COC, miRNA-
224 is involved in COC expansion 59. Other short ncRNA, such as endogenous siRNA, may 
also play a role in oocyte development 57. 
 
In general, while there is an association between ncRNA and reproductive outcomes, exactly 
what is entailed in such reproductive functions is still largely unknown, especially regarding 
the impact of these ncRNA on ovulatory factors in granulosa cells and transcription factors in 
particular. While post-transcriptional regulatory action of miRNA is relatively well-described, 
the activities of lncRNA are much more convoluted, as ncRNA can partake in various 
molecular mechanisms. Further investigations into the roles of miRNA and lncRNA will be 
beneficial in understanding the complex interplay between different protein and ribonucleotide 
factors in the regulation of ovulation. 
1.2.2 Physiological aspects of ovulation 
1.2.2.1 COC expansion and oocyte functions  
COC activation refers to the meiotic resumption of oocyte and modifications in cumulus gene 
expression and the accompanying cumulus layers in peri-ovulatory follicles in prompt response 
to the LH surge. This response in the COC is initiated by EGF-like factors secreted from 
granulosa cells after the LH-surge. A number of important processes and physiological changes 




the first polar body and the second meiotic arrest at MII stage. At the same time, the 
surrounding cumulus cell layers expand and increase in mass as well as gaining additional 
migratory and invasive properties which are necessary for ovulation.  
 
The expansion of the COC matrix is the result of the production and accumulation of 
hyaluronan (HA), a vital component of the extracellular matrix, around cumulus cells 60. The 
synthesis of HA requires the induction of the Has2 gene which is regulated by FSH and 
prostaglandins as well as EGF-like factors 61,62. Other specific extracellular matrix proteins also 
interact with HA, including IαI, which infiltrates the follicle from serum at the time of ovulation 
and aides in the organisation of the COC matrix; TNFAIP6 and PTX3, which form a complex 
that promotes HA-IαI binding 63,64. Another important factor is versican, a proteoglycan 
produced by granulosa cells which is cleaved by ADAM metallopeptidase with 
thrombospondin type 1 motif 1 (ADAMTS1) and plays a role in the COC extracellular matrix 
through HA binding 65. The disruption of these proteins can have detrimental effects on 
extracellular matrix formation and ovulation. For instance, ADAMTS1 KO female mice exhibit 
defective tissue remodelling and vascularisation, altered COC matrix and are overall subfertile 
66. The ablation of TNFAIP6 and PTX3 also results in impaired COC matrix formation and 
sterility in female mice 67. 
 
As cumulus cells and oocytes do not express LHR, COC expansion is initiated by paracrine 
factors that are produced in granulosa cells in response to LH signalling 68. Most important 
among these are EGF-like factors, including AREG, EREG and BTC which are downstream 
of a number of factors including PTGS2/PGE2 69 and PGR 23 that are themselves upregulated 
by the LH-induced PKA/CREB signalling pathway. After protein synthesis, these factors 
diffuse to cumulus cells in which they suppress further production of cGMP and cAMP, 
resulting a decline in cAMP build-up in the oocyte and ultimately triggering meiotic 
resumption 4. KO mouse models of AREG and EREG show a reduction in COC activation, 
with double KO of both AREG and EREG having an accumulative effect 62. Such phenotype 
is also displayed in rats treated with an inhibitor for EGFR, the shared receptor for these factors 
70. However, in each of these cases GVBD is not completely eliminated, suggesting a level of 
redundancy among EGF-like factors as well as the importance of other factors in initiating 
oocyte maturation. The interaction between oocyte and its surrounding somatic cells is not 
unidirectional as oocyte can also reciprocally signal to cumulus cells through specific proteins. 




for the cumulus activation response 71. This highlights the importance of cell-cell 
communication in the ovulation process, not only between somatic cells but also between 
somatic cells and the oocyte. 
1.2.2.2 Tissue remodelling 
Follicle rupture, in which the mature oocyte is released from the peri-ovulatory follicle into the 
oviduct at the follicle apex, is the most important event during ovulation. For this to occur, the 
physical cellular barrier of the follicle, composed of granulosa cells, the follicular basal 
membrane, theca layers and the ovarian surface epithelium needs to be thinned and broken 
down. A number of events happen concurrently during this tissue remodelling process which 
involves the apoptosis of surface epithelial cells, the proteolytic degradation of extracellular 
matrix layers and the basement membrane, the involvement of immune cells, the migration of 
theca cells from the apex, neovascularisation and luteinisation of granulosa cells.  
 
First to undergo degradation during the peri-ovulatory window is the follicular basement 
membrane, which is composed of extracellular matrix substrates including collagen, laminin 
and proteoglycans. These degradation process has been ascribed to the action of a number of 
proteolytic enzymes, included in which are matrix metalloproteases (MMP) with collagenase 
properties. Among the many members of this family, MMP1, MMP2 and MMP9 are the most 
involved in ovulation. MMP1 is localised to the apex of the follicle during ovulation with 
increasing concentration 72. At the same time, MMP2 and MMP9 are also increased in 
granulosa cells and theca cells, respectively, the activity of which leads to the degradation of 
collagen at the site of follicle rupture 73. Other MMP proteins are also associated with ovulation, 
including MMP14, MMP16 74 and MMP19 75, although their roles are less well-known. MMP 
proteins are regulated by inhibitory proteins (TIMP), which are also expressed in the ovary 
during ovulation, indicating that a fine balance between MMP and TIMP needs to be achieved 
to fine-tune MMP protease activity 73. Other proteases also contribute to the degradation 
process, such as plasmin and plasminogen activators 76, ADAMTS1 66 and cathepsin L 77. 
Proteolysis is also required for activating EGF-like factors through cleaving of their precursors, 
thus making it necessary for COC expansion and for coordinating different biological processes 





Another contributor to the proteolytic activities in the ovary are immune cells, which infiltrate 
the ovary as part of the inflammatory response triggered by ovulatory cues. Leukocytes release 
additional chemokines and cytokines to further recruit other immune cells to the site and 
eventually resulting in the release of proteases by the built-up leukocyte population 79. 
Macrophages are the main leukocytes to be recruited to the ovary 80, but other immune cells 
such as neutrophils and T-lymphocytes are also recruited to the theca and medulla layers of the 
ovary, the inhibition which can result in ovulation failure 81. Important leukocyte-secreted 
factors include nitric oxide and reactive oxygen species which likely mediate vasoconstriction, 
circulating leukocyte attraction and prostaglandin production 82. Conversely, granulosa and 
cumulus cells can themselves produce immune factors. These include interleukin 6 (IL6), 
which has a role in COC expansion 83; LIF and its receptor which act in support of IL6 in 
promoting ovulation 84 and TLR2/4, which promote sperm capacitation and fertilisation in the 
oviduct 85. 
 
Another important part of the tissue remodelling process is the generation of new vasculature 
around the peri-ovulatory follicle, which is necessary for the formation of the CL from the 
ovulated follicle by providing nutrients and hormones to the developing CL 86. The 
angiogenesis process in granulosa cells requires the expression of vascular endothelial growth 
factor (VEGF), which is expressed in granulosa and theca cells, as well as luteal cells post-
ovulation 87. The expression of VEGF is reliant on progesterone, as shown by downregulation 
of VEGF in sows treated with the PGR antagonist RU486 86. In turn, the proper development 
of follicular vascularity is important for luteal blood flow and progesterone production 88. 
Disruption of VEGF in macaque monkeys leads to abnormal ovarian functions, particularly 
abnormal oestrous cycle length due to dysregulation of steroidogenesis 88. Another important 
mitogen factor is FGF2, which is associated with hypoxia-inducible factor 1 subunit alpha 
(HIF1α) in early-phase CL and the suppression of FGF2 results in luteal deficiency 89.  
1.2.2.3 Vasoconstriction and muscular contraction 
During ovulation, it is essential that follicle rupture happens at the apex of the follicle to allow 
for the release of the oocyte into the oviduct. Apart from proteolytic enzymatic actions, 
precisely-timed muscle contraction as well as vasocontraction at the apex are also required for 
this to occur 90. The key factor for contraction during ovulation are endothelin proteins, 




ovulation 90. EDN2 is regulated by PGR, as shown in a lack of EDN2 expression in PGRKO 
mice 91, which is likely through the activity of intermediary transcription factors HIF 92 and 
peroxisome proliferator activated receptor gamma (PPARγ) 93. EDN2 KO mouse models that 
are specific to the ovary or granulosa cells have confirmed the importance of EDN2 in 
ovulation, with KO female mice displaying impaired follicle rupture and fertility 94. It has been 
shown that EDN2 is responsible for ovarian follicular contraction as well as vasodilation, with 
contraction of ovarian tissues triggered by treatment with EDN2; vice versa, blocking 
endothelin using antagonists leads to anovulation 90,91,95. Other factors, such as prostaglandins, 
are also involved in determining the spatial orientation of follicle rupture, as shown in treatment 
with prostaglandin inhibitor in rats that leads to spatially random ruptured follicles 96.  
1.2.3 Dysregulation of ovulation and targets for contraception 
It is clear that the success of reproduction is dependent on ovulation, which is itself under the 
strict modulation of endocrine and ovarian paracrine network. Irregularities in this process can 
lead to anovulation and infertility in women. Ovulation disorders are one of the leading causes 
of infertility, accounting for 25% of cases 97. The most clinically relevant disorders for 
anovulation are in polycystic ovarian syndrome (PCOS) and obesity. PCOS, characterised by 
aberrant androgen production and hyperinsulinemia, is highly associated with anovulation, 
resulting in a 70-80% infertility rate in PCOS women 98. The mechanisms under which PCOS 
can affect ovulation is still largely unclear; but it is likely that multiple factors, including 
dysregulation of neuroendocrine 99 and metabolic 100 pathways, that lead to abnormalities in 
reproductive functions ranging from folliculogenesis to ovulation. Evidences have also 
indicated a link between high BMI and anovulatory infertility, with cases of insensitivity to 
gonadotropin also observed in obese infertility patients 101. Genetic mouse models and diet 
studies have shown that obesity has an effect on folliculogenesis, ovulation 102, embryo 103 and 
foetal development potential 104,105. Multiple factors are likely to contribute to the effect of 
obesity on anovulation. This includes mitochondria dysfunction, metabolic stress and 
lipotoxic-induced apoptosis 106. A conclusion on the exact mechanisms is still under 
investigation. 
 
On the other hand, a further understanding in the regulatory mechanisms of ovulation can also 
allow for finely tuned control of the ovulation process, a key goal of female contraception. The 




which act to blunt gonadotropin secretion through artificially elevated progestin level, thus 
maintaining low FSH and LH levels and preventing follicle development and ovulation 107. 
However, as such therapies are based on the disruption of essential hormones that are involved 
in diverse biological processes throughout the body, considerations need to be given to 
potential side effects. The evidence for many undesirable effects of progestin contraception has 
been obtained in subsequent observations and studies, these include thromboembolism, breast 
and uterine cancer risks and depression. Currently-used oral contraceptives have existed since 
the 1960s with unfortunately little genuine change in the technology since its implementation; 
clearly, the improvement of the current technology and the development of alternative 
contraceptive means are vital. However, the advancement of such methods is constrained by 
our limited understanding on the specific mechanisms of ovulation in which a multitude of 
ovulatory factors are required, many of which are also prominent in other tissues, most 
importantly PGR and oestrogen receptor (ER). The fact that these transcription factors are able 
to modulate different molecular targets and biological processes in different tissue contexts 
points to distinct tissue-specific molecular mechanisms at play, however such distinction 
between their ovarian functions and other tissue types have not been examined in detail. A 
deeper understanding in the precise mechanisms at play will be vital in the development of 
novel contraceptives specifically targeting ovulation. 
 
1.3 PROGESTERONE RECEPTOR 
Progesterone, together with other hormones including androgens and oestradiol, belongs to a 
group of sex steroids that has shown profound importance in the regulation and maintenance 
of the normal reproductive physiology. Traditionally referred to as ‘pregnancy hormone’, in 
the last twenty years evidence has shown that progesterone is more involved in the regulation 
of female reproductive potential than initially assumed. The main mode of action of 
progesterone is through its nuclear transcription factor receptor PGR, which is present in the 
uterus, oviduct, and mammary gland. Most importantly, PGR is expressed in the ovary and has 
major roles in ovulation. 
1.3.1 PGR structure 
PGR belongs to the nuclear receptor subfamily 3 group C (NR3C) and is encoded by the PGR 




domains in PGR, with exon 2 to 8 being fundamental to PGR structure and functions, while 
transcription from different promoters gives rise to various transcript variants 108. There are 
also G/C rich regions embedded within the promoter of PGR which have been characterised as 
SP1/SP3 binding sites and shown to be crucial in PGR transcriptional regulation 109,110. 
 
The receptor structure in general is made up of four distinctive domains 111 (Figure 1.3). The 
DBD, which is highly conserved between species, is located in the centre of the molecule and 
comprises two zinc finger elements that facilitate receptor binding to the canonical DNA motif 
PGR response element (PRE/NR3C), the consensus sequence of which is 5’-
GTTACAAACTGTTCT-3’, but most importantly, must contain the palindrome ACAnnnTGT. 
Located at the C-terminal of the receptor is the ligand binding domain (LBD) which interacts 
with ligands, such as progesterone and R5020, and supports dimerisation of two PGR units. 
This region is also known as ligand-dependent transactivation function-2 (AF-2) domain. Also 
aiding transactivation is a short variable hinge region between the LBD and DBD which is 
important in stabilising the association between the inactive receptor and the heat shock protein 
complex as well as the bidirectional shuttling of ligand-bound PGR in and out of the nucleus 
112. The most variable region of the receptor is the N-terminal region, which contains additional 
ligand-independent AF-1 and AF-3 and is critical in the specificity of PGR activity 113. An 
inhibitory function (IF) domain is also located in the N-terminus between AF-3 and AF-1 and 
is important for suppressing PGR activities through blocking the transactivation function of 
AF-1 and AF-2 114,115. The PGR protein also includes an IKEE sequence in the N-terminal that 
is targeted by SUMO-1 for sumoylating modifications and is important for PGR auto-
inhibition. 
 
Translation from alternative start sites results in two main ligand-binding PGR isoforms, 
termed PGR-A and PGR-B 116. PGR-B is the full-length isoform that possesses an additional 
164 amino acid in the N terminus (and thus the AF-3 domain). This addition to the 
transactivation region of the B isoform is critical in mediating the specificity in progesterone 
regulatory function by allowing PGR-B to bind to exclusive co-activators. This also grants 
PGR-B the unique ability to evade the inactivation effect by antagonists (RU486 and 
ZK112993) through sumoylation mechanism 114. PGR-A, the other main isoform of PGR, lacks 
the first 164 amino acids seen in the B-isoform, thus has weaker transactivation properties than 
PGR-B and is unable to form AF-3 specific interactions with co-regulators 117. However, PGR-




tissues and can act as a trans-repressor to PGR-B 118. Two other truncated isoforms, termed 
PGR-C and PGR-M, have also been identified. PGR-C, which has been identified in the uterus 
in different species, lacks one of the zinc fingers in the DBD but retains the full LDB. This 
renders the C-isoform incapable of binding DNA, however it can still interact with other PGR 
isoforms 119-121. Similarly in PGR-M, which has only been identified in humans and not mice, 
is transcribed from exon 4-8 of the human PGR gene, thus lacking the N-terminal and DBD 
122,123. Instead, it consists of the hinge and LBD capped with a 16-amino acid sequence encoded 







Figure 1.3 Structure of the PGR protein.  
The PGR protein is composed of different domains (from N- to C-terminus): NTD with 
transactivation properties and containing two AF regions (AF-3 and AF-1), DBD that binds 
DNA, hinge region that stabilises the PGR-HSP inactive complex and plays a role in PGR 
shuttling between cellular compartments, LBD which interacts with ligands and has a role in 
dimerisation of PGR monomers, also contains another transactivation function domain (AF-2). 
Transcription from different TSS leads to the formation of four functional isoforms: full-length 
PGR-B, PGR-A without the first 165 amino acid (and thus AF-3), PGR-C without the NTD 






1.3.2 PGR functions in the ovary 
In the rodent ovary, PGR is exclusively expressed in granulosa cells of peri-ovulatory follicles 
124,125. In granulosa cells of mice 125, human 126 and other species 127,128 PGR is transiently 
induced in mature follicles in response to the LH surge and declines during oestrous. The 
expression of PGR can also be induced by forskolin, cAMP or FSH treatment of cultured 
granulosa cells 129. PGR mRNA level reportedly peaks at 4 h post-LH treatment in vitro 130 and 
gradually declines within 24 h, which matches the pattern observed in vivo 131. PGR protein 
level is the highest at 5-7 h post-LH surge and there is a strong preference for the enrichment 
of isoform A compared to B.  
1.3.2.1 Studies on PGRKO mouse model 
Progesterone is a key factor in mammalian ovulation, especially in follicle rupture. It has been 
well-established that inhibition of progesterone by PGR antagonist R486 results in ovulation 
suppression in rodents 130,132 and humans 133 . Treatment with PGR antagonists also promotes 
apoptosis as well as DNA damage. Research on PGRKO mouse models has shed more light 
on the role of PGR in female reproduction. Homozygous female PGRKO mice are shown to 
be infertile when crossed with wild-type (WT) male mice 134. Subsequent histological 
assessment shows that in contrast to the typical characteristics of the WT ovary, the ovary of 
super-ovulated PGRKO mice contains a large number of unruptured mature follicles and an 
absence of CL. This PGRKO phenotype is preserved even when PGRKO ovary is grafted into 
WT females, while WT ovary transplanted into PGRKO mice still ovulates normally (Akison 
and Robker, unpublished data), demonstrating that anovulation in PGRKO mice is due to 
defects arising from the lack of PGR in the ovary and not other organs. Interestingly, the 
retained oocytes are still fully matured and capable of being fertilised and developing into 
normal pups 135. This result is supported by previous observations that PGR level is relatively 
low in cumulus cells and shows that the absence of PGR is important in follicular rupture but 
not for oocyte maturation. In addition, granulosa cells in these follicles are able to differentiate 
into a luteal phenotype with the P450ssc enzyme marker. Although the role of PGR in oocyte 
maturation has been disclaimed, other studies challenge this idea and show that PGR might be 
involved in oocyte development at least to some degree. There have been reports of PGRKO 
oocytes being less capable of undergoing maturation in mouse, assessed through the rate of 
germinal vesicle breakdown in pre-ovulatory follicles 136 as well as limited evidence in humans 




other hand, studies on bovine follicles are less conclusive. While inhibiting progesterone by 
the antagonist RU486 could improve blastocyst rate in bovine IVF in one study 138, others show 
that COCs treated with RU486 and trilostane have poorer embryo development 139.  
 
As stated above, the role of PGR in ovulation has also been confirmed in most vertebrate 
species. Of note is a PGRKO zebrafish model in which female KO fish also show oocyte 
entrapment in the ovary and infertility 140. Interestingly, analysis of the PGR-dependent 
transcriptome in this zebrafish model shows that in pre-ovulatory follicular cells PGR is 
responsible for the regulation of a number of genes 141, including Zbtb16, Runx1 and RUNX1-
regulated ovulatory genes (Ptgs2, Rgcc 142,143) . However, since there is no clear cumulus-
granulosa specification in fish follicles and the expression of PGR in piscine pre-ovulatory 
somatic-oocyte complex was not described, it is hard to determine whether PGR holds 
exclusive granulosa functions like in mammals. Still, the fact that PGRKO results in similar 
phenotype across different species indicates a high level of conservation in PGR function at 
this primary level of fertility control. 
1.3.2.2 Target genes of PGR in ovulation 
While PGR acts as a transcription factor through binding a consensus response element within 
the genome, in a range of cell types, the transcriptomic profile is very tissue-specific. In the 
ovary specifically, PGR has been linked to the regulation of a wide range of genes, some of 
which have been confirmed to be key factors in ovulation. For instance, Adamts1 is a PGR-
regulated gene in ovary and ADAMTS1 KO mice have a severely reduced rate of ovulation 
due to follicle rupture failure 66,144,145. Another group of proteins, endothelin, is also induced 
by PGR and is linked to ovulation in rodents 90,94. AREG and EREG, both being upregulated 
in the presence of PGR, play an important role in cumulus expansion and meiotic resumption 
in response to LH signal 61,62,70. PGR also supports granulosa cell survival by upregulating 
PCNA and downregulating caspase-3. Other genes, such as Ctsl, Pparg and Hif1a, are highly 
up-regulated by PGR and might be of importance in oocyte development 35,77,92,93. In other 
tissues, however, PGR affects very different sets of genes, suggesting that different key 




1.3.2.3 Isoform-specific roles of PGR in ovulation 
Both PGR-A and PGR-B are induced by LH stimulation in the pre-ovulatory follicle; however, 
the two isoforms do not have the same level of expression. In granulosa cells, the A:B ratio 
remains at 2:1 throughout the ovulatory cascade, suggesting that while both may have an effect 
on ovulation, the role might predominantly require the A isoform 125. Interestingly, this ratio 
differs in other tissues, which might help to explain the differences in the function of PGR 
between tissue types. PGR isoforms also have distinct temporal distribution in the ovary 132,146. 
While both isoforms are found in theca cells, granulosa cells and luteal cells, PGR-A is only 
found upon the LH surge and during CL formation, whereas PGR-B is found at all stages of 
development 146. The generation of KO mouse model targeting PGR-A and PGR-B separately 
allows for an opportunity to dissect the function of each isoform. PRAKO mice exhibit a 
similar anovulatory phenotype as total PGRKO mice, with gonadotropin-stimulated mice 
failing to ovulate, although the impairment is less complete than total PGRKO phenotype 147. 
In contrast, ovulation is normal in PRBKO mice undergoing the same treatment 148. 
Interestingly, it has also been shown that PGR-A has the ability to specifically repress PGR-B 
activity in the breast 114 and uterus 149, which further emphasises the importance of tissue 
specific A:B ratio and how that might affect PGR functions.  
 
It is clear that PGR plays an important role in the ovary; still, much is still unknown about the 
mechanism under which PGR itself is regulated, especially in the reproductive tract. 
Furthermore, PGR is responsible for the regulation of genes that are unique to the ovary, and 
while the PGR-regulated ovulatory gene profile has been identified, it is still unknown how 
PGR achieves tissue specificity and whether elements controlling the activity of PGR are 
involved in the process. The interaction between PGR and other coactivators has been 
addressed in previous studies; however, none has focused on characterising potential PGR 
partners in the ovary. Considering how differently PGR behaves between cell types, it is 
necessary to actively investigate the regulatory mechanism for PGR in the ovary. 
1.3.3 PGR functions in the oviduct 
In the oviduct, PGR is expressed mostly in the epithelial and muscle cells and is dependent on 
the oestrous cycle stage. It is generally constitutively expressed at high level until just prior to 
ovulation when there is a decline in PGR expression 125,150-153. This pattern of expression is 




expression of the two main PGR isoforms in a spatial manner has also been observed in the 
mouse oviduct, where PGR-A is found mostly in stromal cells and PGR-B in epithelial cells, 
with each isoform having a distinct pattern of expression through the oestrous cycle, indicating 
possible distinct functions in each cell type 146. PGR-C isoform has also been found in the 
bovine oviduct during the follicular phase, suggesting a specific role for the C-isoform 119. 
 
In rodents, carefully timed treatment with the PGR antagonists RU486 or ZK98734 during the 
period of embryo transport through the oviduct leads to premature embryo entrance into the 
uterus 154,155. This is the result of progesterone-modulated ciliary functions, shown in a reduced 
beat frequency in oviducal cilia in human Fallopian epithelial tissues 156. Thus, PGR is likely 
acting as a modulator to the transport of oocyte and embryo post-ovulation, likely to promote 
fertilisation and early embryo development in an intra-oviductal microenvironment, and also 
perhaps acting in favour of sexual selection by promoting sperm competition 157. While this is 
difficult to portray in vivo and the PGRKO mouse model shows no gross morphological 
difference between WT and KO animals, microarray analysis has identified a number of genes 
that are dependent on the expression of PGR in the oviduct, including known PGR-dependent 
genes such as Adamts1 and Zbtb16 152. Other genes that are associated with cell movement and 
migration were also identified, including Itga8, as well as genes important for muscle functions 
(Myocd, Des, Atgr2), oviductal epithelial cell secretion (Edn3) and embryo implantation (Prlr). 
However, since PGRKO females are anovulatory, it is unclear whether PGR deficiency in the 
oviduct has any physiological impact on fertilisation and embryo development. A tissue-
specific KO model will be required for further investigations.  
1.3.4 PGR functions in the uterus 
In the mouse and human uterus, PGR is expressed in the epithelial, stromal and muscle cells, 
and unlike in the ovary, PGR is constantly expressed regardless of the presence of progesterone 
125. Similar to the ovary, both of the main PGR isoforms are expressed in the uterus, with PGR-
A holding important reproductive functions and PGR-B being less critical for uterine functions 
147,148. The expression of PGR-A, but not PGR-B, is inducible by oestradiol treatment 147. 
PRAKO mice do not show the normal inhibition of proliferation of the uterine epithelium after 
progesterone treatment, indicating that the A-isoform is important for mediating differentiation 





PGR has profound roles in the uterus from the pre-implantation window up to parturition. The 
early impact of PGR on uterine preparation for pregnancy is shown in PGRKO mouse models. 
In total PGRKO female mice there is a lack of decidualisation in the uterus in response to 
artificial stimulation as well as a lack of proliferation inhibition in response to progesterone 
treatment 134. Analysis of the PGR cistrome in human endometrial stroma indicates that PGR 
chromatin binding is promoted in the presence of ligand 158. Further analyses of PGR-
dependent transcriptomes in mouse and human uterine tissues have identified various 
downstream targets, including GATA2, a transcription factor of import in embryo implantation 
159-161.  
 
During parturition, the onset of labour is signalled by a decrease in PGR activity through a 
drastic drop in progesterone level, which is observed in non-human animals 162. However, in 
human, circulating progesterone level remains elevated up to birth and rather than a systematic 
decline in progesterone level, uterine progesterone is metabolised at a local level, which leads 
to a decrease in ligand-dependent PGR activity and parturition induction 163. In rodents, 
artificial disruption of PGR activity through RU486 treatment is sufficient to initiate 
myometrial contraction and induce a labour state whereas progesterone treatment can prolong 
pregnancy. Progesterone withdrawal in the uterus is necessary to induce labour, which involves 
a change in PGR functions in response to progesterone. During this process, there is a shift in 
the expression dynamics of different PGR isoforms, with PGR-A known to be significantly 
upregulated in the uterine myometrium obtained from in-labour women, which dramatically 
increases the PGR-A:PGR-B ratio 149. PGR-C has also been reported to be upregulated in 
human myometrium during parturition 120. During labour, while PGR-B level remains 
unchanged, there is a significant induction of PGR-A, resulting in an increase in PGR-A:PGR-
B ratio 164. Oddly enough, in cultured human myometrial cells PGR-A is not reported to have 
transactivation functions in response to progesterone treatment, instead it is PGR-B that 
responds to progesterone treatment in reporter assays 164,165. However, PGR-A has a repressive 
action on PGR-B activity, as seen in a lack of progesterone-induced response in the reporter 
assay when PGR-A is present, indicating that PGR activities in the uterus are likely a result of 
PGR-A controlling PGR-B actions in a hormone-dependent manner. In myometrium, each 
isoform can have specific intracellular localisation that is reliant on the presence of ligands 163. 
In the presence of progesterone, PGR-A is found to translocate from the nucleus into the 
cytoplasm, whereas ligand-bound PGR-B shows a reversed shuttling direction. As 




loss of nuclear PGR-B activity might be proven important for labour. Current theories propose 
a shift in PGR isoform activation and action. In a pre-labour state, high systemic and local 
progesterone level promotes ligand-dependent PGR-B transactivation and trans-repression 
activities, most likely through the recruitment of transcriptional activator or repressor 
complexes to target genes. Upon progesterone withdrawal at term, PGR-A gains ligand-
independent nuclear functions and suppresses the activity of PGR-B, leading to an upregulation 
of contraction and inflammation genes that are required for the initiation of parturition 166,167. 
1.3.5 PGR functions in mammary tissues and other reproductive functions  
The interrelationship between PGR isoforms as well as distinct isoform functions have been 
extensively studied in the context of normal and cancerous mammary tissues, where each PGR 
isoform is involved in normal mammary development as well as cancer progression. Unlike in 
the female reproductive tract, PGR-B is of great importance in normal mammary development. 
Female mice that have ablated B-isoform show impaired ductal development as a result of 
reduced ductal sidebranching 148, which leads to decreased lactation. Conversely, excessive 
PGR-B expression leads to inappropriate alveolar growth 168. While PGR-A KO mice do not 
display mammary abnormalities, it has been shown to also play a role in the ductal 
development. A and B isoforms display distinctive temporal expression pattern in mouse 
mammary tissue, with PGR-A being the predominant form pre-pregnancy and PGR-B playing 
a major role in alveologenesis during pregnancy 169. Thus, the tight regulation of each isoform 
is crucial for normal mammary development and functions during puberty and pregnancy. In 
mammary tumour, such precise activities are disrupted with a leaning towards aberrant PGR-
A expression, which was shown in a transgenic mouse model where overexpression of the A 
isoform leads to ductal hyperplasia and loss of structural integrity, the hallmarks of cancer 
development 170. A shift in the otherwise 1:1 isoform ratio also results in poorer prognostic 
outcome in breast cancer patients 171.  
 
Within the cell, PGR isoforms also show different spatial expression patterns, with PGR-A 
mostly localised to the nucleus while PGR-B is shuttled between the cytoplasm and nucleus, 
suggesting that PGR-B has both nuclear and extra-nuclear functions in breast cancer cells 172. 
Such differences in compartmentalisation patterns between the two isoforms also allows for 
interaction with unique co-regulators and affects downstream gene expression. An example of 




independent manner, while at the same time a PRE-possessing gene, Sgk, is exclusively 
regulated by nuclear PGR-A 173. More broadly, PGR-A and PGR-B modulate specific 
transcriptomes in breast cancer in a ligand-dependent as well as ligand-independent manner 
171,174. It has been shown using T47D cells expressing either isoform that in the presence of 
ligands PGR-B has stronger transactivation functions than PGR-A, resulting in unique 
transcriptomes being regulated by each isoform 175. Such enhanced transactivation is ascribed 
to the extra AF-3 domain that is only present in the B isoform. Subsequent studies have also 
shown PGR-A to play a prominent trans-repressive role to PGR-B in the context of breast 
cancer through interaction with the PGR-B N-terminal IKEE sequence 114.  
 
While the literature on PGR in mammary tissue is extensive, there are fundamental differences 
in PGR characteristics in the breast versus the reproductive tract, not just in the predominant 
isoform but also in the temporal pattern of expression in response to reproductive markers 
(oestrous cycle and pregnancy). This makes PGR actions in these two contexts highly 
distinctive and it would be amiss to assume ovarian or uterine PGR mechanisms and actions to 
be the same as in mammary tissues, making it necessary to study the action of PGR in its 
appropriate contexts.  
1.3.6 PGR functions in other tissues and non-reproductive cancer 
While the majority of PGR function is in the female reproductive system, evidence has emerged 
for potential PGR roles in other organs. This includes cardiac mitochondrial functions, where 
the truncated PGR-M isoform has been identified to play a role 123. In mice, the Pgr gene lacks 
the distal intron 3 which encodes the unique amino acid sequence found in human PGR-M and 
is thus reported to not express PGR-M 176. To circumvent this, a transgenic mouse model that 
expresses human PGR-M exclusively in the heart has been generated for studies on PGR-M 
function. As the metabolic profile of these transgenic mice is not fully described, it is uncertain 
whether the presence of PGR-M (or lack thereof) is crucial for vital metabolic functions. 
However, an elevation in genes responsible for mitochondrial functions has been observed in 
this mouse model. Knockdown of PGR-M in T47D cells results in the repression of 
progesterone-induced promotion of mitochondrial membrane potential, whereas HeLa cells 
treated with R5020 show an increase in oxygen consumption and thus cellular respiration when 
transfected with PGR-M 123. PGR-M has also been found to interact with mitochondrial 




Introducing PGR-M through genome editing into a mouse model artificially prone to heart 
failure is shown to be protective of cardiac dysfunctions in male mice, indicating a possible 
sex-specific protective role of PGR-M in heart diseases 176.  
 
Steroid receptors play a big role in osteogenesis and have profound implications on bone-
related diseases. Among these, the role of ER have been extensively studied 177; however, 
increasing evidence has also pointed to a role for PGR. PGR is present in osteoblast cells in 
bones and increasing evidence has indicated a role of PGR in osteogenesis, as shown in various 
PGRKO mouse studies 178-180. In particular, PGR acts upon selective areas on the skeleton and 
results in an accumulation of bone mass, which together with oestradiol likely affects bone 
development during puberty in females and results in the sexual differences in bone mass and 
the higher risk of osteoporosis and other related diseases in females.  
 
PGR is expressed in different parts of the brain, including hypothalamus, hippocampus and 
synapses 181. Most notably, in the hypothalamus, PGR participates in the mediation of the 
feedback loop that regulates the oestrous cycle. The role of PGR in the hypothalamic-pituitary-
ovarian axis has been shown through a Kiss-cre PGRKO mouse model that specifically 
knockdown PGR in kisspeptin neurons 182. Female KO mice exhibit abnormal oestrous cycling 
and subfertility. There is reduced LH production in response to exogenous oestradiol 
stimulation and subsequently lower ovulation rate. This is likely a functional consequence to 
the cooperation between PGR, kisspeptin and ER-α, all of which are shown to colocalise in 
kisspeptin neurons. A role for PGR in the regulation of sexual behaviour has also been 
implicated in PGRKO female mice in which KO females fail to display the typical lordosis 
reflex in response to male mice 134. Isoform-specific knockout mouse models points to PGR-A 
having a more important role in sexual behaviours, both in the presence and absence of ligand 
183. Sexual dimorphism in PGR isoform-specific activities is also observed in different parts of 
the brain. In rats, there is a predominance of PGR-A as opposed to PGR-B that is observed in 
the hypothalamus, preoptic area, hippocampus and olfactory bulbs in females but not in males, 
which might have implications on gender-specific sexual behaviours, oxytocin receptor and 




1.3.7 Molecular mechanism of PGR action 
1.3.7.1 Ligand-dependent and -independent molecular mechanisms 
As a ligand-binding transcription factor, the main function of PGR involves regulating gene 
expression through direct DNA binding in a ligand-dependent manner (Figure 1.4). Newly 
translated PGR proteins reside in the cytoplasm in an inactive state that is maintained in the 
absence of ligands through interaction with heat shock proteins 185. However, when ligands are 
present, binding between ligand and PGR facilitates conformational change in PGR that leads 
to the release of PGR from the multiprotein complex, translocation of the ligand-bound PGR 
into the nucleus and dimerisation with other PGR units. The canonical pathway of PGR 
involves recruitment of the PGR dimer to the canonical PRE motif leading to the induction or 
repression of specific PGR-regulated genes depending on the interactions with co-activators or 
co-repressors. The influence of PGR is not only restricted to genes with known PRE. In recent 
years, it has been shown that some of the PGR-regulated genes in granulosa cells not only lack 
the PRE sequence but instead possess distinct G/C-rich regions located in their promoters that 
bind SP1 and SP3 transcription factors 186. Further investigation has shown that the removal of 
these SP1/SP3 binding sites significantly reduces the effect of PGR as an inducer. It is now 
suggested that the interaction between PGR and these SP1/SP3 sites, either directly or 
indirectly, is important in the regulation of target genes. Interestingly, these SP1/SP3 sites are 
also present in the promoter region of the PGR gene itself, implying that PGR is capable of 
auto-regulation. 
 
In specific tissue context, PGR is capable of acting in a ligand-independent manner through a 
number of different mechanisms. Ligand-independent PGR has been shown to be activated by 
dopamine in the mouse brain and PGR can be activated through phosphorylation by a cAMP-
dependent PKA pathway or by CDK2, which can then act as a transcription factor through 
chromatin binding 187. PGR is also capable of non-transcriptional regulatory roles, for example 
by activating the Src/Ras/Raf/mitogen-activated protein kinase (MAPK) signalling cascade in 
the cytoplasm 173,188. However, ligand dependent activity of PGR in these tissues still has 







Figure 1.4 Ligand-dependent molecular pathway of PGR.   
In the absence of ligands, PGR is retained in an inactive complex containing HSP56 and HSP90 
in the cytoplasm. Upon ligand binding, the inactive complex is disassociated and PGR 
translocate into the nucleus where it dimerises with other PGR monomers. The PGR dimer acts 
as a transcription factor through binding the consensus PGR response element at target DNA, 
recruiting other components of the transcription machinery and regulating downstream gene 
expression. Alternatively, in genes such as Adamts1, PGR can also be tethered to non-canonical 





1.3.7.2 Regulation of PGR isoforms 
In general, PGR-B has higher transcriptional activity than PGR-A, as seen through reporter 
assays in different cellular contexts 117. This is due to the additional presence of AF-3 in the B- 
isoform, specifically the LxxLL amino acid motifs in AF-3 which interacts with class I 
coactivators and can by itself promote gene expression in reporter assays 189. While the 
transactivation function of PGR-A is comparatively weaker than PGR-B, it has been shown 
that PGR-A is capable of regulating the activity of PGR-B. In the uterus during labour, PGR-
A can repress PGR-B transactivation action in response to progesterone 164.  The mechanism 
of this regulation is unlikely to be through PGR-A mediating the expression of PGR-B, for 
exogenous addition of PGR-A does not alter PGR-B level 165. Instead, PGR-A binds to the N-
terminal IKEE sequence of PGR-B to regulate its transactivation functions 114. This has 
important physiological implications, notably in the induction of parturition in the uterus as 
well as the isoform-driven functions of PGR in different breast cancer subtypes. The truncated 
PGR-C isoform has also been shown to repress PGR-B transactivation through direct binding 
and interfering with PGR-B binding to target PRE 120. The trans-repressive role of PGR-A also 
applies to other steroid nuclear receptors as PGR-A can also suppress the transactivation of GR 
and AR in a ligand-dependent manner 118. Other steroid receptors in turn have also been shown 
to regulate PGR expression, with the complex interplay between PGR and ER-α in mammary 
tissues being particularly of interest 190,191. Recently, it has also been determined that GR is 
capable of influencing the canonical genomic actions of PGR 192. GR and PGR are shown to 
be part of the same transcription complex that binds target chromatin sites in breast cancer cells 
in a ligand-dependent manner and can either hinder or promote PGR binding at choice target 
genes, indicating an additional layer of PGR regulation in mammary carcinoma.  
1.3.7.3 Co-regulators of PGR 
Like other steroid receptors, PGR has no intrinsic chromatin remodelling capability, rather, the 
nuclear receptors work in conjunction with other members of the transcription complex in order 
to exercise its transcriptional regulatory functions. Traditionally, protein partners of PGR and 
other NR3C were determined through exploratory yeast two-hybrid systems using steroid 
receptors as bait as well as in vitro protein pull-down. Using these, a number of partners of 
potential functional importance was identified, including SRC, c-SRC and Sra1. A large body 
of work are based in the context of breast cancer and particularly breast cancer cell line models, 




activities in tumorigenesis and subsequent prognostic outcomes. More recent studies, taking 
advantages of immunoprecipitation techniques, were able to investigate in vivo interactions 
between PGR and its binding partners. A number of co-regulators have also been identified in 
the uterus where PGR plays an important role in uterine receptivity to embryo implantation 
and parturition. However, while the importance of PGR in ovulation is indisputable, its 
mechanism, including the involvement of other transcription regulators to form the regulatory 
complex in the ovary remains unexplored. Many transcription factors, previously associated 
with PGR in other biological contexts, are expressed in the reproductive tract including ovary 
and are involved in reproductive processes, making them likely potential partners for PGR in 
this context. A list of known interactors of PGR is shown in Table 1.1, and following are some 
of the most well-studied co-modulators of PGR with important implications on PGR activities, 
especially in the context of PGR reproductive functions. 
(a) SRC  
One of the most well-known co-regulators of steroid receptors is the aptly-named steroid 
receptor coactivator (SRC) family. Among the earliest coactivator groups to be discovered, this 
includes three members SRC-1, SRC-2 and SRC-3 which have all been indicated to interact 
with different steroid receptor members involving the highly conserved LxxLL motif in their 
AF domains 193. PGR has been shown to form interactions with all three SRC members in 
various cell line models 181,194-197. While the interaction between PGR and SRC members has 
not been illustrated in reproductive tissues, it is important to note that SRC proteins have been 
shown to play an important role in female reproduction in studies independent to PGR. 
 
SRC-1 and SRC-3 are capable of binding PGR in a ligand-dependent manner, which has been 
shown in vitro 198 and in vivo in breast cancer 197,199. Studies in in vitro system have shown that 
the LBD of PGR interacts with SRC-1, upon such binding SRC-1 can enhance the 
transactivation of PGR 194. This ability to promote PGR transactivation can be explained by 
the HAT activity of SRC-1, which has a preference for acetylation of H3 and H4 200. 
Furthermore, SRC-1 can also interact with other HAT proteins both in vitro and in vivo, thus 
promoting the recruitment of other histone modifiers to target acetylation sites for additional 
chromosomal modifications in preparation for transcription. One such example is CBP/p300, 
which can act in synergy with SRC-1 to promote PGR and ER transactivation of gene 




has further elucidate the relationship between different components of the nuclear receptor-
related transcription complex. Using a combination of cryogenic electron microscopy and 3D 
modelling, Yi et al. have illustrated the order of recruitment of ER coactivators at target 
chromatins, in which SRC-3 proteins act as linkage between ER and CBP/p300 that in turn 
acetylates nearby histones and facilitates transcription 202.  
 
The role of the SRC family in reproduction has been investigated using a number of KO animal 
models. SRC-1 KO mice are shown to be fertile; however, KO females display a failure to 
mount a decidualisation response to artificial stimulation and leads to a reduction in ductal 
development in mammary tissues, similar to what is observed in total PGR and PGR isoform-
specific KOs 203. This points to the possible role of SRC-1 as a PGR coactivator in different 
tissue contexts. SRC-1 can also influence the level of PGR expression, as has been shown in 
the uterus 199,204. In the mouse ovary, SRC-3 is found in oocytes yet not in granulosa cells, 
however SRC-3 KO animals do exhibit lower ovulation rate that is not a result from entrapped 
oocytes 205. The fact that SRC-3 is not found in a typical PGR-occupied cellular compartment 
and the difference in phenotype shows that the effect of SRC-3 on fertility is unlikely due to 
interaction with PGR in the ovary and more likely because of an independent role in oocyte 
development. In mammary tissues, SRC-3 plays a role in the regulation of PGR expression and 
the ablation of SRC-3 leads to a reduction in ductal sidebranching, a phenotype commonly seen 
in PRBKO female mice 199,205. Thus, this indicates a functional similarity between SRC-3 and 
PGR-B and suggesting SRC-3 to be a specific B-isoform co-modulator. It remains 
undetermined whether SRC-1, 2 or 3 mediate PGR function in granulosa cells. 
(b) c-SRC 
Not to be confused with the previously discussed SRC, c-SRC is not a transcription factor but 
is instead a non-receptor tyrosine kinase belonging to the SRC kinase family that is active 
outside of the nucleus. c-SRC is known to interact with various steroid receptors through 
distinct domains and while it is unlikely that c-SRC has a role on PGR transcriptional functions 
through DNA interaction, c-SRC is highly involved in various processes in the ovary, 
especially in folliculogenesis, oocyte maturation and ovulation where PGR action is crucial. 
Thus, it is worth taking a further look at the relationship between PGR and c-SRC and its 




As the name suggests, c-SRC phosphorylates tyrosine residues of target proteins 206. The 
activation of c-SRC involves auto-phosphorylation at specific tyrosine or through interaction 
with FAK/CAS 207. Thus, c-SRC is involved in an array signalling pathways, including but not 
limited to MAPK, PI3K/AKT and FAK pathways 208,209. c-SRC is also capable of interacting 
with other SR, including ER, AR and GR; in the case of PGR in particular, the interaction with 
c-SRC is dependent on the DBD of PGR 210 and occurs outside of the nucleus 173. More 
importantly, while both PGR-A and PGR-B can form interaction with c-SRC in vitro 210, c-
SRC is exclusively extra-nuclear and thus readily forms interaction with PGR-B and not PGR-
A in breast cancer cells, leading to isoform-specific transcriptional functions 173. 
 
Due to its involvement in various signalling pathways, the role of c-SRC in the ovary is many-
fold. Phenotypically, the ablation of s-SRC leads to infertility in both male and female mice 
and SRCKO females exhibit impaired follicular development, have less antral follicles and 
increased atretic follicles compared to WT littermates 211. These mice also fail to ovulate but 
can mount a partial ovulatory response if given exogenous gonadotropin. On a molecular level, 
inhibiting c-SRC activity interferes with the PI3K-PKC-ERK1/2 pathway and results in 
primordial follicle developmental arrest 212. In granulosa cells, activated c-SRC is involved in 
the PI3K-AKT signalling cascade that results in granulosa cell proliferation 68. Phosphorylated 
c-SRC can also act in conjunction with ADAM17 to activate the EGFR pathway, thereby 
promoting gene expression that is important for luteinisation in granulosa cells (Cyp11a1 and 
Hsd3b1) and COC maturation and expansion in cumulus cells (Has2 and Tnfaip6) 213. The role 
of c-SRC in other reproductive tissues is less known, although an interaction between ER-α 
and c-SRC has been shown to affect the growth of uterine leimyoma cells 214 while c-SRC is 
known to regulate the expression and phosphorylation of AR in prostate cancer 208. It is 
unknown what the relationship between c-SRC and PGR is in the reproductive tract, especially 
the ovary where the non-transcriptional role of PGR remains unexplored.  
(c) Sra1 
The name of steroid receptor RNA activator, or Sra1, reflects the history of discovery for this 
long non-coding RNA co-activator. Originally discovered in an attempt to identify potential 
steroid receptor partners through yeast two-hybrid screening, Sra1 was found to have no typical 
protein coding gene structure and subsequently shown to act as a generic steroid receptor 




AR and ER 215,216. The AF-1 domain of PGR is shown to be important for Sra1 regulatory 
effect and Sra1 has also been found in the SRC-1 dependent transcription complex. 
Subsequently, a short functional protein encoded by Sra1 has also been discovered (termed 
SRAP), making this the first case of a dual functional RNA/protein encoding gene 217. 
 
Relevant to PGR action, Sra1 is found to be upregulated in tumours in the breast, uterus and 
ovary 218. Transgenic mice expressing human Sra1 are shown to be subfertile and exhibit a 
dysregulation in breast development, with aberrant ductal development and a hyperplasia 
phenotype that are precursors to tumorigenesis, suggesting a role for Sra1 in controlling the 
proliferation and developmental rate in mammary tissues 218. The addition of Sra1 also leads 
to a significantly higher level of ligand-dependent PGR expression in mammary glands. There 
has been no report of Sra1 and SRAP in physiologically normal female reproductive tissues, 
thus it is unknown whether they regulate PGR reproductive functions under normal 
circumstances. While the role of Sra1 and SRAP in reproduction remains elusive, they have 
been linked to a number of reproductive disorders, including cervical cancer 219, ovarian 
endometriosis 220 and polycystic ovarian syndrome 221. 
(d) JUN/FOS 
JUN and FOS proteins belong to the activator protein 1 (AP-1) transcription factor family, a 
large group of transcription factors that form interactions with target DNA through a basic 
Leucine zipper (bZIP) domain and are known to form homodimers as well as heterodimers 
with other AP-1 transcription factors. The AP-1 family plays a role in various biological 
contexts, and in respect to the female reproductive tract, JUN/FOS proteins have been shown 
to be involved both in ovarian and uterine processes.  
 
In rodents, JUN/FOS proteins have been shown to be expressed in granulosa cells in a specific 
manner. JUN proteins, including c-JUN and JUNB are induced with forskolin treatment in vitro 
while JUND is maintained at a high level even without treatment 222. FOS proteins, such as c-
FOS, FRA1 and FRA2 are also induced by ovulatory cues in granulosa cells, whereas FOSB 
is downregulated in the presence of forskolin. In vivo granulosa cells show an induction of 
JUNB, JUND and FRA2 by hCG stimulation, with proteins being upregulated 4 h post-hCG. 
In human, JUNB, JUND and FOS but not c-JUN is present in granulosa cells of antral follicles 




hCG stimulation. Interestingly, among these four proteins, FOS has also been shown to be 
PGR-regulated in granulosa cells. PGR binding is found at the promoter region of FOS and 
treatment with PGR antagonist leads to a specific suppression in FOS expression.  
 
JUN/FOS transcription factors have been linked to steroidogenesis in the ovary. In the KGN 
human granulosa tumour cell line, JUN proteins repress the ovarian-specific expression of 
Cyp19a1 through binding the canonical CREB motif in the proximal promoter, thereby 
supporting the attenuation of oestradiol synthesis in granulosa cells and the transition into a 
differentiated state in response to ovulatory cues 224. c-FOS has been shown to be involved in 
the negative regulation of StAR in rat ovaries through direct binding to AP-1 binding sites in 
its promoter region 225. In rat granulosa cells, FOS is found to interact with AP-1 binding sites 
in the promoter of Ptges, Slco2a1 and Abcc4 which are involved in prostaglandin production 
in granulosa cells. However, whether such binding leads to a FOS-dependent transcription of 
these genes remains unexplored. Other members of the JUN/FOS family, such as JDP2, are 
associated with the strict regulation of FSH, the disruption of which can lead to early 
reproductive cessation 226. While the importance of JUN/FOS members in ovulation still 
remains to be explored, it has been shown in Caenorhapditis elegans that JUN/FOS are vital 
for ovulation 227. Transgenic C. elegans that lack JUN/FOS are anovulatory with entrapped 
eggs in the ovary. This is a result of the JUN/FOS influence on the IP3 signalling pathway that 
is responsible for ovulation. Recently, very high enrichment of the AP-1 binding sites, 
canonically recognised by JUN/FOS transcription factors, was observed in open chromatin 
regions in peri-ovulatory mouse granulosa cells, indicates the important transcriptional 
regulatory role of JUN/FOS during ovulation 228. 
 
A number of JUN/FOS members have been identified to form interactions with PGR, most 
notably in the uterus. In human myometrial cell lines, PGR has been shown to interact with 
members of the JUN/FOS family in an isoform-specific manner. Both A- and B-isoforms form 
physical interaction with c-JUN, JUNB, JUND, c-FOS and PGR-A also forms preferential 
interaction with FRA1 and FRA2 163. Such interactions have specific impacts on the regulation 
of gene expression in the uterus during labour. For example, the presence of the JUNB/JUND 
leads to a repression of the PGR-regulated expression of Gja1 likely through interaction with 
the target chromatin at AP-1 binding sites in its promoter, which is reversed in the presence of 
the FRA2/JUND heterodimer. Overall, in the context of the pre-labour uterus, PGR-B acts in 




genes, thereby suppressing the expression of genes that are fundamental for labour induction. 
Using different PGR constructs, it has been shown that two JUN dimerization proteins, JDP1 
and JDP2, can interact with the PGR DBD regardless of the presence of ligands 229,230. 
However, in the presence of R5020, JDP-PGR interaction can enhance PGR-mediated 
transactivation through specifically promoting the AF-1 domain function. 
(e) SP1/SP3 
SP1 and SP3 belong to the Kruppel like factor (KLF) transcription factor family that possess a 
zinc finger DNA binding domain and bind G/C-rich sequences known as G/C-boxes at target 
promoters. SP1/SP3 are responsible for the regulation of gene expression both in normal and 
cancer cells. In the normal ovary, SP1/SP3 are responsible for gene expression regulation at 
different stages, including but not restricted to Adamts1 186, Nr5a2 231, Rhox5 232, Ctsl  35, Ereg 
233, Igfbp3 234, Egr1 30 and Notch2 235. SP1/SP3 are ubiquitously expressed and in the majority 
of cases, SP1/SP3 manifest their transcriptional functions through interaction with other 
transcription factors, including SF-1, PGC-1α, GABP, CBP/p300 and PGR, indicating a role 
of SP1/SP3 as a general pioneer factor for other transcription factors. Physiologically, this has 
an impact on steroidogenesis and follicle rupture during ovulation; however, as SP1/SP3 are 
vital in various tissues and developmental contexts, the specific role for SP1/SP3 in ovarian 
development and ovulation have not been directly examined through global knockout models. 
A recent study using an SP1 knockout model in cultured mouse perinatal ovaries however has 
indicated an important role of SP1 in the development of primordial follicles, especially 
through regulating the activities of forkhead box L2 (FOXL2), a critical factor in early 
folliculogenesis consistent with a pioneer function regulating granulosa-specific chromatin 
structure 235.  
 
SP1/SP3 are known to act as a recruiter of other transcription factors through direct protein-
protein interaction to target promoters that harbour SP1/SP3 binding G/C-boxes, thereby 
regulating downstream gene expression. This interaction has been illustrated in the ovarian 
context, in the regulation of Lhcgr via SP1/SP3 interaction with GATA4 in human luteal cells 
236 and the collaboration between SP1 and ER-α in regulating Mmp19 in mouse granulosa cells 
237. In respect to PGR transcriptional regulatory function, a number of PGR target genes have 
been shown to possess SP1/SP3 binding sites yet lack the canonically recognised PRE motif in 




contains three distinct SP1/SP3 motifs within 1000 bp upstream of its TSS 186. Through reporter 
assays, it has been shown that these SP1/SP3 sites are vital for the transcriptional regulatory 
role of PGR on Adamts1 expression. Similarly, in other genes, such as Cdkn1a, Snap25 and 
GdA, the presence of SP1/SP3 binding sites in the promoter region has been shown to be 
important for PGR-dependent transcriptional regulation of said genes 238,239. Remarkably, PGR 
can also regulate its own expression in a progestin-dependent manner through interaction with 
SP1/SP3 binding motifs in the PGR proximal promoter region, as described in human 
endometrial stromal cells 240. While the direct interaction between PGR and SP1 was 
hypothesised but not demonstrated in these instances, it has been shown in a separate study in 
T47D and ZR-75 breast cancer cell lines that SP1 and PGR co-bind SP1/SP3 sites in the 
promoter region of F3 gene to promote its activation 241.  
 
A recurring mode of trans-regulation can be observed in many PGR-binding co-modulators, 
that is, their ability to regulate the expression of PGR in different cellular contexts. This has 
been identified in the transcriptional regulation of PGR by JUN/FOS transcription factors in 
breast cancer cells 242,243 as well as by SP1/ER-α in breast cancer cells 109 and peri-ovulatory 
granulosa cells 110. Perhaps this is a self-sustaining mechanism in which members of the protein 
complex are inducible by their potential protein partners, thereby helping sustaining the 
transcription complex and thus downstream gene expression. This would be of special interest 





Table 1.1 List of transcription regulators that form protein-protein interaction with PGR 
 





BTEB1 promotes PGR-B transactivation Uterus Mammalian 2-
hybrid 
244 





CBP/p300 promotes progestin-dependent 
tumour growth and proliferation 






repression of parturition, 
interacts with PGR in the 
hypothalamus 
Uterus co-IP246 246 
Uterus Proximity ligation 
assay (PLA) 
163 





regulates the cytoplasmic 
Src/Erk pathway in cancer, 
interacts with and promotes 
PGR-B transactivation, interacts 
with PGR in the hypothalamus 
in vitro GST pulldown 210,181 
Breast cancer co-IP 210 
Yeast system Yeast 2-hybrid 210 
In vitro GST pulldown 190,181 
CUEDC2 
  
promotes PGR ubiquitination 
and degradation 
Breast cancer GST pulldown 247 
Breast cancer co-IP 247 
E6-AP 
  
depending on contexts, can 
promote PGR ubiquitination and 
degradation or acts as PGR 
coactivator, promotes PGR-B 
transactivation 
Yeast system Yeast 2-hybrid 248 
Breast cancer co-IP 249 
ERBB2 
  
forms a complex together with 
STAT3, regulates progestin-
dependent cell cycle progression 
Breast cancer IF 39 
Breast cancer co-IP 39 
ERK-2 regulates the Src/Erk pathway in 
cancer 






tumour growth and proliferation, 
regulates the Src/Erk pathway in 
cancer, promotes PGR-B 
transactivation 
Yeast system Yeast 2-hybrid 190 
in vitro GST pulldown 190 
Breast cancer co-IP 190,191,25
1 
Breast cancer co-IF 191 
FOXO1 Interacts with PGR in the 
hypothalamus and influences 
energy metabolism 




interacts with unliganded PGR-A 
to promote parturition 







expression of pro-inflammatory 
genes and induces parturition 
Uterus co-IP 252 
Uterus PLA 252 
GR Shares mutual target DNA with 
PGR and can promote or hinder 
PGR-DNA binding in a ligand-
dependent manner 
Breast cancer Co-IP 192 
Breast cancer Co-IF 192 
Breast cancer Sequential ChIP 192 
HMG1 promotes PGR-DNA binding 
through DNA conformational 
change 
Breast cancer co-IP 253 
HP1G / 
HDAC1 
forms a repressive complex  Breast cancer co-IP 254 
HSP90 / 
HSP56 
interacts with ligand-free PGR to 
maintain PGR tertiary folded 
state 
Yeast system Yeast 2-hybrid 255 
JAB1 
  
promotes PGR transactivation, 
stabilise PGR/SRC-1 interaction 
  






in vitro GST pulldown 256 
JDP1 / JDP2 
  
promotes PGR transactivation 
  













Yeast system Yeast 2-hybrid 258 












repression of parturition through 
PGR transactivation 
Uterus co-IP 246 
Uterus FLAG IP 259 
in vitro GST pulldown 260 
in vitro GST pulldown 259 
Uterus PLA 163 
SP1 promotes progestin-dependent 
tumour growth and proliferation 




tumour growth and proliferation 
Yeast system Yeast 2-hybrid 194,241 
In vitro GST pulldown 181,194 
Breast cancer FLAG IP 181,194,19
5 









SRC-3 promotes progestin-dependent 
tumour growth and proliferation 
Breast cancer FLAG IP 195-197 
STAT3 regulates progestin-dependent 
cell cycle progression 
Breast cancer co-IP 195,261 
Breast cancer Co-IF 181,196,19
7,261 
SUMO-1 sumoylates PGR and promotes 
PGR transactivation 








1.3.7.4 PGR action at enhancers 
Traditionally described only in the context of proximal promoters, the transcriptional role of 
steroid receptors and PGR in particular has been extended to the regulation through distal 
enhancer elements in the genome, which has been previously described for various steroid 
receptors 263,264. In the context of PGR, the focus on enhancer activation stems from cistromic 
studies in mammary cells in which PGR is found to mainly occupy regions that are distal to 
gene boundaries 265-268. Subsequently, the functional impact of such interaction between PGR 
and various enhancer sites has been identified, which can have permissive or suppressive 
effects on downstream gene expression. For example, PGR is recruited to the enhancer of 
Hsd2b11 through co-binding with STAT5A and promotes the expression of 11β-HSD2 269. In 
contrast, PGR interacts with the upstream enhancer of Csn2 in the presence of ligand as a 
competitive measure to suppress PRL/glucocorticoid-induced expression of β-casein 270. In the 
uterus, PGR enrichment is also found in distal intergenic regions and is critical in 
transcriptional regulation, such as in the induction of Ihh by PGR in conjunction with GATA2 
160,271. In other reproductive tissues, such as granulosa cells and oviducts, the involvement of 
PGR in modulating enhancer functions remains unknown. 
 
1.4 RUNX TRANSCRIPTION FACTOR 
The Runt-related Transcription Factor (RUNX) family, historically referred to as Core Binding 
Factor Alpha (CBFA) and more familiarly known as Acute Myeloid Leukaemia (AML) factor 
in the respective cancer contexts, consists of three known members: RUNX1 (CBFA2/AML1), 
RUNX2 (CBFA1/AML3) and RUNX3 (CBFA3/AML2), with high level of structural 
conservation between members of the family as well as between different species 272. RUNX 
transcription factors are most well-known as oncogenic factors in acute myeloid leukaemia and 
other cancer types; however, evidence has shown them to also play a role in female 
reproduction.  
1.4.1 Structure of RUNX proteins 
RUNX1, RUNX2 and RUNX3 are encoded by three separate genes, with RUNX1 and RUNX3 
being closer homologs to one another than to RUNX2 272. In each of the three RUNX genes, 
the utilisation of two separate promoters that are either distal or proximal gives rise to two 




pattern and roles in tissue-specific contexts. Aside from these two main variants, there are a 
number of other lesser-known RUNX isoforms, the compositions as well as functions of which 
are still poorly understood. 
 
The molecular structure of the RUNX proteins is highly conserved, with homologs identified 
in both invertebrate and vertebrate animal groups and contains a number of functional domains 
that are shared between all three RUNX proteins 273 (Figure 1.5). On the N terminus is the runt 
homolog domain (RHD), so named due to its homology with the Drosophila runt gene, and is 
responsible for binding to the canonical RUNT DNA motif as well as for hetero-dimerisation 
with CBFβ, the RUNX canonical dimerising protein partner which lacks DNA binding 
capacity. The presence of CBFβ is highly important for ensuring the affinity between RUNX 
and target DNA as well as for stabilising the RUNX complex, even though CBFβ by itself does 
not interact with target DNA. Downstream of the RHD are a number of functional domains, 
including two AF domains (AD) important for the transcriptional regulatory function of RUNX 
and a putative inhibitory domain (ID) that bind co-repressors. A nuclear matrix-targeting signal 
(NMTS) domain is involved in nuclear matrix attachment and localisation of RUNX in nuclear 
subdomains, with an additional replication activation domain within the NMTS that is 
associated with the DNA replication machinery. At the C-terminal end of RUNX is a VWRPY 
site which binds the co-repressors from the Groucho/TLE family. In RUNX2, an extra 








Figure 1.5 Structure of RUNX proteins.  
RUNX1, RUNX2 and RUNX3 share the majority of important domains (from N- to C-
terminus): RHD that binds the RUNT motif at target DNA, AD with transactivation properties, 
NMTS domain is important for nuclear localisation of RUNX, ID which binds co-repressors 
and a VWRPY site that binds additional co-repressors. RUNX2 has an additional 
glutamine/alanine-rich site at the N-terminus which contains another transactivation domain 





1.4.2 RUNX functions in the ovary 
1.4.2.1 RUNX1 
The ovarian expression of RUNX1 has been identified in a number of species in association 
with granulosa cell functions. In the rat ovary, RUNX1 is absent in primary and secondary 
follicles, but in antral follicles RUNX1 is expressed at a basal level and is induced by hCG 
stimulation up until the luteinisation of granulosa cells 143,274. RUNX1 is detectable in 
granulosa cells of peri-ovulatory follicles in human 275 and is also present in the theca layer 
independent of the LH surge. The RUNX1 pattern of expression is replicable in an in vitro 
culture system in which the level of RUNX1 translation is induced by hCG as well as forskolin 
and phorbol myristate acetate 143,276. Further investigation showed that a number of intracellular 
molecular pathways following the LH surge, including PKA/adenylate cyclase and MAPK 
pathways, are important for the upregulation of RUNX1. In the goat ovary, RUNX1 is 
expressed in oocytes, granulosa cells as well as theca cells at different stages of follicle 
development.  
 
In rat and goat granulosa cells, RUNX1 is involved in the LH-regulated production of 
progesterone and oestradiol through regulating the expression of Cyp11a1, which encodes an 
enzyme that catalyses the conversion of cholesterol to pregnenolone, the precursor to 
progesterone. RUNX1 also induces the expression of Ptgs2 in peri-ovulatory rat granulosa cells 
through direct binding to RUNT sequences in its promoter 277. RUNX1 also regulates Hapln1 
and Rgcc which are genes shown to be upregulated in peri-ovulatory granulosa cells, although 
their ovulatory roles remain speculative 278. Unlike for PGR and other ovulatory factors, which 
benefited from studies on KO mouse models, the historical lack of a viable RUNX1 KO model 
has prevented attempts to study the ovulatory role of RUNX1 in a summative way. While recent 
attempts have been made to generate tissue-specific RUNX1 KO and data are emerging in the 
field, thus far a global characterisation of RUNX1-dependent ovarian transcriptome and 
cistrome have not been described in detail. 
1.4.2.2 RUNX2 
Like RUNX1, RUNX2 is highly expressed in rat and mouse granulosa cells of antral follicles 
as well as CL arisen from ovulated follicles 275. RUNX2 is also found to be upregulated in rat 




granulosa cells and an increase in RUNX2 expression in cumulus cells is also associated with 
poor pregnancy success in infertility patients 279.  
In rat granulosa cells, RUNX2 is responsible for the regulation of a number of peri-ovulatory 
genes, including Ptgs2 and Ptgds (which are involved in prostagladin synthesis), Fabp6 (the 
ablation of which in granulosa cells leads to a reduction in ovulation in mice) 280, Acbc1a, Rgcc 
and Mmp13 275. Interestingly, RUNX2 is also a regulator of RUNX1, as indicated in the binding 
of RUNX2 at the Runx1 promoter in granulosa cells and the induction of known RUNX1 
targets Ptgs2 and Tnfaip6 when there is a loss of RUNX2 in vitro 281. RUNX2 is also capable 
of binding to the Ptgs2 promoter region known to be targeted by RUNX1, suggesting a 
redundant mechanism between RUNX1 and RUNX2. Remarkably, heterozygous deletion of 
RUNX2 in the context of CBFβ ablation resulted in infertility in female KO mice which was 
not achievable in single CBFβ KO. However, ovulation still occurred albeit at a lower rate, 
suggesting that RUNX2 regulates multiple processes that are important for successful 
pregnancy. Similar to RUNX1, global RUNX2 ablation proves lethal and cannot be used for 
reproductive studies, thus the specific role of RUNX2 in ovulation still remains to be explored. 
1.4.2.3 RUNX3 
Like the other two RUNX transcription factors, RUNX3 has also been identified in the mouse 
ovary, specifically in granulosa cells 282. Unlike RUNX1 and RUNX2, RUNX3 is present in 
follicles at all stages of development, although whether RUNX3 can be further induced by the 
LH surge has not been examined. However, this difference in expression pattern likely explains 
the distinct role of RUNX3 in the ovary and female reproduction, which is evidenced in studies 
on the RUNX3 KO mouse model. While the standard global RUNX3 KO on a C57BL/6 mouse 
genetic background is proven to diminish the vitality of in utero foetuses and newborn pups 
283,284, a global RUNX3 KO model on a BALB/c background is shown to produce viable 
offspring and thus was used to examine the importance of RUNX3 on female fertility 285. Due 
to somatic defects associated with RUNX3, the long-term fecundity of RUNX3 KO mice has 
not been reported. While ovulation in RUNX3 KO females can be induced by exogenous 
hormone stimulation, naturally cycling RUNX3 KO females do display a classic anovulatory 
phenotype, with developed antral follicles but no CL observed. The normal phenotype can be 
restored through cross-transplanting WT and KO ovaries, in which ovulation is observable in 
KO-to-WT ovaries and ovulation failure occurs in WT-to-KO ovarian transplants. This implies 




can be explained by the influence of RUNX3 in the production of reproductive hormones in 
the hypothalamus during the oestrous cycle, where RUNX3 is normally present 282. RUNX3 
deficiency leads to an alteration in the expression of Fshb, Lhb and Cga in the pituitary, 
demonstrating a role of RUNX3 in FSH and LH production 282,286. This results in a decrease in 
ovarian levels of Cyp11a1, Cyp19a1, Fshr and Lhcgr, which has implications for 
steroidogenesis in the ovary, shown as a repression in oestradiol- and progesterone-induced 
proliferation in ovarian epithelial cells. Other than regulating the oestrous cycle, RUNX3 is 
also involved in folliculogenesis by regulating the expression of activins and inhibins in the 
ovary, leading to a reduction in follicle number at all stages and an increase in atresia.  
1.4.2.4 CBFβ 
Unlike RUNX proteins which are upregulated and nuclear localised in granulosa cells, the level 
of CBFβ remains unchanged throughout ovulation and is reported to be present in both the 
nuclear and cytoplasmic compartment of granulosa cells 275. However, as the dimerisation of 
RUNX proteins with CBFβ is crucial for effective DNA binding of RUNX and the ablation of 
CBFβ still results in viable offspring, CBFβ has been targeted as an indirect way to investigate 
RUNX functions in knockout mouse models. The role of CBFβ in the ovary has been well 
documented through two granulosa cell-specific CBFβ KO mouse models, with CBFβ deletion 
in the ovary being conditional in granulosa cell by using Cyp19a1 and Esr2-cre transgenic 
models, which are expressed in granulosa cells from the FSH-dependent secondary follicle 
stage 274,287. In both conditional KO models, CBFβ KO females were subfertile compared to 
WT littermates and while some ovulation still occurred at a lower rate, these mice failed to 
form proper CL after ovulation. Female KO mice also exhibited abnormal oestrous cycles, 
reduced vascularisation of the ovary and reduced circulating progesterone level in response to 
the LH surge. Microarray analysis of CBFβ KO granulosa cells showed that the absence of 
CBFβ lead to changes in the expression of genes responsible for ovulation, luteal formation 
and steroidogenesis (eg Edn2, Ptgs1, Lhcgr), which likely accounted for the reduced ovulation 
rate. Interestingly, the ablation of CBFβ resulted in an increase in RUNX1 transcriptional and 
translational levels, whereas the level of RUNX2 was unaffected. Unlike RUNX1 and RUNX2 
which localise in the nucleus, CBFβ could be found in both the nuclear and cytoplasmic 
compartments, suggesting that CBFβ can hold non-transcriptional functions independent of 




1.4.3 RUNX functions in other reproductive tissues 
Apart from its role in ovulatory granulosa cells, RUNX1 is also known to be important in the 
female-specific commitment in foetal gonad differentiation, best known to be regulated by the 
master transcription factor FOXL2. RUNX1 is expressed in female gonads of a number of 
vertebrates, including human, mouse, turtle and fish 288,289. Studies on tissue-specific KO 
mouse models have shown that RUNX1 works closely with the female-determinant FOXL2 at 
a functional as well as chromatin binding level, shown through colocalisation in foetal 
granulosa cells and mutual chromatin targets and downstream regulated genes which are 
important for granulosa cell functions 286. Not just in the gonads, RUNX1 is also involved in 
the cell fate commitment of epithelial cells in the Müllerian duct, the precursor for the female 
reproductive tract 290. 
 
In the male gonad, RUNX2 is found to be present in the testis and sperm, however does not 
seem to play a role in sperm motility 291. The presence of RUNX2 in mammary epithelial cells 
is important in the regulation of lactation through direct transcriptional regulation of b-casein 
292. RUNX2 also regulates the expression of Cldn11 in mammary epithelial cells, which is 
important in the normal differentiation of the mammary gland. While RUNX2 is normally 
upregulated by the LH surge, an overexpression of RUNX2 has been detected in cumulus cells 
of PCOS patients 279 where it represses the expression of Cyp11a1 and Cyp19a1 293.  
 
All three RUNX proteins are expressed in the uterus during early pregnancy. Curiously, they 
all have a very similar pattern of expression in the uterus, being detectable in luminal, glandular 
epithelium and stromal cells of the uterus of female mice and is especially induced by 
decidualisation and at embryo implantation 294-297. In ovariectomised mouse uterus the RUNX1 
mRNA level is acutely responsive to oestradiol treatment but has a delayed response to 
progesterone treatment 295. Here, RUNX1 is responsible for the regulation of genes involved 
in decidualisation, especially in the remodelling of the extracellular matrix (Mmp2, but not 
Mmp9) and angiogenesis (Ptgs2 and Ptges). RUNX2 is also involved in angiogenesis in mouse 
uterus through regulating Ptgs2 and Vegf and in extracellular matrix (Mmp9), likely through 
an association with CEBPβ 296. RUNX3 has a gradual response to oestradiol treatment, whereas 
progesterone has no effect on RUNX3 expression 294. RUNX3 KO female mice are shown to 
have poorly-developed uterus that are lighter in weight and in glandular development 285. 




recurrent theme, in which RUNX members are shown to possess distinct expression profiles 
and roles in the same tissue type, alluding to distinct regulatory mechanisms for each RUNX 
member. 
1.4.4 Molecular mechanisms of RUNX 
All three members of the RUNX family act as transcription factors to regulate downstream 
gene expression. RUNX proteins share the same basic molecular mechanism at the chromatin 
level, where all three RUNX proteins bind the canonical RUNT motif (5′-PuACCPuCA-3′) at 
target DNA sites. Such interaction can occur in proximity to the target TSS within the promoter 
regions or can be more distal to the genebody and even within the genebody, for example in 
intronic regions 299. The transcriptional activity of RUNX is highly dependent on the interaction 
with myriads of other transcriptional modulators in a cell-specific manner. Aside from direct 
DNA binding, RUNX can also exert influence on a number of important signalling pathways. 
For instance, all three RUNX are involved in the regulation of the Wnt/β-catenin pathway 300 
as well as the TGFβ-regulated signalling cascade 273.  
 
The molecular mechanisms of each of the RUNX proteins have been studied at some length, 
especially in the context of cancer and development. As all RUNX proteins share similar key 
domains, including RHD and AD/NMTS that are prime targets for co-modulator binding, it is 
likely that the three RUNX transcription factors share a number of mutual co-regulators. 
However, not only have mutual molecular pathways identified in these three proteins, a number 
of distinct mechanisms have also been discovered for each protein, suggesting that RUNX 
proteins possess a level of redundancy as well as specificity depending on the biological 
context. 
1.4.4.1 Transcriptional co-regulators of RUNX 
The bulk of literature on RUNX mechanisms is in the context of carcinoma and development, 
in which areas RUNX members historically play prominent roles. As previously discussed for 
PGR, such interactions are often highly cell-specific and cannot be inferred for all biological 
contexts. However, as a number of known co-modulators of RUNX are concurrently expressed 
in granulosa cells during ovulation, it is reasonable to expect a level of similarities in co-
modulator dependent RUNX regulatory mechanisms and if this is not the case, it would be of 




Like other transcription factors, the roles of RUNX proteins are reliant on interactions with 
various co-modulators in a context-specific manner. In the context of osteoblast functions, 
where RUNX proteins have prominent roles, interactions with other transcription factors such 
as TWIST1 301, CEBPβ 302, c-JUN and c-FOS 303 are important in RUNX transcriptional 
regulatory functions. In megakaryocytes, the interaction between RUNX1 and GATA1 
promotes cell differentiation 304. In lymphocytes, the RUNX interactome, including members 
of the T-box 305 and ETS families 303, is involved in cell fate determination and differentiation. 
Interestingly, members of the GATA and JUN/FOS family have been show to play important 
roles in ovulation, including GATA4, GATA6 306, c-JUN and c-FOS, among other JUN/FOS 
members 223. It would be of interest to investigate the interaction between RUNX and these 
transcription factors in the context of female reproduction. While RUNX proteins play various 
roles in different parts of the female reproductive tract, the role of the relevant interactomes 
have not been discussed in any of these tissue types, rendering the tissue-specific underlying 
mechanisms of RUNX poorly understood. 
 
There is evidence for RUNX roles in regulating SR-induced gene expression. RUNX1 and 
RUNX2 have been shown to interact with AR and GR at the Slp enhancer element in vitro, 
suggesting a role of RUNX proteins in regulating hormone-induced transcription 307. Such 
interaction is through the DBD that is typical of all SR, thus it is likely that RUNX can also 
form physical interactions with other SR. Subsequent studies have elucidated the impact of 
such interactions, such as the synergistic regulation of Snai2 by AR and RUNX2 in prostate 
cancer 308, the trans-sequestering effect of AR and RUNX2 on each other in osteoblasts 309 and 
functional links between AR and RUNX1 in epididymis epithelial cells 310. RUNX also plays 
a role in ER-α functions, as shown in bones 311 and breast cancer 312.  
 
Not only can RUNX proteins act as pioneer factors through direct tethering other transcription 
factors to novel target chromatins but can also exert their influence through promoting 
chromosomal conformational changes, allowing for the formation of open chromatin spaces 
that are available for the occupancy of other transcription factors. In support of this, evidence 
has indicated the cooperation between RUNX1 and RUNX2 with the SWI/SNF chromatin 
remodelling complex. RUNX1 shares mutual chromatin binding sites with SWI/SNF 
components at genes that are important in haematopoiesis and has a role in the recruitment of 
the SWI/SNF complex to such binding sites, therefore exhibiting a recruiter function 303. In 




accessibility, as shown in reduced histone 3 lysine 27 acetylation (H3K27ac) markers at 
RUNX1 binding targets 313. For RUNX2, interaction with SWI/SNF is observed in osteoblast 
and dependent on the co-biding of CEBPβ . 
 
Whilst RUNX proteins are mainly known for activation functions, RUNX can also interact 
with a number of co-repressors in order to suppress specific gene expression. One such co-
repressors is the Groucho/TLE/Grg (TLE) family through the VWRPY motif at the C-terminus 
of RUNX. TLE proteins are ubiquitous repressors that are employed by various transcription 
factors and specifically the interaction of RUNX2 with TLE leads to the repression of RUNX2-
regulated promoters 314. Additionally, RUNX1 also interacts with mSin3A, a stabilising 
component of the HDAC complex, resulting in the expression of RUNX1-modulated genes. 
RUNX can also form interaction with various HDAC proteins, including HDAC1-4 and 
HDAC6 in various biological contexts 303,314. Such interactions result in transcriptional 
suppression of target genes through various means, either from altering the open chromatin 
state, modifying nearby transcription modulators or preventing RUNX from binding target 
DNA. In one example observed in the SAOS-2 osteosarcoma cell line, RUNX2 is shown to 
repress rRNA synthesis through recruiting the histone acetyltransferase HDAC1 to target 
rRNA repeats, leading to the deacetylation of the upstream regulator UBF which is important 
for the expression of rRNA genes 315. In another, HDAC4-RUNX2 interaction in chondrocytes 
blocks RUNX2 from accessing target DNA, thereby inhibiting RUNX2 transcriptional 
activities 316. Other co-repressors of RUNX include CoAA 317, the Polycomb repressor complex 
318 and SKI 319. In other instances, interactions with other transcription factors that are not 
global transcription suppressors can also have a repressive effect on RUNX transactivation 
activities. For example, FOXP3 can bind RUNX1 at its ID region to inhibit RUNX1 action in 
T-lymphocytes; similarly, interaction between RUNX2 and SOX9 promotes degradation of 
RUNX2 in mesenchymal stem cells 303. Furthermore, there are cases where one co-factor can 
have multiple specific effects on RUNX activities, such as YAP1, which acts as a repressor to 
RUNX2 314 but can enhance transcriptional activator when binding to RUNX3 320.  
1.4.4.2 RUNX action on enhancers 
Apart from its role at target promoters, RUNX can also exert influence on gene expression 
through distal enhancer elements. This has been described in various haematopoietic cell lines 




of the Tcr family 323. In natural killer T cell precursor cells, RUNX1 also interacts with specific 
enhancer loci in the introns of Zbtb16 in order to regulate its expression 324. Similarly, RUNX2 
can direct the expression of Col10a1 in chondrocytes 325, Snai2 in prostate cancer 308 and 
Mmp13 in osteoblasts 326 through binding their respective upstream enhancers.  
 
1.5 HYPOTHESIS & AIMS 
1.5.1 Main hypothesis 
The process of ovulation, regulated by various regulatory elements acting in coordination with 
one another, is critical for successful fertilisation and pregnancy. The expression of PGR in 
mural granulosa cells is especially essential for ovulation in which PGR acts as a master 
transcription factor for various downstream biological processes that are necessary for 
ovulation to occur. Elsewhere in the female reproductive tract, PGR is vital for the coordination 
of a number of reproductive processes occurring prior to and during pregnancy, including the 
transportation of oocytes and embryos, the preparation for embryo implantation and the 
regulation of labour. Although much is known about the physiological consequence of PGR 
activity in reproductive tissues, exactly how these unique roles are achieved on a molecular 
level in a tissue-specific manner is not understood. Combining the fact that PGR can target 
chromatin through binding diverse motifs and that PGR is known to cooperate with many 
transcription factors in different tissue settings, it is likely that partnerships with unique co-
regulators allow PGR to achieve tissue-specific chromatin binding and gene regulatory 
patterns. This study aims to discover finely-tuned contextual PGR-chromatin interactions and 
tissue-specific roles of PGR, specifically in the ovulating ovary, in combination with 
comparisons across the reproductive tract, to understand the shared and unique activities of 
PGR. The refined mechanistic understanding of ovulation and PGR action will identify new 
targets for contraceptive and cancer therapeutics, while also reveal novel approaches for the 
management of ovulatory infertility. 
 
Thus, the main hypothesis of this thesis is that: 
 
Progesterone receptor interacts with other transcription factors in tissue-specific complexes 
to target unique chromatin sites in different reproductive tissues, leading to tissue-specific gene 




1.5.2 Specific hypotheses and aims 
Hypothesis 1: The PGR cistrome in different reproductive tissues possesses unique patterns 
that are important to the regulation of tissue-specific genes and functions 
PGR is essential for various functions in the female reproductive tract, especially ovulation in 
the ovary. To perform these diverse roles, PGR regulates highly divergent gene sets in each 
organ. It is likely that a fundamental divergence between PGR functions in each tissue is due 
to differences in PGR-chromatin binding patterns, but this has not been directly investigated. 
To address this hypothesis, the aims were to: 
- Characterise the PGR cistrome in peri-ovulatory granulosa cells through PGR 
chromatin immunoprecipitation – sequencing (ChIP-seq) 
- Define the active chromatin landscape in peri-ovulatory granulosa cells through 
H3K27ac ChIP-seq 
- Characterise the relationship between PGR cistrome and the active chromatin landscape 
along with the PGR-dependent granulosa cell transcriptome identified through 
microarray and the complete ovulatory gene expression profile during ovulation 
identified through RNA-seq 
- Identify tissue-specific characteristics of PGR regulation in mouse reproductive tissues 
through comparison of PGR-bound cistromes in ovary and uterus 
The results for this hypothesis are in Chapter 2 and 3. 
 
Hypothesis 2: PGR interacts with a selective group of co-regulators in granulosa cells during 
ovulation 
Analysis of the PGR cistrome indicated possible interaction between PGR and other 
transcription factors in granulosa cells and that selective interaction between PGR and tissue-
specific co-regulators could explain how PGR achieve unique roles in reproductive tissues. 
PGR and other NR3C receptors are also known to interact with other transcription factors in 
other cell types. Furthermore, a number of ncRNA has also been identified as regulators to 
PGR and NR3C receptor function. However, the transcription complex containing PGR in 
granulosa cells has never been investigated.  
To address this hypothesis, the aims were to: 
- Identify transcription factors that are present in the PGR transcription complex in peri-




- Confirm the presence of ncRNA partners in the PGR transcription complex in peri-
ovulatory granulosa cells through RNA co-immunoprecipitation 
The results for this hypothesis are in Chapter 4. 
 
Hypothesis 3: RUNX1 is a co-regulator of PGR in peri-ovulatory granulosa cells 
Results from Hypotheses 1 and 2 indicated a possible role of RUNX1 as a PGR co-regulator. 
While RUNX1 regulates gene expression in granulosa cells during ovulation, the overall 
RUNX1-dependent transcriptome has never been previously described. It is likely that RUNX1 
and PGR share similar chromatin binding properties and this interaction may be a part of the 
mechanism for unique chromatin-binding and specific ovulatory functions for each 
transcription factor, which in turn affects the granulosa cell transcriptome.  
To address this hypothesis, the aims were to: 
- Characterise the properties of RUNX1 cistromes in different developmental stages 
through comparative analysis of RUNX1 cistrome in adult and foetal granulosa cells, 
especially differences in RUNX1 target chromatin before and after the LH surge 
- Identify similarities between PGR and RUNX1 chromatin binding properties in peri-
ovulatory granulosa cells through comparative analysis of PGR and RUNX1 ChIP-seq 
and their consequence on ovulatory gene expression profile 
- Investigate the dynamics of the interaction between PGR and RUNX1 in response to 
ovulatory cues through proximity ligation assay 
The results for this hypothesis are in Chapter 5 and 6. 
 
Hypothesis 4: PGR isoforms mediate distinctive regulation of genes in granulosa cells during 
ovulation 
PGR consists of two main isoforms, PGR-A and PGR-B, which can have different expression 
pattern and are responsible for various unique roles in different tissue contexts. While both are 
present in the reproductive tract, PGR-A is the only one known to be essential for ovulation 
while PGR-B plays a lesser role in the reproductive tract. However, the specific roles of PGR 
isoforms on gene expression in peri-ovulatory granulosa cells have not been previously 
investigated in detail.  
To address this hypothesis, the aims were to: 
- Identify the unique roles of PGR isoforms in the peri-ovulatory transcriptome through 




- Investigate the relationship between PGR and RUNX1 cistrome on isoform-specific 
cistromes 
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CHAPTER 2 PGR interacts with transcriptionally active 




Progesterone (P4) is an essential reproductive hormone produced by the ovarian follicular 
granulosa cells immediately prior to ovulation. Progesterone has diverse pleiotropic roles and 
plays a primary role in controlling fertility as the essential mediator of ovulation 1. Progesterone 
mainly functions through the direct binding and activation of its target receptor PGR, a nuclear 
receptor that has profound importance in the regulation and maintenance of normal female 
reproductive physiology. PGR belongs to the 3-Ketosteroid receptor family and includes two 
isoforms, PGR-A and PGR-B, both of which are present in most PGR-positive cells. However, 
PGR-A is more important for ovarian and uterine functions whereas PGR-B plays the main 
role in the mammary gland 2,3.  
 
In reproductive tissues, PGR shows distinct functions that are highly dependent on the tissue 
context, revealed in studies on PGRKO mouse models 4. In the pre-ovulatory ovary, PGR is 
expressed exclusively in granulosa cells in response to the ovulatory LH-surge 5. Treatment 
with RU486, a PGR antagonist, results in ovulation suppression in rodents 6,7 and humans 8. 
PGRKO female mice are infertile due to complete anovulation with the corpus luteum 
containing the entrapped oocyte  4. The role of PGR on oocyte development is more unclear - 
oocytes from KO mice that have undergone IVM are capable of fertilisation and, following 
uterine transfer, developing into normal pups 9. However, in vitro studies in other mammalian 
species, have shown that PGR antagonist treatment has detrimental effects on cumulus 
expansion 10. The ovulatory role of PGR is also critical in primates and humans as illustrated 
by PGR antagonist or gene knockdown 11. In the ovary, PGR is responsible for the induction 
of genes that are critical for ovulation, such as Adamts1, Edn2 and Pparg in granulosa cells 12-
14. PGR also plays a number of roles in the reproductive tract including oocyte and embryo 
transport in the oviduct  and decidualisation in the uterus 4, which are achieved through 
regulating specific genes 15-17. Although PGR regulates large suites of genes in many 




Previous studies on PGR-dependent transcriptome profile have been performed independently 
however, and there has been no direct comparative investigation across different target tissues.  
 
The canonical PGR-dependent transcriptional regulation is most well-studied in breast cancer 
in which PGR is a ligand-dependent nuclear transcription factor 18. Upon binding P4, activated 
PGR translocates into the nucleus and binds to regulatory motifs, most often containing the 
PRE/NR3C motif. The canonical PRE/NR3C motif is an inverted palindrome, but it is 
recognised that the PRE/NR3C motif can vary depending on neighbouring transcription factor 
binding or other chromatin modifiers 19. The influence of PGR is also not uniquely restricted 
to genes with known PRE/NR3C, as interaction between PGR and other transcription factors 
can recruit PGR to non-consensus motifs 20,21. This has been reported in the ovary for PGR-
induced Adamts1 which does not have PRE/NR3C in the defined regulatory region but 
possesses G/C-rich regions in the proximal promoter region that bind to SP1/SP3 co-mediators 
22. An interaction between PGR and SP1/SP3 at these sites has been proposed as a mechanism 
for PGR-mediated gene regulation.  
 
Previous studies on PGR action have largely focused on identifying PGR-regulated genes using 
targeted reporter assays or genomic screening 22-24, which does little to explain the selective 
and tissue-dependent action of PGR on the genome. Recent studies have begun to define the 
molecular pathway of PGR action in the reproductive tract, assisted by improved genome-wide 
molecular technologies 16,25,26. However, no studies have yet investigated the molecular 
pathway involving PGR in the ovary or how the specialised physiological roles in different 
reproductive organs are achieved through the same receptor signalling mechanism. An 
understanding of the mechanism responsible for the diversity in PGR action between different 
target tissues may reveal key details of PGR functions; considering how differently PGR 
functions between cell types, including normal versus cancerous cells, it is valuable to actively 
investigate these contrasting regulatory mechanisms. In this chapter, the PGR chromatin-
binding cistrome was characterised in relation to the open chromatin landscape defined by 
H3K27ac in peri-ovulatory granulosa cells through PGR ChIP-seq. The impact of PGR binding 
on transcription regulation was investigated through comparison with the PGR-dependent 
transcriptome obtained from microarray analysis of PGRKO granulosa cells, as well as the 






2.2 MATERIALS & METHODS 
2.2.1 Animals 
CBA x C57BL/6 F1 (CBAF1) mice were obtained from The University of Adelaide, 
Laboratory Animal Services. All mice were maintained in 12 h light /12 h dark conditions and 
given water and rodent chow ad libitum. All experiments were approved by The University of 
Adelaide Animal Ethics Committee and were conducted in accordance with the Australian 
Code of Practice for the Care and Use of Animals for Scientific Purposes (ethics no 
m/2015/075). 
2.2.2 Peri-ovulatory time course experiment 
2.2.2.1 Time course sample collection 
A total of 69 mice were used for three replicates of the experiment. Samples were collected 
from mice that were either not stimulated, equine chorionic gonadotropin (eCG)-stimulated or 
eCG + hCG-stimulated for 4, 6, 8, 10, or 12 h. The allocation of mice according to these time 
points is listed in Table 2.1. For eCG-stimulated samples, female CBAF1 mice at 3 weeks of 
age were administered intraperitoneally (i.p) 5 IU eCG (Lee Biosolutions, Maryland Heights, 
MO, USA). For eCG + hCG-stimulated samples, mice were injected with 5 IU hCG (Merck, 
Sharp and Dohme) 46 h post-eCG and sacrificed according to allocation plan. Mice were culled 
by cervical dislocation and whole ovaries were dissected and placed in αMEM media. For 
obtaining RNA and protein, ovaries were punctured using 26G needle and the COC and 
granulosa cells (GC) released from ovaries were pooled together, transferred into 1.5ml tubes, 
briefly centrifuged to remove excess media and snap frozen in liquid nitrogen. All samples 





Table 2.1 Mouse allocation per stimulation time point for the time course experiment.  
The number of mice shown below is for one replicate (total 69 mice for three replicates).   
Time point Mice Ovaries Ovaries for RNA Ovaries for Protein 
Unstimulated 5 10 4 6  
eCG  46 h 3 6 3  3   
eCG + hCG 4h 3 6 3   3   
eCG + hCG 6 h 3 6 3   3   
eCG + hCG 8 h 3 6 3   3   
eCG + hCG 10 h 3 6 3   3   
eCG + hCG 12 h 3 6 3   3   
Total number 23 46 Total mice (3 replicates) 69 
 
2.2.2.2 mRNA level quantification 
RNA from COC/GC collected from the time course collection was purified using RNeasy Mini 
Kit and accompanying protocol (Qiagen, Hilden, Germany). Briefly, cells were lysed in 350 µl 
lysis buffer with added β-mercaptoethanol and the lysate was applied to spin column for 
purification. RNA was treated with DNase I while on column and eluted with 15 µl H2O. Final 
RNA concentration was measured using the Nanodrop 2000 Spectrophotometer (Thermo 
Fisher). cDNA from purified RNA was synthesised using the Superscript III First-Strand kit 
and accompanying protocol (Thermo Fisher). 500 ng of purified RNA was used per reaction. 
To confirm that there was no genomic DNA contamination, ‘no reverse transcriptase’ negative 
controls were included. The reaction was conducted in a GeneAmp PCR System 9700 (Applied 
Biosystems, Thermo Fisher) at the following setting: 25oC for 10 minutes, 50oC for 50 minutes, 
85oC for 5 minutes, 4oC to cool. Then, 2 U RNAse H were added to each sample for RNA 
digestion and the samples were incubated for a further 20 minutes at 37oC. cDNA was then 
diluted in H2O for a final concentration of 5 ng/µl. cDNA was stored at -20
oC for short term or 
-80oC for long term prior to use. 
 
RT-qPCR for gene expression analysis was done using Taqman assays (Appendix 1) and Gene 
Expression Mastermix (Thermo Fisher). The following components were included per every 
10 µl reaction: 5 µl Mastermix, 0.25 µl Taqman assay, 3.75 µl H2O and 1 µl cDNA. The 
reaction was run in a QuantStudio 12K Flex Real-Time PCR System (Thermo Fisher) and the 
thermal cycle setting was as follows: 50oC for 2 minutes, 95oC for 10 minutes, [95oC for 15 
seconds, 60oC for 1 minute] x 40 cycles. Controls included the absence of cDNA (H2O control) 




quantification of gene expression was presented as the relative expression of three replicates 
normalised to the unstimulated sample, with Rpl19 as the housekeeping gene, using the delta 
delta CT formula. Data normality was confirmed using the Shapiro-Wilk test due to the small 
number of data points. Statistical significance was determined through one-way ANOVA with 
Tukey test for multiple comparison.  
2.2.2.3 Protein level quantification 
Lysate was prepared from COC/GC pooled from 3 ovaries by adding 100 µl LDS Sample 
Buffer 4x (Thermo Fisher), 1 µl β-mercaptoethanol and 1 µl benzonase, then incubated for 10 
minutes at 65oC for cell lysis and protein denaturation. Western blot was performed using pre-
set Bolt 4-12% Bis-Tris Plus gels (Thermo Fisher) in MES running buffer (Thermo Fisher) in 
a Bolt Mini Gel Tank (Thermo Fisher). For each well, 5-10 µl denatured lysate was loaded and 
5 µl of Precision Plus protein standard (Bio-Rad, Gladesville, NSW, Australia) was used as the 
protein ladder. Electrophoresis was at 165 V for 40 minutes at room temperature or until the 
loading dye had run off the gel. Protein from the gel was transferred onto nitrocellulose 
membrane in a standard transfer sandwich at 15 V for 35 minutes at room temperature. Protein 
loading was confirmed by Ponceau S staining for 5 minutes and prior to blocking the stain was 
removed by incubating with phosphate buffered saline (PBS). The membrane was blocked in 
Odyssey Blocking buffer for 1 h at room temperature or overnight at 4oC. Primary and 
secondary antibodies were prepared accordingly to Appendix 2 and membrane was stained for 
at least 1 h at room temperature on constant rotation (from secondary antibody incubation 
onwards, the membrane container was kept in the dark throughout incubation). Membrane was 
washed three times with PBS + 0.05% Tween-20 (pH 7.4) after each incubation and finally 
rinsed briefly with PBS before imaging. For fluorescent detection, the membrane was imaged 
using the LiCor Odyssey 9120 Imaging System (LiCor, Lincoln, NE, USA) with accompanying 
software. Statistical significance was determined through two-way ANOVA with Tukey test 
for multiple comparison. 
2.2.3 ChIP-seq 
2.2.3.1 Experiment 
Super-ovulation in 21-day old CBAF1 female mice was induced by injecting mice i.p with 5 
IU eCG and 5 IU hCG 46 h post-hCG. Mice were culled and dissected at 6 h post-hCG for 




liquid nitrogen and shipped in liquid nitrogen to Active Motif (Carlsbad, CA, USA) for ChIP-
seq. Two samples from at least 5 mice with a minimum of 1x107 cells were used for PGR ChIP 
(both replicates) and H3K27ac (one replicate). Briefly, cells were fixed in 1% formaldehyde 
for 15 minutes and quenched with 0.125 M glycine. Chromatin was isolated by the addition of 
lysis buffer, followed by disruption with a Dounce homogenizer. Lysates were sonicated and 
the DNA sheared to an average length of 300-500 bp. Lysate was precleared with protein A 
agarose bead (Invitrogen, Waltham, USA) and PGR ChIP was performed using antibodies as 
listed in Appendix 3. Protein-chromatin complexes were washed, eluted from beads and 
subjected to RNase and proteinase K treatment. Reverse crosslinking was through overnight 
incubation at 65oC. DNA was purified by phenol-chloroform extraction and ethanol 
precipitation. Isolated chromatin was confirmed using qPCR on specific genomic regions with 
expected PGR and H3K27ac interaction in triplicate using SYBR Green Supermix (Bio-Rad). 
Illumina sequencing libraries were prepared from the ChIP and input DNA by the standard 
consecutive enzymatic steps of end-polishing, dA-addition, and adaptor ligation. After a final 
PCR amplification step, the resulting DNA libraries were quantified and sequenced on 
Illumina’s NextSeq 500 (75 nt reads, single end). 
2.2.3.2 Bioinformatics analysis 
Bioinformatics analysis was conducted in a combination of R, web-based tools, software and 
Linux command line as per appropriate for the tool. An overall workflow chart and main 
bioinformatics tools used for bioinformatics analysis are as described in Figure 2.1 and Table 
2.2. Unless otherwise indicated, all analysis was performed using the mm10 assembly as the 
mouse genome. For all datasets, the quality of raw data was assessed using FASTQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc). Next, 75-base sequences were 
aligned using Bowtie2 algorithm 27. The reproducibility of biological replicates was assessed 
using Irreproducibility Discovery Rate (IDR) criteria 28. As the two replicates showed good 
level of correlation, peaks were called individually for each replicate. Peak calling from read 
count against input control followed the algorithm for MACS2 29 with a p-value cut-off = 10-
10 and a mouse genome size of 1.87x109. Initial analysis showed a high level of overlapping 
between replicates, with the majority of peaks called in replicate 2 identifiable in replicate 1, 
thus the overlapped peaks identified via ChIPpeakAnno package 30  in R were used as the 




conservative dataset. A summary of library size, sequence length, alignment rate and peak 
count is included in Appendix 4. 
 
 
Figure 2.1 Bioinformatics workflow for the analysis of ChP-seq data.  
Input sources are indicated in orange boxes. Steps in the analysis are indicated in blue boxes, 





Table 2.2 Tools used for bioinformatics analysis of ChIP-seq data 
Goal Package/tool Reference 
Conversion from SRA to FASTQ format SRA tools 
(http://ncbi.github.i
o/sra-tools/) 





Genome annotation Bowtie2 27 
Reproducibility of data IDR 28 
Read combination samtools 31 
Peak calling MACS2 29 
Peak visualisation on UCSC Genome Browser UCSC toolkits 32 
Circos plot plotting Rcircos 33 
Correlation via PCA deepTools 34 
Correlation via correlation coefficient deepTools 34 
Peak/Gene overlapping ChIPpeakAnno 30 
Read count frequency against TSS ChIPseeker 35 
Genome distribution ChIPseeker 35 
Canonical pathway - ChIP-seq GREAT 36 
Gene Ontology analysis GREAT 36 
Gene Ontology summary and visualisation REVIGO 37 
Canonical motif mapping MEME 38 
Known motif and de novo motif analysis HOMER 39 
Motif localisation HOMER 39 





Correlation of genomic coverage between ChIP-seq datasets was assessed through deeptools 
commands, with all correlation coefficients passing statistical significance 34. Genome 
distribution of peaks was determined using ChIPseeker package 35 in R, with gene boundaries 
set as ±3 kb of the transcription start site (TSS) / transcription end site (TES) (i.e. TSS - 3 kb 
assigned as promoter and TES + 3kb assigned as downstream) and regions that did not fall into 
this range considered to be distal intergenic. Read count frequency plotting was done using the 
ChIPSeeker package in R for peaks within ±3 kb of the TSS. Functional analysis of peaks, 
including canonical pathways and Gene Ontology analysis, was through GREAT 36. 
Visualisation of Gene Ontology result was through REVIGO 37. Functional analysis of 
microarray / RNA-seq identified differentially expressed genes (DEG) was through the IPA 
software (QIAGEN). For the identification of motif map on the whole mouse genome, the 




2.3) and mapping was conducted using the fimo command in MEME Suite 38. Motif analysis 
for known and de novo sequence motifs was performed using HOMER motif finding algorithm, 
with random 200 bp-long sequences from the mouse genome used to estimate motif frequency 
in random sequence (motif enrichment over background). For visualisation of ChIP-seq data 
on the UCSC Genome Browser in mm10 genome, output BEDGRAPH files from MACS2 
were processed and converted to BIGWIG files using the UCSC toolkit 40. Files were stored in 
the public server of Galaxy 41 and uploaded to the UCSC Genome Browser. Visualisation of 
PRE/NR3C loci are through GFF files generated from the fimo command in MEME Suite on 
the UCSC Genome Browser 38. All data are publicly available and both raw and processed data 
can be accessed from the GEO Database (GEO accession number: GSE115820). 
 
Table 2.3 Position weight matrix for the PRE/NR3C motif from HOMER Motif Database 
that was used for the identification of the motif map.  
Each row corresponds to a nucleotide in the consensus sequence and each column corresponds 
to nucleotide A, C, G or T. The number represents the probability of each nucleotide to be 






strands: + - 
 
Background letter frequencies (from unknown source): 
A 0.250 C 0.250 G 0.250 T 0.250 
 
letter-probability matrix: alength= 4 w= 13 nsites= 1 E= 0e+0 
 
0.000000 0.000000 1.000000 0.000000 
0.639000 0.087000 0.117000 0.157000 
1.000000 0.000000 0.001000 0.000000 
0.000000 1.000000 0.000000 0.000000 
0.919000 0.001000 0.001000 0.079000 
0.200799 0.171828 0.225774 0.401598 
0.383000 0.113000 0.109000 0.395000 
0.339339 0.303303 0.146146 0.211211 
0.000000 0.000000 0.000000 1.000000 
0.000000 0.000000 1.000000 0.000000 
0.000000 0.000000 0.000000 1.000000 
0.179000 0.146000 0.066000 0.609000 





Granulosa cells from super-ovulated CBAF1 female mice were collected at 46 h post-eCG or 
6 h post-hCG as previously described. Cells were fixed in 1% formaldehyde for 15 minutes at 
37oC and quenched with 0.125 M glycine for 10 minutes at room temperate. Cells were washed 
twice with cold PBS and lysed in lysis buffer (10 mM HEPES, 100 mM KCl, 0.5% NP-40) for 
30 minutes at 4oC. Lysate was sonicated using a Bioruptor Plus (Diagenode, Denville, NJ, 
USA) for 15 minutes at High setting, 30 secs on 30 sec off, then centrifuged at 10000 g for 15 
minutes to remove cell debris. To measure protein concentration, Bradford assay using Bio-
Rad Protein Assay Dye Reagent Concentrate (Bio-Rad) was performed, with bovine serum 
albumin (BSA) at concentrations of 40-640 µg/ml were used as protein standards and 
measurements taken in duplicate for each sample using the Synergy H1 Hybrid Reader 
(BioTek, Winooski, VT, USA) and the accompanying Gen5 2.00 software.  
 
For immunoprecipitation, Protein A+G magnetic beads (Merck, Burlington, MA, USA) was 
washed and blocked in BSA (1 mg/ml) and incubated with 4 µg antibodies (PGR or IgG control 
– Appendix 3) for 30 minutes at room temperature. Lysate was incubated with antibody-bound 
beads in IP buffer (25 mM Tris (pH 7.4), 5 mM EDTA, 150 mM KCl, 0.5 mM DTT, 0.5% NP-
40) for at least 16 h at 4oC, with one volume of lysate retained as lysate input. Beads were 
washed in IP buffer 5 times for 5 minutes each, then reverse crosslinking was by heating 
protein-bound beads and lysate input in proteinase K buffer for 30 minutes at 55oC. Lysate was 
removed from beads and DNA was purified using phenol extraction. Briefly, one volume of 
phenol:chloroform:isoamyl was added to the bead elute and lysate input, then DNA was 
precipitated from the aqueous phase at -80oC for at least 2 h by the addition of ammonium 
acetate and ethanol. Precipitated DNA was washed with 70% ethanol and eluted in 50 µl TEN 
buffer (0.01 M Tris-HCl pH 8, 1 mM EDTA pH 8, 0.1 M NaCl). 
 
qPCR was performed using SYBR Green Master Mix (Thermo Fisher) and primers specific to 
target chromatins of PGR as indicated in ChIP-seq. Primers are listed in Appendix 1. qPCR 
was run on the 7900HT Fast Real-Time PCR System (Applied Biosystems, Thermo Fisher) 
with the following thermal cycle settings: 50oC for 2 mins, 95oC for 10 mins, [95oC for 15 secs, 
60oC for 1 min] x 40 cycles. DNA enrichment result was presented as fold enrichment of PGR 






100 ∗  2𝐶𝑇𝑖𝑛𝑝𝑢𝑡−𝐶𝑇𝐼𝑔𝐺
 
CTinput : CT value of lysate input  
CTPGR : CT value of PGR elute 
CTIgG : CT value of IgG elute 
 
Statistical significance was determined through one-way ANOVA with Tukey test for multiple 
comparison. 
2.2.5 Microarray data 
Gene lists for granulosa cell microarray on PGRKO vs PGR+/± mice were originally from Lisa 
Akison’s thesis 42, now published and publicly available (GEO accession number: GSE92438) 
43. Canonical pathway analysis was performed using IPA software (Qiagen). 
 
2.3 RESULTS 
2.3.1 The expression of PGR in peri-ovulatory granulosa cells 
The temporal transcriptional pattern of Pgr expression during ovulation was confirmed by RT-
qPCR on mouse granulosa cells at various hCG-stimulated time points. The expression of Pgr 
was significantly and transiently induced during the pre-ovulatory period, being highest at 4 h 
post-hCG stimulation compared to later time points (Figure 2.2A). Western blot on protein 
extracts across the same time-course mimicked the mRNA expression and showed both 
isoforms – PGR-A (83 kDa) and PGR-B (115 kDa) – induced from 4 h post-hCG, achieving 







Figure 2.2 PGR mRNA and protein are induced by the LH surge in granulosa cells.  
(A) PGR mRNA expression in unstimulated (unstim) or eCG and hCG-primed granulosa cells 
in  eCG 44 h only (0 h) or eCG 44 h + hCG at the indicated times. Fold change is displayed as 
normalised to the housekeeping Rpl19 gene and relative to the unstim sample. N = 3 biological 
replicates, each replicate is from 3-5 mice per time point. Statistical significance was 
determined through one-way ANOVA with multiple comparison, p-value < 0.0001. Bars with 
different superscripts are significantly different. (B) Western blot of PGR in granulosa cells 
during ovulation (unstim or eCG + hCG 0-12 h post-hCG). Western blot was performed in N=3 
biological replicates, with 3-5 mice per time point per replicate. For each replicate, Western 
blot was performed for PGR (top panels) and H3 (bottom panel) as the nuclear control. 
Quantification of Western intensity for PGR-A (red bars) and PGR-B (blue bars) is displayed 
as fold change to the H3 and to the unstimulated sample. Statistical analysis was through one-





2.3.2 PGR-dependent transcriptome in peri-ovulatory granulosa cells 
To identify PGR target genes in granulosa cells, microarray analysis was performed on 
granulosa cells obtained at 8 h post-hCG stimulated PGRKO and PGR heterozygous female 
mice. Details for this experiment have been previously published 15. Selection criteria of p-
value ≤ 0.01 and |logFC| ≥ 1 were applied in order to determine DEGs from the total gene list 
and from the more than 20,000 genes originally identified in the microarray, 61 DEGs were 
selected (Appendix 5). Among these DEGs, almost all (60/61 genes) were downregulated in 
PGRKO granulosa cells, indicating that their induction is dependent on the presence of PGR, 
including known PGR target genes Zbtb16 and Adamts1 (Figure 2.3A and 2.3B). These DEGs 
belonged to a number of canonical pathways, including those specific to reproductive tissues 
such as oestradiol-dependent breast cancer signalling and ovarian cancer signalling (Figure 
2.3C). Interestingly, CXCR4 signalling pathway was one of the most enriched pathways, which 






Figure 2.3 PGR-dependent differentially expressed genes in PGRKO vs PGR+/- peri-
ovulatory granulosa cells.  
(A) Volcano plot of granulosa cell microarray data. The horizontal dashed line indicates p-
value cut-off (-log(p-value) ≥ 2). The vertical dashed lines indicate fold change cut-off (|logFC| 
≥ 1). Genes that meet these criteria are indicated in blue. Genes that have been selected for 
panel B are indicated in red. List of DEG is in Appendix 5. (B) Examples of genes that are 
significantly differentially expressed in PGRKO granulosa cells. (C) Canonical pathway 
analysis of PGR-regulated DEG identified in microarray. 61 DEG that were determined from 
granulosa cell microarray were analysed for enriched pathways using the IPA software. 





2.3.3 Characteristics of PGR chromatin-binding properties in peri-ovulatory 
granulosa cells  
2.3.3.1 Quality control of PGR ChIP-seq 
As seen from Figure 2.2A, the protein level of PGR was highest at 6 h post-hCG stimulation 
in granulosa cells, which suggested that PGR activity would be the highest at this time point 
and was thus chosen for investigation of PGR cistrome in granulosa cells. For this, ChIP-seq 
targeting PGR was performed on granulosa cells harvested at 6 h post-hCG stimulation. Two 
biological replicates were used for ChIP-seq, each with at least 1x107 cells, with the input 
control pooled from both replicates. Sequencing quality control for each replicate and the 
pooled input was conducted using the FASTQC package in R, which judged the quality of 
sequencing based on sequence quality, sequence content, GC content, length distribution, 
sequence duplication level and adaptor content. Overall there was no major failed flag in any 
of the dataset, thus no failed reads were removed and all sequences were included in the 
subsequent analysis.  
2.3.3.2 Assessing robustness and selection of consensus PGR binding sites 
To confirm the robustness of the ChIP-seq assay, the reproducibility of the biological replicates 
was investigated using IDR 28 criteria and the correlation between the two replicates was 
examined. IDR analysis showed the typical correlation pattern of peaks identified in high-
quality ChIP-seq data, including good consistency in peak ranking between the two replicates 
(Appendix 6A) and a pronounced inflection in the IDR-peak count curve. Further assessment 
also confirmed the level of correlation between the two replicates. The read count frequency 
of the two replicates relative to the TSS was highly similar (Appendix 6B), with binding sites 
from both replicates congregating near the TSS. Pearson correlation coefficient test showed 
that there was a high correlation between the two replicates, with a 0.95 correlation coefficient 
(Appendix 6C). An average of 24770 PGR peaks were identified, each duplicate having 31958 
and 17582 peaks respectively. Global comparison showed that the majority of binding sites in 
replicate 2 was in common with replicate 1 (accounting for 15553 binding sites, or 48.67% of 
replicate 1 and 88.46% of replicate 2) (Appendix 6D). The shared 15553 sites between the two 
replicates, aligning to 8656 genes, represented the most conservative set of binding sites and 





In-house PGR ChIP followed by qPCR also validated the reproducibility of the assay. ChIP 
was performed on mouse granulosa cells stimulated with eCG followed by 6 h hCG or no hCG, 
using a PGR antibody targeting a different immunogen from the one used for ChIP-seq (thus 
validating the specificity to PGR of the antibodies used). Purified chromatins following PGR 
pull-down were used for qPCR with primers specific to chromatin targets that were observed 
to have PGR binding or no PGR binding (negative control) via ChIP-seq. ChIP-qPCR results 
reflected the pattern previously observed and thus validated the ChIP-seq result, with PGR 
target chromatins being enriched in hCG-stimulated granulosa cells compared to unstimulated 






Figure 2.4 Validation of PGR ChIP-seq through ChIP-qPCR.  
ChIP-qPCR was performed on mouse granulosa cells obtained with (6 h) or without (0 h) hCG 
stimulation using antibodies for PGR or IgG negative control. Primers were designed against 
PGR binding sites according to ChIP-seq data and against a PGR non-binding region (negative 
control – NC). Data is normalised to IgG pull-down. Black bars are 6 h post-hCG and grey bars 
are 0 h post-hCG granulosa cells. Statistical difference between 6h and 0h samples was 
determined using two-way ANOVA test with multiple comparison. Asterisk indicates 





2.3.3.1 PGR preference for transcriptionally active promoters in granulosa cells 
As seen in the PGR-dependent transcriptome, PGR is responsible for the upregulation of gene 
expression, thus it is likely that PGR occupancy is enriched at transcriptionally active 
chromatin sites. To investigate this, PGR and H3K27ac occupancy in granulosa cells were 
analysed in parallel. Characterisation of TSS-proximal PGR and H3K27ac peaks showed that 
both were highly enriched very close to TSS; furthermore, the two datasets displayed a 
commonly observed pattern to previously shown H3K27ac-transcription factor topography, 
with PGR peaks generally falling into the valley of two flanking H3K27ac peaks (Figure 2.5A). 
Approximately three-quarters of PGR binding sites overlapped H3K27ac peaks that were 
associated with 6385 genes (Figure 2.5B), suggesting that PGR indeed mostly binds to 
transcriptionally active regions. Interestingly, 61.88% of the overlapping PGR and H3K27ac 
peaks were situated in promoter regions, mostly within 1 kb of a TSS. Conversely, non-
overlapping PGR or H3K27ac peaks were relatively randomly distributed in relation to gene 
structures. In the case of PGR-unique peaks, nearly 40% of identified peaks fell within 
genebodies, mostly in intergenic and intronic regions. An example of H3K27ac and PGR 
colocalisation is depicted in a section of chromosome 3, in which the majority of PGR binding 
sites overlapped with H3K27ac sites, especially in proximity to a genebody (Figure 2.5C). This 
was also observed in PGR-regulated genes; for example in Mt2, a PGR-induced gene in 
granulosa cells as determined in the PGRKO transcriptome (Figure 2.5D), prominent PGR 
peaks overlapping with H3K27ac peaks were detected surrounding the TSS of the gene, most 
notably in the proximal 5’ region, suggesting that this region is a PGR-responsive promoter 










Figure 2.5 PGR associates with transcriptionally active promoters in granulosa cells.  
(A) Read count frequency of PGR peaks (orange) and H3K27ac peaks (green) in relation to 
transcription start sites (TSS). (B) Venn diagrams showing the peak count for PGR and 
H3K27ac and genes with peaks. In each case > 70% of PGR peaks overlap with H3K27ac 
peaks. Genome distribution of PGR in association with H3K27ac is shown on the right. 
Genome distribution is displayed as stacked bar graphs and peaks were divided into PGR-
unique (top), PGR/H3K27ac overlap (middle) and H3K27ac-unique (bottom). Genomic 
features include promoters (< 1 kb, 1-2 kb and 2-3 kb), 5’ UTR, 1st intron, other introns, exons, 
3’ UTR and downstream of TES (within 3 kb). Peaks that are not in these features are classified 
as distal intergenic. (C) Example of H3K27ac and PGR binding sites in the mouse genome 
visualised through UCSC Genome Browser. Tracks are located at chromosome 3 and 
normalised to the same scale. Genes and direction of transcription are indicated by black 
arrows. From top to bottom: H3K27ac (green), PGR (orange) and input control (purple). (D) 
Example of H3K27ac and PGR binding sites at the genomic region for Mt2. The red arrow 







2.3.3.2 Functional consequences of the PGR cistrome 
In order to obtain a scope of the role of PGR chromatin binding in transcription regulation in 
peri-ovulatory granulosa cells, genes identified in the PGR cistrome were also compared with 
the ovulation transcriptome, obtained from RNA-seq of granulosa cells from 8 h post-hCG 
treated mice (Appendix 7). Among the 2179 genes identified in RNA-seq, one-third (or 750 
genes) were overlapped with genes annotated to PGR peaks (Figure 2.6A). Interestingly, PGR 
peaks in association with peri-ovulatory transcriptome were prominently enriched in promoter 
regions (about 40%). These results suggest that indeed PGR employs interaction with the 
promoter region to regulate target genes. 
 
The functional impact of PGR cistrome was assessed on a global scale through pathway and 
Gene Ontology enrichment analysis of PGR peaks in conjunction with H3K27ac peaks. The 
results showed that PGR and H3K27ac peaks showed functional similarities, with both datasets 
being enriched for pathways involving cell cycle, transcription and translation regulation 
(Figure 2.6B) and similar ontological terms identified in both groups (Figure 2.6C). This 
showed that not only did PGR and H3K27ac shared spatial interaction at the chromatin level 






Figure 2.6 Consequence of PGR binding on PGR-dependent gene expression and peri-
ovulatory transcriptome.  
(A) Venn diagram showing DEG in 8 h post-hCG granulosa cell RNA-seq (ovulatory DEG) in 
relation to genes with PGR binding sites from ChIP-seq (top) and genome distribution of PGR 
peaks identified in peri-ovulatory transcriptome (bottom). (B) Top ten most enriched pathways 
associated with binding sites for H3K27ac (green) and PGR (orange). Bars indicate fold 
enrichment of pathways (bottom x axis). Circles indicate -log(FDR) value (top x axis). (C) 
Gene Ontology analysis of PGR and H3K27ac binding sites. Ontological terms associated with 
biological processes were obtained from analysis of PGR and H3K27ac ChIP-seq and 
condensed using REVIGO. Each reduced term is displayed as a circle with the diameter 
correlating to the -log10(p-value) of said term. Terms of the same umbrella of biological 




2.3.3.3 PGR interacts with PRE as well as non-canonical chromatin motifs 
Canonically, PGR is known to interact with the PRE sequence (more generically the NR3C 
motif, termed PRE/NR3C from now) at target promoters in order to regulate gene expression. 
However, as PGR shared a response element with other NR3C receptors, such as AR and GR, 
it is likely that PGR only binds to a selective number of PRE/NR3C loci in the genome. In 
order to investigate the extent of PGR binding coverage on PRE/NR3C motif, PGR peaks in 
granulosa cells were compared against global PRE loci in the mouse genome. Using a stringent 
PRE sequence that is restricted to only full-site PRE (Table 2.3), 37869 loci were identified on 
the DNA plus strand (or 75607 loci on both strands), among which 642 were bound by PGR, 
representing 4.43% of PGR binding peaks (Figure 2.7A). As PGR can bind to both 
transcriptionally active and inactive chromatins, the possible difference in the level of PRE 
occupancy between chromatins in different active states was also investigated through parallel 
analysis of PGR and H3K27ac binding sites for overlap with the stringent global PRE map. 
Approximately half of previously identified PGR binding at PRE loci was shared with 
H3K27ac (344 sites), which suggested that the chromatin state, while important, was not 
critical in allowing PGR to bind to PRE and also meant that PGR recruitment to active 
chromatin is not solely reliant on binding to PRE. Interestingly, H3K27ac could also bind PRE 
loci independently of PGR binding, suggesting the possibility that other transcription factors, 
likely other members of the NR3C family, also functioned through the canonical NR3C 
pathway in peri-ovulatory granulosa cells. Genome distribution analysis showed that PRE loci 
tended to be found in distal intergenic regions, an understandable result given that the majority 
of the genome is not defined as genes. In comparison there was an enrichment for proximal 
promoter-occupied PRE among PGR-H3K27ac shared peaks, supporting the concept that PGR 
interacts with transcriptionally active promoters and to some extent via interaction with the 






Figure 2.7 PGR binding properties to the canonical PRE motif in granulosa cells.  
(A) Venn diagram showing PGR peaks from ChIP-seq in relation to genome-wide consensus 
PRE locations. PRE sites within the entire mouse genome were identified using FIMO in 
MEME Suite searching for the consensus PRE sequence. 5% of PGR peaks overlapped with 
these consensus PRE sites. (B) Genome distribution of total PRE loci (left) and PRE loci that 





Apart from the canonical pathway, PGR binding has also been implied at chromatins without 
the PRE/NR3C motif. An example of a non-canonical PGR-binding region is shown for the 
Adamts1 gene, a well characterised PGR-regulated gene in granulosa cells. Reporter assays 
have shown that PGR is important for the regulation of Adamts1 proximal promoter 22 and this 
was confirmed with identified distinct PGR ChIP peaks in this region (Figure 2.8A); however, 
the sequence at this site contains no identifiable PRE/NR3C motif. Rather, there were three 
G/C-rich boxes in the sequence previously determined to be SP1/SP3-binding sites and were 
critical for the PGR-mediated induction of Adamts1 22. Together with the fact that there is a 
low level of PRE loci occupied by PGR binding indicates that apart from the known chromatin 
motif, the majority of PGR-chromatin binding is not restricted to a recognised canonical 
PRE/NR3C. To determine other sequence motifs through which PGR commonly interacts in 
granulosa cells, analysis of enriched motifs in the PGR ChIP-seq peak dataset was performed 
using HOMER. The canonical PRE/NR3C sequence was the most enriched motif (7.2-fold) in 
the ChIP-seq data compared to the predicted random occurrence of this sequence motif (Figure 
2.8B). This motif was also enriched in PGR peaks in association with ovulatory DEGs as 
identified from peri-ovulatory granulosa cells. Interestingly, a number of other transcription 
factor binding motifs were also significantly enriched, albeit at lower level than PRE/NR3C. 
Among the top enriched known motifs were those that were targeted by transcription factors 
belonging to bZIP (JUN/FOS), GATA, NR5A2 nuclear receptor, bZIP (CEBP) and RUNT 
families, which were also identified in DEG-binding PGR peaks except for the NR5A motif. 
de novo motif analysis, which identified the actual enriched sequences without presumptive 
assignment to known motifs, highly reflected the known motif results, with sequences most 
likely matched to bZIP (JUN/FOS), PRE/NR3C, RUNT, NR5A2, CEBP and GATA motifs 
being the most enriched in the ChIP-seq dataset (Figure 2.8C). Interestingly, the majority of 
highly enriched motifs localised near the PGR peak centre, especially within 100 bp of peak 
centre (Figure 2.8D). More specifically, there was a high enrichment of the canonical 
PRE/NR3C motif at the peak centre as expected, whereas for other motifs the localisation range 
was relatively wider, especially in the case of NR5A and RUNT motifs. This was strikingly 
different to the motif localisation pattern seen in H3K27ac peaks, in which the bZIP (JUN/FOS) 
and NR5A2 displayed a two-peak pattern flanking approximately 200 bp on either side of 
H3K27ac peaks and other motifs were much less enriched. Together these findings indicate 
that PGR selectively binds to a specific subset of PRE/NR3C in this target cell genome and 
also potentially acts in conjunction with other transcription factors to regulate gene expression, 









Figure 2.8 Properties of PGR-binding motifs in granulosa cells.  
(A) PGR binding sites in the mouse genome visualised through UCSC Genome Browser. The 
track shown is located in chromosome 16 at the genomic region for Adamts1. The red arrow 
indicates the TSS (arrow tail) and direction of transcription. The sequence of the most 
prominent PGR peak is listed below, with the TATA box underlined and previously described 
PGR-binding G/C-rich sites in red. (B) Top most common known sequence motifs found to be 
enriched at PGR binding sites in granulosa cells (orange) and PGR binding motifs in ovulatory 
DEG from RNA-seq (aqua). Bars indicate fold enrichment of motif to background (bottom x 
axis). Circles indicate -log(p-value) (top x axis). Motifs were ranked by -log(p-value). Where 
multiple motifs belonging to the same transcription factor family were identified, only a 
representative that was the most enriched by fold-change over background is displayed in the 
graph. (C) De novo motifs identified by HOMER from PGR binding cistrome. Motifs selected 
to display here are based on p-value and the most enrichment from each transcription factor 
family. (D) Heatmap displaying the localisation of motifs in relation to PGR (left) and 
H3K27ac (right) peak centre. Motifs previously identified in (B) were analysed for distribution 







It is known that PGR plays diverse roles in reproductive tissues, enabling P4-PGR signalling 
to coordinate various physiological processes in female reproduction. In the ovaries in 
particular, PGR is induced in granulosa cells of antral follicles by the LH surge and is a key 
determinant in ovulation, thus is crucial for female fertility. While the physiological effects of 
PGR and a handful of PGR downstream target genes have been investigated over the years, a 
full picture of the PGR transcriptome remains unclear. More importantly, as our understanding 
of context-specific molecular mechanisms of steroid receptor in influencing transcription 
regulation expands, it is important to characterise the PGR cistrome in peri-ovulatory granulosa 
cells to gain a full appreciation of the PGR ovulatory roles.  
 
In peri-ovulatory granulosa cells, PGR strongly favours interaction with transcriptionally 
active promoter regions, with more than half of shared PGR/H3K27ac binding sites found 
within 3 kb of TSS. Such a phenomenon seems to be specific to granulosa cells, for in other 
cellular contexts, less than 25% of total PGR binding is in upstream proximity to TSS 20,44. 
This is further highlighted in the degree of promoter enrichment in PGR binding sites that are 
found in proximity to ovulatory genes as indicated through hCG-stimulated granulosa cell 
RNA-seq, with more than one-third of PGR binding sites found in the proximal promoter 
regions 3 kb upstream of TSS. This confirms the importance of the classic transcriptional 
regulatory mechanism of direct promoter binding in PGR ovulatory functions. Apart from the 
strong enrichment of PGR binding at proximal promoter regions, PGR binding sites can also 
be distributed elsewhere in the genome, especially within intronic and intergenic regions. This 
suggests that PGR can exert influence on downstream target genes without binding their 
promoters and rather through other means, for example enhancer elements that are either distal 
or intronic. The role of PGR in enhancer actions has been previously described, such as in 
regulating the uterine expression of Ihh 17, Rankl and calcitonin genes 45. In the context of 
ovulation however, the enhancer role of PGR has not been previously described. The lack of 
direct PGR promoter binding can be observed in known PGR target genes, such as Zbtb16, 
Ereg and Pparg. In these instances, PGR binding can be found within the genebody, especially 
in introns. Whether such intronic binding is critical for the regulation of these genes or whether 
PGR actions are via interaction with unidentified enhancer sites that are distal to these target 
genes through chromatin looping is still unknown. As enhancer actions and chromatin 




as well as topologically associating domains (TAD) specific to granulosa cells during ovulation 
would be required to determine whether PGR is acting in conjunction with any distal regulatory 
elements to regulate these genes.  
 
Another important discovery in the PGR cistrome is the presence of other non-canonical motifs 
that are enriched alongside the consensus motif at PGR binding sites. Aside from the 
PRE/NR3C motif, those that are canonically recognised by other transcription factor families 
were also enriched at various levels and excitingly, ovulatory functions have previously been 
indicated in members of these families, which emphasises functional similarities between PGR 
and other transcription factors in granulosa cells. The range of non-PRE/NR3C motifs enriched 
in the PGR-bound intervals included those for bZIP (JUN/FOS), GATA, NR5A2 and RUNT 
families. These findings indicate that unique interactions of PGR with bZIP (JUN/FOS), 
NR5A2, RUNT and GATA may each contribute to the granulosa-specific PGR action in 
ovulation. These partner transcription factors potentially regulate granulosa-specific chromatin 
remodelling to establish accessibility to specific PRE/NR3C as pioneer factors or through 
direct protein-protein interactions with PGR; suggesting that in granulosa cells, PGR not only 
utilises direct PRE/NR3C-binding to interact with target chromatin but also that tethering of 
PGR to target chromatin domains through alternative accessory transcription factors is 
responsible for the functional diversity in granulosa cells. Supporting this hypothesis, this study 
demonstrates the previously hypothesised binding of PGR to specific G/C-rich sites in the 
Adamts1 gene promoter, which contains no PRE/NR3C motif but has been shown through 
promoter-reporter analysis to be required for PGR-dependent induction of Adamts1 
transcription 22.  This model of SR-comodulator cooperation has also been previously described 
for GR and AR.  Specifically, GR transcriptional regulation in endometrial cells is also shown 
to rely on association with pioneer factors, including FOXA1 along with the canonical 
PRE/NR3C 46 and likewise, the switch in AR action in normal versus malignant prostate cancer 
is related to context-specific interactions with FOXA1 or JUN/FOS co-regulators 47. Recent 
studies of PGR in progesterone-primed uterus have indicated GATA2 as a candidate partner of 
PGR action in uterine tissue 17 and JUN/FOS proteins to be in contact with PGR in an isoform-
specific manner in the myometrium 48. Taken with these previous reports of steroid receptor 
tethering to non-canonical motifs through accessory factors, these findings support a 
mechanism whereby granulosa-specific PGR action is mediated by interaction of PGR with 
JUN/FOS, NR5A2 and RUNT transcription factors. While the in silico analysis can only act 




for PGR can be selected for future investigations, which will require other protein-protein 
assays such as immunoprecipitation, mass spectrometry or proximity ligation assay.  
 
Importantly, these findings do not undermine the importance of the canonical pathway of PGR 
in which binding of PRE/NR3C is employed to recruit PGR to target chromatin sites. In 
granulosa cells, the consensus PRE/NR3C motif (5’-GnACAnnnTGTnC-3’) dominated 
amongst genome-wide PGR-bound sequences, implying that the main mode of PGR function 
is through directly binding chromatin via the canonical PRE/NR3C motif. However, as more 
than 98% of PRE/NR3C loci are not utilised by PGR in granulosa cells, certainly specific 
regulatory mechanisms are at play in determining the selection of appropriate target sites in the 
context of peri-ovulatory granulosa cells. Likely that such specificity is determined through the 
activities of other transcription factors acting in conjunction with PGR, either as pioneer factors 
or through a role as chromatin remodellers, in order to tether PGR to selective chromatin 
targets. Thus, future studies into the specificity of PGR in different biological contexts will 
benefit from taking into account the relevant interactomes. 
 
This chapter is the first to define the genome-wide PGR cistrome in granulosa cells in response 
to the ovulatory signal, when PGR induction and its response to progesterone are essential for 
ovulation and hence female fertility. The application of genome-wide microarray in PGRKO, 
RNA-seq and PGR ChIP-seq in granulosa cells allows us to investigate the impact of PGR 
chromatin binding events on the PGR-dependent transcriptome as well as the global ovulatory 
transcriptome. PGR was shown to favourably interact with transcriptionally active promoter 
regions, with profound importance on the regulation of PGR-dependent as well as the global 
ovulatory gene profile. Motif analysis of PGR binding sites indicated a role of a transcription 
complex responsible for the regulation of ovulatory genes with a multitude of specific 
ovulatory factors acting in conjunction with PGR. This new knowledge of PGR cistromic 
activities in granulosa cells will be useful in discerning differences in the physiological roles 
of PGR in the context of different reproductive tissues. These differences will be investigated 
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CHAPTER 3 Tissue-specific PGR cistromes and consequences 




PGR is expressed in various parts of the female reproductive tract and shows distinct functions 
that are highly dependent on the tissue context, which has been revealed in studies on PGRKO 
animal models. In the ovary, PGR is transiently expressed in granulosa cells in response to the 
LH surge 1,2 and is a key factor in ovulation, which is illustrated in an anovulatory phenotype 
in PGRKO female mice 3.  PGR is also involved in biological processes in other parts of the 
female reproductive tract in preparation for pregnancy and during parturition. In the oviduct, 
PGR is involved in the transporting of oocytes and embryos through regulating ciliate 
movement 4 and in the uterus PGR is involved in preparation for embryo implantation 3 as well 
as inducing human labour at term 5. Prior to pregnancy, PGR functions are initiated by 
progesterone production in response to the LH surge; however, exactly how such diverse roles 
are achieved through the same endocrine factor is still not well understood. 
 
As PGR is known as a transcription factor that regulates gene expression, differences in PGR 
functions are likely due to specific gene expression regulation patterns that are PGR-dependent 
in different tissue contexts. In these various cell types, PGR mediates distinct genes that are 
critical for tissue-specific functions. For example, PGR modulates genes that are important for 
ovulation in granulosa cells (Adamts1 6, Areg and Ereg 7) and importantly also promotes the 
expression of a number of transcription factors, for instance Pparg and Hif1a 8,9, defining the 
role of PGR in initiating the ovulatory transcriptional cascade. In the oviduct, PGR is found to 
regulate Myocd and Edn3 that are important for muscle contraction and epithelial cell secretion 
10, whereas in the progesterone-responsive uterus PGR modulates the expression of Gata2 and 
Ihh 11. While the PGR-derived transcriptome has been profiled in different reproductive 
contexts, there has been no consolidation of these data in an attempt to explain the tissue 





PGR exerts its transcriptional regulatory role mainly through the canonical molecular 
mechanism, which involves the activation of PGR through ligand binding, nuclear 
translocation, dimerisation and interaction with the canonical PRE/NR3C motif at target DNA. 
Genes without the PRE/NR3C motif in their regulatory regions can also be indirectly 
influenced by PGR through an interaction with intermediate transcription factors. An example 
of this is shown in the PGR-induced Adamts1 gene in granulosa cells which possesses SP1/SP3 
binding sites that are critical for PGR regulation of this gene 12. Instances of PGR binding at 
non-canonical DNA targets have also been identified in the uterus, especially in the regulation 
of Zbtb16 11,13. However, it is unknown whether such mechanism is also employed by PGR in 
granulosa cells. 
 
Due to the highly selective roles of PGR in different tissue contexts, it is vital that differences 
in the PGR transcriptional regulatory pathways are clarified. The specific roles of PGR in 
different tissue contexts have been previously examined in normal vs cancerous human 
mammary cell lines 14 as well as between human breast cancer and uterine leimyoma that are 
positive for PGR 15. In all of these comparisons, PGR has been shown to hold distinct cistromic 
properties. However, such comparisons were made in the context of cancers where PGR actions 
are of particular interest, yet in the normal reproductive tract where PGR has prominent but 
different functions, no studies have yet investigated how the specialised physiological roles in 
different reproductive organs are achieved through the same receptor signalling mechanism. 
Thus, such characteristics cannot be implied for PGR action in the reproductive tract, making 
it valuable to actively investigate these contrasting regulatory mechanisms in the context of 
female reproduction, which is crucial in understanding the mechanisms that are responsible for 
the diversity in PGR action between different target tissues. 
 
The PGR cistrome and transcriptome in peri-ovulatory granulosa cells have been established 
in Chapter 2, in which direct PGR binding at transcriptionally active promoters was found to 
be crucial for PGR-regulated gene expression. Furthermore, potential co-modulators of PGR 
were identified that might play a role in modulating the ovulatory role of PGR in granulosa 
cells. In following that, this chapter investigated the diverse reproductive roles of PGR on a 
genomic level. First, tissue-specific PGR-dependent transcriptomes were defined from 
microarray analysis of PGRKO granulosa cells, the oviduct and uterus, followed by 




uterus in order to determine unique context-specific molecular mechanisms involved in PGR 
action in reproduction. 
 
3.2 MATERIALS & METHODS 
3.2.1 Animals 
CBFA1 mice were obtained from The University of Adelaide, Laboratory Animal Services. 
All mice were maintained in 12 h light /12 h dark conditions and given water and rodent chow 
ad libitum. All experiments were approved by The University of Adelaide Animal Ethics 
Committee and were conducted in accordance with the Australian Code of Practice for the Care 
and Use of Animals for Scientific Purposes (ethics no m/2015/075). 
3.2.2 ChIP-seq  
3.2.2.1 Experiment 
PGR ChIP-seq on granulosa cells was performed as part of the experiments described in 
Chapter 2 (section 2.2.3.1). Briefly, super-ovulation in 21-day old CBAF1 female mice was 
hormonally stimulated with eCG and hCG, then culled and dissected at 6h post-hCG for whole 
ovary extraction. PGR ChIP-seq was performed by Active Motif on two biological replicates 
of granulosa cells from at least 5 mice each with a minimum of 1x107 cells. Briefly, cells were 
fixed in formaldehyde and lysed in lysis buffer, then chromatin was sonicated and precleared 
with agarose beads. PGR pull-down was through an antibody for PGR as indicated in Appendix 
3. PGR-associated chromatin was washed, eluted from beads, treated with proteinase K and 
RNase. DNA was purified through phenol-chloroform extraction and ethanol precipitation. 
Illumina sequencing libraries were prepared from the ChIP and input DNA by the standard 
consecutive enzymatic steps of end-polishing, dA-addition, and adaptor ligation. After a final 
PCR amplification step, the resulting DNA libraries were quantified and sequenced on 
Illumina’s NextSeq 500 (75 nt reads, single end). PGR ChIP-seq on progesterone-treated uterus 
has been published 13; briefly, 6-week old ovariectomised female C57BL/6 mice were 
administered subcutaneously with vehicle (oil) or 1 mg P4 and the uterus was dissected 1 h 
after injection. Sample processing and ChIP-seq was as described above. The raw sequencing 




3.2.2.2 Bioinformatics analysis 
Bioinformatics analysis was conducted using appropriate tools as described in Section 2.2.3.2. 
Quality check of sequencing data for all samples showed no warnings. Genomic alignment and 
peak calling from read count against input was as previously described. A summary of library 
size, sequence length, alignment rate and peak count is shown in Appendix 5. Downstream 
analysis of peaks was as previously described in section 2.2.3.2. The obtainment of the global 
PRE/NR3C map was as described in section 2.2.3.2. 
3.2.3 Microarray analysis 
Gene lists for oviduct and uterus microarray on PGRKO vs PGR+/± mice were from previously 
published datasets 10,11,16. Gene lists for granulosa cell microarray on PGRKO vs PGR+/± mice 
were originally from Lisa K Akison’s PhD thesis 17, now published and publicly available 
(GEO accession number: GSE92438) 18. Upstream regulator analysis was performed using IPA 
software (Qiagen) and regulators belonging to category ‘ligand-dependent nuclear receptor’ 
and ‘transcription regulator’ were selected. P-value ≤ 0.01 and |logFC| ≥ 1 criteria were applied 
to obtain significant DEG for subsequent comparisons. Gene Ontology analysis was performed 
using R packages and canonical pathway analysis was performed using IPA software as listed 
in Figure 2.1 and Table 2.2. 
 
3.3 RESULTS 
3.3.1 PGR regulates specific transcriptomes in granulosa cells, oviduct and 
uterus 
PGR exhibits tissue-specific functions in the reproductive tract, most likely due to the different 
PGR-regulated transcriptome profile in these tissues. In order to confirm this hypothesis the 
difference in PGR target genes in reproductive tissues was demonstrated by comparing PGR-
dependent DEGs identified by microarray analysis of PGRKO mouse uterus and oviduct with 
those in granulosa cells. Gene lists were obtained from the original analysis done for each tissue 
type and the uniform DEG selection criteria were applied as previously described. Through 
this, 41 and 81 DEGs were identified in the uterus and oviduct, respectively, which are listed 
in Appendix 8 and Appendix 9. Comparison between the three tissues showed few overlaps 
between PGR-dependent gene sets – only 7 genes were differentially expressed in more than 




genes, Efnb2, was regulated in the inverse manner between granulosa cells and uterus, being 
significantly upregulated (2.2-fold) in PGRKO uterus yet downregulated (3.7-fold) in 
granulosa cells. Upstream regulator analysis via IPA for each tissue showed that for all three, 
PGR was confirmed within the top 10 candidates and regulating the same number of genes in 
each tissue (5-7 genes), alongside other potential transcription factors (Figure 3.1B). Gene 
Ontology and pathway analysis also showed a wide range of unique ontological terminologies 
and molecular pathways enriched in each tissue (Figure 3.1C, Figure 3.2). These confirm that 










Figure 3.1 Differences in PGR-regulated transcriptome in granulosa cells, oviduct and 
uterus.  
(A) Venn diagram of DEG identified in PGRKO vs PGR+/± granulosa cells (orange), oviduct 
(green) and uterus (blue). DEG was compiled from independent microarrays performed on 
PGRKO vs PGR+/± uterus, oviduct and granulosa cells with full gene lists available in 
Appendix 5, 8 and 9. Overlapped genes that were identified in more than one tissue type, with 
accompanied PGRKO to PGR+/± fold change are listed in the table. (B) Upstream regulators 
of DEG in granulosa cells (orange), oviduct (green) and uterus (blue) as identified through IPA, 
showing the top 10 identified regulators (p-value cut-off = 0.05). (C) Gene Ontology analysis 
of DEG in granulosa, oviduct and uterus. Ontological terms associated with biological 
processes were obtained from analysis of DEG in granulosa cells, oviduct and uterus and 
condensed using REVIGO. Each reduced term is displayed as a circle with the diameter 
correlating to the -log10(p-value) of said term. Terms of the same umbrella of biological 











Figure 3.2 Canonical pathway analysis of DEG in the uterus, oviduct and granulosa cells.  
DEG were subjected to analysis using IPA software with core analysis on default setting. 
Pathways were selected for those with -log(p-value) ≥ 2 in at least one tissue. -log(p-value) is 
shown for each tissue type – uterus (blue), oviduct (green), granulosa cells (orange). When a 





3.3.2 Characteristics of PGR chromatin-binding properties in progesterone-
responsive uterus  
In order to discern the difference in progesterone-responsive PGR cistrome in granulosa cells 
versus uterus, first the PGR cistrome in uterus in response to P4 or vehicle (oil) treatment at 4 
h post-stimulation was investigated which has been previously described 13. To reduce bias that 
might occur due to differences in analysis and make it more comparable to the granulosa cell 
ChIP-seq data, the uterus ChIP-seq data was re-analysed in parallel to granulosa cell ChIP-seq, 
using the latest mouse genome assembly (mm10). This analysis was also helpful in validating 
the bioinformatics workflow that was created for granulosa cell ChIP-seq.  
 
Characterisation of TSS-proximal PGR peaks in both treatments showed a similar 
topographical pattern of chromatin binding in each treatment (Figure 3.3A). Overall 13240 
binding sites were identified in P4-treated uterus and 3004 in oil treatment (Figure 3.3B), 
among which 2218 sites (or 74% of oil-identified peaks and 16% of P4 peaks) were shared 
between the two treatments. This indicates that while there was a basal level of PGR-chromatin 
occupancy in the absence of PGR ligand, treatment of P4 not only sustained the majority of 
basal binding but also led to an increase in PGR chromatin occupancy. Interestingly, PGR 
peaks in the uterus showed a strong inclination for intergenic region binding regardless of the 
treatment, with a minimum of 40% of peaks unique to each treatment as well as peaks shared 
in both being found in distal intergenic regions (Figure 3.3C). In comparison, occupancy in the 
promoter region was remarkably low, with less than 20% of peaks found in the proximal 
promoter region. An example of PGR occupancy with and without ligand is shown for two 
PGR-regulated genes in the uterus as identified through microarray. Mthfd2, which is 
upregulated in P4-treated uterus, possessed intense PGR binding signals that were not observed 
in oil-treated uterus (Figure 3.3C). Klf6, a gene downregulated in P4 treatment, exhibited 
prominent PGR binding in its proximity in and oil treatment that were also found in P4 
treatment (Figure 3.3D). These confirm that PGR is capable of binding chromatins despite the 











Figure 3.3 Correlation between PGR binding sites in uteri treated with P4 or vehicle 
control.  
(A) Read count frequency of PGR ChIP-seq peaks in P4 treatment (light blue) or oil treatment 
(dark blue) in relation to the TSS. (B) Venn diagrams showing the peak count for P4 and oil 
treatments (left) and gene with peaks (right). Peaks were divided into oil-unique (top), 
treatment overlap (middle) and P4-unique (bottom) for genomic distribution analysis. Genome 
distribution is displayed as stacked bar graphs and includes promoters (< 1 kb, 1-2 kb and 2-3 
kb), 5’ UTR, 1st intron, other introns, exons, 3’ UTR and downstream of TES (within 3 kb). 
Peaks that are not in these features are classified as distal intergenic. (C) Example of P4-
specific PGR binding sites at the genomic region for Mthfd2. Tracks are normalised to the same 
scale, with signal track for P4 treatment (light blue) and oil treatment (dark blue). The red arrow 
indicates the TSS (arrow tail) and direction of transcription. (D) Example of PGR binding sites 





Distinctions in PGR binding properties in the uterus might be due to differences in PRE loci 
preference in the presence or absence of ligand. To investigate this, PGR cistrome in P4 and 
oil treatment was compared against global PRE map. P4-induced as well as basal (oil) binding 
sites showed a relatively high level of PRE occupancy (approximately 11% in each treatment) 
(Figure 3.4A). However, the majority of occupied loci in the oil treated were also found in the 
P4 condition (98% of sites), once again showing that PGR binding is independent of the 
presence of P4. Among PGR-occupied PRE/NR3C loci, there was a slight increase in promoter 
enrichment, however the majority of loci was still found in the intergenic region (Figure 3.4B). 
To further investigate the nature of PGR-bound chromatins in the uterus, enriched motifs were 
discovered in PGR peaks with and without P4 treatment. The canonical PRE/NR3C motif was 
very highly enriched in both treatments (18.6-fold in P4 and 17.3-fold in oil) (Figure 3.4C). 
Other transcription factor binding motifs, including GATA, Homeobox, ERE and bZIP, were 
also enriched albeit at a much lower relative level, which was also supported by de novo motif 
analysis (Figure 3.4D-E). This showed that in the uterus, PGR binding of PRE/NR3C was 










Figure 3.4 Properties of PGR-binding motifs the uterus.  
(A) Venn diagram showing PGR peaks from P4 and oil ChIP-seq in relation to global PRE 
loci. 13% of PGR-bound peaks in presence of P4 overlap with PRE sites. (B) Genome 
distribution of total PRE loci (top) and PRE loci that had PGR binding with oil treatment 
(middle) and P4 treatment (bottom), as extracted from (A), convergent areas. (C) Heatmap 
showing most common known transcription factor recognition motifs found to be enriched at 
PGR binding sites in the uterus in P4 or oil treatment. Motifs were ranked by -log(p-value) and 
among motifs from the same transcription factor family, the one that was most enriched by fold 
enrichment to background frequency is displayed in the graph. (D) De novo sequences 
identified by HOMER enriched in PGR-bound peaks after P4 treatment. Motifs presented are 
those from each transcription factor family with the most significant p-value and the most 





3.3.3 Distinctions between PGR cistrome in granulosa cells vs uterus 
PGR resulted in different transcriptomes and functional profiles in different reproductive 
tissues, for which it was hypothesised that differences in the cistromic properties were 
responsible. The difference between PGR chromatin binding properties between granulosa 
cells and uterus was confirmed through examining the correlation between the two PGR 
cistromes, with the Pearson correlation coefficient between 0.63-0.68 for granulosa cells/uterus 
data pairs (Figure 3.5A). Plotting of the read count frequency in relation to TSS for 
progesterone-responsive PGR binding sites in granulosa cells and uterus showed that while 
PGR was enriched in close proximity to the TSS in both tissues, this was much more 
pronounced in granulosa cells than in the uterus (Figure 3.5B). Overall there were 1206 binding 
sites shared between granulosa cells and uterus, accounting for approximately 810 annotated 
genes or 9% of all peaks in each tissue (Figure 3.5C). Analysis of genome distribution 
highlighted significant differences between the two tissue types, with peaks found only in the 
uterus being most enriched in the distal intergenic regions (42%). Granulosa-unique peaks 
however were most likely to be found in the proximal promoter regions (51%), especially 
within 1 kb of the TSS. Instances of differential PGR binding in granulosa cells and uterus 
could be seen in Figure 3.5D, in which PGR-dependent genes in each tissue, such as Wnt11 in 
the uterus and Abhd2 in granulosa cells, possessed tissue-unique PGR binding sites. PGR also 
bound to introns of many genes, such as in Zbtb16, a PGR-dependent gene in mouse granulosa 
cells which has also been reported as PGR-induced in human and mouse endometrial stromal 
cells19. Despite Zbtb16 being PGR-regulated in both tissues, the PGR interaction profile 
between the uterus and ovary was distinctive. While there were shared peaks between the two 
tissues, granulosa cells also exhibited a number of specific peaks and interestingly, only half 
of the discovered peaks had the consensus NR3C/PRE sequence. These intronic PGR-binding 
sites have been shown to be key regulatory elements in the uterine response to progesterone. 
Genes associated with PGR binding in the two tissue types also belonged to different pathways, 
with granulosa cell binding sites being involved in transcriptional and translational regulation 
of gene expression, whereas uterus-patterned binding sites were more important in cellular 
functions, including angiogenesis, cell adhesion and migration (Figure 3.6A). Different 
functional classifications were also enriched in the two datasets, further confirming that there 











Figure 3.5 Correlation between PGR binding sites in granulosa cells vs uterus.  
(A) Pearson correlation matrix for granulosa cells ChIP-seq replicate 1 and replicate 2 and 
uterus ChIP-seq with P4 and oil treatment. The correlation in genomic coverage between all 
datasets was analysed and organised in hierarchical order. (B) Read count frequency of PGR 
ChIP-seq peaks in granulosa cells (pink) and progesterone-responsive uterus (blue) in relation 
to the TSS. (C) Venn diagrams showing the peak count for uterus and granulosa cells (top) and 
gene with peaks (bottom). Genome distribution of PGR peaks in uterus and granulosa cells is 
shown below. Genome distribution is displayed as stacked bar graphs and peaks were divided 
into uterus-unique (top), overlap (middle) and granulosa-unique (bottom). Genomic features 
include promoters (< 1 kb, 1-2 kb and 2-3 kb), 5’ UTR, 1st intron, other introns, exons, 3’ UTR 
and downstream of TES (within 3 kb). Peaks that are not in these features are classified as 
distal intergenic. (D) Example of tissue-specific PGR binding patterns on the genome. PGR 
binding sites are shown for granulosa cells (pink) and uterus (blue) at the genomic region for 
Wnt11 (uterus-specific), Abhd2 (granulosa-specific) and Zbtb16 (tissue-specificity within a 
gene). Tracks are normalised to the same scale, the red arrow indicates the TSS (arrow tail) 
and direction of transcription. Black arrows indicate granulosa-specific peaks and black outline 






Figure 3.6 Functional consequence of PGR cistrome in uterus and granulosa cells.  
(A) Top ten most enriched pathways of genes associated with PGR binding sites for granulosa 
cells (orange) and uterus (pink). Bars indicate fold enrichment of pathways and circles indicate 
-log(p-value) value. (B) Gene Ontology analysis of PGR ChIP-seq peaks in granulosa and 
uterus. Enriched ontological terms for PGR ChIP-seq data were obtained and reduced. Each 
reduced term is displayed as a circle with the diameter correlating to the -log10(p-value) of 






To elucidate the sequential difference in target chromatins between granulosa cells and uterus, 
motif analysis was performed for tissue-specific PGR binding sites. While PRE/NR3C was 
highly enriched in both tissues in comparison to background signals, it was the obvious 
preferred target for PGR in the uterus more so than in granulosa cells (Figure 3.7A). Again, 
while other transcription factor binding motifs were also discovered at uterus binding sites, 
these were much less enriched in relation to PRE/NR3C, whereas non-canonical motifs were 
enriched to a comparable degree to the canonical PRE/NR3C motif in granulosa cells. 
Interestingly, additional differences were also evident in non-PRE/NR3C motifs enriched in 
PGR cistrome from either tissue type, in which peaks specific to the uterus interacted with 
motifs belong to CP2, Homeobox and SOX families while peaks in granulosa cells included 
strongly enriched motifs for bZIP, RUNT, NR5A and CEBP transcription factor families. 
When the localisation of PRE/NR3C motif was examined in more detail, the degree of 
PRE/NR3C centricity in PGR-targeted chromatins in the uterus was very clear, with a high 
level of the canonical motif found in the centre of uterus-unique and tissue-shared PGR peaks 
(Figure 3.7B), whereas in contrast there was lower PRE/NR3C motif occupancy in granulosa-
unique binding sites. These results demonstrate fundamental differences in the chromatin 
targets of PGR in different tissues, in which the canonical motif was significantly more 
preferred in the uterus, while in granulosa cells occupancy of other motifs (and hence 






Figure 3.7 Properties of PGR-binding sequences in tissue-specific binding sites.  
(A) Top most common known TF-binding motifs found to be enriched at PGR binding sites in 
granulosa cells (orange) and uterus (blue). The top 5 motifs from each tissue are shown. Bars 
indicate fold enrichment of motif to background (bottom x axis) and circles indicate -log(p-
value) (top x axis). Motifs were ranked by -log(p-value) and among motifs from the same 
transcription factor family, the one that was most enriched by fold enrichment to background 
frequency is selected. (B) Heatmap displaying the localisation of the PRE/NR3C canonical 
motif in relation to the centre of peaks in only granulosa cells (top), overlap (middle) and only 
in the uterus (bottom). The frequency of PRE/NR3C was analysed for distribution within 520 





The various physiological phenotypes associated with PGR functions in different parts of the 
female reproductive tract leading up to pregnancy have been well-defined. However, few 
attempts have been made to describe the molecular mechanisms that allow PGR to achieve 
pleiotropic actions in the reproductive tract. This study is the first to consolidate PGR-
dependent transcriptomes obtained from different reproductive tissues and contrast PGR 
cistromes in progesterone-responsive granulosa cells and the uterus to show that PGR is 
responsible for the regulation of tissue-specific genes through selective interaction with distinct 
PRE/NR3C motifs in the genome of each cell type and with novel accessory transcription 
factors. 
 
The results confirm that the tissue specificity of PGR action has a transcriptomic basis which 
involves PGR exerting diverse physiological roles in different target organs through the 
regulation of widely different sets of genes. The lack of mutual genes, major differences in 
known upstream regulators of these genes, and distinctly enriched canonical pathways point to 
variances in the underlying transcriptional regulatory mechanisms employed by PGR in 
different tissue contexts. The transcriptomes used in this analysis are somewhat limited in their 
coverage and sensitivity to transcripts of low abundance, which is likely why relatively low 
numbers of genes (41-81 genes) were identified in each tissue type. With advances in current 
technology, most relevantly as RNA-seq becomes more established and well-used, future 
studies taking advantage of such technology will be able to achieve wider coverage of these 
transcriptomes. To date, there has been no report of similar experiment using a more 
comprehensive technique, apart from the PGR-dependent granulosa transcriptome (to be 
covered in Chapter 7).  
 
As PGR controls vastly different sets of genes in different reproductive tissues, it is reasonable 
to suggest that unique PGR chromatin targeting patterns are responsible for such drastic 
differences in downstream targets. Indeed, PGR possesses a remarkable tissue-specific 
inclination for binding to specific gene regions depending on the tissue type. Less than 10% of 
PGR binding sites was found to be mutually bound in granulosa cells and the uterus. Consistent 
with these findings, a similar study comparing PGR cistromes between T47D breast cancer cell 
line versus primary leiomyoma found less than 15% overlap in PGR-binding sites 15. In 




were also strikingly different. In granulosa cells PGR favoured binding to very proximal gene 
promoter regions, with over 50% of granulosa specific PGR-binding sites within 3 kb upstream 
of a TSS. PGR is only transiently present in granulosa cells, which may bias chromatin binding 
towards the most accessible chromatin regions in key granulosa cell target genes, likely primed 
through binding pioneer transcription factors. In comparison, in the uterus where PGR is 
constitutively present, progesterone-activated PGR more commonly bound distal intergenic 
regions, alluding to PGR role in enhancers, which has been previously seen in other biological 
contexts 11,20. Thus in the uterus, PGR may contribute to the formation of TADs and segmenting 
the genome into a permissive 3-dimensional functional structure (chromatin looping), primed 
for a specific response to ligands which are provided by ovarian granulosa cells at ovulation 21.  
Most exciting is the discovery of possible cell-specific mechanisms through which PGR 
interacts with target genomes. In both target tissues, PGR, like all NR3C receptors including 
GR and AR, binds to the core PRE/NR3C motif. However, the degree of PRE/NR3C 
occupancy was strikingly different between the two tissues of enquiry. In PGR binding 
intervals unique to the uterus, or shared between uterus and granulosa cells, the NR3C/PRE 
binding motif and NR3C/PRE half sites were highly represented while in comparison these 
motifs were far less common in granulosa-specific intervals. As different subsets of PRE/NR3C 
were utilised in granulosa cells and in the uterus, this suggests that PGR chromatin occupancy 
of PRE/NR3C is highly selective in the genome of different tissues, which requires precise 
regulation. Cell-specific PGR actions in carcinoma have been shown to rely on context-specific 
accessory factors 15. In the context of reproduction, this study shows that not only was the 
consensus PRE/NR3C motif targeted at different levels, PGR also interacted with non-
canonical motifs in a tissue-specific manner. Some transcription factor families were equally 
targeted in both tissues, such as GATA transcription factors, whereas for others the level of 
enrichment was highly specific. In granulosa cells, the RUNT motif was uniquely targeted, 
whereas uterine PGR tended to bind members of the SOX family. RUNX transcription factors, 
including RUNX1 and RUNX2, are key regulators of gene expression in granulosa cells during 
ovulation 22,23. Interestingly, SOX2 was also identified to be an upstream modulator of uterine 
genes. Although the exact roles of SOX2 on normal uterine functions are still not well explored, 
SOX2 expression independent of progesterone has been shown in the normal mouse uterus 24 
and SOX2 also plays a role in endometrial cancer 25. As distinct groups of transcription factor 
families are involved in PGR action in granulosa cells vs the uterus, it is possible that they are 




in which distinct groups of modulators recruit PGR to different chromatin sites through 
tethering or through remodelling chromatin compactment.  
 
Following the description of PGR cistrome in peri-ovulatory granulosa cells in which PGR was 
vital for the regulation of ovulation, this chapter characterised the distinction in PGR roles in 
different reproductive tissues, including transcriptomic and cistromic differences. PGR-
specific gene expression patterns were identified in progesterone-responsive granulosa cells, 
oviduct and uterus and PGR showed striking dissimilarities in PGR cistromic properties in 
progesterone-responsive granulosa cells and uterus. These results show that PGR employs 
distinctive molecular pathways in different reproductive tissues, especially through the 
coordination with tissue-specific groups of co-factors, in order to modulate separate groups of 
genes that result in specific PGR-regulated physiology. Through common motif analysis, a 
number of such prospective transcription factors were selected for subsequent studies. In the 
next chapters, the physical interaction between PGR and these binding candidates in ovulatory 
granulosa cells was explored and thus shed light on the specific underlying molecular 
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The process of ovulation involves the complex interplay of multiple physiological events under 
the control of an array of regulatory factors, encoded by a myriad of genes. Regulating these 
genes are a cast of transcription factors, including PGR, likely acting in conjunction with each 
other to mutually co-regulate target genes. While the role of PGR in ovulation has been 
extensively studied, the involvement of co-modulators in this biological context has been 
overlooked. Aside from PGR, a number of transcription factors have been accredited with 
ovulatory roles in granulosa cells and are herein hypothesised to act as co-regulators of PGR 
in this context. Indeed, analysis of motifs enriched at granulosa cell PGR binding sites  
confirmed that PGR did not solely rely on the canonical mechanism but indeed predominantly 
targeted other non-canonical motifs across the genome in order to access regulatory control of 
genes without dependence on PRE/NR3C that are invariable in their position in the genome of 
all PGR-responsive tissues. Such interaction was also specific to the tissue context, with 
different groups of motifs being enriched in PGR binding cistromes in granulosa cells versus 
the uterus, indicating divergent molecular mechanisms being utilised by PGR depending on 
the presence of other transcription factors. From this analysis, potential binding candidates of 
PGR have been identified, including transcription factors with known roles in granulosa cells 
during ovulation. 
 
Included in these potential PGR partners are members of the RUNT, NR5A and JUN/FOS 
family, each of which plays a role in granulosa cells in response to the LH surge. The RUNT 
motif is recognised by the RUNX transcription factor family and members of this group, in 
particular RUNX1 and RUNX2, are upregulated in granulosa cells by ovulatory cues 1,2. In 
peri-ovulatory granulosa cells, RUNX1 and RUNX2 are known to regulate the expression of a 
number of genes, including those involved in prostaglandin synthesis (Ptgs2, Ptgds) 2,3, 
metabolism (Fabp6) 2 and steroidogenesis (Cyp11a1) 1, suggesting functional similarities with 
PGR 4. The physiological impact of RUNX has been indirectly investigated through KO mouse 
models for CBFβ, the canonical dimerising partner of RUNX, in which CBFβ KO female mice 




granulosa cells 5. The TGATCA motif is recognised by members of the JUN/FOS protein 
family which share a common basic Leucine zipper DNA-binding tertiary structure. JUN/FOS 
proteins play important roles in the ovary, especially in steroidogenesis 6. While the effect of 
JUN/FOS on follicular rupture in vertebrate species has not been demonstrated, in C. elegans 
JUN/FOS are shown to be important for ovulation 7. NR5A2, also known as liver receptor 
homolog 1 (LRH1), is an orphan (ligand-less) receptor that is important in the regulation of 
steroidogenesis as well as cytoskeletal remodelling prior to ovulation 8,9. The ablation of LRH1 
in granulosa cell-specific knockout mouse models results in an anovulatory phenotype, 
including entrapped mature oocytes in follicles that become atretic and the lack of corpus 
luteum formation 10-12. While LRH1 is present in granulosa cells at different stages of 
development 13, the LRH1 cistromes are shown to be highly dynamic in response to LH 
signalling, with LRH1 chromatin binding events shifting to open chromatin spaces that are 
made available after the LH surge 8. 
 
While PGR and other granulosa cell transcription factors regulate similar functional outcomes, 
it is unknown whether PGR forms direct complexes with any of these transcription factors in 
granulosa cells. However, an interaction between PGR and JUN/FOS proteins have been 
previously described in human myometrial cells in which the physical interaction between 
various JUN/FOS proteins and specific PGR isoforms has an impact on the intricate regulation 
of genes that are important for the induction of labour 14. Furthermore, RUNX members have 
been shown to interact with AR and GR to regulate their transactivation efficiency 15-17. Other 
candidate binding partners of PGR as suggested in PGR ChIP-seq have also been linked to 
ovarian development and ovulation (GATA4, GATA6 18) or have been shown to interact with 
PGR in other tissue contexts (GATA2 19). In general, an interaction between these candidates 
and PGR has never been described in the context of granulosa cells. More importantly, even 
though many of such transcription factors are highly active in peri-ovulatory granulosa cells, 
the functional association between these transcription modulators and PGR during ovulation 
has not been previously explored.   
 
Apart from other transcription factors, PGR action can also be modulated by RNA components, 
especially lncRNA. The classic RNA regulator of PGR and other steroid receptors is Sra1, a 
lncRNA that forms a physical interaction with steroid receptors and promotes the activity of 
the AF-1 domain 20. Curiously, Sra1 can also exhibit steroid receptor regulatory function in the 




in the context of tumorigenesis, their relevance in female reproduction remain poorly 
understood. However, transgenic mice with overexpressed Sra1 are shown to be subfertile and 
the presence of Sra1 and its protein counterpart has been linked to reproductive disorders that 
affect the ovary and uterus 22-25. Another lncRNA that has been attributed to steroid receptor 
regulation is Gas5. The genomic structure of Gas5 is complex, with 12 exons and snoRNA-
encoding intronic regions that result in various combination of isoforms due to alternative 
splicing and intronic retention 26. Gas5 isoforms are shown to be differentially regulated, 
alluding to possible functional differences between variants. Furthermore, snoRNA encoded in 
the Gas5 introns are also known to be functional 27. Unlike Sra1 where a functional protein has 
been identified, so far there has been no protein products found for Gas5. Originally linked to 
cellular response to stress conditions, Gas5 also plays prominent roles in the modulation of 
steroid receptor activity, especially GR 28. In this context, Gas5 forms a physical interaction 
with the DBD domain of GR, thereby competes with target DNA for GR occupancy and 
inhibits GR transactivation functions. In the same vein, Gas5 is shown to be capable of PGR 
binding 29; however, whether such interaction is also possible in tissues with normal PGR 
actions and results in changes in PGR activities is still unknown. The roles of Gas5 on 
reproductive physiology, especially ovarian functions, remain unknown. However, evidence 
from our lab has shown that Gas5 is present in human cumulus cells and is associated with 
pregnancy outcomes 30 and other studies have indicated the presence of Gas5 in oocytes and 
granulosa cells 31,32. Both lncRNA and other short ncRNA including miRNA have been shown 
to play various roles in ovarian functions, such as oocyte development 33 and ovulation 34. This 
highlights the importance of lncRNA and other poorly-described ncRNA in the ovary, 
especially in the ovulation process. The fact that ncRNA are usually present in low abundance 
also makes them easily overlooked. 
 
While enriched motif analysis of the PGR ChIP-seq data has indicated a number of 
transcription factor families with potential interaction with PGR, this conclusion is inferred 
from the motif sequences and is not direct proof of transcription factor interactions.  It is also 
unable to differentiate between members of a transcription factor family with shared DNA 
binding motif and thus cannot conclude the exact protein partner to PGR. Hence, it is necessary 
to confirm such interactions using other in vitro and in vivo methods. The aim of this chapter 
was to confirm the physical interaction between potential protein partners and PGR in the 
context of peri-ovulatory granulosa cells. To do this, proximity ligation assay (PLA) was 




recognition of antibodies to their target proteins and coordinated fluorescent markers that 
requires very close (within 40 nm) proximity of the two target proteins. Cultured granulosa 
cells responding to an ovulatory stimulus were used to demonstrate physical interactions 
between proteins at an in vivo cellular level. For each of the transcription factor families, 
hypothesised PGR-interacting candidates were selected based on previous knowledge of their 
roles in ovulatory granulosa cells, and most importantly, evidence from PGR ChIP-seq 
indicating enrichment of motifs for these factors in PGR binding sites. Additionally, in order 
to comprehensively address potential PGR interacting partners, ncRNA that are known to 
interact with steroid receptors in other biological contexts were also assessed for possible 
interaction with PGR in peri-ovulatory granulosa cells using RNA co-immunoprecipitation 
(RIP). 
 
4.2 MATERIALS & METHODS 
4.2.1 Animals 
CBAF1 mice were obtained from The University of Adelaide, Laboratory Animal Services. 
All mice were maintained in 12 h light /12 h dark conditions and given water and rodent chow 
ad libitum. All experiments were approved by The University of Adelaide Animal Ethics 
Committee and were conducted in accordance with the Australian Code of Practice for the Care 
and Use of Animals for Scientific Purposes (ethics no m/2015/075). 
4.2.2 Tissue collection 
Super-ovulation in 21-day old CBAF1 female mice was induced by injecting mice i.p with 5 
IU eCG and 5 IU hCG 46 h post-eCG. Mice were culled and dissected at 0, 4, 6 or 8 h post-
hCG for intact ovaries. Tissues were fixed in 4% formaldehyde overnight at 4oC, then on the 
next day were washed in PBS and stored in 70% ethanol at 4oC. Tissues were embedded in 
paraffin and sectioned using the microtome into sections of 5 µm thickness, then placed on 
polylysine-coated positively-charged slides.  
4.2.3 Granulosa cell culture and treatment 
For granulosa cell collection, 21-day old CBAF1 female mice were stimulated with 5 IU eCG 
and culled at 46 h post-eCG. Ovaries were dissected from the tract and punctured using a 26G 




removed from the dish and granulosa cells were counted before being seeded into an 8-well 
chamber slide (minimum 100,000 cells/well) previously coated with fibronectin to promote 
cell adhesion by incubating for 1 h with 5 µg/ml recombinant fibronectin in PBS. Cells were 
incubated at 37oC, 5% CO2 for 90 minutes then washed with PBS in order to remove any dead 
cells and remaining tissue debris and then cells were incubated overnight. The next day, cells 
were treated with hCG (final concentration 2 IU/ml) and R5020 (final concentration 100 nM) 
for 6 h at 37oC, 5% CO2. 
4.2.4 Cell line culture and treatment 
T47D human breast cancer cells were maintained in RPMI 1640 media (Sigma) supplemented 
with 10% foetal calf serum (FCS, Sigma), 10 µg/ml insulin (Sigma), 0.5 U/ml penicillin 
(Sigma), 50 µg/ml streptomycin (Sigma), 1X non-essential amino acid (Thermo Fisher) and 
1X GlutaMAX (Thermo Fisher) at 37oC, 5% CO2. Prior to treatment, cells were seeded at 
50,000 – 200,000 cells/well into an 8-well chamber slide in the above standard RPMI 1640 
media and left overnight to adhere to the well surface. Cells were treated with R5020 diluted 
in ethanol (final concentration 100 nM) or vehicle (ethanol) at 37oC, the length of treatment 
depending on the assay. 
4.2.5 Immunofluorescence 
4.2.5.1 Tissue sections 
Sections were dewaxed and rehydrated with xylene and ethanol, then antigen retrieval was by 
boiling slides in citrate buffer (pH 6) or basic buffer (pH 9) in a pressure cooker for 20 minutes, 
with the buffer condition determined after empirical testing for each antibody. Sections were 
blocked with 9% normal goat serum and 1% BSA in TBS for 1 h at room temperature. Sections 
were incubated with primary antibodies (listed in Appendix 10) diluted to 1:500 in 1% serum 
for 1 h at room temperature or overnight at 4oC  and with corresponding secondary antibodies 
diluted to 1:2000 in 1% serum for 1 h at room temperature. Hoechst 33342 at 1:1000 dilution 
was included in the secondary incubation to stain nuclei. Slides were then mounted with 
mounting media (Dako, Agilent, Santa Clara, CA, USA) and coverslips, and sections imaged 




4.2.5.2 Cell cultures 
Cells were cultured on coverslips in a 6-well plate or cultured directly in an 8-well chamber 
slide and underwent treatment according to the assay and cell type. The dosage of hCG is 
standard in the lab for granulosa cell culture and the dosage of R5020 was determined after 
testing of different dosages. After treatment, media was aspirated and cells were gently washed 
twice with PBS. Cells were fixed in 4% formaldehyde for 10 minutes at room temperature, 
washed three times with PBS and permeabilised with 0.01% Triton X-100 in PBS for 1 h at 
room temperature. After washing three times with PBS, cells were blocked using 9% normal 
goat serum and 1% BSA in PBS for 1 h at room temperature. Cells were incubated with primary 
antibodies diluted to 1:500 in 1% serum for 1 h at room temperature or overnight at 4oC and 
with corresponding secondary antibodies diluted to 1:2000 in 1% serum for 1 h at room 
temperature. Hoechst 33342 at 1:1000 dilution was included in the secondary incubation to 
stain nuclei. Slides were then mounted with mounting media and coverslips, and imaged using 
the Olympus FV3000 confocal laser scanning microscope. 
4.2.6 Proximity Ligation Assay 
PLA was performed using the Duolink PLA Probes and PLA Fluorescence in situ Detection 
Kit Red (Sigma) and followed the manufacturer’s protocol. For ovarian tissues, sections in 
paraffin were processed as for IF, including dewaxing, antigen retrieval and permeabilisation. 
For cultured cells, cells were fixed and permeabilised as described for IF. For blocking, the 
provided Blocking Buffer was used for blocking for 1 h at 37oC. Samples were incubated with 
primary antibody couples raised in distinct species that recognise each of the target proteins, 
diluted in Antibody Diluent, for 2 h at room temperature or overnight at 4oC (see list of 
antibodies in Appendix 10). Cells were then incubated with secondary antibody PLA probes 
of appropriate species modified with oligonucleotide for 1 h at 37oC, then probes were ligated 
for 30 minutes at 37oC, followed by the amplification and fluorescent nucleotide incorporation 
reaction at 37oC for a minimum of 100 minutes. Between steps, slides were washed using the 
provided wash buffers following the manufacturer instructions. Slides were mounted with 
Prolong Gold Mounting Media with DAPI (Thermo Fisher), cured for at least 1 h at room 
temperature in the dark and then stored at -20oC prior to imaging. Slide imaging was performed 
using an Olympus confocal microscope at a minimum of 60x magnification. Specific positive 
signals from this method require that the two proteins of interest are within 40 nm and indicate 




was performed in triplicates and PLA signals were identified as fluorescent puncta using the 
‘Count Maxima’ function in ImageJ 35.  
4.2.7 RNA co-immunoprecipitation 
Granulosa cells from super-ovulated CBAF1 female mice were collected at 6 h post-hCG as 
previously described. Cells were fixed in 1% formaldehyde for 15 minutes at 37oC and 
quenched with 0.125 M glycine for 10 minutes at room temperate. Cells were washed twice 
with cold PBS and lysed in lysis buffer for 30 minutes at 4oC. Lysate was sonicated using a 
Bioruptor Plus (Diagenode, Denville, NJ, USA) for 15 minutes at High setting, 30 secs on/ 30 
sec off, then centrifuged at 10,000 g for 15 minutes to remove cell debris. To measure protein 
concentration, Bradford assay using Bio-Rad Protein Assay Dye Reagent Concentrate (Bio-
Rad) was performed, with BSA at concentrations of 40-640 µg/ml used as protein standards 
and measurements taken in duplicate for each sample using the Synergy H1 Hybrid Reader 
(BioTek, Winooski, VT, USA) and the accompanying Gen5 2.00 software. For 
immunoprecipitation, Protein A+G magnetic beads (Merck, Burlington, MA, USA) were 
incubated with 4 µg antibodies (as indicated in Appendix 3) for 30 minutes at room 
temperature. Lysate was incubated with antibody-bound beads in IP buffer (25 mM Tris (pH 
7.4), 5 mM EDTA, 150 mM KCl, 0.5 mM DTT, 0.5% NP-40) for at least 16 h at 4oC, with one 
volume of lysate retained as lysate input. Beads were washed in IP buffer 5 times for 5 min 
each, then reverse crosslinking was by heating protein-bound beads and lysate input in 
proteinase K buffer (Sigma) for 30 minutes at 55oC. Lysate was then isolated from magnetic 
beads. RNA was isolated from immunoprecipitated extracts using Trizol extraction method. 
Briefly, bead elute and lysate input were incubated with 250 µl of Trizol (Thermo Fisher), then 
50 µl chloroform was added. RNA was precipitated from the aqueous phase by the addition of 
isopropanol and freezing at -80oC for at least 2 h, followed by centrifugation. Precipitated RNA 
pellets were washed with 75% ethanol, dissolved in 100 µl water and treated with rDNase I 
(Ambion, Thermo Fisher) for 30 minutes at 37oC. cDNA from purified RNA was synthesised 
using Superscript III kit and accompanying protocol (Thermo Fisher) as described in section 
2.2.2.2. 500 ng of purified RNA was used per reaction. qPCR was performed as described in 
section 2.2.2.2 using SYBR Green Master Mix with primers designed for specific RNA targets, 







4.3.1 Expression of PGR and other transcription factors in peri-ovulatory 
follicles 
The in situ expression of PGR in the ovaries during the peri-ovulatory window was confirmed 
using immunofluorescence with PGR antibody on ovarian sections obtained from female mice 
stimulated with eCG + hCG for 0-8 h. PGR was not observed without hCG treatment (0 h) and 
was detectable from 4 h post-hCG, remaining high until 8 h post-hCG, with PGR expressed 
specifically in granulosa cells of antral follicles (Figure 4.1A). Negative controls (IgG control 
and no primary antibody control) showed low to undetectable nonspecific fluorescent signals. 
The specificity of hCG induction was confirmed in immunofluorescence for H3K27ac specific 
antibody. This mark of active chromatin was constitutively present, shown in pre- and post-
hCG ovaries which displayed prominent staining signals (Figure 4.1B). The acetylation of the 
transcription factor CBP, previously shown to enhance CBP transactivation functions 36, was 
also shown to be induced by hCG treatment. 
 
From PGR ChIP-seq motif analysis, a number of potential co-factors were identified. Among 
these non-canonical motifs, the RUNT motif, recognised by the RUNX transcription factor 
family, was specifically targeted by PGR in granulosa cells yet not in the uterus. To confirm 
the presence and localisation of RUNX members, ovarian sections were stained with antibodies 
against RUNX1, RUNX2 and their dimerising partner CBFβ. Both RUNX proteins showed no 
signals in antral follicles pre-hCG while CBFβ showed some staining in granulosa cells (Figure 
4.2). All proteins were induced in antral follicles after hCG stimulation, with the highest 






Figure 4.1 Immunofluorescent detection of PGR and transcription markers in ovarian 
sections. 
(A) Immunofluorescent detection of PGR in ovarian sections. Ovaries were obtained from mice 
stimulated for 46h with eCG and 0, 4, 6 or 8 h with hCG. Ovarian sections were stained for 
PGR (red) and nucleus using Hoechst 33342 (blue). Negative controls included species 
(mouse) IgG isotype (IgG control) and secondary antibody only (No primary Ab). Scale bar 
for PGR staining = 100 µm, for No primary Ab control = 300 µm. (B) Immunofluorescent 
detection of H3K27ac and acetyl-CBP/p300 in ovarian sections. Ovaries were obtained from 
mice stimulated with eCG for 44 h or eCG followed by hCG for 6 h. Red fluorescence indicates 
positivity for H3K27ac (left panels) or acetyl-CBP (right panels). Images are representative of 







Figure 4.2 Immunofluorescent detection CBFβ, RUNX1 and RUNX2 in ovarian 
sections.  
Ovaries obtained from mice stimulated for 46 h with eCG and 0, 4, 6 or 8 h with hCG were 
processed for immunohistochemical detection of CBFβ (row 1), RUNX1 (row 2) and RUNX2 
(row 3). Antibody labelling is in red and nuclear staining in blue. Staining in antrum is due to 





4.3.2 Validation of the PLA methodology in tissues and cell culture 
The PLA technique was validated in the human breast cancer cell line T47D which has high 
level of endogenous PGR that could rapidly respond to progesterone treatment. This was 
confirmed through immunofluorescence of T47D cells treated with the PGR agonist R5020, 
where the nuclear localisation of PGR was displayed in T47D as soon as 1 h after R5020 
treatment, as opposed to the lack of nuclear PGR signal in the vehicle-treated control (Figure 
4.3A). With R5020 treatment there was a co-localisation between PGR and H3K27ac in 
immunofluorescence (IF) and PLA signal was detected in cell nuclei 90 min after R5020 
treatment, suggesting that PGR is in close proximity to H3K27ac and thus transcriptionally 
active chromatin (Figure 4.3B). To validate the efficiency of the PLA method in detecting 
protein-protein interactions in different cellular compartments, the nuclear PGR/H3K27ac 
interaction as well as the cytoplasmic/membrane interaction between beta-catenin and e-
cadherin were examined using PLA, in which abundant PLA puncta signifying the expected 
complexes were detected. PLA also showed that the physical PGR/H3K27ac interaction was 
present only after 90 minutes of treatment, although PGR localisation to the nucleus was 
already observed at 60 minutes post-treatment, showing the highly dynamic nature of PGR 






Figure 4.3 Dynamics of PGR/H3K27ac interaction in R5020-treated T47D cells.  
(A) Immunofluorescent detection of PGR and H3K27ac in R5020-treated T47D cells. T47D 
cells were treated with vehicle control for 1 h or 100 nM R5020 for 1, 6 or 24 h. From top to 
bottom: Hoechst (blue), PGR (red), H3K27ac staining (green) and merged. (B) Proximity 
ligation assay in T47D cells treated with R5020. T47D cells were treated with 100 nM R5020 
for 60 or 90 minutes and PLA was performed for PGR/H3K27ac (left), b-catenin/e-cadherin 





4.3.3 Interaction of PGR and co-partners in peri-ovulatory granulosa cells 
As the PLA protocol was confirmed on cultured T47D cells, PLA was attempted on paraffin-
embedded ovarian sections from 6 h post-hCG ovaries. For confirmation of the method, protein 
pairs chosen were for RUNX1/RUNX1 (using antibodies targeting different regions of the 
RUNX1 protein, presumably nuclear interaction), b-catenin/e-cadherin (cytoplasmic 
interaction) and mIgG/rIgG (negative control). However, the commonly observed PLA puncta 
were not specifically observed and instead ubiquitous fluorescence signal was observed in all 
samples, including nuclear, cytoplasmic interactions and negative control (Figure 4.4). 
Optimising protocols using different antigen retrieval, antibody incubation and washing 
conditions had no effect on the nonspecific fluorescent signal. 
 
To overcome the non-specific labelling in fixed whole tissue, the interaction between PGR and 
potential TF partners was subsequently investigated in cultured peri-ovulatory granulosa cells 
treated with hCG and progestin. To confirm that the cell culture system mimicked the 
phenotype of in vivo granulosa cells, granulosa cells obtained from eCG-stimulated mice were 
cultured and immunofluorescence was performed after hCG + R5020 treatment for 6 h. The 
treatment resulted in the expected pattern of expression for target proteins in the nucleus, in 
which PGR is specifically induced by the treatment regime whereas H3K27ac is constitutively 
present. Other transcription factors such as RUNX1, RUNX2 and CBFβ were also present in 
treated granulosa cells, showing that the in vitro system could closely portray the biology 
observed in vivo (Figure 4.5).  
 
The interaction between PGR and RUNX members in a transcription complex was examined 
using PLA targeting different protein-protein interactions. PLA of progestin-treated cells 
showed positive signals for interaction between PGR and H3K27ac and acetyl-CBP/p300 in 
the nucleus of granulosa cells, as expected since these complexes are known as part of the 
transcription machinery (Figure 4.6). Positive interaction was also observed between both 
RUNX1 and RUNX2 and their dimerising partner CBFβ in the nucleus, confirming that RUNX 
proteins were active in granulosa cells, as well as between RUNX proteins and CBP/p300. 
Excitingly an interaction between RUNX transcription factors and PGR was observed. 
PGR/CBFβ PLA signals were also observed, not only in the nucleus but also in the cytoplasm 







Figure 4.4 Proximity ligation assay in ovarian sections.  
Ovarian sections were obtained at 6 h post-hCG stimulation and subjected to PLA protocol. 
Protein pairs include RUNX1 (rabbit antibody)/RUNX1 (mouse antibody) and b-catenin 
(rabbit antibody)/E-cadherin (mouse antibody). Negative control includes mIgG (mIgG) 
(mouse antibody)/rIgG (rabbit antibody). From top to bottom: Hoechst (blue), PLA signal (red) 






Figure 4.5 Immunofluorescent detection of PGR and associated transcriptional markers 
in cultured granulosa cells treated with hCG and R5020.  
Granulosa cells were harvested from ovaries at 44 h post-eCG and treated with vehicle control 
or 2 IU/ml hCG and 100nM R5020 for 6 h. Immunohistochemistry was performed for 
H3K27ac and PGR in untreated/treated cells (column 1-2), RUNX1, RUNX2 and CBFβ in 








Figure 4.6 Interaction between PGR and RUNX members in granulosa cells treated with 
hCG and R5020.  
Granulosa cells were harvested from ovaries at 44 h post-eCG and treated with hCG and R5020 
for 6 h in vitro. PLA was performed for antibody combinations (PGR, H3K27ac, CBP/p300, 
CBFβ, RUNX1 and RUNX2) as indicated or IgG negative controls (H3K27ac/IgG, PGR/ IgG 





Since the canonical motifs for the bZIP (JUN/FOS) transcription factor family and for 
NR5A2/LRH1 were also highly enriched at PGR binding sites in granulosa cells, the potential 
interaction between PGR and members of these families was also investigated. The expression 
of cJUN, JUNB and JUND, which are members of the bZIP family, were determined in in vitro 
granulosa cells treated with hCG and R5020, of which only JUND showed prominent signals 
(Figure 4.7). Correspondingly, PLA signal was only observed with PGR/JUND antibody pairs. 
LRH1 and PGR/LRH1 interactions were also detected in hormone-treated cultured granulosa 
cells, confirming close spatial interactions between PGR and JUND as well as LRH1 in peri-






Figure 4.7 Interaction between PGR and bZIP (JUN/FOS) members and LRH1 in 
granulosa cells treated with hCG and R5020.  
Granulosa cells were harvested from ovaries at 44 h post-eCG and treated with hCG and R5020 
for 6 h. Antibodies against c-JUN, JUNB, JUND or LRH1 were used for immunofluorescence 
(left) or PLA (right). Red indicates protein presence (IF) or protein interactions (PLA). Blue is 






4.3.4 Interaction of PGR and non-coding RNA in peri-ovulatory granulosa 
cells 
In order to investigate the potential role of RNA binding in PGR transcriptional regulation, 
PGR-RNA interaction was investigated using RIP. To validate the RIP methodology, RIP-
qPCR was performed on granulosa cells with or without hCG stimulation using an antibody 
targeting the splicing complex protein SNRNP70 that binds the U1 snRNA. U1 expression was 
confirmed in granulosa cells through qPCR which showed U1 to slightly increase at 6 h 
compared to 0 h hCG stimulation (Figure 4.8A). RIP-qPCR showed that in relation to the IgG 
pull-down negative control there was an enrichment of U1 snRNA in granulosa cells at 6 h 
post-hCG compared to 0 h (Figure 4.9A). As SNRNP70-U1 are involved in alternative splicing 
and thus would naturally be found in a complex with immature mRNA, a gene with a single 
exon was selected as the biological negative control, which should not be spliced and thus not 
involved with the splicing complex. Indeed, Oxct2, a single exon gene, was not enriched in 
SNRNP70 pull-down in comparison to IgG pull-down, confirming that the RIP methodology 
was consistent in enriching protein-bound RNA.  
 
To investigate PGR-bound RNA in granulosa cells during ovulation, PGR-pull down was 
performed on granulosa cells at 0 or 6 h post-hCG and qPCR was performed on PGR-bound 
RNA isolated from the lysate. Sra1 was induced in granulosa cells during ovulation, peaking 
at 8 h post-hCG stimulation (Figure 4.8B). RIP-qPCR showed that Sra1 was enriched in 
immunoprecipitates using PGR antibody compared to IgG and more enriched in 6 h post-hCG 
granulosa cells in comparison to 0 h (Figure 4.9B). Alongside Sra1, Gas5, a lncRNA repressor 
of steroid receptors and another potential RNA regulator of PGR, was investigated as a binding 
partner. Gas5 includes 12 described exons and there is a high level of alternative splicing as 
well as intron retention in Gas5. As spliced isoforms of Gas5 have been shown to be important 
in various Gas5 activities, three primer assays targeting different Gas5 exons were examined 
for enrichment in PGR pull-down. All three assays showed a decrease in expression in peri-
ovulatory granulosa cells (Figure 4.8C-E). Gas5 expression reached the lowest level at 8 h 
post-hCG in assay 22 (exon 11-12), assay 23 (exon 6-7) showing a more subtle trend in 
downregulation. In RIP-qPCR, assay 22 showed a tendency for enrichment in PGR pulldowns 
compared to IgG which was highest after 6 h compared to 0 h hCG stimulation. However, 
qPCR with assay 21 showed high Gas5 enrichment with PGR pulldown at both 0 h and 6 h 
















Figure 4.8 The expression of non-coding RNA and in peri-ovulatory granulosa cells.  
RT-qPCR was performed on granulosa cells from mice not treated with eCG/hCG (unstim) or treated 
with eCG + hCG for the indicated time (0-12 h). Primers targeting U1 (A), Sra1 (B) and Gas5 using 
three different assays (C-E) were used. Rpl19 was used as housekeeping gene and gene expression 
is displayed as fold change to unstim. N = 3 biological replicates, each replicate is from 3-5 mice 
per time point. Statistical significance was determined through one-way ANOVA with multiple 
comparison. p = 0.0497 (U1), p = 0.0001 (Sra1), p = 0.0002 (Gas5 assay 22), p = 0.0557 (Gas5 





Figure 4.9 Interaction between PGR and RNA partners in granulosa cells.  
(A) RIP of SNRNP70 in granulosa cells from ovaries that were eCG-primed (0h) or eCG + 
hCG-primed (6 h). Purified SNRNP70-bound RNA was assayed for the interaction with U1 
and Oxct2 by RT-qPCR. (B) RIP of PGR in granulosa cells as in (A). Purified PGR-bound 
RNA was assayed by RT-qPCR for the interaction with Sra1 and Gas5 (using three specific 
assays targeting different genomic regions). Statistical analysis was performed using two-way 
ANOVA test. N = 3 independent experiments. Black bars are 6 h post-hCG granulosa cells and 







The PGR cistromes in reproductive tissues have highlighted a number of transcription factor 
binding motifs enriched in PGR bound intervals, suggesting a potential interaction with the 
relevant transcription factor recruits PGR-binding in a mutual transcription complex. Here this 
study confirms the expression and interaction between PGR and a number of candidate 
transcriptional modulators in mouse granulosa cells in response to the LH surge, with potential 
implications for ovulatory functions. From the granulosa cell PGR ChIP-seq data, members 
from the most highly enriched transcription factor families were selected for investigation of 
potential interactions with PGR. These include members of the RUNX family (RUNX1, 
RUNX2, CBFβ), JUN/FOS family (c-JUN, JUNB, JUND) and NR5A (LRH1), which all have 
previously been indicated to play a role in the ovary, especially in granulosa cells during 
ovulation 1,2,5,6,10. Almost all of these candidate proteins were found to be expressed in cultured 
granulosa cells in response to the ovulatory cues, with the exception of c-JUN and JUNB. 
Excitingly, physical interactions with PGR and each of these expressed transcription factor 
proteins was demonstrated through PLA. These results support the hypothesis that PGR binds 
chromatin in granulosa cells in complexes that include RUNX1 and RUNX2 as well as LRH1 
and JUND.  The disparity in c-JUN and JUNB expression in vitro vs in vivo granulosa cells 
has been previously reported 6, thus it remains to be determined whether c-JUN and JUNB  in 
fact do interact with PGR in the in vivo setting. For the majority of candidate proteins, the 
interaction with PGR was found to be in the nucleus of hCG-stimulated granulosa cells, 
indicating the presence of the PGR transcription complex in the nucleus where it exhibits 
actions at the genomic level.  
 
Transcription factors are known to have vastly different windows of expression during 
ovulation, with the expression of some proteins maintained throughout different stages of 
development and sustained in the ovary during ovulation (i.e. LRH1 37) whereas others have a 
much shorter expression window (i.e. PGR). Not only that, within the peri-ovulatory window 
these transcription factors might also display optimal activity at different time points; for 
example, investigation into the LRH1 cistrome has shown LRH1 to be active and occupying 
transcriptionally active chromatin by 4 h post-hCG stimulation in granulosa cells 8, which is 
before the peak of PGR activity. Coupled with the highly transient nature of protein-protein 
interactions in the transcription complex 38, this means that it is difficult to capture the PGR/co-




while DNA-binding transcription factor families can be implied as candidate PGR partners 
through motif analysis of the PGR ChIP-seq data, other co-modulators that do not bind DNA 
cannot be identified using this method. This includes transcription adaptors that act as linkages 
for components of the transcription complex without direct interaction with DNA 39. The most 
well-known example of an SR-binding adaptor is the SRC family, consisting of SRC-1, SRC-
2 and SRC-3, each of which can interact with various steroid receptors including AR, GR and 
PGR 40. SRC proteins do not directly bind DNA but maintain the integrity of the transcription 
complex by acting as a bridge between different DNA-binding factors and the general 
transcription machinery. Future experiments involving PLA as well as immunoprecipitation 
and mass spectrometry will be able to explore other potential components of the ovarian PGR 
transcription complex. The temporal pattern of protein-protein expression is not the only 
critical aspect as the order of interaction between different components is also decisive in the 
formation of the protein complex. Using various in vitro and in vivo methods, a model for the 
SR/SRC complex has been generated, with SRC-3 units acting as a physical linkage between 
ER-α and CBP/p300, making SRC-3 essential for the ER-α transcription complex 41. Thus, it 
is essential to take into consideration the temporal and sequential dynamics of PGR/co-
modulator interactions when investigating the PGR-inclusive transcription complex, which is 
yet to be studies in such detail. 
 
H3K27ac, being a generic marker for transcriptionally active chromatin regions, was shown 
with immunofluorescence to be present in ovarian sections regardless of treatment conditions. 
Acetyl CBP/p300 was only detected post-LH using a specific antibody that only detects the 
acetylated Lys1499 amino acid of CBP/p300 and not total CBP/p300. It is known that the HAT 
activity of CBP/p300 can result in auto-acetylation at specific sites, which enhances the HAT 
function of CBP/p300 36. While the acetylation state of CBP/p300 has never been examined in 
the context of its action in granulosa cells, this new data suggests that together with 
phosphorylation, acetylation might be another way through which CBP/p300 becomes 
activated in response to the LH-induced signalling cascade. 
 
The potential involvement of ncRNA on PGR activities in peri-ovulatory granulosa cells was 
also implicated in this study. Through RIP, Sra1, a classic RNA modulator of steroid receptors 
in general and PGR in particular, was found to bind PGR specifically after hCG stimulation. 
Gas5, another known steroid receptor interactor, was also found to bind PGR after hCG 




targeting a different exonic region of the Gas5 gene, the only one that was enriched for PGR 
binding was for exon 11-12. Interestingly, this is also the Gas5 region with known interactions 
with SR; specifically, Gas5 exon 12 has been shown to form a hairpin folding structure that 
mimics the conformation of the PRE/NR3C DNA motif and thus can compete against target 
DNA in binding with GR, thereby sequestering GR away from target genes and suppressing its 
transactivation functions 28. The roles of either Sra1 or Gas5 in ovulation are virtually 
unknown; but the discovery that these lncRNA interact with PGR in a LH-inductive manner 
suggests that they exert regulatory functions on PGR in granulosa cells. Intriguingly, Gas5 
transcripts bearing the PGR-interacting region are found to be downregulated during ovulation 
in granulosa cells, whereas Sra1 is upregulated after the LH surge, suggesting that these 
lncRNA are engaged in different regulatory mechanisms. Both Sra1 and Gas5 are also known 
to interact with a wide range of NR3C receptors 25,29, including AR, GR and MR that are also 
present in the ovary with important functions, especially in luteinisation 42-44; thus it will be 
important to also investigate the role of these lncRNA on the regulation of these SR. Some 
evidence has also linked Gas5 abundance to the anovulatory condition PCOS 45, suggesting 
that this may have an important role in regulating ovarian hormone responsiveness. The roles 
of other lncRNA in the ovary have also been implied, including Neat1 46, Xist and Zfas1 47. In 
addition, a growing number of transcriptomic studies have identified specific subsets of 
lncRNA that are upregulated in a cell-specific manner in the ovary 47-49. Whether any of these 
lncRNA acts upon regulating ovulatory transcription factors, especially PGR, is still unknown 
and would require further investigations. 
 
As the complexities of transcriptional regulation are revealed, it is apparent that the 
participation of non-promoter sequences such as enhancers and distal intergenic regions also 
play a vital role in modulating transcription of distal genes. In addition, modulating interactions 
between transcriptional regulators and protein or nucleotide (i.e. ncRNA) co-factors, is critical. 
Thus, it is important to investigate the transcriptional complex as a whole in order to gain a full 
comprehension of how gene expression is regulated uniquely in each cell context. Through 
investigating potential protein partners derived from the granulosa PGR ChIP-seq data, the 
interaction between PGR and a number of transcription factors have been determined. Among 
the confirmed physical partners of PGR are members of the RUNX family, including RUNX1, 
which were found to be exclusively enriched  with PGR ChIP in peri-ovulatory granulosa cells 
and not in the uterus. RUNX1 is involved in diverse processes in granulosa cells in a 




regulation in ovulation. Despite this, the ovulatory role of RUNX1 has never been put into 
context with other transcription mediators in granulosa cells. Thus, the next chapters further 
interrogated the contextual cistromic properties of RUNX1 in granulosa cells and the functional 
interaction between RUNX1 and PGR. This chapter also explored the potential role of  
lncRNA, in particular Sra1 and Gas5, in PGR action and further studies in the RNA 
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CHAPTER 5 RUNX1 chromatin interaction in granulosa cells 





RUNX1 belongs to the RUNX transcription factor family together with two other members 
RUNX2 and RUNX3, all of which recognise the canonical RUNT sequence (5′-PuACCPuCA-
3′) 1. The transcriptional activity of RUNX transcription factors involves the formation of a 
heterodimer with CBFβ, which by itself does not directly interact with target DNA but can 
promote RUNX DNA binding efficiency. Traditionally known as an important tumorigenesis 
factor in acute myeloid leukaemia, members of the RUNX family are also involved in 
developmental processes in various organ systems, such as haematopoiesis in the liver and 
ossification of cartilage in skeletal formation 2,3. Within the last 10 years, RUNX members 
have been shown to be expressed in the reproductive tract, indicating the potential role of 
RUNX in a range of female reproductive processes. RUNX1 in particular has been detected in 
both the ovary and uterus of rodents 4,5 as well as in human granulosa cells 6. In the ovary, 
RUNX1 is present in granulosa cells during foetal development and at adulthood, where it 
plays different important roles in each context 4,5.  
 
In the adult rat ovary, RUNX1 expression is induced by the LH surge and is upregulated during 
the peri-ovulatory window 4. Studies in in vitro cultured rat granulosa cells have shown that 
RUNX1 expression is responsive to ovulatory cues, including stimulation by hCG, forskolin 
and phorbol myristate acetate 4. RUNX1 ablation using siRNA in cultured goat granulosa cells 
leads to a decrease in progesterone and oestradiol production through downregulation of genes 
that are involved in progesterone synthesis 7. RUNX1 also acts as a transcriptional regulator of 
other genes in granulosa cells, including Mt1a, Hapln1 and Rgcc, through direct binding at 
their promoter sites, 4. RUNX1 has been demonstrated to be vital for foetal development since 
global RUNX1 KO leads to foetal death 2; and thus this mouse model cannot be used to 
investigate female fertility. However, a granulosa cell-specific KO model targeting CBFβ, the 




failure and subfertility in the female KO mice 8. Of note, this phenotype is very similar to what 
observed in the PGRKO mouse model 9, albeit with lesser severity, suggesting a possible 
functional cooperation between RUNX1 (and other RUNX transcription factor) and PGR in 
the context of ovulation. Currently this concept has remained unexplored due to the lack of a 
fully-described RUNX1-dependent transcriptome in granulosa cells as well as the lack of an 
inducible tissue-specific RUNX1 KO animal model.       
 
Apart from its role in ovulation, RUNX1 is also reported to be important in the feminisation of 
gonadal somatic cells in female foetuses. RUNX1 is highly upregulated specifically in the 
female gonad especially during early foetal development, which has been observed in multiple 
vertebrate species including human, suggesting a high level of conservation of RUNX1 
function 10. In mouse foetal gonads, RUNX1 colocalises with FOXL2, a transcription factor 
well-defined as a female-patterned determinant in granulosa cells 10. Furthermore, RUNX1 and 
FOXL2 share many mutual target chromatin regions and downstream genes. Double 
RUNX1/FOXL2 KO female gonads express the Sertoli cell marker DMRT1 and show the 
development of testis cords, which does not fully manifest in single RUNX1 KO or FOXL2 
KO female gonads. This suggests an important role of RUNX1, in conjunction with FOXL2, 
in driving the differentiation of bipotential somatic cells to granulosa cells.  
 
Other members of the RUNX transcription family, namely RUNX2 and RUNX3, are also 
found to be expressed in the reproductive tract and involved in female fertility. Like RUNX1, 
RUNX2 is also upregulated in granulosa cells after the LH surge 11. A cre-lox transgenic mouse 
model with complete ablation of CBFβ but only partial deletion of RUNX2 (CBFβ -/- RUNX2 
+/-) shows reduced ovulation rate and sterility in female mice 8. In peri-ovulatory granulosa 
cells, RUNX2 is responsible for the transcriptional regulation of genes important in ovulation, 
including Ptgs2, Ptgds and Mmp13, though direct binding at RUNT motifs in their promoter 
regions 11,12. RUNX3, also expressed in the ovary, is involved in transcriptional regulation of 
inhibins and aromatase in granulosa cells; yet is not critical for ovulation, as shown in a global 
RUNX3 KO mouse model 13. Instead RUNX3 appears to play a more vital role in regulating 
the gonadotrophin feedback loop through acting on kisspeptin neurons in the hypothalamus 
13,14. All three RUNX members have also been identified in mouse endometrial stromal cells 





It is clear that RUNX1 plays various important roles in granulosa cells, from granulosa cell 
specialisation to ovulatory regulation. Because of this, studies on RUNX1 function in fertility 
in an in vivo context is made difficult due to potential confounding effects from the influence 
of RUNX1 on ovarian development. A granulosa cell- and ovulation-specific RUNX1 KO 
model would be crucial in revealing the specific role of RUNX1 in ovulation. Furthermore, as 
RUNX1 canonically acts as a transcription factor with important roles in development and 
function of several different tissues, it is likely that RUNX1 can target different chromatin 
regions in a context-specific manner to achieve specific roles. Thus, a full description of the 
RUNX1 cistrome in granulosa cells in different biological contexts is also necessary to 
determine the differentiation-dependent characteristics of RUNX1 chromatin binding 
properties. Thus, the primary aim of this chapter is to characterise the chromatin binding 
properties of RUNX1 in granulosa cells in different biological contexts. Granulosa cells were 
obtained from prenatal ovaries, where RUNX1 acts as a determinant for granulosa cell 
differentiation from the bipotential somatic cells, and from adult granulosa cells after eCG 
stimulation (pre-LH) or after eCG/hCG stimulation for 6 h (post-LH). The latter time point 
corresponds to the time when PGR ChIP-seq was performed and when RUNX1 expression is 
highest during the peri-ovulatory window. RUNX1 target chromatin regions were 
characterised to determine basal and time point-specific RUNX1/chromatin interactions. 
Specifically, the effect of the LH surge on RUNX1 cistrome was investigated in detail. 
 
5.2 MATERIALS & METHODS 
5.2.1 Animals 
For peri-ovulatory granulosa cell experiments, CBAF1 mice were obtained from The 
University of Adelaide, Laboratory Animal Services. All mice were maintained in 12 h light 
/12 h dark conditions and given water and rodent chow ad libitum. All experiments were 
approved by The University of Adelaide Animal Ethics Committee and were conducted in 
accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific 
Purposes (ethics no m/2015/075). 
 
For foetal granulosa cell experiments, CD-1 mice were purchased from Charles River 
Laboratories (Wilmington, MA, USA) and maintained at the NIEHS Animal Facility as 





5.2.2 Peri-ovulatory time course experiment 
5.2.2.1 mRNA level quantification 
COC/GC samples from CBAF1 female mice at different eCG/hCG stimulation time points 
were obtained and RNA extraction and cDNA synthesis were as described in section 2.2.2.2. 
RNA from COC/GC collected from one ovary per time point per replicate was used for cDNA 
synthesis and RT-qPCR. RT-qPCR was performed on Runx1, Runx2, Runx3 and Cbfb as well 
as the housekeeper gene Rpl19 using Taqman assays as listed in Appendix 1. Presentation of 
data and statistical analysis were as previously described in section 2.2.2.2.  
5.2.2.2 Protein level quantification 
Lysate from COC/GC pooled from ovaries of 3-5 mice per time point per replicate from the 
eCG/hCG time course was prepared as described in section 2.2.2.3. Western blot was 
performed on denatured lysate, with primary antibodies for RUNX1, RUNX2, CBFβ and H3 
listed in Appendix 2. Protein quantification was as previously described in section 2.2.2.3. 
5.2.3 ChIP-seq experiments 
5.2.3.1 Adult mouse granulosa cell collection 
Super-ovulation in 21-day old CBAF1 female mice was induced by injecting mice i.p with 5 
IU eCG and 5 IU hCG 46 h post-eCG. Mice were killed by cervical dislocation and ovaries 
dissected at either 46 h post-eCG (termed RUNX1 0h) or after 46 h eCG plus 6 h -hCG (termed 
RUNX1 6h). Granulosa cells were collected from punctured ovaries, snap frozen in liquid 
nitrogen and shipped in liquid nitrogen to Active Motif (Carlsbad, CA, USA) for ChIP-seq. 
Two samples from at least 5 mice with a minimum of 1x107 cells were used for RUNX1 ChIP. 
Details of this experiment are similar to as previously described in section 2.2.3.1. Briefly, cells 
were fixed, lysed, sonicated and precleared prior to immunoprecipitation. 20 µg of chromatin 
from each replicate was used for ChIP-seq with 10 µl RUNX1 antibody (provided by Dr Yoram 
Groner and Dr Ditsa Levanon 17, the Weizmann Institute of Science, Israel – Appendix 3). 
Bound chromatins were isolated and sequencing libraries were prepared for ChIP and input 




5.2.3.2 Foetal granulosa cells  
ChIP-seq was performed on ovaries that were separated from the mesonephros of E14.5 CD-1 
mouse embryos and snap frozen in liquid nitrogen (from now termed RUNX1 E14.5). Full 
details of the experiment can be found in the according publication 10. Briefly, two independent 
ChIP-seq experiments were performed by Active Motif using 20-30 μg of sheared chromatin 
from pooled embryonic ovaries (100-120 ovaries per ChIP) and 10 μl of RUNX1 antibody. 
ChIP-seq libraries were sequenced as single-end 75-mers by Illumina NextSeq 500, then 
filtered to retain only reads with average base quality score > 20.  
5.2.3.3 Bioinformatics analysis 
Bioinformatics analysis was conducted using appropriate tools as described in section 2.2.3.2. 
Quality check of sequencing data for all samples showed no warnings. For consensus peak 
selection of RUNX1 6h data, as the two replicates showed good correlation, peaks were called 
individually for each replicate. For RUNX1 0h and RUNX1 E14.5 data, as quality control 
showed variation between the two replicates, reads were combined for both replicates and for 
input controls from both replicates using samtools 18. Peak calling from read count against input 
was as previously described. Initial analysis showed a high level of overlap between replicates 
from RUNX1 6h samples, with the majority (99.1%) of peaks called in replicate 2 also 
identifiable in replicate 1, thus the overlapped peaks identified via ChIPpeakAnno 19 package 
were used as the consensus data. Downstream analysis of peaks was as previously described in 
section 2.2.3.2. For the identification of the RUNT motif map on the whole mouse genome, the 
corresponding position weight matrix was obtained from the HOMER Motif Database (Table 
5.1) and mapping was conducted using the MEME Suite. Enriched motif analysis was as 
previously described in section 2.2.3.2. RUNX1 E14.5 ChIP-seq data is publicly available and 






Table 5.1 Position weight matrix for the RUNT motif HOMER Motif Database that was 
used for the identification of the motif map.  
Each row corresponds to a nucleotide in the consensus sequence and each column corresponds 
to nucleotide A, C, G or T. The number represents the probability of each nucleotide to be 





5.3.1 RUNX transcription factors are induced in granulosa cells during ovulation 
Since each of the RUNX family members (Runx1, Runx2 and Runx3) have been shown to play 
a role in the ovary, the temporal pattern of expression of all three RUNX mRNA transcripts 
and proteins, plus their dimerising partner CBFβ, was examined in granulosa cells through RT-
qPCR and Western blot. Among the three RUNX transcription factors, only RUNX1 and 
RUNX2 showed significant upregulation during the peri-ovulatory window. For RUNX1, the 
mRNA and protein levels were low but detectable in granulosa cells from unstimulated and 0h-
hCG granulosa cells but were rapidly induced (20-40 fold respectively) within 4 h and peaking 
6 h post-hCG (Figure 5.1A). Runx2 mRNA was also induced up to 600-fold and reached 
highest level at 8 h post-hCG, however RUNX2 protein level was induced by 6 h and continued 
ALPHABET= ACGT 
 
strands: + - 
 
Background letter frequencies (from unknown source): 
A 0.250 C 0.250 G 0.250 T 0.250 
 
MOTIF 1 HAACCACADV 
 
letter-probability matrix: alength= 4 w= 10 nsites= 1 E= 0e+0 
0.574000 0.159000 0.031000 0.236000 
0.895000 0.001000 0.103000 0.001000 
0.870000 0.029000 0.100000 0.001000 
0.001000 0.997000 0.001000 0.001000 
0.001000 0.997000 0.001000 0.001000 
0.885000 0.001000 0.066000 0.048000 
0.001000 0.997000 0.001000 0.001000 
0.913000 0.057000 0.001000 0.029000 
0.398000 0.067000 0.339000 0.196000 




to rise, reaching 60-fold over unstimulated granulosa cell level by 12 h post-hCG (Figure 5.1B). 
Runx3 was not significantly upregulated in response to hCG (Figure 5.1C) and thus protein 
expression was not investigated. The mRNA expression of Cbfb, the dimerising partner for 
RUNX proteins, was only slightly upregulated during the peri-ovulatory window however 










Figure 5.1 RUNX / CBFβ mRNA and protein are induced by the LH surge in granulosa 
cells.  
Expression of RUNX1 (A), RUNX2 (B), RUNX3 (C) and CBFβ (D) was determined through 
RT-qPCR quantification of mRNA (left panel), Western blot (middle panel) and protein 
quantification (right panel). For mRNA expression, RT-qPCR was performed on granulosa 
cells obtained either without eCG or hCG (unstim) or eCG + hCG 0-12 h stimulation. Fold 
change is displayed as normalised to the housekeeping Rpl19 gene and relative to the unstim 
sample. N = 3 biological replicates, each replicate is from 3-5 mice per time point. Statistical 
significance was determined through one-way ANOVA with multiple comparison, p < 0.0001 
(Runx1), p = 0.0011 (Runx2), p = 0.4742 (Runx3), p = 0.0039 (Cbfb). Bars with different 
superscripts are significantly different. For Western blot, granulosa cells from ovaries treated 
in the same way were used, with n = 3 biological replicates and each replicate consisting of 
ovaries from 3-5 mice per time point. Quantification of Western intensity is displayed as fold 
change normalised to the housekeeping nuclear protein H3 and relative to unstim. Statistical 




5.3.2 Characteristics of RUNX1 cistromes in granulosa cells in different 
developmental contexts 
5.3.2.1 Assessing robustness and selection of consensus RUNX1 binding sites 
The induction of RUNX1 protein in granulosa cells peaked at 6 h post-hCG suggests that 
RUNX1 activity would be the highest at this time point; this coincides with the peak PGR 
protein abundance and thus was chosen for ChIP-seq analysis. This time point also allowed for 
compatible comparison with the existing PGR and H3K27ac ChIP-seq datasets. To investigate 
the chromatin binding properties of RUNX1 in response to the LH surge, RUNX1 ChIP-seq 
was performed on eCG-stimulated mouse granulosa cells with and without further hCG 
treatment (termed RUNX1 6h and RUNX1 0h respectively). RUNX1 is not only present in 
adult granulosa cells but is also expressed in foetal granulosa cells and has demonstrated 
important roles in the female-oriented differentiation of supporting cells in the ovary. To 
determine whether the characteristics of RUNX1 cistrome are conserved through different 
developmental stages, the RUNX1 cistrome in foetal granulosa cells was also examined 
(referred to as RUNX1 E14.5). Two biological replicates from foetal ovary pools were used 
for ChIP-seq with a separate input control for each replicate 10. For all three sample groups, the 
sequencing quality control for each replicate and input control was conducted using the 
FASTQC package in R prior to analysis, which showed no major inconsistency. 
 
To confirm the robustness of RUNX1 ChIP-seq, the reproducibility of each pair of replicates 
was assessed using IDR and correlation parameters. The two biological replicates of RUNX1 
0h displayed a higher level of variation, shown in the number of peaks passing IDR correlation 
criteria and the Pearson correlation coefficient value (correlation coefficient = 0.93) (Appendix 
11A). The pattern of RUNX1 0h binding sites between replicates were comparable to one 
another, despite a difference in the total number of peaks per replicate, with 854 peaks shared 
between the two replicates (or 90.18% of replicate 1 and 27.25% of replicate 2. The high 
concordance of replicate 1 with replicate 2 and higher number of peaks in replicate 2 indicate 
that the variation was likely due to a lower ChIP-seq efficiency in replicate 1, hence in order 
to mitigate the potential for false negatives (i.e. actual RUNX1 binding sites not represented in 
this dataset) the two replicates were combined for peak calling and the resulting combined 2383 





As seen previously with PGR ChIP-seq, IDR analysis of 6h RUNX1 showed a correlation 
pattern of peaks identified in high-quality ChIP-seq data, such as good consistency in peak 
ranking between the two replicates and a pronounced inflection in the IDR curve (Appendix 
11B). The two replicates were highly correlated, as seen in the overall pattern of RUNX1 
binding and the Pearson correlation coefficient test (correlation coefficient = 0.96). In total, 
28671 binding sites were identified in replicate 1 and 18761 binding sites were in replicate 2. 
Global comparison showed that the majority of binding sites in replicate 2 was in common with 
replicate 1 (accounting for 18594 binding sites, or 64.85% of replicate 1 and 99.11% of 
replicate 2). The shared 18594 sites between the two replicates represented the highest 
confidence set of binding sites and were thus chosen as the RUNX1 6h dataset for subsequent 
analyses.  
 
While there was correlation between the two RUNX1 E14.5 replicates, peak ranking exhibited 
less consistency between two replicates (Appendix 11C). Furthermore, while the peak pattern 
from both replicates showed a strong inclination for TSS binding, there was a slight shift in 
peak summit between the two replicates and there was also a slightly weaker correlation 
between the two replicates than previously seen in other ChIP-seq replicates (Pearson 
correlation coefficient = 0.92). In total, there was a 3-fold difference in the number of identified 
peaks between the two replicates (1561 and 4941 peaks in replicate 1 and 2 respectively), with 
1028 peaks shared between the two replicates (65% of replicate 1 and 20% of replicate 2). All 
of this indicates a moderate difference between the two biological replicates, which from 
experience is commonly observed in pooled embryonic samples. Again, in order to mitigate 
the potential for false negatives, reads from both replicates were combined and peaks called 
from the pooled reads were treated as the consensus RUNX1 binding site list. By combining 
the two replicates 6538 peaks were identified. The high overlap among each of the RUNX1 
ChIP-Seq datasets in subsequent analysis suggests that false positives are rare in the datasets. 
5.3.2.2 Mutual and context-specific RUNX1 binding sites in granulosa cells 
RUNX1 ChIP-seq from adult (RUNX1 6h, RUNX1 0h) and foetal (RUNX1 E14.5) granulosa 
cells were comparatively analysed. PCA analysis of the three read coverage datasets showed 
two distinct clusters, with RUNX1 0h and RUNX1 E14.5 grouping together away from 
RUNX1 6h (Figure 5.2A). This was confirmed with a correlation matrix which showed that 




coefficient = 0.88), which was greater than the correlation between either dataset to RUNX1 
6h (Figure 5.2B). However, regardless of the biological context, RUNX1 peaks in both adult 
and foetal granulosa cells congregated in close proximity to the TSS (Figure 5.2C).  
 
Among the 18504 binding sites in post-hCG granulosa cells 5128 sites were shared with foetal 
granulosa cells (78% of total foetal binding sites or 28% of total RUNX1 6h sites) (Figure 
5.2D). 1169 binding sites (or 49% and 18% of total RUNX1 0h and RUNX1 E14.5 binding 
sites respectively) were shared between RUNX1 0h and RUNX1 E14.5. Interestingly, 1161 of 
1169 sites were also shared with RUNX1 6h, indicating that not only was there a basal 
maintenance level of RUNX1 chromatin binding in granulosa cells but also a large number of 






Figure 5.2 Correlation between RUNX1 binding sites in different biological contexts  
(A) Principle component analysis (PCA) of RUNX1 ChIP-seq in E14.5 ovary or granulosa 
cells from eCG + HCG 0 h or 6 h. (B) Pearson correlation coefficient between RUNX1 0 h, 
RUNX1 6 h and RUNX1 E14.5 datasets. The correlation in genomic coverage between all 
datasets was analysed and organised in hierarchical order. (C) Read count frequency of 
RUNX1 0 h, RUNX1 6 h and RUNX1 E14.5 ChIP-seq peaks in relation to the TSS. (D) Venn 





5.3.2.3 RUNX1 regulates different pathways in a context-specific manner 
Figure 5.2D shows that RUNX1 targets different subsets of chromatin regions depending on 
the biological context in granulosa cells. To explore the context-specific roles of RUNX1 
activity, RUNX1 binding sites from the three datasets were divided into further subcategories 
of interest based on the timing of RUNX1 occupancy: foetal-specific (binding sites found only 
in RUNX1 E14.5), constitutive (binding sites found in all three contexts), adult-specific 
(binding sites found only in RUNX1 6h and RUNX 0h), LH-specific (binding sites found only 
in RUNX1 6h) (Figure 5.3A-D). An example of chromatin binding pattern was shown for each 
subcategory, which showed context-specific RUNX1 binding events.  
 
In foetal-specific RUNX1 binding sites (Figure 5.3A), there was a strong enrichment for 
binding at promoters (73% occupancy in proximal promoter regions), especially within 1 kb 
upstream from a TSS. A similar pattern was also observed in constitutively bound sites, with 
more than 85% binding sites being enriched in promoter regions (Figure 5.3B). In RUNX1 
binding sites found in adult granulosa cells, this pattern was not as strong: 30% of adult-specific 
RUNX1 sites were present within 3 kb of TSS  (Figure 5.3C) and more than half of hCG-
induced sites occupied promoters (Figure 5.3D). This showed that in biological contexts where 
RUNX1 is functionally active, such as in foetal granulosa cells or in peri-ovulatory granulosa 
cells, RUNX1 binding is purposely promoter-centric and is likely involved directly in 
transcriptional regulation.  
 
To explore the consequences of RUNX1 on specific biological pathway regulation, Gene 
Ontology enrichment of each subcategory was examined. Common biological pathways 
enriched in all four datasets mostly belonged to normal cellular functions, such as metabolism, 
gene expression regulation and cellular response to external stimuli pathways. Between foetal- 
and adult-patterned binding sites, an enrichment of different groups of pathways was observed. 
In the foetal-specific RUNX1 cistrome, pathways that were important in developmental 
processes, including differentiation and embryonic development, were highly abundant (Figure 
5.3A); however, in adult-patterned cistromes RUNX1 binding sites were associated more with 
cell cycle/apoptosis and cellular organisation (Figure 5.3B-D). 
 
The impact of RUNX1 binding in adult granulosa cells on gene expression regulation during 




regulated by an ovulatory stimulus (DEGs in granulosa cells 0h vs 8h hCG-stimulation 
identified through RNA-seq) (Figure 5.3E). RUNX1 interaction at ovulatory genes were 
largely LH-specific and not from constitutive RUNX1 binding (790 DEGs to 74 DEGs, 
respectively), suggesting that de novo RUNX1 binding specifically induced due to the LH 
surge is highly functionally important to the resultant gene expression changes. However, there 
were also 74 DEGs that were found with RUNX1 binding in all biological context and 45 
DEGs with RUNX1 binding at both 0h and 6h post-hCG, indicating that the maintenance of 
basal RUNX1 chromatin binding may also play a part in gene regulation during ovulation. 
Remarkably RUNX1-bound genes constituted more than one-third of all identified ovulatory 
DEGs, which further confirmed the importance of RUNX1 binding on consequential gene 










Figure 5.3 Gene categories associated with RUNX1 binding throughout ovarian 
folliculogenesis.  
(A-D) Subcategories of RUNX1 ChIP-seq datasets divided into groups according to the 
presence of peaks unique to early granulosa cell differentiation E14.5 (A), constitutively 
present at all developmental stages (B), adult-specific (C) or LH-specific (D). In panels A-D 
clockwise from top left corner: Venn diagram with coloured areas illustrating the subcategory 
of RUNX1-bound peaks. Example genes with RUNX1 peaks in E14.5 ovaries (yellow), in 
granulosa cells after eCG stimulation (blue) or hCG (pink). Gene ontological terms enriched 
in each subcategory of RUNX1 bound genes showing major clusters of ontological terms 
(circled and labelled accordingly). Distribution of peaks among genomic features including 
promoters (< 1 kb, 1-2 kb and 2-3 kb), 5’ UTR, 1st intron, other introns, exons, 3’ UTR and 
downstream of TES (within 3 kb). Peaks that are not in these features are classified as distal 
intergenic. (E) Volcano plot of all ovulatory DEGs with RUNX1 binding. DEGs were 
identified through RNA-seq comparison of granulosa cells following eCG only vs eCG + hCG 
8 h stimulation. DEGs that met statistical criteria (|logFC| ≥ 1 and -log(p-value) ≥ 2) are 
graphed. DEGs with no RUNX1 binding at any stage are in black, with LH-induced RUNX1 
binding in red, with adult-patterned RUNX1 binding in blue and constitutive RUNX1 binding 





5.3.2.4 RUNX1 binds to different motifs in foetal and adult granulosa cells 
RUNX1 canonically binds to the RUNT motif. The global RUNT motif was mapped in the 
mouse genome, of which there were 41840 loci. To determine the level of RUNX1 coverage 
on the canonical RUNT map, RUNX1 binding sites in the three different granulosa cell 
contexts were compared against global RUNT loci. In adult granulosa cells, 431 of RUNX1 6h 
and 70 of RUNX1 0h binding sites were found to be at a RUNT locus, with 54 sites shared 
between the two time points (Figure 5.4A), indicating that there was an increase in RUNX1-
RUNT binding after the LH surge. In foetal granulosa cells, 73 binding peaks were located at 
a RUNT locus, with the majority of these RUNT loci also found in the RUNX1 6h dataset. 
 
While RUNX1 in both adult and foetal granulosa cells bound to the consensus RUNT motif, a 
large number of RUNX1 peaks were not found to be located a canonical RUNT site. 
Furthermore, as RUNX1 clearly had different roles and targeted different genomic regions in 
different biological contexts, it was hypothesised that RUNX1 also interacted with different 
non-canonical motifs in adult versus foetal granulosa cells. To investigate this, enriched motif 
analysis was performed on RUNX1 peaks that were adult-specific (found only in RUNX1 6h 
and RUNX1 0h), shared (found in all three biological contexts) or foetal-specific (Figure 5.4B). 
In all three groups, the canonical RUNT motif was the most highly enriched (3.8- to 5.6-fold 
over background). In adult-specific binding sites, a number of non-canonical motifs were 
identified, including motifs for NR5A2, PRE/NR3C, GATA and JUN/FOS families. Each of 
these were also previously found enriched at PGR ChIP-seq binding sites.  In foetal-specific 
RUNX1 peaks however, such motifs were not highly enriched or were not at all identified; 
instead motifs such as that for CTCF, HMG and Homeobox transcription factor families were 
found. This suggests potential different transcription factor partners to RUNX1 in adult and 






Figure 5.4 Identity of context-specific RUNX1-binding motifs.  
(A) Venn diagram showing overlap of all RUNT loci within the mouse genome sequence (red) 
with RUNX1-bound peaks in eCG only (RUNX1 0 h – blue) or eCG + hCG 6 h (RUNX1 6h – 
pink), with additional RUNX1 E14.5 ChIP-seq overlay (orange). (B) Top most common known 
motifs found to be enriched at RUNX1 binding sites, displayed as heatmap of fold enrichment 
over background. From left to right: adult-specific, adult-foetal constitutive and foetal-specific 
binding sites. Heatmap colours indicate fold enrichment of motif at peaks and crossed blank 





5.3.3 Distinct RUNX1 cistromes in granulosa cells in response to the LH surge 
5.3.3.1 RUNX1 preferably binds transcriptionally active promoters before and after the 
LH surge 
There were significant differences in adult versus foetal-patterned RUNX1 binding preferences 
and a large induction of RUNX1 regulatory activity in adult granulosa cells in response to the 
LH surge. To dissect the specificity of RUNX1 activity during the peri-ovulatory period, 
RUNX1 cistromes before and after hCG stimulation were examined alongside the active 
chromatin marker H3K27ac in 6 h hCG granulosa cells. As expected, the hierarchical 
relationship between datasets showed that there was a considerably higher level of correlation 
between RUNX1 6h and H3K27ac cistrome than between RUNX1 0h and H3K27ac (Pearson 
correlation coefficient = 0.78 and 0.62, respectively) (Figure 5.5A). Indeed, this was confirmed 
through a global comparison between binding sites for RUNX1 at the two time points, which 
showed a high level of overlapping (2205 peaks, accounting for 11.86% of RUNX1 6h and 
92.53% of RUNX1 0h peaks) (Figure 5.5B). Among the 2205 shared sites, 87% were also 
found to overlap with H3K27ac sites, suggesting that there was a basal level of RUNX1 
occupancy at potential open chromatin sites prior to the LH surge; however this was markedly 
increased after the LH surge, with three-quarters of total RUNX1 6h peaks overlapped with 
H3K27ac peaks (13745 out of 18594 peaks). Analysis of the genomic distribution of RUNX1 
ChIP-seq at transcriptionally active sites showed that promoter occupancy was highly enriched 
at RUNX1 peaks regardless of the time point, showing that even prior to the LH surge RUNX1 
has the potential to target transcriptionally active promoters (Figure 5.5C). An example of LH-
induced RUNX1 binding can be seen in the promoter region of Adamts1 where prominent the 
RUNX1 peak was seen only in RUNX1 6h (Figure 5.5D). Furthermore, when binding sites 
were divided into shared and time point-specific subsets, the overall binding patterns of data 
subsets showed prominent RUNX1 6h binding signals compared to RUNX1 0h, especially at 
shared peaks. As seen previously, the majority of peaks were specific to RUNX1 6h and even 
among shared binding sites, peak intensity was on average higher in RUNX1 6h compared to 
RUNX1 0h (Figure 5.5E-F). Detailed analysis of the genomic distribution of each subset 
confirmed the previous observation of promoter binding preference, with a slight increase seen 










Figure 5.5 LH-dependent RUNX1 chromatin binding properties.  
(A) Pearson correlation coefficient comparisons of the RUNX1 cistromes in granulosa cells at 
eCG (RUNX1 0h) or 6 h (RUNX1 6h) versus H3K27ac ChIP-seq peaks after hCG 6 h. The 
correlation in genomic coverage between all datasets was analysed and organised in 
hierarchical order. (B) Venn diagram showing shared and factor-unique peak counts for 
RUNX1 6h, RUNX1 0h and H3K27ac cistromes. (C) Genome distribution of the overlapped 
RUNX1 0h/H3K27ac and RUNX1 6h/H3K27ac binding sites. Genomic features include 
promoters (< 1 kb, 1-2 kb and 2-3 kb), 5’ UTR, 1st intron, other introns, exons, 3’ UTR and 
downstream of TES (within 3 kb). Peaks that are not in these features are classified as distal 
intergenic. (D) Examples of context-specific RUNX1 binding sites in the genome, showing 
loci with binding specifically at 6h post-hCG (top), 0h post-hCG (bottom) and at both time 
points (middle). Binding intensity of RUNX1 6h is displayed in pink and RUNX1 0h in blue. 
(E) Heatmap of RUNX1 read frequency and visualisation of the pattern of signal intensity (F), 
divided into peaks specific to hCG treatment (6h unique), shared (overlap) and eCG only (0h 
unique) subgroups. Read intensity is displayed in relation to peak centre and the flanking 500 
bp region. (G) Genomic distribution of 6h-specific (top), shared (middle) or 0h-specific 





5.3.3.2 RUNX1 interacts with RUNT as well as non-canonical sequence motifs 
Not all RUNX1 binding in granulosa cells occurs at a canonical RUNT loci. To identify all 
sequences recognised by RUNX1 in adult granulosa cells, motif enrichment analysis was 
performed on RUNX1 0h and RUNX1 6h datasets (Figure 5.6A). As expected, the canonical 
RUNT motif was highly enriched in RUNX1 ChIP-seq in both 0 h and 6 h hCG-treated 
granulosa cells (5.3- and 3.5-fold enrichment to background, respectively). A number of non-
canonical motifs also showed enrichment in the RUNX1 cistromes. For example, apart from 
the canonical RUNT motif, in pre-LH granulosa cells RUNX1 preferably bound motifs for 
NR5A2 (3.7-fold) and GATA (3-fold), whereas post-LH RUNX1 most strongly bound to the 
bZIP (JUN/FOS) motif (4.2-fold enrichment). Other motifs, such as that for CEBP and 
PRE/NR3C motifs were also enriched in both datasets. A similar hierarchy of motifs enriched 
in the RUNX1 6h dataset was found at RUNX1 6h binding sites at ovulatory DEGs identified 
via RNA-seq, in which the motif for JUN/FOS was the most highly enriched (5.4-fold 
enriched), following by RUNT (4-fold) and NR5A2 (3.3-fold). HOMER de novo motif analysis 
supported this result by identifying enriched sequences in ChIP-seq peaks that corresponded to 
the same transcription factor families, as well as other motifs, such as that similar to the ETS 
and CCAAT motifs (Figure 5.6B). Overall, RUNX1 was shown to interact with the RUNT 
motif as well as non-canonical DNA motifs, suggesting an interaction between RUNX1 and 







Figure 5.6 Changing identity of RUNX1 binding motifs in response to LH ovulatory 
signal.   
(A) Heatmap showing most common known motifs enriched at RUNX1 0h and RUNX1 6h 
binding sites or RUNX1 bound genes shown in RNA-seq data to be regulated by hCG-
stimulation of ovulation. Motifs were ranked by -log(p-value) and among motifs from the same 
transcription factor family. (B) De novo motifs identified by HOMER for RUNX1 6h (top) and 
RUNX1 0h (bottom) binding sites. Motifs are selected based on p-value and the most 




5.4  DISCUSSION 
RUNX1 and other members of the RUNX family are associated with the regulation of gene 
expression during ovulation. However, not unlike PGR, the ovulatory role of RUNX1 has never 
been investigated on a global scale or in the context of other ovulatory factors in a regulatory 
system. RUNX1 being a key factor in granulosa cell specification during foetal development 
complicates studies on the ovulatory effect of RUNX1. Thus, it is necessary to separate the 
specific roles of RUNX1 in granulosa cells at different developmental stages in order to fully 
appreciate its impact on ovulation. This study provides first description of RUNX1 activity in 
granulosa cells at the genome-wide level in foetal granulosa cells, where RUNX1 is involved 
in the differentiation of the bipotential gonadal somatic cells, compared to adult granulosa cells 
in response to ovulatory cues, where RUNX1 plays a role in ovulation regulation. Specific 
cistromic patterns were drawn in each biological contexts that had an effect on RUNX1 
functions at these time points.  
 
RUNX1 ChIP-seq in granulosa cells at three developmental time points of interest revealed a 
basal level of chromatin binding from the time of ovarian divergence from the unspecified 
gonad and in adult granulosa cells and an overwhelming increase in peri-ovulatory granulosa 
cells. Almost all constitutively present RUNX1 binding sites were located in proximal 
promoter regions of genes, and included genes that encode histone components of the 
nucleosome (Hist1h2ao, Hist1h4m, Hist1h4n), metabolism (Gapdh), DNA polymerases (Poll, 
Pole4) and ubiquitination process (Ube2m, Ube2f, Ubc), indicating a role of RUNX1 in basic 
cellular functions. Intriguingly, the gene encoding for RUNX1 itself had constitutive RUNX1 
binding in its promoter and introns regardless of time point, suggesting a level of auto-
regulation in RUNX1, perhaps in order to sustain basal level of RUNX1 expression prior to 
ovulatory cues. On the same note, RUNX1 also bound the promoter of RUNX2 in an LH-
inducible manner, implying a role of RUNX1 in regulating RUNX2 expression. The cross-
regulation of RUNX members have previously been described in rat granulosa cells, in which 
RUNX2 was found to bind Runx1 promoter and in vitro RUNX2 ablation via siRNA led to an 
increase in Runx1 expression 12. Knockdown of the RUNX dimerising partner CBFβ in 
granulosa cells also leads to an increase in RUNX1 level whilst RUNX2 level remains 
unaltered 8, which suggests possible compensation mechanisms involved in RUNX regulation. 
Further studies using a viable tissue-specific RUNX1 KO model will be useful in clarifying 




constitutively bound by RUNX1 in granulosa cells, such as Jund, Fos, Klf16, Sox12 and Zbtb1. 
However, while some of these transcription factors have been previously described in the 
context of ovarian functions (JUN/FOS proteins), the majority of these genes have not been 
previously studied in granulosa cells and thus requiring further investigations.  
 
After hCG treatment, there was a significant induction in RUNX1 mRNA and protein 
expression in granulosa cells, leading to an increase in RUNX1 chromatin binding activities, 
which was illustrated by an increase in RUNX1 binding sites after hCG stimulation. Such LH-
induced pattern of cistromic activity in preparation for ovulation has previously been seen in 
other transcriptional regulatory factors 20. The role of RUNX1 in regulatory ovulatory genes is 
shown in comparison between RUNX1-bound genes and genes that are regulated in peri-
ovulatory granulosa cells. RUNX1 bound more than 40% of all identified DEGs which stresses 
the importance of RUNX1 as a master transcription regulator in ovulation. However, LH-
induced RUNX1 binding sites do not solely target proximal promoter regions; rather, following 
hCG there was an increase in intergenic binding incidents compared to constitutive RUNX1 
binding sites. This suggests additional RUNX1 function upon the LH surge, in which RUNX1 
also activates intergenic chromatin targets, likely to be enhancer elements. The role of RUNX1 
at enhancer sites has been previously indicated in other cellular contexts 21-24. Further 
investigations into the role of RUNX1 in the enhancer landscape of peri-ovulatory granulosa 
cells is necessary. Analysis of enriched motifs at RUNX1 binding sites has given us a snapshot 
of the dynamics of the transcription complex in which RUNX1 is involved during ovulation, 
displayed as a clear shift in non-canonical motif binding of RUNX1 that is induced by the LH 
surge. Specifically, there was a striking enrichment of the motif for the bZIP (JUN/FOS) 
transcription factor family at RUNX1 bound DNA at 6 h post-hCG and especially at RUNX1 
binding sites associated with genes regulated by hCG ovulatory trigger. This motif is 
specifically recognised by JUN and FOS transcription factors, including c-JUN, JUNB, JUND 
and c-FOS. In the ovary, JUN/FOS members play an important role in granulosa cell gene 
expression, in particular genes involved in steroidogenesis 25. The same motif was also found 
to be highly enriched at PGR binding sites in the same biological context. This further 
highlights the presence of JUN/FOS transcription factors in granulosa cells during ovulation, 
most likely in association with PGR as well as RUNX1. While an interaction between 
JUN/FOS proteins and RUNX1 has not been previously indicated, JUN/FOS are known to 
interact with PGR in human uterine myometrium 26. The results have also shown genes 




implying another role of RUNX1 in their regulation. Further studies into the relationship 
between PGR, RUNX1 and JUN/FOS in the context of ovulation is required. 
 
RUNX1 was expressed at low level in granulosa cells prior to the LH surge and was not 
detectable through microscopy. However, while there was minimal activity of RUNX1 prior 
to the LH surge, in granulosa cells without hCG stimulation RUNX1 was shown to be capable 
of chromatin binding, particularly proximal promoters, that were later marked as being 
transcriptionally active after the LH surge. Indeed, in the majority of RUNX1 0h/H3K27ac 
peaks, such binding events were maintained through the peri-ovulatory window and was 
present in the RUNX 6h dataset. Interestingly, many non-canonical motifs were enriched at 
RUNX1 binding sites before and after the LH surge, such as PRE/NR3C and GATA motifs 
that are recognised by LH-induced transcription factors (PGR 27, GATA4 and GATA6 28). 
RUNX1 and GATA1 have been previously shown to form a physical interaction and share 
mutual DNA targets that are important for megakaryocyte differentiation 29. Other motifs, such 
as NR5A2, are canonically bound by LRH1, which is present in granulosa cells both before 
and after the LH surge 20. This illustrates a potential role of RUNX1 in ‘priming’ potential 
target chromatins for future activation during the peri-ovulatory window by other factors. 
RUNX1 is not present in abundance in early-staged follicles 4, meaning that between the 
process of granulosa cell specification in foetal ovaries and ovulation RUNX1 activity in the 
ovary was switched off. In zebrafish such a switch was shown to be regulated by CTCF and 
cohesin 30, however whether the same also happens in mammals is still unknown. It would be 
of interest to further explore the role of RUNX1 during later stages of granulosa cell 
differentiation during folliculogenesis but prior to ovulation, and what mechanism regulates 
the silencing of RUNX1 in early life.  
 
Apart from its role in adult ovarian functions, RUNX1 is also involved in the transition of 
undifferentiated gonadal somatic cells to granulosa cells in the bipotential gonad 10. Using 
ChIP-seq targeting RUNX1 binding in foetal ovaries, the global RUNX1 chromatin binding 
landscape was identified with a level of binding specifically found in foetal granulosa cells and 
a large proportion of this shared with that found in adult granulosa cells. Such foetal-specific 
binding pattern was reflected in the canonical pathways that were enriched in the dataset, with 
many involved in developmental processes, such as cell fate commitment, cell differentiation 
and organ morphogenesis. The RUNX1-dependent transcriptome of foetal granulosa cells has  




gene expression regulation has not been investigated in detail. In addition, a number of non-
RUNT motifs were identified to be specifically targeted by RUNX1 in foetal and not adult 
granulosa cells, which indicates potential binding partners of RUNX1 at this distinct 
developmental stage. Included among these is the motif for CTCF, which is uniquely enriched 
in RUNX1 binding sites in prenatal granulosa cells. CTCF is a key factor in chromatin looping 
and the formation of TADs, thus allowing for clusters of genes to be regulated by distal 
enhancer elements within the TAD boundary 31. Understandably, the expression of CTCF is 
crucial for normal gene regulation and physiology and in particular, the role of CTCF in foetal 
development has been implicated in the eye 32, limb 33 and neurons 34. Although the physical 
interaction between CTCF and RUNX1 remains unexplored, as previously mentioned, CTCF 
can regulate the spatial expression of Runx1 in zebrafish embryos 30. Separately, RUNX1 has 
been shown to regulate the activity of enhancer elements in order to regulate target genes in 
other cellular contexts 22-24, for this the initiation and maintenance of specific chromosomal 
conformation would be required. Thus CTCF would be crucial for RUNX1 action and is likely 
in close proximity to RUNX1 binding sites. Conversely, the PRE/NR3C motif was only found 
at RUNX1 binding sites in adult and not foetal granulosa cells. As PGR and RUNX1 also had 
a similar pattern of regulation during the peri-ovulatory window and formed physical 
interaction in granulosa cells, this shows that an interaction between PGR and RUNX1 is 
specific for the context of ovulatory granulosa cells. The interaction between RUNX1 and 
various co-modulators have been shown to be critical to RUNX1 activities in different 
biological contexts 35. In prenatal granulosa cells in particular, RUNX1 has been shown to form 
functional interaction with FOXL2 in order to drive feminisation of gonadal somatic cells 10, 
and in this instance the canonical binding motif for FOXL2 was also identified in foetal 
RUNX1 binding sites. Therefore, future studies on the role of RUNX1 in granulosa cell 
specification would benefit from investigating the relationship between RUNX1 and co-factors 
in this biological context. 
 
To conclude, this chapter offers the first insight into RUNX1 activities in granulosa cells on a 
genomic level in foetal granulosa cells, where RUNX1 is involved in the differentiation of the 
bipotential gonadal cells, and in adult granulosa cells in response to ovulatory cues, where 
RUNX1 plays a role in ovulation regulation. ChIP-seq indicates distinctive RUNX1 cistromes 
in different biological contexts with a basal level of chromatin occupancy found at all time 
points. In the context of adult granulosa cells, RUNX1 mRNA, protein and chromatin binding 




of ovulatory genes in granulosa cells, which highlights the importance of RUNX1 in peri-
ovulatory granulosa cells. As RUNX1 can form a physical interaction with PGR, the next 
chapter investigated the similarities between PGR and RUNX1 cistromes in granulosa cells 





5.5  REFERENCES 
1 Mevel, R., Draper, J. E., Lie-a-Ling, M., Kouskoff, V. & Lacaud, G. RUNX 
transcription factors: orchestrators of development. Development 146, dev148296 
(2019). 
2 Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G. & Downing, J. R. AML1, the 
Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for 
Normal Fetal Liver Hematopoiesis. Cell 84, 321-330, 
doi:https://doi.org/10.1016/S0092-8674(00)80986-1 (1996). 
3 Takarada, T., Hinoi, E., Nakazato, R., Ochi, H., Xu, C., Tsuchikane, A., Takeda, S., 
Karsenty, G., Abe, T., Kiyonari, H. & Yoneda, Y. An analysis of skeletal development 
in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 
(Runx2) knockout mice. Journal of Bone and Mineral Research 28, 2064-2069, 
doi:10.1002/jbmr.1945 (2013). 
4 Jo, M. & Curry, T. E., Jr. Luteinizing Hormone-Induced RUNX1 Regulates the 
Expression of Genes in Granulosa Cells of Rat Periovulatory Follicles. Molecular 
Endocrinology 20, 2156-2172, doi:10.1210/me.2005-0512 (2006). 
5 Bai, Z.-K., Li, D.-D., Guo, C.-H., Yang, Z.-Q., Cao, H., Guo, B. & Yue, Z.-P. 
Differential expression and regulation of Runx1 in mouse uterus during the peri-
implantation period. Cell and Tissue Research 362, 231-240, doi:10.1007/s00441-015-
2174-z (2015). 
6 Wissing, M. L., Kristensen, S. G., Andersen, C. Y., Mikkelsen, A. L., Høst, T., Borup, 
R. & Grøndahl, M. L. Identification of new ovulation-related genes in humans by 
comparing the transcriptome of granulosa cells before and after ovulation triggering in 
the same controlled ovarian stimulation cycle. Human Reproduction 29, 997-1010, 
doi:10.1093/humrep/deu008 (2014). 
7 Gao, K., Wang, P., Peng, J., Xue, J., Chen, K., Song, Y., Wang, J., Li, G., An, X. & 
Cao, B. Regulation and function of runt-related transcription factors (RUNX1 and 
RUNX2) in goat granulosa cells. The Journal of Steroid Biochemistry and Molecular 
Biology 181, 98-108, doi:https://doi.org/10.1016/j.jsbmb.2018.04.002 (2018). 
8 Lee-Thacker, S., Choi, Y., Taniuchi, I., Takarada, T., Yoneda, Y., Ko, C. & Jo, M. Core 
binding factor β expression in ovarian granulosa cells is essential for female fertility. 
Endocrinology 159, 2094-2109 (2018). 
9 Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. 
A., Jr., Shyamala, G., Conneely, O. M. & O'Malley, B. W. Mice lacking progesterone 
receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9, 2266-2278 
(1995). 
10 Nicol, B., Grimm, S. A., Chalmel, F., Lecluze, E., Pannetier, M., Pailhoux, E., Dupin-
De-Beyssat, E., Guiguen, Y., Capel, B. & Yao, H. H. C. RUNX1 maintains the identity 
of the fetal ovary through an interplay with FOXL2. Nature communications 10, 5116 
(2019). <https://doi.org/10.1038/s41467-019-13060-1>. 
11 Park, E.-S., Lind, A.-K., Dahm-Kähler, P., Brännström, M., Carletti, M. Z., 
Christenson, L. K., Curry, T. E., Jr. & Jo, M. RUNX2 Transcription Factor Regulates 
Gene Expression in Luteinizing Granulosa Cells of Rat Ovaries. Molecular 
Endocrinology 24, 846-858, doi:10.1210/me.2009-0392 (2010). 
12 Park, E.-S., Park, J., Franceschi, R. T. & Jo, M. The role for runt related transcription 
factor 2 (RUNX2) as a transcriptional repressor in luteinizing granulosa cells. 





13 Ojima, F., Saito, Y., Tsuchiya, Y., Ogoshi, M., Fukamachi, H., Inagaki, K., Otsuka, F., 
Takeuchi, S. & Takahashi, S. Runx3 regulates folliculogenesis and steroidogenesis in 
granulosa cells of immature mice. Cell and Tissue Research 375, 743-754, 
doi:10.1007/s00441-018-2947-2 (2019). 
14 Ojima, F., Saito, Y., Tsuchiya, Y., Kayo, D., Taniuchi, S., Ogoshi, M., Fukamachi, H., 
Takeuchi, S. & Takahashi, S. Runx3 transcription factor regulates ovarian functions 
and ovulation in female mice. J Reprod Dev 62, 479-486, doi:10.1262/jrd.2016-005 
(2016). 
15 Bai, Z.-K., Guo, B., Tian, X.-C., Li, D.-D., Wang, S.-T., Cao, H., Wang, Q.-Y. & Yue, 
Z.-P. Expression and regulation of Runx3 in mouse uterus during the peri-implantation 
period. Journal of Molecular Histology 44, 519-526, doi:10.1007/s10735-013-9501-z 
(2013). 
16 Guo, C.-H., Yue, Z.-P., Bai, Z.-K., Li, D.-D., Yang, Z.-Q. & Guo, B. Runx2 acts 
downstream of C/EBPβ to regulate the differentiation of uterine stromal cells in mice. 
Cell and Tissue Research 366, 393-401, doi:10.1007/s00441-016-2412-z (2016). 
17 Umansky, K. B., Gruenbaum-Cohen, Y., Tsoory, M., Feldmesser, E., Goldenberg, D., 
Brenner, O. & Groner, Y. Runx1 Transcription Factor Is Required for Myoblasts 
Proliferation during Muscle Regeneration. PLOS Genetics 11, e1005457, 
doi:10.1371/journal.pgen.1005457 (2015). 
18 Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., 
Abecasis, G. & Durbin, R. The Sequence Alignment/Map format and SAMtools. 
Bioinformatics 25, 2078-2079, doi:10.1093/bioinformatics/btp352 (2009). 
19 Zhu, L. J., Gazin, C., Lawson, N. D., Pagès, H., Lin, S. M., Lapointe, D. S. & Green, 
M. R. ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip 
data. BMC Bioinformatics 11, 237, doi:10.1186/1471-2105-11-237 (2010). 
20 Bianco, S., Bellefleur, A.-M., Beaulieu, É., Beauparlant, C. J., Bertolin, K., Droit, A., 
Schoonjans, K., Murphy, B. D. & Gévry, N. The Ovulatory Signal Precipitates LRH-1 
Transcriptional Switching Mediated by Differential Chromatin Accessibility. Cell 
Reports 28, 2443-2454.e2444, doi:https://doi.org/10.1016/j.celrep.2019.07.088 (2019). 
21 Huang, G., Zhang, P., Hirai, H., Elf, S., Yan, X., Chen, Z., Koschmieder, S., Okuno, 
Y., Dayaram, T., Growney, J. D., Shivdasani, R. A., Gilliland, D. G., Speck, N. A., 
Nimer, S. D. & Tenen, D. G. PU.1 is a major downstream target of AML1 (RUNX1) 
in adult mouse hematopoiesis. Nature Genetics 40, 51-60, doi:10.1038/ng.2007.7 
(2008). 
22 Guo, H., Ma, O., Speck, N. A. & Friedman, A. D. Runx1 deletion or dominant 
inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites 
to favor monopoiesis over granulopoiesis. Blood 119, 4408-4418, doi:10.1182/blood-
2011-12-397091 (2012). 
23 Mao, A.-P., Ishizuka, I. E., Kasal, D. N., Mandal, M. & Bendelac, A. A shared Runx1-
bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage development. 
Nature Communications 8, 863, doi:10.1038/s41467-017-00882-0 (2017). 
24 Choi, A., Illendula, A., Pulikkan, J. A., Roderick, J. E., Tesell, J., Yu, J., Hermance, N., 
Zhu, L. J., Castilla, L. H., Bushweller, J. H. & Kelliher, M. A. RUNX1 is required for 
oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia. 
Blood 130, 1722-1733, doi:10.1182/blood-2017-03-775536 (2017). 
25 Choi, Y., Rosewell, K. L., Brännström, M., Akin, J. W., Curry Jr, T. E. & Jo, M. FOS, 
a Critical Downstream Mediator of PGR and EGF Signaling Necessary for Ovulatory 
Prostaglandins in the Human Ovary. The Journal of Clinical Endocrinology & 




26 Nadeem, L., Shynlova, O., Matysiak-Zablocki, E., Mesiano, S., Dong, X. & Lye, S. 
Molecular evidence of functional progesterone withdrawal in human myometrium. 
Nature Communications 7, 11565, doi:10.1038/ncomms11565 (2016). 
27 Robker, R. L., Russell, D. L., Espey, L. L., Lydon, J. P., O'Malley, B. W. & Richards, 
J. S. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin 
L proteases. Proc Natl Acad Sci U S A 97, 4689-4694 (2000). 
28 Bennett, J., Wu, Y.-G., Gossen, J., Zhou, P. & Stocco, C. Loss of GATA-6 and GATA-
4 in Granulosa Cells Blocks Folliculogenesis, Ovulation, and Follicle Stimulating 
Hormone Receptor Expression Leading to Female Infertility. Endocrinology 153, 
2474-2485, doi:10.1210/en.2011-1969 (2012). 
29 Tijssen, Marloes R., Cvejic, A., Joshi, A., Hannah, Rebecca L., Ferreira, R., Forrai, A., 
Bellissimo, Dana C., Oram, S. H., Smethurst, Peter A., Wilson, Nicola K., Wang, X., 
Ottersbach, K., Stemple, Derek L., Green, Anthony R., Ouwehand, Willem H. & 
Göttgens, B. Genome-wide Analysis of Simultaneous GATA1/2, RUNX1, FLI1, and 
SCL Binding in Megakaryocytes Identifies Hematopoietic Regulators. Developmental 
Cell 20, 597-609, doi:https://doi.org/10.1016/j.devcel.2011.04.008 (2011). 
30 Marsman, J., O'Neill, A. C., Kao, B. R.-Y., Rhodes, J. M., Meier, M., Antony, J., 
Mönnich, M. & Horsfield, J. A. Cohesin and CTCF differentially regulate 
spatiotemporal runx1 expression during zebrafish development. Biochimica et 
Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1839, 50-61, 
doi:https://doi.org/10.1016/j.bbagrm.2013.11.007 (2014). 
31 Nora, E. P., Goloborodko, A., Valton, A.-L., Gibcus, J. H., Uebersohn, A., Abdennur, 
N., Dekker, J., Mirny, L. A. & Bruneau, B. G. Targeted Degradation of CTCF 
Decouples Local Insulation of Chromosome Domains from Genomic 
Compartmentalization. Cell 169, 930-944.e922, 
doi:https://doi.org/10.1016/j.cell.2017.05.004 (2017). 
32 Li, T., Lu, Z. & Lu, L. Regulation of Eye Development by Transcription Control of 
CCCTC Binding Factor (CTCF). Journal of Biological Chemistry 279, 27575-27583, 
doi:10.1074/jbc.M313942200 (2004). 
33 Soshnikova, N., Montavon, T., Leleu, M., Galjart, N. & Duboule, D. Functional 
Analysis of CTCF During Mammalian Limb Development. Developmental Cell 19, 
819-830, doi:https://doi.org/10.1016/j.devcel.2010.11.009 (2010). 
34 Hirayama, T., Tarusawa, E., Yoshimura, Y., Galjart, N. & Yagi, T. CTCF Is Required 
for Neural Development and Stochastic Expression of Clustered Pcdh Genes in 
Neurons. Cell Reports 2, 345-357, doi:https://doi.org/10.1016/j.celrep.2012.06.014 
(2012). 
35 Lichtinger, M., Hoogenkamp, M., Krysinska, H., Ingram, R. & Bonifer, C. Chromatin 






CHAPTER 6 The functional and physical interaction between 




PGR is widely expressed throughout the female reproductive tract and is involved in the 
coordination of biological processes required for the establishment of pregnancy. In the ovary, 
it is specifically induced in peri-ovulatory granulosa cells in response to the LH surge and is a 
major determining factor in ovulation, with PGRKO female mice being anovulatory and 
completely infertile 1. In the oviduct, PGR is involved in the active transport of oocytes and 
embryos 2,3, and in the uterus PGR promotes decidualisation and embryo implantation 1. These 
PGR functions are achieved through PGR-dependent gene regulation, including distinct gene 
sets  that are critical for ovulation in granulosa cells 4, ciliate function and motility in the oviduct 
3 and decidualisation factors in the uterus 5. To fully comprehend the influence of PGR on 
tissue-specific gene expression profile, PGR-regulated tissue-specific transcriptomes from 
different reproductive tissues were compared. PGR was confirmed to be responsible for the 
regulation of highly distinct groups of genes in ovary, oviduct and uterus. To further explore 
the tissue-specific roles of PGR in different reproductive tissues, the PGR cistrome in 
progesterone-responsive granulosa cells was also compared to PGR cistrome in the uterus. In 
response to the LH surge in granulosa cells, there was a massive increase in PGR expression 
and function, with PGR targeting transcriptionally active promoter regions. In describing the 
non-canonical targets of PGR in granulosa cells, the RUNT motif was identified to be one of 
the most highly enriched motifs, which is canonically bound by the RUNX transcription factor 
family. Interestingly, RUNT was only implicated as a PGR target in granulosa cells and was 
not enriched in uterine PGR ChIP-seq in progesterone-responsive uterus, implying the RUNX 
transcription factors to be potential co-modulators to PGR in a granulosa-specific context.  
 
The RUNX transcription factor family consists of three members that share a common DNA 
binding domain which recognises the RUNT sequence motif. A heterodimer partner, named 
CBFβ, is required for efficient RUNX-DNA interaction. RUNX1, which is upregulated in 




expression 6. While a global RUNX1 KO mouse model is not viable, female mice that are 
CBFβ KO specifically in granulosa cells experience ovulation failure and are subfertile 7. 
Outside of the ovulation context, the importance of RUNX1 in granulosa cells has also been 
demonstrated in the earliest stages of granulosa cell differentiation in female gonads during 
foetal development 8.   
 
Both PGR and RUNX1 are known to cooperate with other transcriptional co-activators in 
different cellular contexts. PGR can interact with both co-activators and co-repressors 
depending on the biological contexts and result in specific regulation of PGR activities 9. 
Notably, PGR is capable of interacting with other ovulatory transcription factors, including 
members of the JUN/FOS family in human myometrial cells 10 and SP1/SP3 in regulation 
ovulatory genes in granulosa cells 11. RUNX1 and other RUNX transcription factors require 
dimerisation with CBFβ to efficiently bind target genes. RUNX1 has also been found to interact 
with the chromatin remodeller SWI/SNF complex and co-repressors such as HDAC proteins 
and the Groucho/TLE family, as well as various transcription factors 12. RUNX proteins can 
interact with SR, as indicated in osteoblasts and prostate cancer cells where RUNX-steroid 
receptor binding leads to mutual repression of the transactivation function of each other 13,14. 
However, the involvement of PGR and RUNX1 in the same transcription complex and 
consequences on the regulation of ovulatory genes have not been investigated. 
 
With the availability of newly emerging knowledge on the chromatin binding properties of 
ovulatory transcription factors in granulosa cells 15, in which the potential interaction with other 
modulators is crucial for their functions, it is informative that such cistromes are analysed 
alongside one another to gain a full understanding of the transcriptional regulatory interactome 
and how that affects downstream gene expression. In Chapter 5, the context-specific properties 
of RUNX1 cistromes in granulosa cells were demonstrated, in which it was found that RUNX1 
DNA binding was markedly increased upon the LH surge, with the majority of binding sites 
located in proximal promoter regions, which are all features in common with the PGR cistrome. 
Furthermore, an enrichment of the PRE/NR3C motif, canonically targeted by PGR, was also 
found at RUNX1 binding sites, which supports the hypothesis that PGR and RUNX1 interact 
on a chromatin level. In addition, direct RUNX1 binding was localised to the regulatory regions 
of ovulatory genes. Cumulatively, these new findings indicate that PGR and RUNX1 may be 
part of the same transcription complex responsible for the regulation of gene expression in 




granulosa cells in response to ovulatory cues was confirmed by PLA, as well the interaction 
between PGR and RUNX2 and CBFβ. Documented PGR and RUNX1 transcriptional activities 
in peri-ovulatory granulosa cells further point to a functional cooperation between PGR and 
RUNX1 in the regulation of ovulatory genes. To test the hypothesis that there is cooperative 
action of PGR and RUNX1 on a genome-wide level, comparisons were made between the PGR 
and RUNX1 cistromes, as indicated via ChIP-seq. The dynamics of the physical interaction 
between PGR and RUNX transcription factors in peri-ovulatory granulosa cells was also 
investigated. 
 
6.2 MATERIALS & METHODS 
6.2.1 Animals 
For peri-ovulatory granulosa cell experiments, CBAF1 mice were obtained from Laboratory 
Animal Services and maintained as in section 2.2.1.  
6.2.2 ChIP-seq experiments 
PGR and RUNX1 ChIP-seq experiments were conducted as described in section 2.2.3 and 
5.2.3. Briefly, granulosa cells were collected from super-ovulated CBAF1 female mice at 6 h 
after hCG injection and used for ChIP-seq targeting PGR or RUNX1. Bioinformatics analysis 
for ChIP-seq datasets was conducted using appropriate tools as described in section 2.2.3.  
6.2.3 Proximity ligation assay 
PLA was performed on granulosa cells for PGR/RUNX protein-protein interactions as 
described in section 4.2.6. Briefly, granulosa cells were obtained from ovaries of super-
ovulated female CBAF1 mice at 44 h post-eCG stimulation. Granulosa cells were plated in 
fibronectin-coated chamber slides and cultured in DMEM:F12 media before being treated with 
2 IU/ml hCG and 100 nM R5020 for 0-8 h. After treatment, cells were fixed with formaldehyde 
and permeabilised. PLA followed the protocol as previously described, using antibodies 
targeting PGR and RUNX1/RUNX2, and corresponding IgG antibodies were used as negative 
control. Slides were imaged using confocal microscope. Quantification of PLA signal was by 




were used for quantification. The nuclear boundary for each cell was determined through DAPI 
staining, with cytoplasmic region defined as the area outside of the nuclear boundary. PLA 
signals were identified as fluorescent puncta and quantified in using the ‘Count Maxima’ 
function in ImageJ for each cellular compartment. Significantly differences between time 
points were determined through two-way ANOVA with Tukey test for multiple comparison 
for row factor (difference between time points) and column factor (difference between cellular 




6.3.1 Interaction between RUNX1 and the PGR transcription machinery on a 
chromatin level 
6.3.1.1 RUNX1 shares occupancy of promoters with PGR 
RUNX1 binding properties were compared with that of PGR at 6h post-hCG in order to 
determine the relationship between RUNX1 and PGR cistromes. PGR showed a high 
correlation with RUNX1 6h (Pearson correlation coefficient = 0.87) and both transcription 
factors showing equal correlation to the active chromatin marker H3K27ac (correlation 
coefficient = 0.76-0.78) (Figure 6.1A). Overall the chromatin binding patterns of PGR and 
RUNX1 were relatively similar, as seen in a circos plot of all binding sites in the genome 
(Figure 6.1B) and in the read count frequency plot where both PGR and RUNX1 peaks 
overlapped with TSS and were flanked by H3K27ac double peaks (Figure 6.1C). PGR shared 
a remarkable number of mutual binding sites with RUNX1 both prior and after the LH surge, 
with 9704 binding sites identified to have both PGR and RUNX1 binding at 6h post-hCG 
(Figure 6.1D). Among these shared PGR/RUNX1 binding sites, more than 80% were located 







Figure 6.1 PGR and RUNX1 shared mutual chromatin targets in peri-ovulatory 
granulosa cells.  
(A) Pearson correlation coefficient showing relationships between RUNX1, PGR and 
H3K27ac binding sites at 6 h after hCG stimulation. The correlation in genomic coverage 
between all datasets was analysed and organised in hierarchical order. (B) Circos plot showing 
binding sites for PGR (orange), RUNX1 6h (pink), RUNX1 0h (blue) and H3K27ac (green) on 
the whole mouse genome. (C) Read count frequency of PGR, RUNX1 6h, RUNX1 0h and 
H3K27ac ChIP-seq peaks in relation to the TSS. (D) Venn diagram showing shared and factor-





Separating RUNX1 and PGR cistromes at 6h post-hCG into those that were shared or uniquely 
bound by each transcription factor showed that the strong preference for binding close (≤ 1 kb) 
to gene TSS was a predominant characteristic of RUNX1 bound intervals (Figure 6.2A-B). 
Binding sites that were found to have RUNX1 binding, either uniquely-bound by RUNX1 or 
with both PGR/RUNX1 binding, were remarkably highly enriched at proximal promoter 
regions (Figure 6.2C). On the other hand, PGR-unique intervals did not exhibit such a dramatic 
enrichment at promoters, which is not reflective of the genomic distribution of total PGR ChIP-
seq data described earlier in Figure 2.5. These results suggest that the prevalence for proximal 
promoter occupancy by PGR is determined by the presence of RUNX1 at these binding sites. 
Together with the fact that RUNX1 preferably bound transcriptionally active chromatins, these 
imply a possible role of RUNX1 as a pioneer factor for PGR-associated transcription in which 
RUNX1 promotes PGR binding at transcriptionally available promoters. Examples of PGR and 
RUNX1 binding at target chromatin sites can be seen in Figure 6.2D. PGR and RUNX1 were 
also found to bind the promoter and introns of Runx1 and Runx2, suggesting a degree of PGR- 










Figure 6.2 Transcription factor-specific chromatin binding properties of PGR and 
RUNX1 cistrome.  
(A-B) Heatmap of PGR and RUNX1 6h read frequency (A) and visualisation of the pattern of 
signal intensity (B), divided into peaks specific to PGR (PGR unique), shared (overlap) and 
specific to RUNX1 (RUNX1 unique) subgroups. Read intensity is displayed in relation to peak 
centre and the flanking 500 bp regions. (C) Genomic distribution of PGR-specific (top), shared 
(middle) or RUNX1-specific (bottom) binding sites. Genomic features include promoters (< 1 
kb, 1-2 kb and 2-3 kb), 5’ UTR, 1st intron, other introns, exons, 3’ UTR and downstream of 
TES (within 3 kb). Peaks that are not in these features are classified as distal intergenic. (D) 
Example of factor-specific binding sites in the genome, showing loci with binding specifically 
to PGR (top), RUNX1 (bottom) and shared between PGR and RUNX1 (middle). (E) Example 
of PGR and RUNX1 binding at Runx1 and Runx2. Binding intensity of PGR is displayed in 





6.3.1.2 RUNX1 and PGR functional similarities in peri-ovulatory granulosa cells 
To determine whether RUNX1 and PGR shared similar functions in peri-ovulatory granulosa 
cells, canonical pathways enriched by RUNX1 peaks pre- and post-LH were annotated using 
GREAT analysis. Gene Ontology analysis showed that RUNX1 peaks in granulosa cell post-
hCG 6 h were enriched for pathways similar to those found for PGR, mostly those that are 
important for normal cellular functions, such as metabolism, gene expression and response to 
external stimulus (Figure 6.3A). To identify the extent of PGR and RUNX1 cooperation on 
gene regulation at a genome-wide level, PGR-binding and RUNX1-binding genes were 
compared against ovulatory genes identified through RNA-seq of 8h post-hCG granulosa cells. 
Among the 2179 identified DEGs, 788 (36%) DEGs were found to be bound by both RUNX1 
and PGR (Figure 6.3B), while 101 (4.6%) were bound only by PGR or 266 (12%) bound only 
by RUNX1. This means that the majority of RUNX1- (75%) and PGR-bound (89%) DEGs in 
fact shared binding by both transcription factors, implying that simultaneous interaction of both 
PGR and RUNX1 to target chromatin is important for ovulatory gene regulation. As previously 
shown, a slight tendency for promoter occupancy was observed in PGR binding at DEG. 
Interestingly, RUNX1 binding at DEGs exhibited an even greater preference for promoters, 
with more than half of RUNX1 binding sites found to be within 3 kb upstream of a TSS, 
especially within 1 kb of the TSS (Figure 6.3C), again highlighting the importance of RUNX1 
in promoter targeting. As expected, many hCG-regulated genes (i.e. 1024 DEGs) were not 
bound by PGR nor RUNX1 (Figure 6.3B) and these likely represent genes controlled by other 










Figure 6.3 Consequences of RUNX1 binding on gene expression. 
(A) Gene Ontology analysis of PGR and RUNX1 binding sites. Ontological terms associated 
with biological processes were obtained from analysis of PGR and RUNX1 ChIP-seq and 
condensed using REVIGO. (B) Volcano plot of ovulatory DEGs with PGR or RUNX1 binding 
at 6h post-hCG treatment. DEGs were identified through RNA-seq of peri-ovulatory granulosa 
cells and only DEGs that met statistical criteria (|logFC| ≥ 1 and -log(p-value) ≥ 2) are graphed 
(black dots). DEGs with PGR binding are orange, with RUNX1 binding are pink and with both 
PGR and RUNX1 binding are brown. Gene counts for each fraction are summarised in Venn 
diagram. (C) Genome distribution of PGR and RUNX1 6h peaks identified in peri-ovulatory 
transcriptome. From (B), PGR and RUNX1 peaks that were found to bind RNA-seq identified 






6.3.2 The physical interaction between RUNX1 and PGR is highly dynamic in 
the peri-ovulatory window 
A very close spatial association of PGR with members of the RUNX family was demonstrated 
in mouse granulosa cells in vitro at 6 h post-progestin treatment, suggesting a direct physical 
interaction between these two transcription factors. To further investigate the dynamics of these 
interactions, PLA targeting PGR interaction with RUNX1 or RUNX2 was performed on 
granulosa cells treated with hCG + progestin for up to 8h to mimic the in vivo ovulatory 
stimulus. Both RUNX1 and RUNX2 showed positive interaction with PGR that was highly 
induced by hCG + progestin treatment (Figure 6.4). PGR/RUNX1 interaction was absent 
(similar to IgG-only negative controls) before hormone treatment and was increased by 4-6 h 
after treatment after which there was a decrease in signals. PGR/RUNX2 showed a slightly 
different pattern, with the strongest interaction with PGR observed at 5-7 h post-treatment and 
with the protein-protein interaction retained up to 8 h post-treatment. In both PGR/RUNX1 and 
PGR/RUNX2 interactions, the protein pairs were largely found in the nuclear compartment of 
the cell, confirming that PGR and RUNX transcription factors were concurrently interacting 
with chromatin after the addition of ovulatory cues. These results indicate an LH-dependent 












Figure 6.4 LH-dependent dynamic PGR / RUNX interactions in response to ovulatory 
stimulus.  
Granulosa cells were treated in vitro with hCG and R5020 for the duration indicated. (A) 
Representative images of PLA showing the interaction between PGR and RUNX1 (left 
column) and RUNX2 (right column) or IgG control (bottom row). PLA signals are red puncta 
and nuclei were stained with DAPI in blue. Scale bar = 10 µm. (B) Quantification of PLA 
signals, displayed as the number of foci per cell. PLA was performed in 3 biological replicates 
(4 mice per replicate) and quantification was through ImageJ ‘Find Maxima’ function on at 
least three images per condition per replicate. P-value indicates two-way ANOVA statistical 
analysis for row factor (time factor), p = 0.0737 (PGR/RUNX1), p = 0.0251 (PGR/RUNX2). 






Both PGR and RUNX1 are transcription factors that are known to regulate ovulatory genes in 
peri-ovulatory granulosa cells. In the ovary, the temporal and spatial pattern of expression for 
PGR and RUNX1 are highly similar, with both being rapidly and transiently expressed in 
response to the LH surge 6,17. The detailed analysis of the PGR cistrome led to the hypothesis 
that PGR and RUNX potentially cooperate in peri-ovulatory granulosa cells and are involved 
in the regulation of ovulatory gene expression, with a possible direct interaction between the 
two transcription factors. As a physical interaction between PGR and RUNX1 in granulosa 
cells in response to ovulatory cues was also demonstrated, it became imperative that the 
relationship between these two transcription factors on a functional level be explored. To 
investigate this, combined analysis of PGR and RUNX1 cistromes as well as comparison of 
their genome-wide interaction with genes regulated by ovulatory stimulus were performed.   
 
The findings of this chapter showed that PGR and RUNX1 shared a remarkably high number 
of mutual DNA targets, especially within transcriptionally active regions. One remarkable 
observation was the very high prevalence of RUNX1 in promoter-centric PGR binding at a 
level well beyond random chance. PGR chromatin binding is specifically enriched at 
transcriptionally active promoter regions in granulosa cells but not in the uterus. Here it was 
found that PGR-bound sites in the absence of RUNX1 co-binding were dramatically less likely 
to bind to promoter regions, whereas shared PGR/RUNX1 binding sites were as highly 
enriched in proximal promoter regions as RUNX-only bound regions. These results indicate 
that the promoter selective targeting of PGR is dependent on RUNX1. On the other hand, in 
the absence of PGR, RUNX1 still preferentially bound promoter regions, suggesting that the 
co-dependence for promoter targeting was not reciprocal. While the temporal dynamics of 
RUNX1 and PGR chromatin binding was not directly determined, these results lead to the 
implication that RUNX1 may act as a pioneer factor in directing PGR to target chromatin 
regions. The fact that RUNX1-bound sites were enriched for the canonical motif for PGR 
(PRE/NR3C motif) even before the LH surge, supports the conclusions that RUNX1 binds 
chromatin before PGR and that RUNX1 has a role in the granulosa-specific PGR-chromatin 
binding pattern. Consistent with this conclusion, RUNX1 and RUNX3 have been previously 
reported to behave as pioneer factors through the recruitment of chromatin modifiers to open 
up chromatin for the access of other transcription factors 18,19. In addition to the canonical 




modulators, including both activators and repressors, in various biological contexts 20. Further 
studies using a granulosa cell-specific RUNX1 KO mouse model or in vitro RUNX1 
knockdown granulosa cells will be able to test the theory that RUNX1 is necessary for PGR to 
bind its target cistrome. 
 
Functional analysis of PGR and RUNX1 cistromes in combination with ovulatory gene profile 
in granulosa cells showed that PGR and RUNX1 interact on a functional level during ovulatory 
gene regulation. A striking number of hCG-responsive DEGs were found to have both PGR 
and RUNX1 binding in their proximity, indicating a partnership between PGR and RUNX1 in 
regulating downstream gene expression. These mutual target genes underlie the highly similar 
corresponding enriched pathway profiles of PGR and RUNX1 cistromes, as indicated in the 
analysis of Gene Ontology and canonical pathways in PGR and RUNX1 ChIP-seq data. Thus, 
both transcription factors co-ordinately regulate gene expression during ovulation and the 
cooperation between both factors is likely critical for this tissue specific regulation. Among 
mutual PGR/RUNX1 target ovulatory genes are a number of genes identified as PGR-
dependent in previous studies. ADAMTS1, a member of the ADAMTS family, is involved in 
matrix remodelling and morphology of the cumulus-oocyte complex through cleavage of 
versican and a lack of ADAMTS1 can affect ovulation and lead to subfertility in female mice 
21,22. Reporter assays have shown that PGR regulates Adamts1 expression via interaction with 
G/C-box SP1/SP3-binding sites in the Adamts1 proximal promoter region 11. Data from this 
study now shows that both PGR and RUNX1 shared the same binding site at the Adamts1 
promoter, which is not bound by RUNX1 prior to the LH surge. Another mutual target of PGR 
and RUNX1 identified in this study is CXCR4. CXCR4 and its ligand, CXCL12, are induced 
by hCG in granulosa cells in humans and mouse and in sheep these factors have been shown 
to promote cumulus expansion and oocyte maturation 23-25. Other genes that are known PGR 
targets, including Zbtb16, a zinc finger-domain transcription factor shown to be progesterone-
responsive in human endometrial stromal cells 26, and Edn2, a vasoactive growth factor 
implicated in the follicular rupture process 27, are also bound by both PGR and RUNX1. Genes 
that were previously linked to RUNX1 activity are also found to be in fact mutual PGR/RUNX1 
targets, including Hapln1 and Rgcc 28,29. Interestingly, PGR and RUNX1 binding was found in 
open chromatin regions in the gene boundary of both Runx1 and Runx2, implying a role of 
PGR in regulation of Runx1 and Runx2 as well as an auto-regulatory role of RUNX1 and of 
RUNX1 to Runx2. Such cross-regulatory function has previously been described for the CBFβ- 




The cooperation between PGR and specific interactomes in different biological contexts is 
important for the regulation of PGR transactivation functions, as has been well illustrated in 
the context of PGR action in mammary and uterine tissues 9. Direct interaction between PGR 
and RUNX transcription factors was observed in cultured granulosa cells upon stimulation with 
hCG and progestin. The interaction between PGR and RUNX1 or RUNX2 in cultured 
granulosa cells is shown to be dynamically regulated by these ovulatory hormones and 
predominantly in the nuclear compartment, indicating that PGR and RUNX1/2 are likely to be 
involved in the same transcription complex that is activated by the ovulatory LH surge stimulus 
in vivo. These PGR/RUNX interactions highlight the role of RUNX1 and RUNX2 in 
partnership with PGR in granulosa cells to mediate follicular rupture. RUNX1 was selected for 
ChIP-seq analysis because it has been  shown to be important for granulosa cell functions 
through promoting important gene expression 6. However, RUNX2 is also known to be induced 
by the ovulatory stimulus and is involved in both transcription induction and repression in 
granulosa cells 30,31. A more thorough investigation into the RUNX2 cistrome and RUNX2-
dependent transcriptome in peri-ovulatory granulosa cells would be illuminating in fully 
characterising the role of RUNX2 in ovulation. An interaction between RUNX members and 
other SR, namely AR and GR, have also been reported 13,14,32. Intriguingly, these interactions 
involve binding of RUNX to the DBD of steroid receptors, which results in the mutual 
sequestering of steroid receptors and RUNX from target genes and thereby having a repressive 
role on steroid receptors and RUNX activities 33.  In certain contexts however, co-binding of 
RUNX and steroid receptors at target genes can have an additive effect on transcription 
induction 14. Such a mechanism does not seem to be the case in PGR/RUNX interactions in 
granulosa cells where there is a positive impact on the transactivation function of PGR; and 
thus it is likely that a different regulatory mechanism is at play, perhaps involving interactions 
with other secondary modulators.  
 
In summary, the relationship between PGR and RUNX1 has been illustrated in the context of 
ovulation. PGR and RUNX1 formed a physical interaction at target chromatin sites in response 
to ovulatory cues and this had consequences on downstream gene expression. As an interaction 
between PGR and other transcription factors has also been confirmed (RUNX2, JUND and 
LRH1) or implied (GATA, CEBP transcription factors), it is possible that these transcription 
factors are also parts of the mutual transcription complex with PGR and RUNX1. Whether this 




directly interact with DNA, such as HDAC and SRC, in modulating PGR transcriptional 
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Progesterone receptor consists of two major isoforms (PGR-A and PGR-B) that are transcribed 
from two distinct TSS. While the two isoforms share almost all important structural domains 
for ligand response and transcriptional activation, PGR-B possesses an extra 164 amino acids 
at the N-terminus, giving it an additional AF-3 domain that allows for unique interactions with 
a host of coactivators which enhances its transactivation functions 1. While other PGR isoforms 
have also been described, PGR-A and B remain the most prominent isoforms with important 
implications on PGR functions in the reproductive tract and in mammary tissues, both in 
normal physiology and in tumour development.  
 
In the ovary, both PGR isoforms are induced by the LH surge; however, the ratio between 
isoforms (PGR-A:PGR-B) is approximately 2:1 in mouse granulosa cells 2. Even though both 
isoforms are expressed in granulosa cells of pre-ovulatory follicles, PGR-A is accredited as the 
more essential isoform in ovulation. This was determined from studies on KO mouse models 
that are specific to each PGR isoform. As the two isoforms are translated from two distinct 
start codons, SNP mutation at these sites allows for the specific knockout of the A-isoform 
(AKO) 3 or B-isoform (BKO) 4. A similar reproductive phenotype was observed in both total 
PGRKO and AKO 3,5. Specifically, female mice that are null for PGR or mice that have a 
mutation which prevents production of functional PGR-A exhibit a specific failure of follicle 
rupture, but not luteinisation, even after gonadotropin stimulation and are thus infertile 
(PGRKO) or subfertile (AKO) 3,6. Phenotypical similarities between total PGRKO and specific 
AKO mutants are also observed in other reproductive tissues, such as in the uterus where the 
ablation of total PGR or just PGR-A results in a disrupted decidualisation response. However, 
in mammary tissues, the role of PGR-A is not as prominent as PGR-B 3,4. While a number of 
PGR-driven ovulatory genes have been identified in granulosa cells, specific actions of the two 
PGR isoforms have not been investigated. Known PGR-regulated genes in ovary include 




with exclusive regulation by PGR-A has yet to be elucidated, which would solidify the 
importance of PGR-A in the mechanism of ovulation.  
 
The B-isoform, on the other hand, has been largely overlooked in the context of ovarian 
functions due to the lack of abnormal ovarian physiology observed in the BKO mouse model. 
Unlike PGRKO and AKO, female mice lacking PGR-B do not experience anovulation and 
have normal fertility in comparison with WT cohorts 4. However, as AKO female mice are not 
completely infertile, PGR-B potentially has a role that can functionally compensate, albeit only 
partially, in the absence of PGR-A. Since the ablation of PGR-B has no effect on female 
fertility, PGR-A by itself seems to be sufficient in ovulation and other female reproductive 
functions.  In the uterus, PGR-B plays little role before implantation, as seen in the normal 
progesterone-dependent epithelial proliferation in BKO mice 4. In humans, the suppression of 
PGR during labour is important for inducing parturition 10. However, PGR-B female mice are  
fertile, suggesting that there is redundancy in the uterine role of PGR-B in the establishment 
and maintenance of pregnancy 4. In other tissue types, the role of PGR-B is more prominent. 
In mammary tissues, PGR-B is the main factor at play in mammary development, as seen in 
defective alveologenesis and ductal development in mice that have aberrant PGR-B 
overexpression or are PGR-B deficient, respectively 4,11.  
 
While each PGR isoform seems to have discrete tissue-specific functions, the interplay between 
the two PGR isoforms is in fact rather complex and is precisely regulated in a spatiotemporal 
pattern and tissue-specific manner. In tissues that are PGR-positive, both PGR-A and PGR-B 
tend to be present; however, they are often not expressed at equal levels. In the context of 
cancer, changes in the PGR-A:PGR-B ratio can lead to abnormal cellular responses and the 
elevation of tumour development 12. Interestingly, in both of these tissue contexts, PGR-A 
displays trans-repressive functions, not only on the auto-regulation of PGR-B but also other 
steroid receptors including GR and ER 13. In these cases, PGR-A is identified as a suppressor 
of PGR-B activity without affecting PGR-B expression level 1. The peptide sequence IKEE at 
the N-terminus of PGR-B is shown to be important in the PGR-A regulated inhibition of PGR-
B 13, although the exact nature of the inhibitory process, such as the involvement of other co-
repressors or the effect on PGR-B stability, is still poorly understood. In the uterus, this auto-
inhibitory function plays an important role during parturition in which uterine progesterone 
withdrawal induces PGR-A trans-repression function, leading to a suppression of PGR-B and 




of granulosa cells, it is reasonable to suggest that a similar cross-regulatory relationship is 
possible, and since both isoforms are present in peri-ovulatory granulosa cells, it is valid to 
take a further look at the differences in PGR-A and PGR-B activities in granulosa cells. 
 
Chapter 2 previously described the PGR-dependent transcriptome in mouse peri-ovulatory 
granulosa cells. Such transcriptome was obtained from microarray analysis, a relatively 
insensitive approach where only known transcripts of high abundance were identified, thus low 
expressed or novel transcript variants associated with ovulation are not accounted for in the 
microarray dataset. Microarray also fails to capture transcripts that are not well-defined such 
as lncRNA. Furthermore, the specific role of each isoform cannot be dissected from a total 
PGRKO model. With the current advances in transcriptomic analysis and the establishment of 
well-described isoform-specific KO animal models, many of the deficiencies in our knowledge 
of PGR regulation in ovulation can be circumvented, which allows for the establishment the 
specific PGR-A and PGR-B roles. Thus, in order to fully determine the effect of PGR and each 
of its isoforms, isoform-specific transcriptomes were obtained from hCG-stimulated granulosa 
cells from mice that were WT or KO for total PGR, PGR-A only or PGR-B only, using RNA-
seq from total RNA extract. By individually examining the transcriptome-wide consequences 
of individual mutants of PGR-A and PGR-B, the specific contribution of each isoform is 
determined in full detail, which allows for the identification of novel PGR-A and PGR-B 
functions. As PGRKO and AKO female mice have the closest matched phenotypes, it was 
hypothesised that genes regulated by PGR-A would most closely mirror total PGR. 
Furthermore, identifying the genes regulated by PGR-A versus PGR-B using RNA-seq would 
enable a deeper interpretation of the modes of action of each isoform and their potential 
interaction with other transcription factors in granulosa cells. Finally, comparing dysregulated 
transcriptomes in PGRKO to those in the PGR-A and PGR-B specific KOs will refine current 
insights into the genes that may be critical for ovulation. 
 
7.2 MATERIALS & METHODS 
7.2.1 Animals and breeding strategy 
Three transgenic mouse models were used in this chapter, consisting of knock-out strains for 





C.129S7(B6)-Pgrtm1Bwo/OmcJ  (PGRKO) mice are a targeted mutation strain with the Jackson 
Laboratory designation Pgrtm1Bwo (targeted mutation 1, Bert W O'Malley, JAX stock #030883). 
In this model, the Pgr gene was disrupted by the insertion of a neomycin cassette into exon 1, 
which is downstream to the TSS of both isoform A and B. The genetic background for this 
strain is 129S7/SvEvBrd-Hprt+. B6;129S7-Pgrtm1Omc/J (PGR-A KO) mice are a targeted 
mutation strain with the Jackson Laboratory designation Pgrtm1Omc (targeted mutation 1, Orla 
M Conneely, JAX stock #022464). In order to knockout PGR isoform A without disrupting 
isoform B, the translational start site at codon 166 (specific to isoform A) was modified to 
encode alanine. The genetic background for this strain is 129S7/SvEvBrd-Hprtb-m2. B6;129S7-
Pgrtm2Omc/J (PGR-B KO) mice are a targeted mutation strain with the Jackson Laboratory 
designation Pgrtm2Omc (targeted mutation 2, Orla M Conneely, JAX stock #022465). In order to 
knockout PGR isoform B without disrupting isoform A, the start codon of isoform B was 
modified to encode leucine (ATG to CTG). The genetic background for this strain is 
129S7/SvEvBrd-Hprtb-m2. See Figure 7.1A for a schematic of the gene knockout strategy for 
each strain. All three mouse strains were originated from the Baylor College of Medicine and 
the expression of PGR in each strain has been confirmed using Western blot, described in the 
respective publication 3-5. Mice that are null for PGR are hereafter referred to as PGRKO, and 
mice null for one of the isoforms are AKO or BKO; while their WT littermates are referred to 
as PGRWT, AWT or BWT, respectively. 
 
Founder mice were obtained from the Jackson Laboratory at 9 weeks old. Breeding colonies 
were maintained at the Laboratory Animal Services (University of Adelaide, Australia) SPF 
facility. All mice were maintained in 12 h light /12 h dark conditions and given water and 
rodent chow ad libitum. All experiments were approved by The University of Adelaide Animal 
Ethics Committee and were conducted in accordance with the Australian Code of Practice for 
the Care and Use of Animals for Scientific Purposes (ethics numbers m/2018/100 and 
m/2018/122) and guidelines from the Office of the Gene Technology Regulator (OGTR) (IBC 
dealings 14797, 14798 and 14799). In order to establish the breeding colonies from the given 
stock, het/het pairs were established to generate a mixture of WT and KO mice (for 
experiments) and heterozygotes (for future breeding pairs). Animals used in experiments were 




7.2.2 Genotyping of PGRKO mouse strains 
Mice from each strain were genotyped from DNA extracted from ear biopsies at weaning and 
tail tips at culling. Genomic DNA was obtained by digesting tissue in 250 µl Digestion Solution 
(20 mM EDTA, 40 mM Tris, 120 mM NaCl, 1% SDS, pH 8.0) and 5 µl of 10 mg/ml Proteinase 
K (Sigma) at 55oC for at least 4 h with constant shaking. Cellular debris was precipitated by 
adding 250 µl of 4 M ammonium acetate and incubating at room temperature for 15 minutes 
with mixing. DNA was precipitated using 100% ethanol, washed with 70% ethanol and 
resuspended in water.  
7.2.2.1 PGRKO genotyping 
For PGRKO mice, genotyping was through PCR and gel electrophoresis analysis as described 
by JAX. DNA was amplified using primers specific for either the WT Pgr gene or the neomycin 
insert. Genotyping was accomplished by a two-way PCR strategy. The antisense mut primer 
was used with a sense primer from the Pgr gene to amplify a 200 bp product from the mutant 
allele. The antisense WT primer was used with the same sense primer to produce a 262 bp WT 
sequence. For the PCR reaction, GoTaq Flexi DNA Polymerase and accompanied buffer was 
used (Promega, Annandale, NSW, Australia). The components for the 20 µl reaction are: 4 µl 
GoTaq Green Master Mix, 1.2 µl MgCl2, 0.2 µl dNTPs, 0.1 µl sense primer, 0.1 µl antisense 
primer, 0.1 µl DNA Polymerase, 2.5 µl genomic DNA template and 11.8 µl H2O. The thermal 
cycle for this PCR was: 95oC for 2 mins, 40 cycles x [95oC for 1 min, 60oC for 30 secs, 72oC 
for 1 min], then 72oC for 5 minutes and hold at 4oC; using an Applied Biosystems GeneAmp 
PCR System 9700 Thermal Cycler (Applied Biosystems, Thermo Fisher). Amplified products 
were visualised by agarose gel electrophoresis. Primer sequences were: 
PGR sense   5’– GAGGTGGAAGAGGACAGTGG – 3’ 
PGR antisense (WT)  5’– TGGGCACATGGATGAAATC – 3’ 
Neo antisense (mut)  5’– GCCAGAGGCCACTTGTGTAG – 3’ 
 
The genotype of PGRKO animals was determined based on PCR specific to the WT or neo-
containing mutant alleles. Examples with the presence of the WT band (262 bp) and the mut 




7.2.2.2 AKO genotyping 
Genotyping of the PRAKO mouse strain was through real-time PCR followed by end-point 
analysis as described by JAX. DNA was amplified using sense and antisense primers targeting 
the Pgr gene. For the detection of the PGR-A SNP mutation, genotype-specific primers were 
designed with a fluorescence tag at the 5’ end (VIC dye for WT primer and FAM dye for mut 
primer) and MGB quencher conjugated at the 3’ end. Each primer probe detects either the WT 
sequence or mutated SNP sequence. The component for the 10 µl reaction are as follow: 5 µl 
Taqman ProAmp MasterMix (Thermo Fisher), 0.25 µl SNP Taqman assay, 1 µl genomic DNA 
and 3.75 µl H2O. The thermal cycle for this reaction was: 60
oC for 30 secs, 95oC for 10 mins, 
40 cycles x [95oC for 15 secs, 60oC for 1 min], 60oC for 30 secs and hold at 4oC; using a 
QuantStudio12K Flex System (Thermo Fisher). Allelic detection was determined through 
analysis using the corresponding Genotyping function of the QuantStudio System. 
Sequences of the primers and probes are: 
PGR-A sense   5’– GCCATCACTTCCTGGTGTCT – 3’ 
PGR-A antisense  5’– TGGGTGGTGACAGTCCTTTG – 3’ 
PGR-A WT   VIC 5’– CCCGCTCATGAGTCGGC– 3’ 
PGR-A mut SNP  FAM 5’– CCCGCTCGCTAGTCGGC – 3’ 
 
The genotype of AKO animals was determined based on the ratio of KO-specific and WT-
specific fluorescent probe from Taqman assays designed specifically for each mutation. An 
example of allelic discrimination plots is shown in Figure 7.1C, in which WT animals show 
high WT:KO ratio, KO animals with low WT:KO ratio and het animals in between. A negative 
control is included (H2O control) in which neither of the fluorophores was detected.  
7.2.2.3 BKO strain 
Genotyping for the BKO strain is as described above for the AKO mouse strain.  Sequences of 
the primers and probes are: 
PGR-B sense   5’– AGACAGGGGAGGAGAAAAGG – 3’ 
PGR-B antisense  5’– GCGAGACTACAGACGACACG – 3’ 
PGR-B WT   VIC 5’– CGTCATGACTGAGCTGCA G– 3’ 





The genotype of BKO animals was determined based on the ratio of KO-specific and WT-
specific fluorescent probe from Taqman assays designed specifically for each mutation. An 
example of allelic discrimination plots is shown in Figure 7.1D, in which WT animals show 






Figure 7.1 Strategies for KO generation.  
(A) The targeted mutation strategies for all three KO strains involving genetic modification of 
exon 1 of the Pgr gene (encoding the N-terminus of PGR). ATGA and ATGB are the translation 
start sites for PGR-A and PGR-B respectively. For total PGRKO, a Neo cassette was inserted 
into exon 1 downstream of both TSS causing a frameshift mutation to disrupt both isoforms. 
For AKO, the ATG sequence specific for PGR-A was mutated to encode Alanine. The BKO, 
the ATG sequence for PGR-B was mutated to Leucine. (B) Representative gel electrophoresis 
image for genotyping of the PGRKO colony. WT, het and KO genotypes identification was 
based on the presence of the WT band (262 bp) and the mut band (200 bp). (C-D) Allelic 
discrimination plot for genotyping of the AKO colony (C) and BKO colony (D). For each 
strain, isoform-specific SNP are detected by fluorescent Taqman probes and genotype is 




7.2.3 Western blot 
WT and KO 3-4 weeks old female mice were stimulated for superovulation by 5 IU eCG 
followed 46 h later by 5 IU hCG. Mice were killed by cervical dislocation at 6 h post-hCG 
stimulation and ovaries dissected and punctured with a 26G needle for COC/GC isolation.  
Lysate was prepared from COC/GC pooled from 2 ovaries by adding 100 µl LDS Sample 
Buffer, 1 µl β-mercaptoethanol and 1 µl benzonase, then incubation for 10 minutes at 65oC for 
cell lysis and protein denaturation. Western blot was performed and quantified as described in 
section 2.2.2.3. Antibodies for PGR and H3 are as listed in Appendix 2. 
7.2.4 RNA-sequencing 
7.2.4.1 Tissue sample collection and RNA extraction 
21-27 days old female mice that were WT or KO were injected with 5 IU eCG and 5IU hCG 
46 h post-eCG injection. Mice were sacrificed 8 h post-hCG stimulation and ovaries were 
punctured to collect granulosa cells, which were snap frozen in liquid nitrogen upon collection. 
For each knockout strain, 12 female mice of each genotype were used (24 mice per strain). For 
each knockout strain, a total of 4 biological replicates of each genotype were obtained, with 
each biological replicate generated from ovarian material pooled from 3 animals. RNA 
extraction was performed using the RNeasy Mini Kit (Qiagen) as per the manufacturer’s 
protocol, including DNase treatment, and the RNA pellet was resuspended in 15 µl RNase-free 
water. RNA concentration was assessed using the Nanodrop One UV-Vis Spectrophotometer 
(Thermo Fisher). 
7.2.4.2 Sequencing 
Library preparation and sequencing were conducted at the SAHMRI Genomics Facility 
(Adelaide, Australia). Prior to library prep, RNA quality was assessed using the RNA 
ScreenTape System (Agilent, Santa Clara, CA, USA). The Universal RNA-Seq with NuQuant, 
Mouse AnyDeplete kit (Nugen, Redwood City, CA, USA) was used for total RNA library prep. 
Sequencing was performed on the NovaSeq 6000 S1 Sequencing System (Illumina). 
7.2.4.3 Bioinformatics analysis 
Bioinformatics analysis was conducted using the public server of Galaxy 14. An overall 




mouse assembly 15. Datasets from each mouse model were processed together in batch. For all 
datasets, sequencing data was assessed using FASTQC. Next, 101-base sequences were aligned 
to the mouse genome using HISAT2 16. Alignment was filtered using samtools 17 with MAPQ 
30 cut-off. For each alignment, novel transcriptome was assembled and merged together using 
StringTie tools 18 to take into account de novo transcripts. The novel transcriptome assembly 
was annotated using the mm10 genome assembly (GENCODE project, V23 version) using 
GffCompare 19. Read count was performed in relation to the annotated novel assembly using 
featureCounts 20 . Read counts were normalised to the geometric mean calculated for each gene 
across all samples using DESeq2 21. Differential expression analysis and correlation analysis 
between replicates were performed using DESeq2, using the generalised DESeq2 linear model 
as described in the original publication 21: 
 
𝐾𝑖𝑗  ~ 𝑁𝐵(𝜇𝑖𝑗, 𝛼𝑖) 
With counts Kij for gene i, sample j modelled using a negative binomial distribution with fitted 
mean μij and a gene-specific dispersion parameter αi. The fitted mean is composed of a sample-
specific size factor sj and a parameter qij proportional to the expected true concentration of 
fragments for sample j. The coefficients βi give the log2 fold changes for gene i for each column 
of the model matrix X.  
 
Independent filtering was performed as part of the DESeq2 function and genes with low counts 
were removed prior to differential analysis. Differential expression was defined as a fold-
change ≥ 2 (|log FC| ≥ 1) and Benjamini-Hochberg adjusted p-value ≤ 0.01. The enrichment of 
Gene Ontology Biological Process terms was identified using GO::TermFinder 22,23. Upstream 
regulator analysis of DEGs was through the IPA software (QIAGEN). Correlation of samples 
between different strains was through transcriptomic alignment via Salmon 24 and DESeq2. 
Visualisation of RNA-seq data on UCSC Genome Browser was through bigWig files generated 
from merged alignment BAM files using deepTools 25, with reads normalised to 1x depth of 






Figure 7.2 Bioinformatics workflow for RNA-seq analysis.  
Orange boxes indicate input and pre-alignment quality control. Blue boxes are the main 
workflow, in which genomic alignment and transcriptome building were performed. Green 
boxes are the workflow for cross-strain comparison, in which no de novo transcriptome 
building was required. White boxes are output. Each step is listed with the tools used for the 





Table 7.1 Tools used for bioinformatics analysis of RNA-seq data. 
Goal Package/tool Reference 





Genomic alignment HISAT2 16 
Alignment filtering samtools 17 
Novel transcriptome assembly StringTie 18 
Annotation of novel assembly GffCompare 19 
Read counting featureCounts 20 
Differential analysis DESeq2 21 
Gene Ontology analysis / correlation analysis GO::TermFinder 23 
Transcriptomic alignment  Salmon 24 
Generating genomic coverage of reads deepTools 25 
Upstream regulator analysis IPA Core Analysis QIAGEN 
Peak visualisation on UCSC Genome 
Browser 
UCSC toolkits 26 
 
7.3 RESULTS 
7.3.1 PGR protein expression in PGRKO, AKO and BKO ovaries 
To confirm the expression of PGR isoforms in peri-ovulatory granulosa cells from different 
strains, the abundance of each isoform from each of the different PGR mutant mouse strains 
was examined by Western blot using an antibody that could detect both isoforms of PGR 
(Figure 7.3). WT and KO female mice were stimulated for superovulation and COC/GC were 
collected from ovaries at 6 h post-hCG stimulation, the time during the peri-ovulatory window 
when PGR protein levels are highest. In general, as expected, strong bands corresponding to 
PGR-A and PGR-B were evident in granulosa cell extracts of WT mice in each line. These 
bands were not evident in the PGRKO samples and quantitation of fluorescence showed a 
highly significant and equal decrease in both A- and B-isoforms in cells from PGRKO animals 
in comparison to PGRWT. Unexpectedly, both isoforms were also undetectable in AKO 
animals compared to AWT. In the BKO strain, there was the expected loss of visible band for 
the PGR-B isoform and significant reduction in quantifiable B-isoform level; however, there 







Figure 7.3 Expression of PGR-A and PGR-B proteins in granulosa cells of animals from 
each strain.  
Western blot of WT and KO granulosa cells obtained from female mice at 6 h after hCG 
treatment. From left to right: PGRWT, PGRKO, AWT, AKO, BWT and BKO. Western 
membranes were probed with antibodies specific to PGR (both isoforms) and beta-actin 
(housekeeping control). Fluorescence signals for each PGR isoform were quantified and 
normalised to housekeeping and to its respective WT sample. N = 3, statistical significance 
was through two-way ANOVA with multiple comparison, asterisks signifying statistical 





7.3.2 PGR isoform-specific transcriptomes  
As PGR protein level peaks at 6 h post-hCG, it is also reasonable to expect a strong influence 
on target transcriptional regulation occurs shortly after this peak. Accordingly, previous 
experiments have shown that at 8 h post-hCG injection the majority of ovulatory gene 
expression is altered compared to levels prior to hCG treatment (Appendix 7). Thus, the 
isoform-specific PGR-dependent transcriptomes of peri-ovulatory granulosa cells were 
examined at 8 h post hCG. Four biological replicates were used per genotype per mutant strain. 
FASTQC was performed for each file to assess the quality of sequencing. The quality check 
outcome was appropriate for RNA-seq data and no major concerns were identified. A summary 
for each sequencing files, including library size, sequence length, genomic alignment rate and 
gene counts is included in Appendix 12. Prior to differential expression analysis, the correlation 
between replicates was assessed.  
7.3.2.1 Granulosa cell gene expression changes in PGRKO mice 
Correlation analysis showed that in both WT and KO samples from the PGRKO line, replicates 
1-3 were highly similar, as shown by a tight clustering pattern of genomic coverage of reads 
from each sample in the PCA plot and short Euclidean distances between samples of the same 
genotype (Figure 7.4A-B). Samples WT4 and KO4 were not as closely correlated to their 
respective cohorts. These samples were determined to be affected by inefficient library 
preparation and thus were excluded from downstream analysis. Differential expression analysis 
identified a total of 611 DEGs that passed the selection criteria of Benjamini-Hochberg 
adjusted p-value ≤ 0.01 and |logFC| ≥ 1 cut-off (Appendix 13). Among these 611 DEGs, the 
clear majority were downregulated in PGRKO versus PGRWT samples (434 DEGs 
downregulated in PGRKO as opposed to 177 upregulated), indicating a prominent role of PGR 
in transcriptional induction (Figure 7.4C-D). Included in these differentially expressed genes 
were many that have been previously demonstrated to be downstream target genes of PGR and 
in some cases play key roles in ovulation, including Adamts1, Il6, Edn2 and Pparg, all of which 
are significantly downregulated in PGRKO in comparison to PGRWT. Apart from these classic 
PGR targets, however, the majority of identified DEGs have not been previously associated 
with PGR. For instance, the top 10 most upregulated and top 10 most downregulated DEGs 
were all novel downstream targets of PGR (Figure 7.4D). The PGRKO DEGs were associated 
with a number of biological processes, including adhesion, morphogenesis and cellular 









Figure 7.4 Genes differentially regulated in the absence of both PGR isoforms in 
ovulatory granulosa cells.  
(A) PCA plot of RNA-seq replicates for PGRKO and PGRWT granulosa cells collected after 
8 h hCG stimulation. (B) Correlation heatmap for PGRKO and WT replicates. The colour of 
matrix squares indicates sample-to-sample distance as calculated using normalised read counts 
by DESeq2, noted in the bar on the right. (C) Volcano plot of genes identified in PGRKO 
RNA-seq. Genes that are upregulated in PGRKO have a positive logFC value and vice versa. 
All genes with Benjamini-Hochberg adjusted p-value ≤ 0.01 are plotted (black) and genes 
passing the |logFC| ≥ 1 criteria are determined as DEG (blue). Full list of DEG is in Appendix 
13. Selective DEG with known ovulatory functions are labelled in the plot. Examples of the 
pattern of expression for Adamts1 and Edn2 are visualised on the right through the UCSC 
Genome Browser, showing read count build-up for PGR WT (dark red) and KO (red). Tracks 
are normalised to the same scale. (D) Top ten most upregulated and ten most downregulated 
DEGs from PGRKO vs WT RNA-seq, displayed together with logFC and p-value. (E) 
Biological processes enriched in PGKO DEGs, as indicated from Gene Ontology analysis. 





7.3.2.2 Granulosa cell gene expression changes in AKO mice  
Correlation analysis of samples from the AKO strain showed a close resemblance between 
replicates of the same genotype, as shown in PCA plot and the sample-to-sample distance 
matrix (Figure 7.5A-B). The exception was sample KO1, which appeared as an outlier to the 
other KO samples and was thus not included in any further downstream analysis. In total, 686 
DEGs satisfied the |logFC| ≥ 1 and adjusted p-value ≤ 0.01 criteria and were identified to be 
differentially expressed in AKO versus AWT granulosa cells, with about three-quarters of 
DEGs (515 DEGs) downregulated in AKO samples, indicating a preference for gene induction 
by PGR-A (Figure 7.5C, Appendix 14). Similar to PGRKO RNA-seq, a number of known 
ovulatory factors were found to be dysregulated in the AKO samples, such as Pparg and Edn2. 
Other genes that are known PGR targets, such as Zbtb16 and Mt2, were also identified to be 
specifically regulated by PGR-A. Among the most differentially expressed DEGs, the gene 
encoding for PGR itself was the most highly upregulated gene in AKO, suggesting a role of 
the PGR A-isoform in auto-inhibition (Figure 7.5D). Similar to the PGRKO dataset, DEGs 
found in AKO were mostly enriched for pathways involved in cellular development, 









Figure 7.5 Genes differentially regulated in the absence of PGR-A in ovulatory granulosa 
cells.  
(A) PCA plot of RNA-seq replicates for AKO and AWT granulosa cells collected after 8 h 
hCG stimulation. (B) Correlation heatmap for AKO and AWT replicates. The colour of matrix 
squares indicates sample-to-sample distance as calculated using normalised read counts by 
DESeq2, noted in the bar on the right. (C) Volcano plot of genes identified in AKO RNA-seq. 
Genes that are upregulated in AKO have a positive logFC value and vice versa. All genes with 
p-value ≤ 0.01 are plotted (black) and genes passing the |logFC| ≥ 1 criteria are determined as 
DEG (blue). Full list of DEG is in Appendix 14. Selective DEG with known ovulatory 
functions are labelled in the plot. Examples of the pattern of expression for Cited1 and 
Tmem100 are visualised on the right through the UCSC Genome Browser, showing read count 
build-up for AWT (dark green) and KO (green). Tracks are normalised to the same scale. (D) 
Top ten most upregulated and ten most downregulated DEGs from AKO vs WT RNA-seq, 
displayed together with logFC and p-value. (E) Biological processes enriched in AKO DEGs, 
as indicated from Gene Ontology analysis. Only significantly enriched pathways (p-value ≤ 






7.3.2.3 Granulosa cell gene expression changes in BKO mice  
PCA plot of BKO samples and BWT controls showed that while there was a degree of 
clustering within each genotype group there was far less variance between BWT versus BKO   
(Figure 7.6A). Likewise, sample-to-sample Euclidean distances calculated from normalised 
read count indicates that the lack of an obvious clustering pattern is potentially due to the high 
correlation between all samples regardless of genotype (Figure 7.6B). This lack of separation 
in transcriptome identity is observed after differential expression analysis, which identified 
only 143 DEGs, or a quarter of the number of DEGs identified in PGRKO or AKO samples 
(Figure 7.6C-D, Appendix 15). Surprisingly, almost all of these DEGs (138/143 DEGs) were 
upregulated in BKO, suggesting that PGR-B is playing a predominant role as a transcriptional 
repressor in granulosa cells. Due to the low number of DEGs, few enriched pathways were 
identified to be associated with PGR-B regulated DEGs, with the most significantly enriched 









Figure 7.6 Genes differentially regulated in the absence of PGR-B in ovulatory granulosa 
cells.  
(A) PCA plot of RNA-seq replicates for BKO and BWT granulosa cells collected after 8 h hCG 
stimulation. (B) Correlation heatmap for BKO and WT replicates. The colour of matrix squares 
indicates sample-to-sample distance as calculated using normalised read counts by DESeq2, 
noted in the bar on the right. (C) Volcano plot of genes identified in AKO RNA-seq. Genes 
that are upregulated in AKO have a positive logFC value and vice versa. All genes with p-
value ≤ 0.01 are plotted (black) and genes passing the |logFC| ≥ 1 criteria are determined as 
DEG (blue). Full list of DEG is in Appendix 15. Selective DEG with known ovulatory 
functions are labelled in the plot. Examples of the pattern of expression for Vdr and Cd28 are 
visualised below through the UCSC Genome Browser, showing read count build-up for BWT 
(dark blue) and KO (light blue). Tracks are normalised to the same scale. (D) Top ten most 
upregulated and ten most downregulated DEGs from BKO vs WT RNA-seq, displayed together 
with logFC and p-value. (E) Biological processes enriched in BKO DEGs, as indicated from 







7.3.2.4 Unique patterns of gene regulation that are isoform-specific 
To further determine the level of difference between the identified transcriptomes, DEGs that 
are reliant on the presence of either or both of PGR isoforms were compared against each other. 
PCA plot of all datasets displayed a number of clustering patterns (Figure 7.7A). The PGRKO 
samples and their PGRWT controls both clustered separately from the isoform specific groups, 
consistent with the difference between background strains. Variation between WT samples 
from the three strains might have resulted from the genetic differences in the mouse strains 
used to generate KO colonies. The PGRKO line was maintained in the BALB/cJ mouse strain, 
while AKO and BKO animals were crossed into the C57BL/6 line, and different embryonic 
stem cell lines were used for each strain (129S7/SvEvBrd-Hprt+ for PGRKO and 
129S7/SvEvBrd-Hprtb-m2 for AKO and BKO) (JAX). Such variations in the genetic background 
of PGRKO versus the AKO and BKO mouse lines can be expected to cause differences 
between WT controls at the transcriptome-wide level while also yielding the high level of 
similarity between AWT and BWT animals that are nearly genetically identical. More 
importantly, and also as expected, the PGRKO and AKO groups both formed clusters separate 
from their WT controls (with the exception of the described outliers).  There was no distinction 
between BWT and BKO samples, which also overlapped the AWT samples, confirming the 
comparatively limited disruption to gene expression pattern from the absence of PGR-B in 
granulosa cells.  
 
Comparisons of DEGs between the three datasets showed that 289 DEGs were found in both 
PGRKO and AKO datasets (equivalent to 42-47% of total DEGs in either datasets) (Figure 
7.7B-D). All of these DEGs shared the same direction of change relative to WT controls and 
many have been previously identified to be regulated by PGR in granulosa cells (Figure 7.7C). 
On the other hand, very few genes were shared between BKO and the other two transcriptomes 
(10 shared DEGs between PGRKO/BKO and 16 between AKO/BKO) or shared between all 
three datasets (7 DEGs). Among these shared genes, however, there was also an inverse pattern 
of expression observed in BKO, with DEGs upregulated in BKO tending to be downregulated 













Figure 7.7 Correlation between PGR isoform-specific transcriptomes.  
(A) PCA plot of all RNA-seq samples, including PGRKO, AKO and BKO strains (4 replicates 
per sample) (B) Venn diagram of DEG identified in PGRKO vs WT (red), AKO vs WT (green) 
and BKO vs WT (blue) granulosa cells. DEGs were compiled from independent RNA-seq with 
full gene lists available in Appendix 7 (C) Overlapped genes of each comparison, with 
accompanying KO vs WT logFC from corresponding dataset displayed. (D) Examples of 
shared DEGs between transcriptomes, visualised using the UCSC Genome Browser. Tracks 
are normalised to the same scale. For each gene, custom tracks showing read count build-up 
for PGR WT (dark red), PGR KO (red), AWT (dark green), AKO (light green), BWT (dark 





To determine whether different PGR isoforms have unique functional co-modulator partners 
in peri-ovulatory granulosa cells, upstream regulators of PGR isoform-dependent 
transcriptomes were assessed using IPA. In PGRKO and AKO, many transcription regulators 
were shown to have a significant association with these differentially expressed genesets, with 
many shared between the two datasets (Table 7.2). Reassuringly, PGR was identified as one of 
the most highly enriched regulators in both datasets.  Additionally, a number of transcription 
factors that are known to be downstream targets of PGR, such as ZBTB16 (Zinc finger and 
BTB domain containing 16), as well as other transcription regulators with roles in ovulatory 
granulosa cells, including PPARG, NR5A2 (LRH1), GATA4, SP1, CEBP/p300 and JUN/FOS 
were also identified. Conversely, very few transcription regulators were found to be associated 
with PGR-B regulated DEGs. Concurrent with the previous observation of PGR-B inhibiting 
downstream gene expression, other transcription repressors were found to be enriched in this 





Table 7.2 Upstream regulators of PGRKO / AKO / BKO DEGs.  
Upstream regulators associated with DEG sets in PGRKO vs PGRWT, AKO vs AWT and 
BKO vs BWT were identified via IPA. Only transcription regulators and ligand-dependent 
nuclear receptor are shown in this table. A p-value = 0.01 cut-off was applied. Molecules are 











KLF4 0.0000 15 PGR 0.0000 17 RCOR1 0.00128 2 
TCF7 0.0001 6 HDAC1 0.0000 16 DLX6 0.00163 2 
GATA3 0.0001 13 FEV 0.0000 9 DLX2 0.00222 2 
FOXA2 0.0001 12 ESR2 0.0000 23 CRX 0.00314 2 
CEBPA 0.0001 18 FOXO3 0.0001 17 DLX5 0.0034 2 
HTT 0.0001 24 KLF4 0.0001 15 LHX5 0.00999 1 
NR1I2 0.0001 10 NFE2L2 0.0001 20 NKAP 0.00999 1 
NFE2L2 0.0002 17 EZH2 0.0001 18    
THRB 0.0003 11 RORC 0.0001 11    
CEBPB 0.0004 16 SMARCA4 0.0001 25    
RORC 0.0004 9 FOXA2 0.0001 13    
HIF1A 0.0004 16 HTT 0.0001 27    
CEBPD 0.0005 7 PPARG 0.0002 21    
GATA4 0.0007 10 GATA2 0.0002 18    
AHR 0.0007 14 HNF1B 0.0002 9    
PGR 0.0007 12 RXRG 0.0002 5    
SQSTM1 0.0007 5 RXRB 0.0003 7    
FOXO3 0.0009 13 CDX2 0.0003 10    
SOX10 0.0009 4 NFKBIA 0.0003 19    
EZH2 0.0009 14 SIX5 0.0007 4    
NR1I3 0.0009 7 RXRA 0.0009 14    
TBX5 0.0011 6 LMO4 0.0010 3    
SP7 0.0011 3 CEBPD 0.0017 7    
RUNX1 0.0013 9 HIRA 0.0017 3    
RXRA 0.0013 12 PPARD 0.0018 11    
EPAS1 0.0014 10 CDX1 0.0019 5    
NOTCH1 0.0014 11 EPAS1 0.0019 11    
HNF1B 0.0015 7 PLAGL1 0.0021 3    
FOXC2 0.0015 5 ESR1 0.0021 38    
HDAC1 0.0015 11 NR1I2 0.0023 9    
PDX1 0.0016 9 NKX3-1 0.0025 5    
NFKBIA 0.0017 15 ZFPM2 0.0025 3    
PPARG 0.0018 16 HDAC2 0.0026 8    
RORA 0.0019 9 CREB1 0.0027 20    










   
YY2 0.0020 3 HIF1A 0.0035 16    
PAX3 0.0021 9 PIAS1 0.0038 4    
EHF 0.0022 6 AIRE 0.0039 5    
TLX3 0.0023 3 HOXA9 0.0041 9    
ETV5 0.0028 6 AHR 0.0045 14    
MEF2C 0.0028 7 STAT5B 0.0046 12    
CCAR1 0.0029 2 FOS 0.0048 19    
RARB 0.0029 7 NAB2 0.0048 3    
SOX9 0.0030 5 THRB 0.0049 10    
MAFK 0.0031 3 SMAD3 0.0055 11    
NR3C2 0.0033 7 FOXA1 0.0059 8    
GATA2 0.0038 13 SMARCA2 0.0063 5    
RAX 0.0040 2 SOX9 0.0071 5    
ZNF521 0.0040 2 RORA 0.0072 9    
EGR3 0.0041 4 GATA6 0.0072 9    
HNF1A 0.0042 15 Foxp1 0.0083 4    
ZBTB16 0.0044 7 NR3C1 0.0085 21    
POU4F1 0.0049 6 RARB 0.0089 7    
CDX2 0.0053 7 TCF7 0.0090 4    
SIRT1 0.0054 13 NR1H4 0.0091 8    
PRDM1 0.0058 9 GATA4 0.0095 9    
CDX1 0.0059 4 ESRRG 0.0097 4    
ESR2 0.0066 15 LHX1 0.0098 6    
GATA6 0.0067 8       
FOS 0.0067 16       
NR1D2 0.0068 2       
BRMS1 0.0068 2       
BACH2 0.0077 4       
SP1 0.0078 16       
FEV 0.0080 5       
STAT5B 0.0080 10       
CREB1 0.0081 16       
SOX2 0.0083 14       
RARG 0.0084 5       
TP53 0.0084 40       
ZNF281 0.0087 3       






7.3.3 Combined analysis of transcriptomes regulated by ovulatory stimulus, 
PGR-regulated transcriptomes and PGR bound cistromes 
To determine the influence of PGR on the whole ovulatory transcriptome in granulosa cells, 
transcriptomes from PGRKO, AKO and BKO were assessed alongside genes regulated by 
ovulatory stimulus (identified through RNA-seq of mouse granulosa cell transcriptomes before 
vs 8 h after hCG treatment (Appendix 7). Among the 2179 ovulatory DEGs in granulosa cells, 
151 (or 7%) were found to be differentially expressed in PGR transcriptome (25% of PGRKO 
DEGs, Figure 7.8A). Within these DEGs, almost all (146 DEGs) were found to be upregulated 
and only 5 were found to be downregulated in ovulation. Similarly, 144 ovulatory DEGs were 
found in the AKO transcriptome, 139 (97%) of which were upregulated in peri-ovulatory 
granulosa cells. 88 ovulatory DEGs were found in both PGRKO and AKO datasets, confirming 
the predominant role of PGR-A in the overall PGR effect during ovulation. Only 2 ovulatory 
DEGs were found to be exclusively regulated by BKO in granulosa cells. 
 
Nearly half of all ovulatory DEGs have associated PGR or RUNX1 bound ChIP-seq peaks, 
with the majority of DEGs bound by both transcription factors during ovulation. To determine 
the direct impact of PGR and RUNX1 binding on PGR-dependent gene expression, PGR 
isoform-specific transcriptomes were compared against PGR and RUNX1 cistromes (Figure 
7.8B). Surprisingly, despite the previous finding of a very high proportion of PGR and RUNX1 
binding in close proximity to gene bodies or TSS, only a quarter of PGRKO or AKO DEGs 
were found to have PGR or RUNX1 binding in their proximity.  The majority of these DEGs 
had both PGR and RUNX1 binding, indicating a close relationship between RUNX1 and PGR 
in the regulation of mutual target genes. However, about three-quarters of PGR-dependent 
DEGs were found to not have direct PGR binding within the gene proximity, suggesting 
possible regulatory actions via distal enhancer units of PGR or intermediate transcription 
factors. Few DEGs in BKO, however, showed evidence of PGR or RUNX1 direct binding, 
with only 20 DEGs found in common with the ChIP targets of either transcription factors. 
Analysing the genomic distribution of binding sites found at DEGs from different datasets 
showed no remarkable differences from the known binding pattern of PGR and RUNX1, with 
RUNX1 favouring interactions at proximal promoter regions (Figure 7.8C). Cumulatively 
these results indicate that PGR-A is important in the induction of gene expression in ovulation, 
with direct PGR and RUNX1 binding within the gene boundary as well as interaction through 










Figure 7.8 Isoform-specific transcriptome in relation to ovulatory genes and ovulatory 
transcription factors.  
(A) Volcano plot displaying ovulatory DEGs from RNA-seq in 8 h vs 0 h hCG-stimulated 
granulosa cells that are in common with PGR isoform-specific RNA-seq datasets. hCG-
regulated genes found in PGRKO RNA-seq datasets are labelled red, in AKO RNA-seq in 
yellow, in BKO RNA-seq in green, in both PGRKO and AKO RNA-seq in orange and in all 
three PGR datasets in blue. Quantification of each overlapping subset is displayed in the bar 
graph on the right, with DEG that are upregulated or downregulated during ovulation indicated. 
(B) Venn diagrams showing the overlap between genes associated with a peak in PGR and 
RUNX1 ChIP-seq in relation to PGRKO RNA-seq (left), AKO RNA-seq (middle) and BKO 
RNA-seq (right). (C) Genomic distribution of PGR and RUNX1 binding sites that are found in 
PGR DEG, AKO DEG or BKO DEG. Genome distribution is displayed as stacked bar graphs 
and peaks were divided into PGR peaks and RUNX1 in PGRKO RNA-seq (left), in AKO 
RNA-seq (middle) and BKO RNA-seq (right). Genomic features include promoters (< 1 kb, 1-
2 kb and 2-3 kb), 5’ UTR, 1st intron, other introns, exons, 3’ UTR and downstream of TES 






While the important roles of PGR-A and PGR-B on general reproductive physiology has been 
described, the underlying mechanisms by which they can achieve profoundly tissue-specific 
actions differences is still not well understood and no studies have investigated the distinct 
roles of PGR-A and PGR-B in granulosa cell functions. Thus, this study embarked on 
describing the ovulatory transcriptomes that are dependent on each PGR isoform, taking 
advantage of isoform-specific knockout mouse strains and high throughput RNA sequencing, 
and have illustrated isoform-specific gene expression profiles with consequences to ovulation. 
 
A high degree of similarities between transcriptomes that were under the influence of PGR-A 
and total PGR was observed. As expected, many ovulatory genes that are PGR-regulated in 
granulosa cells were indicated in these datasets, such as Edn2, Mt1, Mt2 and Pparg 7,9,27. Some 
of these genes, such as Adamts1, while shown to be statistically downregulated only in 
PGRKO, was also reduced in AKO (logFC = -0.768 with p-value = 2.73E-13). A handful of 
these genes have been shown to be associated with PGR functions in other biological contexts, 
such as Alox12e 28 and Efnb2 29in the uterus. Of particular interest is Zbtb16, which encodes 
for a zinc-fingered transcription factor that has both transcriptional activating and repressing 
roles. Zbtb16 plays a role in mediating the expression of Egr1 in the uterus and PGR has 
previously been shown to regulate Zbtb16 expression through binding sites within its intronic 
body30. Through microarray Zbtb16 was shown as a target gene of PGR in granulosa cells 
during ovulation, which is confirmed with the AKO RNA-seq data. Zbtb16 is also targeted by 
RUNX1 in cells of lymphoid lineage, where the intronic binding of RUNX1 is shown to be 
important for Zbtb16 expression 31 and these same intronic binding sites were also observed 
for PGR and RUNX1 in granulosa cells. Many of these genes remain unfamiliar in the context 
of granulosa cell biology or in relation to PGR functions and require further investigation. 
Conversely, there were also genes previously identified in granulosa cells but which have never 
been linked to PGR, such as Serpina1 32. However, it is clear that the PGR- and PGR-A 
dependent transcriptomes were highly reflective of the global ovulatory transcriptome in 
granulosa cells, the majority of such genes were upregulated during ovulation, indicative of the 
transcriptional activating role of PGR and PGR-A in particular. 
 
Approximately a quarter of genes identified in PGRKO and AKO possessed PGR binding in 




of these genes, it is likely that other mechanisms such as indirect regulation via intermediate 
transcription factors as well as PGR binding distal enhancer regions maybe important for PGR 
action in the majority of genes. Indeed, upstream regulators for PGR-dependent genes 
identified not only PGR as expected, but also a number of transcription factors with potential 
to be regulators of subsets of the PGR-regulated genes. These included CTNNB1, SP1 and 
CEBPα and CEBPβ, which are known to play a role in transcriptional regulation in ovulation 
33-35. RUNX1 was also identified as a likely regulator of the PGR-dependent genes, which 
supports the proposed functional cooperation between RUNX1 and PGR in peri-ovulatory 
granulosa cells. Also in support of this, over a quarter of PGRKO and AKO genes were found 
to have RUNX1 binding in their proximity, with more than 70% of such binding occurring in 
conjunction with PGR binding. As the RUNX1-modulated gene expression pattern in peri-
ovulatory granulosa cells remains unexplored, a better description of this transcriptome would 
help elucidate the degree of functional similarities between these two transcription factors. A 
number of identified upstream regulators were also downstream targets of PGR with known 
roles in ovulation, such as PPARγ and HIF1α 9,36, indicating the role of PGR as a master 
transcription factor that facilitates a signalling cascade by promoting the expression of 
additional intermediary transcriptional regulators.  
 
While there was a large level of overlap between the PGR and AKO transcriptomes, they were 
not completely alike. To explain this, the dimer nature of PGR needs to be considered. Active 
PGR usually exists in a dimerised form of either heterodimer (PGR-A/PGR-B) or homodimer 
(PGR-A/PGR-A or PGR-B/PGR-B). Studies have shown that each PGR isoform has distinct 
co-regulator binding properties that are conveyed to dimers; for example, BTEB1 is found to 
enhance PGR-B transactivation through stronger interaction with the PGR-B homodimer, yet 
has no effect on the PGR-A homodimer and even promotes PGR-A trans-repression of PGR-
B when it binds the PGR-A/PGR-B heterodimer 37. Similarly, PGR-B shows a higher binding 
affinity to SRC-1 and SRC-2 than PGR-A 38. The functional consequences of these different 
dimer forms, however, has not been explored in detail. Although PGR-A is found to have a 
higher expression level than PGR-B in granulosa cells, it is unknown which of the dimer forms 
is the dominant; thus, by selectively removing one isoform in these KO mouse models, PGR is 
almost certainly forced to form homodimers in AKO and BKO, which might lead to 






Unlike for PGRKO and AKO, the BKO transcriptome does not seem to be crucial for ovulation. 
The absence of PGR-B led to far less prominent changes in the gene expression pattern during 
ovulation and very little overlap with either PGRKO or AKO RNA-seq datasets. Interestingly, 
less than 10% of identified genes were downregulated in the absence of PGR-B, suggesting a 
repressive function is the major role of PGR-B in granulosa cells. In support of this, upstream 
regulators associated with PGR-B dependent genes included co-repressors, such as RCOR1 
and REST, which are members of the REST repressor family with important roles in gene 
silencing 39. Such divergent effects on transcriptional regulation has previously been described 
in breast cancer where cells expressing only either PGR isoform have unique transcriptional 
profiles 12.  Thus, the transcriptomic pattern of PGR-B confirms the previously observed lack 
of reproductive defects in BKO female mice, as PGR-B appears to be relatively uninvolved in 
crucial gene regulation in ovulation and may have some roles in transcriptional inhibition. 
 
Intriguingly, Western blot showed that in AKO peri-ovulatory granulosa cells, an absence of 
both isoforms and not just PGR-A was observed. The opposite was not the case in BKO 
granulosa cells in which PGR-A was still present in BKO samples. This hints at a role of PGR-
A in regulating the expression of PGR-B through means that are yet unknown. Curiously 
enough, PGR-A is known to have a repressive effect on PGR-B transactivation in mammary 
and uterine tissues 10,13, and thus cannot explain the ablation of PGR-B in the absence of PGR-
A in this case. Another possibility is that PGR-A has a protective role on PGR-B in granulosa 
cells that prevents PGR-B degradation. Ligand-dependent protein degradation has been 
previously described in multiple steroid receptors including PGR 40,41 and there is evidence of 
PGR isoforms having specific protein stability that is dependent on MAPK-triggered 
phosphorylation 42. These speculations will have to be addressed in more details in future 
studies. If that is indeed the case, this can explain the similarities between PGRKO and AKO 
reproductive phenotypes as AKO reproductive tissues are essentially PGRKO. Despite this, 
transcriptomic differences between PGRKO and AKO colonies suggests that KO of specific 
PGR isoforms can have additional effects on downstream pathways, the nature of which is still 
unknown. Furthermore, it is also likely that this resultant KO effect might be specific only to 
granulosa cells, as B-isoform is still observed in oestrogen-treated AKO uterus 3. More detailed 
studies of the dynamics of PGR-B independent of PGR-A during the peri-ovulatory window 






Due to the depth of the sequencing effort, transcripts of low abundance were also captured in 
these RNA-seq experiments, including ncRNA which can manifest profound physiological 
effects even at low quantity. However, the workflow described for the current analysis, which 
did not separate ncRNA from highly abundant mRNA, would not be able to identify 
differentially expressed ncRNA due to bias to mRNA enrichment. Thus, while the role of 
ncRNA has not been investigated in detail in the current study, the data is available for future 
in-depth studies on the subject and will be helpful for the further understanding of the effect of 
PGR isoforms on the expression of ncRNA and whether there is a subsequent impact on 
granulosa cell functions during ovulation.  
 
Considering that both PGRKO and AKO mutants are anovulatory while BKO mice ovulate 
normally, these new in-depth sets of genes that are regulated in each context provide detailed 
information about the genes that are critical for the mechanism of ovulation.  While a number 
of the genes identified as dysregulated in both PGRKO and AKO mice have been studied in 
ovulation, a detailed set of other genes was also uncovered which remain to be investigated to 
determine their roles.  To this end, it is important that a number of gene ontological pathways 
are conserved between total PGR and PGR-A regulated genesets including Cell Adhesion, Cell 
Development and Neurogenesis.  Further investigation into the pathways and their constituent 
genes is likely to discover new aspects of the ovulatory mechanism. 
 
Overall, this is the first description of the PGR isoform-specific transcriptomes in granulosa 
cells, where PGR plays a crucial role in the regulation of ovulation.  The transcriptome results 
agree with the previously described ovarian phenotype of AKO and BKO mouse models and 
highlight a number of genes with potential novel roles in ovulation that invite further 
investigation. Stark contrasts between isoform-dependent gene expression profiles confirmed 
the prominence of PGR-A in ovulatory functions and that PGR-B had little involvement in the 
regulation of ovulatory genes and is likely involved in other roles, possibly repressing 
transcriptional expression of certain genes. These results once again corroborate previous 
findings on differences in PGR isoform properties and functions that have been observed in 
other cellular contexts and indicate that a distinction between PGR isoforms is highly important 
in investigating PGR actions. The findings support an interaction between PGR and RUNX1 
in many, but not all PGR regulated genes indicating that PGR action in granulosa cells is 




intermediate transcription factors including PPARγ and HIF. Possible additional interactions 
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Ovulation is a complex process in which many cellular and biochemical factors are acting in 
coordination to ultimately result in the release of the mature oocyte into the oviduct for 
fertilisation. A key ovarian hormone that is essential for this process is progesterone, which 
acts through its receptor PGR to regulate numerous downstream target genes that are in turn 
involved in various aspects of ovulation. The undisputable importance of PGR on ovulation 
has been illustrated on a physiological level in the PGRKO mouse model and also in humans 
through the demonstration that PGR antagonists block ovulation. The disruption of PGR by 
either means results in an anovulatory and sterile phenotype in female mice due to failure in 
follicle rupture despite normal oocyte maturation 1,2. Not only is PGR crucial for ovulation but 
it also plays an important role in other tissues throughout the female reproductive tract as a 
coordinator of various biological processes in preparation for pregnancy. PGR is important for 
modulating ciliate movements in the oviduct and therefore the transportation of oocytes and 
embryos through the reproductive tract 3. In the uterus, PGR has a role in decidualisation and 
embryo implantation 1. While it is understood that PGR is a key factor in many aspects of 
female reproduction, it is still unclear how these diverse processes are synchronised by a single 
transcription factor. The goal of this thesis was thus to address the following broad questions:  
 
How can PGR, in response to progesterone, coordinate diverse biological processes in 
different tissue contexts? In the case of ovulation in particular, what are the underlying 
molecular mechanisms that set apart PGR actions in granulosa cells in comparison to other 
reproductive tissue types?  
 
The hypothesis is that unique aspects of the PGR transcription complex different tissue contexts 
allow for PGR actions in granulosa cells to be set apart and enable the coordination of diverse 
biological processes in distinct reproductive tissues. To build the model for PGR transcription 
complex in peri-ovulatory granulosa cells, key aspects of the PGR cistrome, transcriptome and 
interactome were explored in each of the six chapters. A pictorial summary of the thesis 






Figure 8.1 Summary of the thesis.  
Different aspects of the transcription complex involving PGR in peri-ovulatory granulosa cells 





8.2 MAIN FINDINGS 
The goal of the thesis and questions that arose throughout the study were addressed in six 
chapters, with the following main conclusions reached: 
8.2.1 PGR binds chromatin and regulates downstream gene expression in a 
tissue-specific manner  
The main function of PGR is to regulate gene expression through directly binding target DNA, 
canonically at the consensus PRE motif. However, it has been shown that PGR can regulate 
target genes without the PRE motif through tethering by other transcription factors 4. To 
determine whether this is the preferred mechanism in granulosa cells in general, Chapter 2 
explored the PGR cistrome in peri-ovulatory granulosa cells. PGR was found to mostly occupy 
transcriptionally active promoter regions and remarkably, PGR was found to not only interact 
with its canonical PRE motif but also with a number of non-canonical motifs usually bound by 
other transcription factor families. The significance of these PGR chromatin binding events 
was also demonstrated by the integration with PGR-dependent and LH-stimulated granulosa 
cell transcriptomes. 
 
As PGR coordinates distinct biological events in the ovary, oviduct and uterus, it is possible 
that the chromatin binding properties of PGR in different reproductive tissues are also unique, 
resulting in specific PGR-regulated gene expression profiles with consequences on the distinct 
physiological roles of PGR. To confirm this, in Chapter 3, comparisons were made between 
three PGR-dependent transcriptomes in the progesterone-stimulated mouse granulosa cells, 
oviduct and uterus, for which three highly unique groups of genes were identified. Such striking 
differences are likely due to distinct molecular mechanisms employed by PGR in cells from 
different tissues in the reproductive tract. To identify these distinct molecular mechanisms, 
comparative analysis of PGR chromatin binding properties were made in two progesterone-
responsive tissue types – granulosa cells and the uterus. PGR was shown to have highly 
specialised chromatin binding properties – granulosa PGR preferably bound proximal promoter 
regions, which was not observed in uterine PGR, and consequentially leads to the enrichment 
of distinct molecular pathways. Interestingly, PGR not only showed different levels of PRE 
binding but also interaction with distinct groups of non-canonical motifs, indicating that the 
interactome of PGR in different tissues is important in determining tissue-specific 




8.2.2 PGR interacts with a selective group of co-regulators in peri-ovulatory 
granulosa cells especially RUNX1 
Based on the results of Chapter 3, a number of transcription factor families were hypothesised 
to interact with chromatin-bound PGR through motif analysis. However, it is unknown whether 
these transcription factors form a physical interaction with PGR in granulosa cells. As each 
motif tends to be recognised by multiple transcription factors of the same family, candidates 
were selected based on the level of motif enrichment at PGR binding sites as well as on their 
known precedence as an ovarian transcription factor. These included RUNX (RUNX1, 
RUNX2, CBFβ), JUN/FOS (c-JUN, JUNB, JUND) and NR5A (LRH1), all of which are known 
to regulate gene expression in granulosa cells during ovulation 5-10. In particular the RUNX 
binding motif was significantly enriched only in granulosa cells and not the uterus. In Chapter 
4, the physical interaction between PGR and members of the RUNX, JUN/FOS and NR5A 
families was investigated through proximity ligation assay of cultured granulosa cells 
stimulated with hCG and progestin to mimic the earliest responses of the LH surge. Apart from 
c-JUN and JUNB, all candidate proteins were induced and formed a physical interaction with 
PGR in the nucleus of granulosa cells in response to these ovulatory cues, indicating that these 
transcription factors are involved in the PGR-inclusive transcription complex. Also 
importantly, the dynamics of the interactions between PGR and RUNX1 / RUNX2 was also 
investigated in Chapter 6, in which these interactions were shown to be induced within 4-6 h 
after hCG treatment. These results together suggest that PGR-chromatin binding in granulosa 
cells involves a cooperative mechanism forming transcriptional complexes with RUNX, LRH1 
and JUN/FOS families. 
 
RUNX1 is expressed in granulosa cells at different stages of ovarian development and has been 
shown to regulate gene expression in granulosa cells during ovulation 5 and to also be important 
in granulosa specification in the foetal ovary 11. Thus it is important to define the distinct 
RUNX1 cistromes in these biological contexts. Chapter 5 addressed the differences in RUNX1 
cistromes in foetal granulosa cells vs adult granulosa cells before and after the LH surge 
through comparative analysis of RUNX1 ChIP-seq at different biological stages. The results 
highlighted the high level of promoter occupancy by RUNX1 in all biological contexts and 
illustrated an induction of novel RUNX1 chromatin binding sites in response to the LH surge. 
Subsequently, Chapter 6 demonstrated the similarities between PGR and RUNX1 bound sites 




cells. RUNX1 and PGR cistromes showed remarkably high overlap in granulosa cells and the 
two transcription factors also shared the same repertoire of enriched non-canonical motifs, 
indicating potential members of the PGR/RUNX1 transcription complex. Such interaction also 
explains the functional similarities between the two transcription factors.  
 
Aside from other transcription factors, PGR action can also be mediated by interaction with 
lncRNA, such as Sra1 12 and Gas5 13. Various lncRNA have also attributed to ovarian functions 
14; however, the regulatory role of lncRNA on PGR during ovulation has never been addressed. 
The relationship between PGR and its known ncRNA regulators, addressed through RIP, 
showed evidence that Sra1 and Gas5 indeed bound PGR in granulosa cells in response to the 
LH surge; suggesting a possible role for these lncRNA, as well as ncRNA generally, in 
regulating transcriptional complex formation during ovulation.  
 
Overall, these chapters confirm that PGR interacts with a selective group of co-regulators in 
peri-ovulatory granulosa cells, including both other transcription factors and lncRNA. In 
particular, PGR/RUNX1 interaction results in striking similarities between the PGR and 
RUNX1 cistromes. However, RUNX1 bound chromatin in granulosa cells at various 
developmental stages. Most interestingly, the RUNT motif was enriched in PGR cistrome 
while the PRE/NR3C motif was not as enriched in the RUNX1 cistrome. All of these suggest 
that RUNX1 likely plays the role of a pioneer factor to recruit PGR to its granulosa-specific 
target sites. Such an interaction results in important consequences for the downstream 
ovulation-specific gene expression profile. 
8.2.3 PGR-A and PGR-B regulate different transcriptomes in granulosa cells 
Another aspect of specific PGR functions is its multiple isoforms, especially the two main 
isoforms PGR-A and PGR-B. While PGR-B has an additional AF domain that generally 
enhances its transactivation properties compared to PGR-A 15, PGR-A has also been shown to 
have a trans-repressive role on PGR-B 16. Furthermore, PGR usually acts as a dimer made up 
of either the same monomer (PGR-A and PGR-B homodimers) or a mix of the two isoforms 
(PGR-A/PGR-B heterodimer) 17. This results in a complex interplay between the two 
transcription factors and distinctive gene expression profiles driven by the presence of the two 
isoforms. Both isoforms are expressed in PGR-positive tissues, with PGR-A being the 




tissues 18,19. However, while PGR-A has been shown to be more important in determining the 
female reproductive phenotype, this has not been defined by transcriptomic evidence. Thus, to 
determine the isoform-specific transcriptomes, in Chapter 7, RNA-seq was performed on peri-
ovulatory granulosa cells obtained from three KO mouse models – PGRKO, AKO and BKO. 
PGRKO and AKO transcriptomes were shown to be highly similar, with both KO models 
exhibiting suppression of the majority of identified genes as well as many ovulatory genes 
being identified in both datasets, reflected in the high overlap between PGRKO and AKO genes 
and global ovulatory genes in granulosa cells. In contrast, PGR-B seemed to play a lesser 
transactivation function in granulosa cells, with few differentially expressed genes identified 
in BKO. Finally, co-binding of PGR and RUNX1 in proximity to the gene boundary was found 
to be important for the regulation of PGRKO and AKO genes. This suggests that PGR-A and 
RUNX1 may form a specific interaction leading to granulosa-specific PGR-mediated 
transcriptional regulation. 
8.2.4 Overall conclusion of thesis 
A unique cooperation between PGR-A and specific transcription factors, including RUNX1, 
JUND and LRH1 forms a mutual transcriptional complex. Ultimately, such cooperation results 
in the regulation of genes that are important for ovulation. 







Figure 8.2 Schematic conclusion to the thesis, in regards to specialised PGR action in the 





8.3 REMAINING QUESTIONS & FUTURE STUDIES 
This study serves at the first step in building the identity of the transcription complex of PGR 
and at the same time also distinguishing it from PGR mechanisms in other reproductive tissues 
and explaining the tissue-specific roles of PGR in the context of reproduction. In answering 
these questions, a combination of high-throughput techniques (such as ChIP-seq and RNA-seq) 
have been utilised for one of the first times in granulosa cells to identify the cistromic and 
transcriptomic properties of PGR. Such methods naturally generate a massive amount of data, 
and while the overall landscape of PGR action in granulosa cells has been characterised, as was 
intended to answer the questions being raised, this data remains to be further explored in detail. 
Characterisation of PGR chromatin binding properties have indicated a preference for non-
promoter target sites for PGR in both tissue types, but more significantly in the uterus, implying 
that PGR can both interact with proximal promoters as well as more distal enhancer elements 
in a tissue-specific manner. In the context of breast tissues, PGR has been shown to exert 
influence on the transcription of target genes through interaction with specific enhancer sites 
20,21. However, such activity has not been previously described in the context of reproduction. 
For distally binding PGR to influence target genes requires reshaping the chromosomal 
conformation and involves a number of chromatin remodellers, including CTCF and Cohesin 
22. The function of these proteins has been linked to various transcription factors, such as 
FOXA1 and FOXA2 23. Whether the involvement of PGR is only a downstream effect of 
precedent chromatin conformational changes or PGR actively plays a role in chromatin 
restructure is still unknown. To look at this in further detail, the spatial organisation of 
chromatin in peri-ovulatory granulosa cells needs to first be characterised, for instance through 
chromatin conformation capture using Hi-C; alternatively, mapping of chromatin remodellers, 
such as CTCF sites, on the genome through immuno-based methods, can be utilised. This type 
of analysis will also be beneficial for understanding the roles of other transcription mediators 
as well as for constructing the transcription machinery in granulosa cells. Subsequently, the 
contribution of PGR on such chromatin landscape can be investigated utilising PGRKO mouse 
models.   
 
Analysis of the PGR and RUNX1 cistromes has shown a high level of conformity between 
PGR and RUNX1 on a chromatin and functional level, with PGR action at target promoters 
predicted to be reliant on the presence of RUNX1. Furthermore, RUNX1 exhibited a basal 




by PGR post-LH. This suggests that RUNX1 acts as a pioneer factor by binding potential PGR 
target chromatin and tethers PGR to non-traditional target sites during ovulation. Exactly how 
this is achieved is still unknown. Perhaps RUNX1 promotes the ‘loosening’ of the tightly-
packed nucleosome structure by facilitating the recruiting chromatin remodelling factors such 
as SRC and CBP/p300 and thereby making the chromatin site accessible to PGR. Such a 
process has been illustrated in other contexts 24,25; however, whether RUNX1 can similarly 
coordinate this in granulosa cells is thus far unknown. Alternatively, RUNX1 might act as a 
‘bait’ to PGR and form direct interaction with PGR during the random scanning process, in 
which transcription factors scan the chromatin for accessible binding sites 26. Such a model has 
been previously described in CEBPβ tethering of steroid receptors 27,28 and PGR is known to 
interact with SP1/SP3 binding sites to regulate Adamts1 expression 4. Studies into the 
interaction between RUNX1 and chromatin remodellers using immunoprecipitation or 
microscopy methods are vital in testing these hypotheses. Furthermore, tissue-specific 
conditional RUNX1 KO models will be helpful in determining the degree of PGR dependence 
on RUNX1. 
 
Aside from RUNX1, RUNX2 and members of the JUN/FOS and NR5A transcription factor 
families were also shown to form a physical interaction with PGR that was mediated by 
ovulatory stimulation. These are by no means an exhaustive list, since motifs for other 
transcription factor families like CEBP and GATA were also found to be enriched at PGR 
binding sites. These transcription factors have also been linked to the regulation of ovulatory 
genes in granulosa cells 6,9, suggesting possible functional interactions between PGR and these 
co-modulators that require further investigation. In particular, the order in which these proteins 
are recruited to target chromatin sites would be of interest in unravelling the significance of 
each transcription factor in the ovulatory transcription complex. Another component of this 
transcription complex that has not been investigated in this study is the involvement of non-
DNA binding transcription adaptors, such as SRC and HDAC, which could not be identified 
through motif analysis. A full description of the PGR interactome in granulosa cells through 
IP-MS would be able to identify all protein components of the transcription complex involving 
PGR. 
 
From these cistromic and transcriptomic results, a large number of target genes for PGR-A and 
PGR-B have been identified, many of which are novel genes or have never been described in 




differentially expression in AKO granulosa cells and encodes for the transcription factor PLZF. 
While a role of PLZF in granulosa cells has not been characterised, it is found to be a PGR 
target gene in the endometrial stromal cell where it plays a role in regulating decidualisation 
29. Here, PGR binding at enhancer-like elements within the first intron of Zbtb16 is proven to 
be vital for the induction of this gene. Similarly, RUNX1 binding of these Zbtb16 intronic sites 
is important for the regulation of this gene 30. In this current study, both PGR and RUNX1 were 
found to bind these locations in granulosa cells. Further investigations into the expression and 
function of Zbtb16 in ovulation might identify it as a novel ovarian transcription factor.  
 
Analysis of the differences in isoform-specific transcriptomes have clearly shown that PGR-A 
and PGR-B regulated two isoform-specific interactomes, implying the existence of distinct 
mechanisms employed by the two isoforms. So far, the lack of ChIP-grade antibodies that are 
specific to either isoform means that differences in the chromatin binding properties of PGR-
A and PGR-B cannot be detected through conventional ChIP. However, with the availability 
of isoform-specific knockout mouse models, such barriers can be overcome. Other indirect 
approaches, such as investigating the effect of PGR isoforms on chromatin accessibility 
through ATAC-seq, FAIRE-seq or ChIP-seq with histone markers, can also be utilised to 
further discern the significance of each isoform on a chromatin level. However, in support of 
the idea of isoform-specific transcription regulation, PGR-A and PGR-B have previously 
shown clear differences in binding preferences to other transcription factors, such as BTEB1 
and SRC 31, with consequences on downstream gene expression in vitro 32. However, such 
characteristics have not been portrayed in vivo; thus, experiments designed to explore isoform-
specific interactions in an in vivo settings using immuno-based protein capture or proximity 
ligation assays on granulosa cells expressing specific isoforms will be crucial in determining 
any differences in PGR-A and PGR-B co-binding partners. As each of PGR isoforms does not 
solely act independently from one another but can act cooperatively in the form of a 
heterodimer to regulate gene expression, it is also important to consider differences in the 
characteristics of PGR heterodimer vs homodimers and their implications on downstream gene 
expression. In such cases, a transgenic model in which heterodimerisation or homodimerisation 
is enforced, for example through the transfection of a chimeric construct bearing the sequence 
for both PGR-A and PGR-B on the same construct, would help in dissecting the role of each 





While the importance of lncRNA is the focus for many recent exciting studies, there is still 
very little known about their roles in ovulation and only a handful of lncRNA has been 
characterised in detail. Many ncRNA, including lncRNA, are transcribed from introns or the 
complementary strand of a protein-coding gene 33 and are thus often overlooked as a by-product 
of the transcription or splicing events. As ncRNA are often lowly transcribed in cells, yet at the 
same time can still exert important regulatory roles, the conventional method of RNA-seq 
analysis is often unable to discern differential expression patterns of ncRNA. Despite this, a 
number of ncRNA-encoded genes were identified in these datasets. This includes several 
antisense transcripts as well as Rny1 and Rmst, which are virtually unknown to the ovulation 
process. Since none of these ncRNA has been described in detail, especially in the ovary, it is 
unknown whether they play a role in ovulation. The scope of lncRNA involvement in ovulation 
will need to be investigated in further detail, specifically through RNA-seq analysis using 
specific ncRNA-oriented workflow. Conversely, PGR was also found to interact with lncRNA 
(i.e. Sra1, Gas5) in response to the LH surge, suggesting that lncRNA plays a role in regulating 
PGR function in granulosa cells. As this was largely an exploratory study limited to ncRNA 
with known PGR binding capability, the breadth of the PGR ncRNA interactome largely 
remains a mystery. Experimental designs that are more high-throughput, such as RIP-seq, 
would be necessary to uncover the degree of ncRNA action in regulating PGR as well as other 
transcription factors during ovulation. 
 
Overall, through detailed investigation into different aspects of PGR action, including the PGR-
regulated cistrome and transcriptome as well as PGR interactome, a model for the PGR 
transcriptional complex has begun to be described. However, this is unlikely the complete 
picture of the PGR transcription complex in granulosa cells, with many other elements remains 
to be explored. To name a few – what other transcriptional modulators are components of this 
complex, including chromatin-binding transcription factors and non-chromatin binding 
regulators? What is the extent of lncRNA involvement in the regulation of PGR functions? Are 
there differences in the interactome of different PGR isoforms? The answering of these 
questions will require mixed approaches, such as high-throughput techniques looking at 
protein/RNA interactions (immunoprecipitation-mass spectrometry/sequencing) and 
chromatin conformation (ATAC-seq, Hi-C), as well as the utilisation of specific KO models of 
PGR, RUNX1 and other target genes. The generation of a large body of data also provides the 
opportunity for future studies into specific downstream target genes of PGR as well as PGR-




8.4 SIGNIFICANCE OF THIS STUDY 
In the ovary, PGR is an important key transcription factor that determines ovulation, the 
dysregulation of which is likely to contribute to the aetiology of anovulatory infertility, 
observed in various KO mouse models 1,18,19 as well as in human 34. In addition, PGR is also 
present throughout the female reproductive tract as well as non-reproductive tissues such as 
the brain 35, breast 36 and bone 37, where it plays various roles that are specific to the tissue 
context in response to hormones. As PGR acts in diverse organs throughout the body, 
alterations into PGR activities, either pathologically or artificially in hormone therapies for 
contraceptive or therapeutic purposes, can lead to unwanted, perhaps even dangerous, effects 
on other tissues. The effect of unphysiological  hormone actions is most prevalent in the field 
of female contraception, where synthetic oestrogens and progestins are administered as a means 
to repress gonadotropin production and thereby follicle development and ovulation 38. Such 
artificially elevated state of progestin level not only affects the target hypothalamic-pituitary-
ovarian axis and steroidogenesis pathway but can also affect other tissues that are highly 
responsive to progesterone, leading to an array of unwanted side-effects, including thrombosis, 
depression and an increased risk of breast 39 and cervical cancer 40. Progestins and oestrogens 
are also widely used in other therapeutic contexts, especially in the treatment of hormone-
responsive cancers, including breast and endometrial cancer, and also in managing menopausal 
symptoms. While reports on the correlation between hormone therapies and side-effects are 
largely inconclusive 41,42, a number of adverse effects such as thrombosis and breast cancer 
have been found to be associated with prolonged or high dosage of progestin usage in 
endometrial cancer treatment 43 and in menopausal hormone replacement therapy 44,45, 
respectively. Thus, it is important that different therapeutic approaches with minimised adverse 
effects can be devised, for which an understanding in the tissue-specific PGR pathways is 
required. 
 
This study presents the first description of the potential molecular mechanism employed by 
PGR in regulating gene expression that allows for specific functions in granulosa cells during 
ovulation. These insights into PGR action in granulosa cells deepen our understanding of 
tissue-specific mechanisms of PGR in ovulation, which can lead to novel replacements for 
current contraceptive methods, especially the development of contraceptives that can 
specifically block ovulation without these side-effects that often arise with hormone therapies. 




findings provide insight into new and efficient cancer therapeutics targeting specific 






1 Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. 
A., Jr., Shyamala, G., Conneely, O. M. & O'Malley, B. W. Mice lacking progesterone 
receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9, 2266-2278 
(1995). 
2 Gemzell-Danielsson, K., Berger, C. & P.G.L, L. Emergency contraception — 
mechanisms of action. Contraception 87, 300-308, 
doi:https://doi.org/10.1016/j.contraception.2012.08.021 (2013). 
3 Akison, L. & Robker, R. The Critical Roles of Progesterone Receptor (PGR) in 
Ovulation, Oocyte Developmental Competence and Oviductal Transport in 
Mammalian Reproduction. Reproduction in Domestic Animals 47, 288-296, 
doi:10.1111/j.1439-0531.2012.02088.x (2012). 
4 Doyle, K. M. H., Russell, D. L., Sriraman, V. & Richards, J. S. Coordinate 
Transcription of the ADAMTS-1 Gene by Luteinizing Hormone and Progesterone 
Receptor. Molecular Endocrinology 18, 2463-2478, doi:10.1210/me.2003-0380 
(2004). 
5 Jo, M. & Curry, T. E., Jr. Luteinizing Hormone-Induced RUNX1 Regulates the 
Expression of Genes in Granulosa Cells of Rat Periovulatory Follicles. Molecular 
Endocrinology 20, 2156-2172, doi:10.1210/me.2005-0512 (2006). 
6 Choi, Y., Rosewell, K. L., Brännström, M., Akin, J. W., Curry Jr, T. E. & Jo, M. FOS, 
a Critical Downstream Mediator of PGR and EGF Signaling Necessary for Ovulatory 
Prostaglandins in the Human Ovary. The Journal of Clinical Endocrinology & 
Metabolism 103, 4241-4252 (2018). 
7 Park, E.-S., Lind, A.-K., Dahm-Kähler, P., Brännström, M., Carletti, M. Z., 
Christenson, L. K., Curry, T. E., Jr. & Jo, M. RUNX2 Transcription Factor Regulates 
Gene Expression in Luteinizing Granulosa Cells of Rat Ovaries. Molecular 
Endocrinology 24, 846-858, doi:10.1210/me.2009-0392 (2010). 
8 Lee-Thacker, S., Choi, Y., Taniuchi, I., Takarada, T., Yoneda, Y., Ko, C. & Jo, M. Core 
binding factor β expression in ovarian granulosa cells is essential for female fertility. 
Endocrinology 159, 2094-2109 (2018). 
9 Duggavathi, R., Volle, D. H., Mataki, C., Antal, M. C., Messaddeq, N., Auwerx, J., 
Murphy, B. D. & Schoonjans, K. Liver receptor homolog 1 is essential for ovulation. 
Genes Dev 22, 1871-1876, doi:10.1101/gad.472008 (2008). 
10 Battaglia, R., Vento, M. E., Borzì, P., Ragusa, M., Barbagallo, D., Arena, D., Purrello, 
M. & Di Pietro, C. Non-coding RNAs in the Ovarian Follicle. Frontiers in Genetics 8, 
doi:10.3389/fgene.2017.00057 (2017). 
11 Nicol, B., Grimm, S. A., Chalmel, F., Lecluze, E., Pannetier, M., Pailhoux, E., Dupin-
De-Beyssat, E., Guiguen, Y., Capel, B. & Yao, H. H. C. RUNX1 maintains the identity 
of the fetal ovary through an interplay with FOXL2. Nature communications 10, 5116 
(2019). <https://doi.org/10.1038/s41467-019-13060-1>. 
12 Lanz, R. B., Razani, B., Goldberg, A. D. & O'Malley, B. W. Distinct RNA motifs are 
important for coactivation of steroid hormone receptors by steroid receptor RNA 
activator (SRA). Proceedings of the National Academy of Sciences 99, 16081-16086, 
doi:10.1073/pnas.192571399 (2002). 
13 Kino, T., Hurt, D. E., Ichijo, T., Nader, N. & Chrousos, G. P. Noncoding RNA gas5 is 
a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci 
Signal 3, 2000568 (2010). 
14 Yerushalmi, G. M., Salmon-Divon, M., Yung, Y., Maman, E., Kedem, A., Ophir, L., 




Hourvitz, A. Characterization of the human cumulus cell transcriptome during final 
follicular maturation and ovulation. Molecular Human Reproduction 20, 719-735, 
doi:10.1093/molehr/gau031 (2014). 
15 Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H. & Chambon, 
P. Two distinct estrogen-regulated promoters generate transcripts encoding the two 
functionally different human progesterone receptor forms A and B. The EMBO Journal 
9, 1603-1614, doi:10.1002/j.1460-2075.1990.tb08280.x (1990). 
16 Abdel-Hafiz, H., Takimoto, G. S., Tung, L. & Horwitz, K. B. The Inhibitory Function 
in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate 
Autoinhibition and Transrepression. Journal of Biological Chemistry 277, 33950-
33956, doi:10.1074/jbc.M204573200 (2002). 
17 Li, X. & O'Malley, B. W. Unfolding the Action of Progesterone Receptors. Journal of 
Biological Chemistry 278, 39261-39264, doi:10.1074/jbc.R300024200 (2003). 
18 Mulac-Jericevic, B., Lydon, J. P., DeMayo, F. J. & Conneely, O. M. Defective 
mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. 
Proceedings of the National Academy of Sciences 100, 9744-9749, 
doi:10.1073/pnas.1732707100 (2003). 
19 Mulac-Jericevic, B., Mullinax, R. A., DeMayo, F. J., Lydon, J. P. & Conneely, O. M. 
Subgroup of Reproductive Functions of Progesterone Mediated by Progesterone 
Receptor-B Isoform. Science 289, 1751-1754, doi:10.1126/science.289.5485.1751 
(2000). 
20 Subtil-Rodríguez, A., Millán-Ariño, L., Quiles, I., Ballaré, C., Beato, M. & Jordan, A. 
Progesterone Induction of the 11β-Hydroxysteroid Dehydrogenase Type 2 Promoter in 
Breast Cancer Cells Involves Coordinated Recruitment of STAT5A and Progesterone 
Receptor to a Distal Enhancer and Polymerase Tracking. Molecular and cellular 
biology 28, 3830-3849, doi:10.1128/mcb.01217-07 (2008). 
21 Buser, A. C., Obr, A. E., Kabotyanski, E. B., Grimm, S. L., Rosen, J. M. & Edwards, 
D. P. Progesterone Receptor Directly Inhibits β-Casein Gene Transcription in 
Mammary Epithelial Cells Through Promoting Promoter and Enhancer Repressive 
Chromatin Modifications. Molecular Endocrinology 25, 955-968, 
doi:10.1210/me.2011-0064 (2011). 
22 Nora, E. P., Goloborodko, A., Valton, A.-L., Gibcus, J. H., Uebersohn, A., Abdennur, 
N., Dekker, J., Mirny, L. A. & Bruneau, B. G. Targeted Degradation of CTCF 
Decouples Local Insulation of Chromosome Domains from Genomic 
Compartmentalization. Cell 169, 930-944.e922, 
doi:https://doi.org/10.1016/j.cell.2017.05.004 (2017). 
23 Fournier, M., Bourriquen, G., Lamaze, F. C., Côté, M. C., Fournier, É., Joly-
Beauparlant, C., Caron, V., Gobeil, S., Droit, A. & Bilodeau, S. FOXA and master 
transcription factors recruit Mediator and Cohesin to the core transcriptional regulatory 
circuitry of cancer cells. Scientific Reports 6, 34962, doi:10.1038/srep34962 (2016). 
24 Oakford, P. C., James, S. R., Qadi, A., West, A. C., Ray, S. N., Bert, A. G., Cockerill, 
P. N. & Holloway, A. F. Transcriptional and epigenetic regulation of the GM-CSF 
promoter by RUNX1. Leukemia Research 34, 1203-1213, 
doi:https://doi.org/10.1016/j.leukres.2010.03.029 (2010). 
25 Aikawa, Y., Nguyen, L. A., Isono, K., Takakura, N., Tagata, Y., Schmitz, M. L., 
Koseki, H. & Kitabayashi, I. Roles of HIPK1 and HIPK2 in AML1- and p300-
dependent transcription, hematopoiesis and blood vessel formation. The EMBO journal 
25, 3955-3965, doi:10.1038/sj.emboj.7601273 (2006). 
26 Hager, G. L., McNally, J. G. & Misteli, T. Transcription Dynamics. Molecular Cell 35, 




27 Johansson-Haque, K., Palanichamy, E. & Okret, S. Stimulation of MAPK-phosphatase 
1 gene expression by glucocorticoids occurs through a tethering mechanism involving 
C/EBP. J Mol Endocrinol 41, 239-249 (2008). 
28 Sivakumaran, S., Zhang, J., Kelley, K. M. M., Gonit, M., Hao, H. & Ratnam, M. 
Androgen activation of the folate receptor α gene through partial tethering of the 
androgen receptor by C/EBPα. The Journal of Steroid Biochemistry and Molecular 
Biology 122, 333-340, doi:https://doi.org/10.1016/j.jsbmb.2010.08.008 (2010). 
29 Kommagani, R., Szwarc, M. M., Vasquez, Y. M., Peavey, M. C., Mazur, E. C., 
Gibbons, W. E., Lanz, R. B., DeMayo, F. J. & Lydon, J. P. The Promyelocytic 
Leukemia Zinc Finger Transcription Factor Is Critical for Human Endometrial Stromal 
Cell Decidualization. PLoS genetics 12, e1005937-e1005937, 
doi:10.1371/journal.pgen.1005937 (2016). 
30 Mao, A.-P., Ishizuka, I. E., Kasal, D. N., Mandal, M. & Bendelac, A. A shared Runx1-
bound Zbtb16 enhancer directs innate and innate-like lymphoid lineage development. 
Nature Communications 8, 863, doi:10.1038/s41467-017-00882-0 (2017). 
31 Scarpin, K. M., Graham, J. D., Mote, P. A. & Clarke, C. L. Progesterone Action in 
Human Tissues: Regulation by Progesterone Receptor (PR) Isoform Expression, 
Nuclear Positioning and Coregulator Expression. Nuclear Receptor Signaling 7, 
nrs.07009, doi:10.1621/nrs.07009 (2009). 
32 Zhang, X.-L., Zhang, D., Michel, F. J., Blum, J. L., Simmen, F. A. & Simmen, R. C. 
M. Selective Interactions of Krüppel-like Factor 9/Basic Transcription Element-
binding Protein with Progesterone Receptor Isoforms A and B Determine 
Transcriptional Activity of Progesterone-responsive Genes in Endometrial Epithelial 
Cells. Journal of Biological Chemistry 278, 21474-21482, 
doi:10.1074/jbc.M212098200 (2003). 
33 Rearick, D., Prakash, A., McSweeny, A., Shepard, S. S., Fedorova, L. & Fedorov, A. 
Critical association of ncRNA with introns. Nucleic acids research 39, 2357-2366, 
doi:10.1093/nar/gkq1080 (2011). 
34 Pisarska, M. D., Carson, S. A., Casson, P. R., Tong, X., Buster, J. E. & Kieback, D. G. 
A mutated progesterone receptor allele is more prevalent in unexplained infertility. 
Fertility and Sterility 80, 651-653, doi:10.1016/S0015-0282(03)00755-6 (2003). 
35 Acharya, K. D., Nettles, S. A., Sellers, K. J., Im, D. D., Harling, M., Pattanayak, C., 
Vardar-Ulu, D., Lichti, C. F., Huang, S., Edwards, D. P., Srivastava, D. P., Denner, L. 
& Tetel, M. J. The Progestin Receptor Interactome in the Female Mouse Hypothalamus: 
Interactions with Synaptic Proteins Are Isoform Specific and Ligand Dependent. 
eNeuro 4, ENEURO.0272-0217.2017, doi:10.1523/ENEURO.0272-17.2017 (2017). 
36 Obr, A. E. & Edwards, D. P. The biology of progesterone receptor in the normal 
mammary gland and in breast cancer. Molecular and cellular endocrinology 357, 4-17, 
doi:10.1016/j.mce.2011.10.030 (2012). 
37 Rickard, D. J., Iwaniec, U. T., Evans, G., Hefferan, T. E., Hunter, J. C., Waters, K. M., 
Lydon, J. P., O’Malley, B. W., Khosla, S., Spelsberg, T. C. & Turner, R. T. Bone 
Growth and Turnover in Progesterone Receptor Knockout Mice. Endocrinology 149, 
2383-2390, doi:10.1210/en.2007-1247 (2008). 
38 Frye, C. A. An overview of oral contraceptives: mechanism of action and clinical use. 
Neurology 66, S29-36, doi:10.1212/wnl.66.66_suppl_3.s29 (2006). 
39 Beaber, E. F., Buist, D. S. M., Barlow, W. E., Malone, K. E., Reed, S. D. & Li, C. I. 
Recent Oral Contraceptive Use by Formulation and Breast Cancer Risk among Women 





40 Vessey, M. & Painter, R. Oral contraceptive use and cancer. Findings in a large cohort 
study, 1968–2004. British Journal of Cancer 95, 385-389, doi:10.1038/sj.bjc.6603260 
(2006). 
41 Stanczyk, F. Z. & Bhavnani, B. R. Use of medroxyprogesterone acetate for hormone 
therapy in postmenopausal women: Is it safe? The Journal of Steroid Biochemistry and 
Molecular Biology 142, 30-38, doi:https://doi.org/10.1016/j.jsbmb.2013.11.011 
(2014). 
42 Hays, J., Ockene, J. K., Brunner, R. L., Kotchen, J. M., Manson, J. E., Patterson, R. E., 
Aragaki, A. K., Shumaker, S. A., Brzyski, R. G. & LaCroix, A. Z. Effects of estrogen 
plus progestin on health-related quality of life. New England Journal of Medicine 348, 
1839-1854 (2003). 
43 Lee, W.-L., Lee, F.-K., Su, W.-H., Tsui, K.-H., Kuo, C.-D., Hsieh, S.-L. E. & Wang, 
P.-H. Hormone therapy for younger patients with endometrial cancer. Taiwanese 
Journal of Obstetrics and Gynecology 51, 495-505, 
doi:https://doi.org/10.1016/j.tjog.2012.09.003 (2012). 
44 Rossouw, J. E., Anderson, G. L., Prentice, R. L., LaCroix, A. Z., Kooperberg, C., 
Stefanick, M. L., Jackson, R. D., Beresford, S. A. A., Howard, B. V., Johnson, K. C., 
Kotchen, J. M. & Ockene, J. Risks and benefits of estrogen plus progestin in healthy 
postmenopausal women: Principal results from the women's health initiative 
randomized controlled trial. Journal of the American Medical Association 288, 321-
333 (2002). 
45 Collaborators, M. W. S. Breast cancer and hormone-replacement therapy in the Million 







Appendix 1 List of primers used for qPCR, ChIP-qPCR and RIP-qPCR. 
Experiment Target qPCR chemistry Assay # / Primer sequence 
qPCR 
Cbfb Taqman Mm01251026_g1 
Pgr Taqman Mm00435628_m1 
Rpl19 Taqman Mm02601633_g1 
Runx1 Taqman Mm01213405_m1 
Runx2 Taqman Mm00501584_m1 
Runx3 Taqman Mm00490666_m1 
ChIP-qPCR 
Abhd2 SYBR Green Forward: TTG ACA CTC TGC CTC 
AGC AC 
Reverse: CAC CTT CCT GTG GAC 
TTC GT 
Adamts1 SYBR Green Forward: TGA GCT CAG TCG 
GTG CTA AA 
Reverse: CGC TGT ACA AAG TGC 
TGG TC 
Zbtb16 SYBR Green Forward: GCC AGA ACA ATG 
CGT ACA GA 




SYBR Green Forward: CCA GGG TTT GAC CTT 
CTG GAC A 




Gas5 (assay 21) Taqman Mm00657321_g1 
Gas5 (assay 22) Taqman Mm00657322_g1 
Gas5 (assay 23) Taqman Mm03456223_g1 
Oxct2 Taqman Mm00499041_s1 
Sra1 Taqman Mm00491756_m1 
U1 SYBR Green Forward: GGG AGA TAC CAT 
GAT CAC GAA GGT 
Reverse: CCA CAA ATT ATG CAG 





































RUNX1 Abcam ab23980 1/500 Synthetic human 

























Mouse LiCor 926-68020 1/10000 Fluorescence Goat Secondary 
antibody Rabbit LiCor 926-32211 1/10000 Fluorescence Goat 
 
Appendix 3 List of antibodies used in ChIP and RIP. 
Experiment Target Brand Catalogue # 
ChIP-seq 
PGR Santa Cruz Biotechnology Sc-7209 
H3K27ac Active Motif 39133 
RUNX1 In-house - 
ChIP-qPCR 
PGR  Thermo Fisher MA5-12568 
IgG Millipore CS200621 
RIP-qPCR 
SNRNP70 Millipore CS203216 
PGR  Thermo Fisher MA5-12568 




Appendix 4 Summary of ChIP-seq datasets, including library size, sequence length, alignment stats and peak counts 
 
















GC_PR1 42021574 75 95.18 40046280 30069719 75.09 31958 
GC_PR2 41045366 75 95.63 39298828 26271714 66.85 17582 
GC_H3K27ac 39025317 75 97.97 38279931 33628664 87.85 43937 
GC_input 45504914 75 97.61 44496459 40601755 91.25   
Uterus_oil 31584817 36 93.36 29492429 20987521 71.16 3004 
Uterus_p4 31419572 36 95.36 29965710 22856529 76.28 13240 
Uterus_input 36668321 36 99.17 36367487 34028853 93.57   
RUNX1_6h_1 37295205 75 95.54 35668132 25813506 72.37 18761 
RUNX1_6h_2 33899014 75 95.75 32487968 19944795 61.39 28671 
RUNX1_6h_input 35409268 75 97.71 34637522 32122534 92.74   
RUNX1_0h_1 34218195 75 95.25 33451268 20615995 61.63 3134 
RUNX1_0h_2 37130050 75 95.27 35652131 26013416 72.96 947 
RUNX1_0h_input 39783773 75 96.03 36916375 30169512 81.72   
RUNX1_E14.5_1 26252832 75 95.27 25063418 11532018 46.01 1561 
RUNX1_E14.5_2 29540852 75 95 28109185 18502338 65.82 4941 
RUNX1_E14.5_input_1 22604270 75 96.63 21899919 20730920 94.66   




Appendix 5 List of differentially expressed genes in PGRKO vs PGR+/- granulosa cells 
identified through microarray.  
Genes that had |logFC| ≥ 1 and a p-value cut-off of 0.01 were selected as DEG. LogFC is 
displayed as PGRKO vs PGR+/-. 
Gene Symbol logFC p-value Gene Symbol logFC  p-value 
Zbtb16 -13.7345 0.0003 Cd34 -2.6770 0.0001 
Slc7a11 -7.5591 0.0001 Ldhd -2.6442 0.0035 
Hsd17b11 -6.5212 0.0001 Adamts1 -2.5762 0.0019 
Tmem100 -5.3345 0.0028 Rbm35b -2.5681 0.0081 
Gpt2 -4.7675 0.0001 Stxbp6 -2.4634 0.0011 
Arl4d -4.3798 0.0025 Stard5 -2.4531 0.0013 
Sprr2g -4.0126 0.0006 9430020K01Rik -2.3975 0.0025 
Rnf125 -3.7550 0.0017 Susd3 -2.3737 0.0017 
Efnb2 -3.7175 0.0005 Lba1 -2.3663 0.0100 
Slco2a1 -3.6604 0.0099 Rras2 -2.3339 0.0001 
Gnao1 -3.6084 0.0028 Gstm1 -2.3326 0.0020 
Gas7 -3.5699 0.0008 Porcn -2.2888 0.0019 
Tbc1d8 -3.5541 0.0004 Lrp8 -2.2629 0.0088 
Cgn -3.5274 0.0014 Crispld2 -2.2351 0.0010 
Adam8 -3.4781 0.0001 Syne1 -2.1899 0.0055 
Cxcr4 -3.4756 0.0003 Pdlim1 -2.1859 0.0057 
Tdrkh -3.4170 0.0005 Pitpnc1 -2.1853 0.0041 
Snap25 -3.2078 0.0001 Rnf180 -2.1572 0.0036 
Entpd1 -3.1707 0.0001 Vps26a -2.1556 0.0008 
Lepr -3.0562 0.0091 Actn3 -2.1455 0.0011 
Maml3 -3.0398 0.0028 Hrbl -2.1182 0.0041 
Cldn1 -3.0150 0.0017 Dysf -2.0700 0.0051 
Kl -2.8830 0.0010 Fzd1 -2.0453 0.0006 
Glul -2.8799 0.0002 Apol7b -2.0430 0.0016 
Mt2 -2.8766 0.0060 Ccrk -2.0308 0.0003 
Nudt9 -2.8589 0.0062 Etl4 -2.0301 0.0089 
Mkx -2.8130 0.0017 Egfr -2.0191 0.0020 
Sphk1 -2.7980 0.0002 Dclre1b -2.0147 0.0027 
A230067G21Rik -2.7570 0.0014 Slc16a6 -2.0131 0.0019 
Abhd2 -2.7182 0.0005 Apol7b -2.0047 0.0014 
Glul -2.6955 0.0001 Rgmb 2.1630 0.0027 





Appendix 6 Reproducibility and correlation of PGR ChIP-seq replicates.  
(A) Scatter plot of signal scores, peak ranks and peak count based on estimated IDR for 
granulosa PGR ChIP-seq biological replicates. Log(signal) and peak rank are displayed as 
replicate 1 vs replicate 2. Peaks with IDR > 0.01 are in red and peaks with IDR ≤ 0.01 are in 
black. (B) Read count frequency of PGR ChIP-seq peaks in replicate 1 (dark orange) and 
replicate 2 (light orange) in relation to the TSS. (C) Pearson correlation matrix for replicate 1 
and replicate 2. The colour of matrix squares indicates correlation coefficient, noted in the bar 
at the bottom. (D) Venn diagram of peak count in both replicates, showing peaks that are 









Appendix 7 List of differentially expressed genes in 8h vs 0h post-hCG granulosa cells 
identified through RNA-seq.  
Genes that had |logFC| ≥ 1 and a p-value cut-off of 0.01 were selected as DEG. LogFC is 
displayed as 8h vs 0h. 
Gene logFC Adj p-value Gene logFC Adj p-value 
Pgr15L -5.45 3.91E-06 Tspan2 1.16 3.79E-04 
Atp4B -4.71 1.21E-05 Plcd1 1.17 2.71E-04 
1810053B23Rik -4.18 6.86E-04 Gem 1.17 2.58E-05 
Kcne2 -3.37 5.20E-05 Fras1 1.17 4.58E-04 
Ogdhl -3.32 5.08E-06 Klf15 1.17 6.95E-06 
Slco2B1 -3.25 9.36E-06 Pip5K1A 1.17 1.05E-05 
Gm830 -3.22 2.73E-04 Vim 1.17 3.96E-05 
Gm15635 -3.21 1.07E-04 Lrrc75A 1.17 7.27E-06 
Ccdc3 -3.19 8.97E-06 Frat1 1.17 1.16E-05 
4933436F18Rik -3.19 3.18E-04 Wdfy2 1.17 1.82E-04 
Serpina3C -3.18 4.46E-04 Tmem62 1.18 1.47E-05 
Gm26776 -3.18 1.01E-05 Sat1 1.18 8.18E-05 
Gm9515 -3.14 5.97E-05 Coch 1.18 1.74E-04 
Serpina3A -3.04 1.74E-04 Qpct 1.18 6.45E-04 
Tmem25 -2.91 5.65E-06 Phactr1 1.18 0.007539284 
Prph2 -2.89 5.93E-05 Ifrd1 1.18 1.54E-05 
Tmprss13 -2.88 8.83E-05 Gm5820 1.18 1.70E-05 
Mylk4 -2.87 2.89E-04 Ubtd1 1.18 7.01E-05 
St8Sia1 -2.79 5.59E-04 A330041J22Rik 1.18 1.51E-05 
Gpr179 -2.78 3.07E-05 Klhl2 1.18 7.05E-05 
P2Rx2 -2.78 1.41E-05 Pcdh18 1.18 9.08E-04 
1700030I03Rik -2.72 0.001285065 Fgf2 1.19 6.86E-05 
Adra2A -2.68 4.01E-06 Nfkbia 1.19 1.51E-05 
Ism2 -2.67 5.04E-04 Apbb3 1.19 1.64E-05 
Mug-Ps1 -2.66 3.90E-04 Mapk13 1.19 0.004468639 
Gm14085 -2.64 3.97E-06 Ptpn9 1.19 1.76E-05 
Large2 -2.63 5.59E-06 Setd7 1.19 3.59E-04 
Gm17641 -2.60 1.00E-04 4933425L06Rik 1.20 0.002847759 
Gprc6A -2.57 0.00194785 Tmem38B 1.20 4.16E-04 
Mmd2 -2.57 8.95E-06 Plau 1.20 0.003489281 
Asic4 -2.55 1.11E-05 Rundc3B 1.20 0.001290571 
Sybu -2.52 1.37E-04 Chst1 1.20 0.001824497 
Slfn4 -2.51 3.60E-04 Ston1 1.21 3.17E-04 
Tmem221 -2.51 5.11E-05 4931440P22Rik 1.21 7.25E-05 
Clec1A -2.50 1.30E-05 Mrfap1 1.21 5.83E-05 




Aifm3 -2.50 1.00E-05 Abtb2 1.21 1.03E-04 
Defb20 -2.50 0.001411865 Cdyl2 1.21 0.001574878 
Bc035044 -2.49 1.80E-05 Klhl36 1.21 8.78E-04 
Phyhip -2.47 3.52E-05 Vat1 1.21 1.02E-05 
Dock8 -2.45 7.41E-06 Fam83F 1.21 0.001689579 
Fndc5 -2.43 8.95E-05 Rnu2-10 1.21 0.001279607 
Nphs2 -2.43 1.47E-05 Cbr3 1.22 0.002981693 
Adgrg7 -2.43 2.63E-04 Heyl 1.22 2.77E-05 
Scgb3A1 -2.41 6.68E-05 Pip4K2A 1.22 0.001157224 
Gm37264 -2.41 9.64E-05 Fam78B 1.23 3.27E-05 
Ccbe1 -2.39 1.00E-06 Bfar 1.23 3.46E-06 
Gm45540 -2.39 3.57E-04 Arid3A 1.23 5.59E-04 
Emilin3 -2.38 1.52E-04 Bex1 1.23 1.33E-05 
Clec9A -2.37 5.15E-05 Ezr 1.23 3.52E-05 
Pipox -2.36 1.61E-05 Ugdh 1.23 4.45E-07 
Gm15816 -2.34 1.85E-05 Deptor 1.23 1.63E-04 
Gm4926 -2.33 3.72E-04 Fam110B 1.23 7.14E-04 
Olfm1 -2.32 1.07E-05 Gstm1 1.23 2.16E-04 
Dock2 -2.32 2.74E-05 B4Galt6 1.23 0.004769457 
Fam183B -2.32 6.13E-05 Arntl 1.23 1.08E-04 
Nppc -2.31 9.66E-04 Pygm 1.23 5.57E-04 
Gm10319 -2.31 2.88E-04 Map4K3 1.24 1.02E-04 
Gm12065 -2.31 5.43E-05 Spint1 1.24 1.50E-04 
Dapl1 -2.30 9.31E-04 Atp13A3 1.24 4.31E-04 
Fam178B -2.29 4.63E-04 Bcl6B 1.25 0.001854321 
Oca2 -2.29 3.89E-04 Gpr35 1.25 1.60E-04 
Cox4I2 -2.28 8.56E-05 Slc6A8 1.25 6.54E-06 
Fam196B -2.27 0.002117816 Map7D1 1.25 3.86E-05 
Tmem130 -2.27 3.29E-04 Actn1 1.25 1.48E-05 
Tmem52 -2.27 5.22E-06 Gpr153 1.25 0.005101659 
Gm18609 -2.27 1.76E-04 Add3 1.25 3.65E-04 
Ano1 -2.26 2.12E-05 Phip 1.25 8.78E-06 
Srcin1 -2.25 5.76E-06 2210408F21Rik 1.25 0.00850106 
Gja6 -2.25 1.25E-04 Ptn 1.25 0.00426192 
Ptges -2.24 4.82E-06 Spats2L 1.25 5.30E-05 
Hbegf -2.23 3.21E-05 Hspb8 1.25 1.54E-04 
Cbs -2.21 2.68E-06 Coq10B 1.25 4.25E-06 
Dnah2 -2.21 6.72E-05 Kcng3 1.26 0.003272843 
Car14 -2.21 6.04E-05 Tgfbr2 1.26 1.32E-05 
Gm45060 -2.21 1.10E-04 Slc41A2 1.26 1.93E-05 
Fam81A -2.21 5.39E-05 Serpinb1A 1.27 1.70E-05 




Bb365896 -2.20 1.70E-04 Rhbdf2 1.27 5.22E-06 
Ank1 -2.19 8.59E-06 Nrn1 1.27 5.04E-05 
Gm13944 -2.18 4.03E-04 Man2A1 1.27 4.12E-06 
Cela2A -2.17 6.39E-04 Lrrc4 1.27 2.80E-04 
Slc28A1 -2.17 3.13E-05 Zc3H12C 1.27 2.94E-06 
Efcab1 -2.17 1.01E-04 Vav2 1.27 3.02E-06 
Ankrd35 -2.17 8.14E-05 Itga7 1.28 0.006632074 
Slc13A4 -2.16 4.06E-04 Glis3 1.28 2.31E-04 
Alms1-Ps2 -2.16 2.56E-04 Cc2D1A 1.28 1.79E-04 
Adam5 -2.15 6.48E-05 Idi1 1.28 4.17E-06 
Slc5A4B -2.15 1.03E-04 Top1 1.29 2.76E-06 
Mybpc3 -2.15 1.53E-04 St6Gal1 1.29 8.56E-05 
Upk3A -2.14 3.80E-04 Cfap45 1.29 0.001504323 
Fxyd6 -2.14 9.76E-05 Fam214B 1.29 2.86E-04 
Serpina5 -2.14 8.06E-05 Fdps 1.29 2.55E-05 
H60B -2.13 4.34E-04 Chrd 1.29 0.002025125 
Rapsn -2.12 7.40E-05 Prkcdbp 1.29 0.001612037 
Hsd11B2 -2.12 4.71E-06 Epb41L3 1.29 0.003313947 
Paqr6 -2.10 1.41E-05 Midn 1.29 1.51E-05 
Drd4 -2.08 1.51E-04 H2-Q10 1.29 0.005738259 
Gm11638 -2.07 1.74E-05 Tns1 1.30 6.46E-04 
Nr0B1 -2.06 1.15E-04 Rhou 1.30 2.80E-04 
Cfap70 -2.06 9.42E-05 Zcchc16 1.30 2.51E-05 
Dhh -2.06 5.12E-05 Npas3 1.30 0.007655035 
1110002J07Rik -2.06 2.33E-04 1810011O10Rik 1.30 0.001367197 
Limch1 -2.06 7.82E-06 Prkx 1.30 4.91E-07 
  March10 -2.05 1.11E-05 Rusc2 1.30 0.002839731 
Pik3Cg -2.05 0.003123826 Zyx 1.30 4.31E-04 
Cnnm1 -2.05 4.53E-06 Avpi1 1.30 0.001283998 
Fabp3 -2.05 2.39E-05 Bcat1 1.31 8.71E-04 
 March1 -2.04 0.001509433 S1Pr1 1.31 0.004015118 
Gm36670 -2.04 0.002049851 Stk17B 1.31 4.22E-06 
Atp2A3 -2.03 1.71E-04 Dgkh 1.31 1.43E-05 
Ihh -2.03 4.52E-04 Ywhaz 1.31 1.05E-05 
Adam3 -2.03 4.72E-04 Hephl1 1.31 2.00E-05 
Gjc3 -2.03 0.001228419 Slc7A3 1.31 0.001937097 
Adhfe1 -2.03 2.60E-05 Spock3 1.32 4.64E-05 
Slc19A3 -2.02 3.08E-05 Aacs 1.32 1.82E-05 
Gm11611 -2.01 2.09E-05 Cnga1 1.32 9.32E-04 
Raet1D -2.00 5.39E-04 Pgap2 1.32 1.12E-05 
Mtcl1 -1.99 5.08E-06 Fndc1 1.32 9.36E-05 




Rassf2 -1.99 1.33E-04 Jazf1 1.32 0.001156616 
Tcp11X2 -1.99 7.97E-04 Camk4 1.32 8.19E-05 
1700007K13Rik -1.99 3.50E-04 1500017E21Rik 1.33 2.39E-04 
Flt4 -1.98 1.43E-05 Bzw1 1.33 9.16E-07 
Plxdc1 -1.98 5.35E-04 Trim46 1.33 0.002975589 
Mfsd7C -1.98 6.35E-06 Colec12 1.33 8.89E-04 
Bb218582 -1.98 1.59E-04 Epha4 1.33 0.0015131 
Aldh1A7 -1.98 1.26E-04 Inpp1 1.33 3.78E-06 
Scrn2 -1.98 2.88E-06 Itgb3 1.33 1.66E-04 
Smim10L2A -1.97 4.77E-05 Slc37A2 1.33 5.49E-05 
Alms1-Ps1 -1.97 0.001097512 Alpl 1.33 0.002431242 
Me3 -1.97 7.91E-06 Anxa2 1.33 2.31E-04 
Ciart -1.97 1.49E-04 Kdm4D 1.33 2.35E-04 
Icam4 -1.96 2.35E-04 Cd47 1.33 1.38E-05 
Gm10129 -1.96 5.47E-06 Gpc4 1.34 6.00E-05 
Apof -1.96 0.001001805 Pitrm1 1.34 5.24E-07 
Glb1L2 -1.96 7.67E-05 Vcl 1.34 4.71E-06 
Slc47A2 -1.95 9.36E-06 Tnfrsf21 1.34 9.73E-04 
Adamts5 -1.95 9.99E-06 Nin 1.34 4.22E-06 
Shisa6 -1.95 2.02E-05 Appl2 1.34 2.11E-05 
Dppa1 -1.94 8.18E-04 Kcnk5 1.34 2.65E-05 
Txk -1.94 1.77E-05 Usp18 1.34 0.006173675 
Aif1L -1.94 3.86E-05 Mvd 1.34 4.87E-05 
Sspn -1.93 1.35E-05 Dcaf4 1.34 0.00193989 
Gm15958 -1.93 1.16E-04 Tacc1 1.35 4.64E-05 
Dsp -1.93 6.40E-06 Ripk2 1.35 4.20E-06 
Myo15B -1.93 5.59E-06 Slc39A14 1.35 1.64E-05 
Nat8F3 -1.92 3.05E-04 Rhbdf1 1.35 7.91E-06 
Aldh3B1 -1.92 1.58E-05 Pde4B 1.35 2.18E-04 
Tex15 -1.92 1.64E-05 Sox11 1.35 3.15E-04 
D330045A20Rik -1.91 9.99E-05 Pla2G15 1.35 3.12E-05 
Trpv4 -1.91 4.10E-05 Dnajc6 1.35 0.001188876 
Fam234B -1.90 1.31E-05 Ate1 1.35 0.001129948 
Abca4 -1.89 2.84E-04 Endod1 1.35 3.50E-05 
Capn5 -1.89 5.91E-05 Plk2 1.35 9.29E-05 
Prss23Os -1.89 3.54E-05 Lgi2 1.35 0.0010021 
Gm13619 -1.89 5.26E-04 Tes 1.36 3.63E-06 
Csdc2 -1.89 4.47E-06 Slc3A2 1.36 3.02E-06 
Pm20D1 -1.88 9.02E-05 Tbl1Xr1 1.36 5.72E-06 
Gm38034 -1.87 1.46E-04 Pdlim5 1.36 9.18E-06 
Psd -1.87 0.001379085 Jarid2 1.36 8.67E-07 




Fkbp6 -1.87 1.99E-04 Zfp462 1.37 4.57E-06 
Gm30292 -1.87 5.93E-05 Dnah7A 1.37 3.92E-04 
Mro -1.87 2.30E-05 Ier5 1.37 1.48E-05 
Hsf3 -1.86 3.54E-05 A930001C03Rik 1.37 0.002196057 
P2Ry6 -1.86 1.38E-04 Tceal7 1.37 1.15E-04 
Efcab12 -1.86 1.70E-05 Msmo1 1.37 6.35E-06 
Apoc3 -1.86 3.08E-05 Tmeff1 1.37 3.44E-05 
Gm13442 -1.85 4.93E-05 Sorcs1 1.37 5.45E-04 
Adgrg1 -1.85 1.04E-04 Fam189A2 1.37 7.43E-04 
Hpgd -1.85 8.48E-06 Nhsl1 1.37 2.73E-04 
Tmem171 -1.85 3.11E-05 Tnip2 1.37 7.27E-06 
Lyrm9 -1.85 6.78E-05 Hk2 1.37 2.85E-06 
Prss23 -1.85 5.48E-05 Hmgcs1 1.37 2.14E-05 
G6Pc2 -1.85 0.005466033 Cnn3 1.37 5.33E-06 
B130011K05Rik -1.85 2.73E-04 Fzd9 1.37 0.005360215 
Ces2G -1.84 6.74E-04 Fam198B 1.38 3.65E-04 
Rec8 -1.84 2.09E-04 E130308A19Rik 1.38 2.06E-04 
Art4 -1.84 2.09E-06 Foxp1 1.38 5.18E-05 
Gm2044 -1.83 3.68E-04 Abi3 1.38 0.001158614 
Nat8 -1.83 0.001964124 Tmem144 1.38 9.92E-06 
Aox4 -1.83 8.36E-04 Map3K2 1.38 1.36E-06 
Thbs2 -1.82 9.65E-05 Cited2 1.38 3.48E-06 
Colgalt2 -1.81 0.001116162 Stxbp6 1.38 1.18E-04 
Syt13 -1.81 3.59E-04 Il10Ra 1.38 0.003684575 
Gm15512 -1.81 6.61E-05 Adam19 1.38 3.19E-05 
Carmil3 -1.81 2.54E-06 Cd24A 1.39 1.98E-04 
9330102E08Rik -1.81 5.95E-06 Rab6B 1.39 5.81E-04 
Dok2 -1.80 7.83E-05 Atf5 1.39 2.39E-05 
Gabra4 -1.80 0.00132886 Fam84A 1.39 1.77E-04 
Slc47A1 -1.80 4.30E-05 Map1A 1.40 7.21E-06 
Gm38059 -1.80 0.003001613 Fam131B 1.40 8.56E-05 
Sarm1 -1.80 3.52E-04 Hpse 1.40 2.47E-05 
Omd -1.80 6.30E-05 Ppcs 1.40 4.82E-06 
Fxyd1 -1.80 7.87E-05 Tjp2 1.40 3.83E-06 
Foxl2Os -1.80 1.03E-05 Cyp51 1.40 7.11E-06 
Gm9560 -1.80 1.66E-04 Ier2 1.40 0.00393738 
Aldh1B1 -1.79 4.34E-05 Cpne3 1.40 2.29E-07 
Arhgap22 -1.79 2.24E-05 Tmem198B 1.40 3.17E-05 
Gpr155 -1.79 1.61E-04 Il1R1 1.41 4.65E-06 
C230038L03Rik -1.79 8.39E-06 Mxi1 1.41 1.51E-05 
Rgs11 -1.79 2.06E-05 Cd63 1.41 9.66E-06 




Gm44913 -1.78 0.002885691 Arpc1B 1.41 6.81E-06 
Gm9801 -1.78 2.71E-04 Odc1 1.41 1.00E-05 
Cadm3 -1.78 4.39E-04 Pde4Dip 1.42 5.87E-06 
9530059O14Rik -1.78 7.28E-05 Rnu1A1 1.42 0.007897724 
Gm16282 -1.78 2.98E-04 Slc16A10 1.42 3.15E-05 
Gm26580 -1.77 0.002479011 Furin 1.42 5.35E-05 
Aqp8 -1.77 1.74E-04 Pcdh9 1.42 0.001954522 
Gm44386 -1.77 4.65E-04 Gm15471 1.43 3.60E-04 
Cacna1A -1.77 3.37E-04 Msantd3 1.43 3.26E-05 
4930452B06Rik -1.77 3.85E-05 Epb41L1 1.43 1.46E-06 
Grin2C -1.77 1.89E-06 Gm36569 1.43 6.98E-04 
Itih5 -1.77 0.001135826 Bicd1 1.43 9.18E-06 
Gm9961 -1.76 1.50E-04 Klhl29 1.43 0.001891385 
Phex -1.76 1.69E-04 Mlh1 1.43 1.60E-05 
Inhbb -1.76 6.72E-04 Dach2 1.43 8.27E-04 
Kcnq5 -1.76 1.61E-05 Rin1 1.44 0.002804753 
Gm2155 -1.76 8.35E-05 E130307A14Rik 1.44 2.40E-04 
Sec31B -1.76 3.30E-05 Pcdh11X 1.45 3.96E-04 
Cyp2S1 -1.75 1.32E-04 Kcnab1 1.45 1.35E-04 
Klf1 -1.75 8.56E-05 Hira 1.45 2.36E-05 
Cxxc4 -1.75 4.78E-05 Sorbs3 1.45 6.42E-05 
Ankrd63 -1.75 4.81E-04 Zdhhc23 1.45 1.25E-05 
Gm11653 -1.75 8.52E-04 Sorbs2 1.45 0.008490469 
Gper1 -1.75 2.03E-05 Vmp1 1.46 4.17E-06 
Cadps -1.75 1.68E-04 Rhoj 1.46 6.07E-04 
3110080E11Rik -1.75 0.005064643 Hs6St2 1.46 8.74E-06 
Il15 -1.74 6.30E-05 Rwdd2A 1.46 5.20E-04 
Tmie -1.74 1.57E-05 Dusp5 1.46 3.26E-05 
Sema7A -1.74 7.38E-05 Dgkk 1.46 4.64E-04 
Gm44409 -1.74 0.007386999 Brsk1 1.47 8.98E-05 
Derl3 -1.73 8.57E-07 Agpat9 1.47 3.82E-05 
Maneal -1.73 3.68E-04 Lrrc8C 1.47 0.001213797 
Gm5134 -1.73 8.12E-05 Tuba1C 1.47 4.20E-06 
Tenm4 -1.72 1.57E-05 Nkx6-2 1.47 4.44E-04 
Plxnc1 -1.72 3.11E-04 Slc16A13 1.47 7.11E-06 
Gm26660 -1.71 2.31E-04 Zfand5 1.48 1.04E-06 
Plin1 -1.71 3.00E-04 Tspan5 1.48 3.01E-05 
Gm36948 -1.71 0.001503974 Plekhg2 1.48 1.21E-05 
Rbm20 -1.71 1.24E-05 Lpin3 1.48 7.11E-06 
Pclo -1.71 9.89E-05 Cers6 1.48 1.45E-06 
Zfp185 -1.70 1.09E-05 Palld 1.48 2.94E-04 




Adam18 -1.70 1.13E-04 Tnr 1.48 0.002030627 
Dnph1 -1.70 6.51E-05 Myrf 1.48 2.51E-04 
Greb1L -1.70 6.24E-05 Asgr2 1.48 2.30E-04 
Aoc3 -1.69 0.004085145 Rnf19A 1.48 7.15E-06 
Epb41L4B -1.69 2.13E-05 Hectd2 1.48 2.44E-05 
Mycbpap -1.69 4.34E-05 Vapa 1.48 1.04E-06 
1810065E05Rik -1.68 5.38E-04 Tmem150B 1.49 3.25E-04 
Gm43088 -1.68 9.13E-05 Rhob 1.49 1.99E-04 
Gm10010 -1.68 0.001496503 Kdr 1.49 0.004719172 
9030617O03Rik -1.68 4.27E-06 Gda 1.50 2.10E-06 
Chst8 -1.68 1.83E-04 Cacnb2 1.50 0.00279867 
Akr1C14 -1.68 9.79E-04 Fcgr3 1.50 0.003462478 
Rgs3 -1.67 1.44E-05 Sh3Bp4 1.50 4.12E-06 
Prrg3 -1.67 7.26E-05 Pdlim1 1.50 3.58E-05 
Tnni3 -1.67 1.48E-04 Slc4A4 1.50 1.31E-04 
Spef2 -1.67 0.002854909 Zswim4 1.51 8.21E-05 
Grap2 -1.67 0.001139595 Casc1 1.51 7.39E-05 
D430019H16Rik -1.66 3.71E-05 6030408B16Rik 1.51 0.002364239 
Dnah2Os -1.66 1.59E-04 Mbnl1 1.51 4.13E-06 
Strip2 -1.66 1.56E-05 Arhgap32 1.51 8.65E-06 
Sspnos -1.66 2.04E-05 Nabp1 1.51 5.08E-06 
Gm45061 -1.66 1.52E-04 Bcl6 1.51 1.73E-05 
Nckap5 -1.66 6.25E-05 Aw551984 1.51 0.001066339 
Kirrel3Os -1.66 6.05E-04 Cntnap5B 1.51 3.24E-04 
Acacb -1.66 4.02E-05 Nfe2 1.51 0.001552375 
Gulo -1.65 2.74E-05 1500009L16Rik 1.51 4.77E-05 
Atp1B2 -1.65 2.94E-05 Lss 1.51 3.83E-06 
Angptl2 -1.65 7.11E-06 Nab1 1.51 4.39E-06 
Zfp385B -1.65 1.85E-05 Il17Ra 1.51 2.99E-06 
Sptbn5 -1.65 2.18E-04 Creb5 1.52 8.42E-04 
Gm16183 -1.64 0.002188914 Zfp36L1 1.52 1.13E-05 
Gm11652 -1.64 0.008315402 Aloxe3 1.52 0.007891551 
Tppp3 -1.64 5.32E-05 Pmepa1 1.52 2.01E-05 
Trib2 -1.64 9.57E-04 S1Pr3 1.52 2.75E-04 
Chrdl1 -1.64 1.20E-04 Hs3St1 1.52 2.05E-06 
Fam180A -1.64 1.07E-04 Spred2 1.53 4.12E-06 
Cyp27A1 -1.64 1.33E-04 Slco5A1 1.53 1.63E-04 
Grik3 -1.64 5.62E-06 Plcb4 1.53 6.68E-04 
Rgs6 -1.63 2.45E-05 4930483K19Rik 1.53 2.14E-05 
Eldr -1.63 1.49E-05 Tifa 1.53 2.11E-04 
Sct -1.62 0.002081995 Iah1 1.53 3.06E-06 




Siae -1.62 4.44E-05 Adgrv1 1.54 8.67E-05 
Rgs13 -1.62 1.28E-04 Shisa5 1.54 4.32E-06 
Alpk3 -1.61 1.01E-06 Cdc73 1.54 7.98E-05 
Ephx1 -1.61 4.11E-04 Echdc2 1.55 1.41E-04 
Abca9 -1.61 2.26E-04 Insig1 1.55 2.62E-06 
Glrb -1.61 4.43E-05 Ang 1.55 0.001321952 
Ly6G6D -1.61 0.001041243 Hmgn3 1.55 3.66E-05 
Dock9 -1.61 1.27E-04 Pawr 1.56 1.58E-05 
Cd59B -1.61 3.40E-04 Mocs1 1.56 0.0017965 
Kctd14 -1.60 4.34E-05 Kcnab3 1.56 0.001228253 
Fam13A -1.60 5.86E-04 Tcp11L2 1.56 0.003090432 
Smoc1 -1.60 1.41E-04 Fam129B 1.56 0.004635882 
Ddah1 -1.60 5.78E-05 Cln5 1.56 8.67E-07 
Gm15740 -1.60 0.002762767 Tle3 1.56 2.39E-05 
Fam19A4 -1.59 9.82E-04 Klf6 1.56 1.35E-04 
Tulp2 -1.59 0.001100992 Vgll3 1.56 3.58E-04 
Grem2 -1.59 0.006014387 Hr 1.57 8.45E-04 
2810030D12Rik -1.59 1.12E-04 Cfap69 1.57 5.75E-05 
Scn2A -1.59 4.35E-04 Id2 1.57 1.57E-04 
Rbfox3 -1.59 3.03E-04 Reep1 1.57 5.59E-06 
Efhc1 -1.59 4.48E-05 Rora 1.57 0.002647898 
Gm25837 -1.59 3.50E-05 Itga4 1.57 4.03E-04 
Hey2 -1.59 7.83E-05 Cyr61 1.57 0.001021827 
Eya2 -1.58 3.69E-05 Anxa11 1.57 4.78E-04 
Gm26892 -1.58 0.007774682 Dnah7C 1.57 3.06E-06 
Nme4 -1.58 9.64E-05 Mical1 1.58 1.03E-05 
Sugct -1.58 0.002390684 Dchs1 1.58 2.47E-04 
Foxo1 -1.57 2.58E-05 Rnf152 1.59 0.002018111 
Gm9747 -1.57 1.02E-04 Plpp3 1.59 2.03E-05 
Tmem231 -1.57 3.51E-06 Creb3 1.59 3.48E-06 
Slc25A35 -1.57 1.01E-05 Dlk1 1.59 6.07E-04 
Lgr6 -1.57 5.17E-04 Tead1 1.59 9.18E-06 
Fancd2Os -1.56 0.001203405 Gnao1 1.59 0.001342406 
A330094K24Rik -1.56 6.36E-05 Epas1 1.59 0.003346671 
Kank1 -1.56 2.39E-05 Sik1 1.59 1.79E-05 
D3Ertd751E -1.56 3.00E-05 Dyrk2 1.60 2.65E-05 
Syt7 -1.56 5.54E-04 Lsm11 1.60 3.62E-06 
Gm10489 -1.56 8.64E-04 Acy3 1.60 3.15E-04 
St3Gal4 -1.55 4.76E-04 Tuba8 1.61 0.002905168 
E330023G01Rik -1.55 9.46E-04 Cadm1 1.61 1.13E-05 
Lmntd2 -1.55 1.43E-04 Eva1C 1.61 8.38E-04 




Acad12 -1.55 1.91E-05 Kbtbd11 1.61 4.21E-04 
Tmem182 -1.55 1.10E-04 Shb 1.62 3.26E-04 
Gm39090 -1.55 0.005131948 Milr1 1.62 2.43E-04 
H3F3Aos -1.55 1.54E-04 Cpeb2 1.62 1.09E-05 
Fam198A -1.55 4.34E-04 Luzp2 1.62 2.98E-04 
Cyp19A1 -1.55 0.006189017 Fkbp1A 1.63 1.81E-06 
Pde11A -1.55 6.34E-05 Hdc 1.63 0.002582809 
Iigp1 -1.54 2.76E-04 9430020K01Rik 1.63 0.001376125 
Dcc -1.54 0.001223486 Pdlim7 1.63 5.14E-05 
Paqr8 -1.54 1.46E-04 Gm8216 1.63 0.004186573 
Rragb -1.54 8.22E-06 Ephx2 1.63 2.57E-06 
Gstt1 -1.54 3.24E-04 Pde10A 1.63 6.04E-05 
Bc064078 -1.54 1.26E-04 Nrp1 1.64 0.001160945 
Dsc2 -1.53 4.55E-04 Gm11427 1.64 1.15E-04 
Ifit2 -1.53 6.84E-05 Dusp1 1.64 0.00375423 
Dagla -1.53 1.01E-05 Ddx28 1.64 3.96E-06 
Gm26576 -1.53 0.001308271 Filip1 1.64 0.001552902 
Fam162B -1.53 0.005826405 Gm29054 1.64 6.19E-04 
Tmem45A -1.53 9.49E-04 Gm2427 1.65 2.10E-04 
Mctp1 -1.53 5.01E-05 Aa414768 1.65 2.39E-05 
Rmi2 -1.52 1.19E-04 Acly 1.65 5.12E-07 
Mylk3 -1.52 0.001658965 Ctps 1.65 1.08E-06 
Lrrc10B -1.52 8.79E-05 Atf3 1.65 8.60E-04 
Ntng1 -1.52 5.99E-04 Rab11Fip1 1.65 1.13E-05 
Dhrs3 -1.52 5.59E-06 Plekhh3 1.66 3.06E-06 
Gm2447 -1.52 7.16E-04 Cotl1 1.66 7.02E-06 
Slc25A18 -1.52 3.03E-06 Peak1Os 1.66 3.08E-04 
Aph1A -1.52 3.11E-05 Gm37784 1.66 2.08E-05 
Enpp5 -1.52 6.36E-05 Coro2B 1.66 0.003967384 
Sez6 -1.51 8.60E-04 Ddit4 1.66 4.21E-06 
Gm26794 -1.51 1.39E-04 Jdp2 1.66 1.49E-04 
Otof -1.51 5.12E-05 Mfsd6 1.67 1.04E-05 
Sdf2L1 -1.51 7.88E-05 Sh2B2 1.67 6.50E-04 
Gpha2 -1.51 2.07E-04 Sorl1 1.67 9.29E-05 
Slc17A9 -1.51 3.96E-05 Iqck 1.67 1.50E-04 
2610203C22Rik -1.50 0.003319656 Mast4 1.67 4.82E-05 
Hcn2 -1.50 1.15E-04 Kctd11 1.67 1.00E-06 
Gm15941 -1.50 8.51E-04 Nab2 1.67 4.18E-06 
Lims2 -1.50 9.54E-04 Gas7 1.68 0.001223972 
Magee2 -1.50 6.85E-04 Lncpint 1.68 0.007954862 
Ly6G6E -1.50 2.47E-04 Igsf3 1.68 1.95E-06 




Gm45607 -1.50 1.37E-04 Cd180 1.68 7.44E-05 
Steap3 -1.50 1.95E-05 Card19 1.68 3.99E-04 
Cyp2J9 -1.49 2.58E-05 Mis18A 1.68 4.17E-06 
Zdhhc1 -1.49 1.54E-06 Tpm4 1.68 2.75E-07 
Dpyd -1.49 1.81E-06 Sorbs2Os 1.68 0.007786702 
Otor -1.49 8.82E-04 Gm21814 1.69 1.36E-04 
Ccdc158 -1.49 1.51E-05 Pcdh17 1.69 1.52E-04 
Nrm -1.49 1.04E-05 Notch2 1.69 1.51E-05 
Kifc2 -1.49 6.81E-05 Zfp53 1.69 1.80E-05 
Gm29444 -1.48 1.68E-04 Eid2 1.69 4.06E-06 
Itpr2 -1.48 1.82E-06 Arf6 1.69 3.23E-07 
Cacna1D -1.48 1.49E-04 Sema3D 1.69 0.001293607 
Rhpn1 -1.48 6.60E-05 Gm13068 1.69 5.24E-05 
Kcnj3 -1.47 1.67E-04 Hspb1 1.70 0.006242778 
Irs1 -1.47 1.03E-04 1700108F19Rik 1.70 1.86E-04 
Sytl4 -1.47 3.96E-05 Akap2 1.70 0.00123745 
Gm37270 -1.47 0.00121693 Arhgef12 1.70 1.51E-05 
Adck5 -1.47 7.67E-05 Mgst1 1.70 6.74E-07 
Nceh1 -1.47 1.49E-05 Peak1 1.70 6.06E-06 
Nox4 -1.47 9.08E-04 Lgmn 1.70 1.32E-04 
Pcyt1B -1.47 5.44E-05 Gm45667 1.70 0.001642782 
3632451O06Rik -1.47 0.003431754 Sfrp4 1.70 6.39E-04 
Plcb2 -1.47 0.001871964 Rbm47 1.71 5.44E-05 
Nrep -1.46 1.21E-05 Hey1 1.71 5.88E-04 
9630013D21Rik -1.46 9.41E-04 Maff 1.72 3.06E-06 
Rimklb -1.46 8.22E-05 Slc25A30 1.72 1.51E-05 
Slc9A3 -1.46 6.11E-04 Gm42538 1.72 3.91E-06 
Dhtkd1 -1.45 2.03E-05 Angptl4 1.72 1.25E-04 
Tspan18 -1.45 6.35E-06 A530013C23Rik 1.72 9.13E-05 
Tmtc4 -1.45 1.65E-05 Zcchc12 1.72 2.03E-04 
Pdk1 -1.45 5.83E-05 Gfra1 1.72 3.07E-05 
Dok7 -1.44 1.54E-05 Dock10 1.73 1.38E-05 
Zbtb8B -1.44 1.33E-05 Gpr85 1.73 5.44E-05 
Agbl3 -1.44 1.51E-05 Luzp1 1.73 1.19E-06 
Gm28175 -1.44 3.07E-04 Rgs2 1.73 5.27E-07 
Clmp -1.44 2.93E-04 Sntb1 1.74 5.56E-04 
Hnmt -1.44 2.88E-04 Ptpro 1.74 0.001474322 
Tram2 -1.44 1.10E-04 Ndrg1 1.74 1.04E-04 
D130017N08Rik -1.44 2.22E-04 Ggct 1.74 7.50E-06 
Atp5S -1.44 5.89E-05 Epha2 1.74 0.004694183 
Gpr165 -1.44 4.78E-04 Ptk2B 1.75 2.62E-04 




Gm28221 -1.44 3.03E-04 S100A10 1.75 1.64E-05 
Slc2A5 -1.43 6.43E-04 Col4A1 1.75 2.05E-04 
Evc -1.43 3.96E-06 Zfp189 1.75 6.74E-07 
Atf7Ip2 -1.43 2.95E-04 Edn1 1.76 0.00520389 
Epha8 -1.43 0.001221517 Zfp948 1.76 3.21E-06 
Gm26859 -1.43 2.50E-04 Gm37335 1.76 8.58E-06 
Akr1C13 -1.43 1.23E-04 Tgfb1 1.76 5.08E-06 
Neu3 -1.43 4.17E-06 Rras2 1.76 2.55E-05 
Bmpr1B -1.43 2.71E-04 Rnf128 1.76 1.46E-06 
Gm45650 -1.42 0.004907226 Dram1 1.76 4.47E-05 
Fuca2 -1.42 1.92E-04 Irf2Bpl 1.76 7.97E-06 
Neurl1B -1.42 1.88E-04 Prox1 1.77 1.21E-04 
Cd82 -1.42 3.92E-05 Zfp13 1.77 1.60E-05 
Cd7 -1.42 5.93E-04 Cd44 1.77 7.99E-05 
Echdc3 -1.42 8.93E-06 Gm15511 1.77 0.008071149 
Stra6 -1.42 1.77E-04 Nudt9 1.77 1.52E-04 
A430018G15Rik -1.42 2.57E-04 Camk2N2 1.77 1.90E-04 
Mccc2 -1.42 4.12E-06 4930517G19Rik 1.77 0.001217213 
Amdhd1 -1.42 3.65E-04 Pde4D 1.78 2.59E-05 
Osr2 -1.42 9.20E-04 Fetub 1.78 1.90E-07 
Vmn2R9 -1.41 0.005067543 Gm33023 1.78 5.56E-05 
Nat8F4 -1.41 4.20E-06 Mrgpre 1.78 2.35E-04 
Gm13571 -1.41 0.001109251 Itgax 1.78 1.29E-04 
Cryl1 -1.41 1.40E-05 Dnaja4 1.78 1.10E-05 
Gsg1L -1.41 1.21E-04 Kif5A 1.79 1.60E-04 
Tmem220 -1.41 2.21E-04 Igfbp3 1.79 0.001756423 
Isoc2B -1.41 7.38E-05 Itgb1Bp1 1.79 1.58E-05 
Syt9 -1.41 0.00123148 Klf13 1.79 1.22E-05 
Slc38A5 -1.41 1.88E-04 Rubcnl 1.79 6.08E-04 
Mansc1 -1.40 3.81E-06 Efhd1Os 1.79 0.009932081 
Kcnh2 -1.40 1.98E-04 Arid5A 1.79 2.33E-04 
Lzts1 -1.40 1.29E-04 Gm20186 1.80 1.01E-05 
Spata18 -1.40 5.50E-04 Zfp354B 1.80 7.05E-05 
Clybl -1.40 1.85E-05 Gm15645 1.80 2.41E-04 
Gm12473 -1.40 6.23E-05 Wnk4 1.80 2.53E-04 
Aire -1.40 1.96E-04 Lrrfip1 1.80 6.78E-05 
Khk -1.40 4.29E-05 Slc25A33 1.80 5.08E-06 
Mycl -1.40 3.04E-04 Arid5B 1.81 1.19E-05 
Bc067074 -1.39 7.59E-04 Boc 1.81 1.63E-05 
Caskin1 -1.39 3.05E-05 Mgp 1.81 1.25E-04 
Slc27A1 -1.39 8.93E-06 Gclc 1.81 3.90E-07 




Wdr31 -1.39 1.05E-04 Syt12 1.81 5.93E-04 
Plekhd1Os -1.38 2.37E-04 Hs6St1 1.81 5.59E-06 
Aw549542 -1.38 5.17E-04 Slc35E4 1.82 3.50E-05 
Npr2 -1.38 1.97E-04 Kcnk6 1.82 5.71E-04 
Gm37459 -1.38 0.005861513 Lpar1 1.82 1.51E-05 
Folr1 -1.38 4.68E-04 Lypd6B 1.83 1.76E-04 
Dcaf12L1 -1.38 2.14E-05 Gm26586 1.83 2.29E-07 
Gm20402 -1.38 1.70E-05 Chsy3 1.83 4.10E-05 
Fshr -1.38 2.68E-06 Sertad1 1.83 6.35E-06 
Eri3 -1.38 9.36E-06 Frat2 1.83 1.88E-05 
Cep83Os -1.38 6.74E-05 D430041D05Rik 1.84 0.008437018 
Duox2 -1.38 0.001829747 Cytip 1.84 0.001776843 
4930480K23Rik -1.38 7.94E-05 Rnu5G 1.84 1.85E-04 
Zmym6 -1.38 2.52E-06 Smarca1 1.84 1.31E-05 
Cyfip2 -1.37 3.59E-05 Sav1 1.84 9.63E-06 
Csrnp3 -1.37 1.26E-04 Sipa1L2 1.84 6.14E-06 
Naglu -1.37 0.001534467 Gm16192 1.85 4.11E-04 
Adamts12 -1.37 6.04E-04 Gli3 1.85 7.29E-06 
Astn1 -1.37 0.002140513 Sstr3 1.85 0.0033641 
Syp -1.37 1.51E-04 Enpp1 1.85 5.28E-06 
Arhgef28 -1.37 3.70E-05 Klf12 1.85 0.001653798 
Stox1 -1.37 9.65E-04 Gtdc1 1.85 7.11E-06 
Tln2 -1.37 1.19E-05 Aqp11 1.86 0.00289988 
Myo5C -1.36 4.53E-06 1700099I09Rik 1.86 2.68E-04 
Abhd3 -1.36 2.16E-04 Ybx1 1.86 6.74E-07 
Kirrel3 -1.36 0.002731864 Anxa11Os 1.86 0.001202137 
Tmem14A -1.36 7.03E-05 Dusp8 1.87 1.10E-04 
Prkdc -1.36 6.27E-06 Cobll1 1.87 3.19E-07 
Fam234A -1.36 0.001063501 Mb 1.87 0.007263376 
Katnal2 -1.36 4.45E-04 Abca1 1.87 7.97E-06 
Dixdc1 -1.36 8.68E-05 Osgin1 1.87 1.07E-04 
4930581F22Rik -1.36 2.73E-04 Zfp423 1.88 9.89E-05 
Gm26723 -1.35 3.27E-05 Gadd45B 1.88 2.62E-05 
Slc12A7 -1.35 3.53E-05 Napepld 1.88 5.08E-06 
Ncald -1.35 8.74E-06 Gm16229 1.88 6.54E-06 
Pde8B -1.35 6.39E-05 Fignl2 1.88 1.46E-04 
Zdhhc15 -1.35 3.80E-05 Stard5 1.89 0.002648517 
Tanc2 -1.35 5.62E-05 Slc6A6 1.89 2.18E-06 
Fcgr2B -1.35 0.001269966 Gm38484 1.89 3.00E-05 
Gm15735 -1.35 8.64E-05 Galnt3 1.90 4.38E-04 
Npb -1.35 1.98E-04 Gm14052 1.90 0.003841943 




Bc043934 -1.35 5.45E-05 Nrxn1 1.90 4.43E-04 
Psd4 -1.35 5.65E-05 Tnfrsf23 1.91 1.21E-04 
Tdrd5 -1.35 3.36E-05 Col4A2 1.91 1.04E-04 
Rapgef4Os1 -1.34 1.48E-04 Scd1 1.91 5.25E-06 
Tmem206 -1.34 5.35E-04 Sgk1 1.91 5.49E-04 
Sod3 -1.34 9.67E-04 Adm 1.92 0.002956144 
Agtr2 -1.34 3.22E-04 Ncs1 1.92 1.33E-05 
Unc93B1 -1.34 1.75E-05 Gprc5B 1.92 1.61E-05 
Nav2 -1.34 8.12E-05 Crem 1.92 3.05E-05 
Rassf4 -1.34 1.73E-05 Lmna 1.93 8.91E-05 
Smpdl3B -1.34 4.21E-04 Gm45838 1.93 4.32E-04 
Dock5 -1.34 0.001871936 Irak2 1.93 7.55E-04 
Foxq1 -1.34 0.002310483 Ppp1R13B 1.93 2.29E-07 
Nubpl -1.34 9.73E-05 Junb 1.94 0.001806731 
Fhl1 -1.34 5.61E-05 Zfp786 1.94 2.74E-04 
Zfr2 -1.34 1.64E-05 Ttc39C 1.95 4.17E-06 
Lypd6 -1.33 0.006595882 Parp8 1.95 4.02E-07 
Tecta -1.33 0.002812197 Cblb 1.95 4.91E-07 
Syt14 -1.33 1.38E-05 Hgf 1.96 0.004529303 
Pak3 -1.33 6.58E-05 Cgn 1.96 1.05E-04 
5430419D17Rik -1.33 0.002394733 Tmem255A 1.96 2.15E-05 
Inhba -1.33 0.002950285 Gm15684 1.96 0.002158475 
Rab3Il1 -1.33 2.97E-05 Efs 1.96 6.58E-04 
Gm20629 -1.33 0.003528883 Hs3St5 1.97 8.34E-05 
Snapc5 -1.33 1.37E-05 Fdx1 1.97 2.29E-07 
Slc35G1 -1.33 1.23E-04 Parp16 1.97 1.27E-04 
Gstz1 -1.32 1.07E-05 Tubb6 1.97 1.61E-06 
Nek10 -1.32 0.001306077 Pla1A 1.97 6.74E-07 
Bphl -1.32 2.24E-05 Dtnb 1.97 1.67E-04 
Nemp2 -1.32 1.58E-05 Kcnk2 1.98 3.07E-05 
Abcc3 -1.32 2.00E-05 Slc16A11 1.98 2.28E-04 
Kif26A -1.32 1.66E-05 Mt1 1.98 5.33E-06 
Pm20D2 -1.32 3.71E-04 Pcsk6 1.98 1.67E-06 
Uba7 -1.32 1.34E-04 Ramp2 1.98 1.76E-04 
Gas6 -1.32 0.002378226 Entpd7 1.99 1.31E-06 
Pde9A -1.32 5.17E-05 Adamts1 1.99 2.12E-05 
Mir130C -1.32 3.42E-04 Gm15419 1.99 1.05E-04 
Mboat1 -1.32 3.59E-05 Gm45719 2.00 0.00236821 
Loc102640772 -1.32 3.86E-04 Gabra5 2.00 2.04E-04 
Ly75 -1.31 5.64E-05 Lrp8 2.00 5.08E-06 
Idua -1.31 7.11E-06 Synj2 2.00 2.16E-04 




Metrn -1.31 8.96E-06 0610040F04Rik 2.00 1.41E-05 
Ctsh -1.31 3.05E-04 Slc8B1 2.00 1.55E-04 
Nlrc5 -1.31 2.97E-05 Slc23A2 2.00 1.82E-06 
Sil1 -1.31 5.83E-05 1700017B05Rik 2.01 1.51E-06 
Relt -1.31 1.89E-05 Glp2R 2.01 0.008027756 
G0S2 -1.31 6.46E-04 Ccdc160 2.01 1.44E-06 
Foxred2 -1.31 3.30E-06 Gm15473 2.01 8.31E-05 
4930502E18Rik -1.30 1.22E-04 Baz1A 2.01 8.67E-07 
Gm42600 -1.30 8.00E-04 Ostf1 2.01 1.00E-04 
Zfp808 -1.30 7.94E-05 Klc1 2.01 8.93E-06 
Pfkm -1.30 1.31E-05 Gm16092 2.02 1.38E-04 
Cd59A -1.30 0.001622232 Vstm5 2.02 0.002221257 
Susd1 -1.29 1.88E-04 Map6 2.03 1.74E-04 
Lrrc48 -1.29 6.51E-05 Slit2 2.03 1.10E-04 
Myocd -1.29 3.02E-04 Lrrk2 2.03 7.24E-06 
Tmem260 -1.29 6.37E-05 Cd34 2.04 3.44E-07 
Mfsd2A -1.29 0.00100425 Tex30 2.04 4.08E-07 
Gm15401 -1.29 3.44E-05 Heg1 2.05 1.86E-04 
Gm43581 -1.29 0.002399536 Bc100451 2.06 0.005133448 
Kyat3 -1.29 8.39E-05 Rab7B 2.06 4.60E-06 
Rab19 -1.29 0.002183685 Gm28592 2.06 1.89E-05 
Morn2 -1.29 2.13E-05 Ttc9 2.06 8.95E-06 
Cdca7L -1.29 2.50E-05 Msi1 2.06 1.19E-06 
Bbs10 -1.28 9.15E-05 Rbp4 2.06 0.00361678 
Gm38402 -1.28 0.001105049 Per1 2.06 1.56E-05 
Zfp934 -1.28 3.16E-04 Osmr 2.07 2.63E-04 
Tmem229B -1.28 1.32E-04 Corin 2.07 2.83E-04 
Hoga1 -1.28 3.53E-04 Mbp 2.07 0.001014265 
Iqgap2 -1.28 2.78E-04 Vcan 2.07 1.81E-06 
Sardhos -1.28 1.25E-04 Wbp1L 2.07 4.36E-06 
Vstm4 -1.28 1.36E-04 Sytl5 2.07 5.02E-04 
Fbp1 -1.28 3.35E-04 Ramp1 2.07 0.001756966 
Gm27196 -1.28 1.57E-04 Gm15543 2.07 5.65E-06 
Tmem117 -1.27 7.34E-05 Zpr1 2.08 2.15E-05 
Gm6277 -1.27 1.20E-04 Osbpl3 2.08 1.82E-06 
Qsox2 -1.27 2.11E-04 Nhsl2 2.08 8.66E-04 
Gm14048 -1.27 2.46E-04 Bcl11B 2.10 0.009396127 
Pir -1.27 3.13E-04 Il7 2.10 2.64E-05 
Gm4890 -1.27 9.51E-05 6530402F18Rik 2.10 5.16E-04 
Acad10 -1.27 1.99E-04 Gm27252 2.10 2.75E-04 
Wnt5B -1.26 3.96E-04 Adgrl2 2.10 3.11E-05 




Pak6 -1.26 1.75E-04 Tex16 2.11 9.51E-04 
Extl1 -1.26 8.54E-04 Prkar1B 2.11 4.85E-05 
Fcgrt -1.26 4.09E-04 Gas2L1 2.11 1.05E-05 
Exoc3L -1.26 1.18E-04 Gm15475 2.12 7.01E-04 
Gm3704 -1.26 0.001113917 Phlda1 2.12 4.59E-05 
Dynap -1.26 5.04E-04 Fgf12 2.12 2.01E-04 
Gm37969 -1.26 4.61E-04 Trf 2.12 8.39E-06 
Coq8A -1.26 3.46E-05 Zpld1 2.12 8.25E-07 
Gm11832 -1.25 0.004764623 Prr16 2.12 2.34E-04 
Rasgrp4 -1.25 8.92E-05 Gm15856 2.12 0.002329315 
Tbc1D4 -1.25 4.08E-05 Trpc5 2.12 9.73E-06 
Gm38910 -1.25 4.26E-04 D16Ertd472E 2.13 3.83E-06 
Hdac11 -1.25 4.00E-04 Dtnbos 2.13 0.002977447 
Pik3Ip1 -1.25 2.68E-04 Tnfrsf8 2.14 2.90E-04 
Cntln -1.25 5.59E-06 Gm16897 2.14 1.58E-06 
Sh3D21 -1.25 0.001233457 Mgam 2.14 2.66E-04 
Arsg -1.25 1.55E-05 Stc1 2.15 0.00338419 
Gng7 -1.25 9.66E-04 Aqp2 2.15 0.002492321 
Ptprd -1.25 2.39E-05 Sytl3 2.15 1.63E-05 
Mef2C -1.25 6.13E-05 Gm13477 2.15 0.001346394 
Lrrc8D -1.25 1.55E-05 Agfg2 2.16 4.60E-06 
Plekhd1 -1.24 1.72E-05 Pfkfb4 2.16 1.51E-05 
Pomt1 -1.24 2.28E-04 Gm11560 2.17 5.12E-05 
Spice1 -1.24 6.37E-05 Atp4A 2.17 3.38E-04 
Gm44238 -1.24 9.21E-04 Arhgdib 2.17 0.00119038 
Epn2 -1.24 9.18E-06 Gm43031 2.17 6.40E-06 
Gm43189 -1.24 0.006799834 Clec10A 2.17 8.64E-04 
Antxr1 -1.24 2.55E-05 Hmgcll1 2.17 1.81E-04 
Phactr2 -1.24 2.39E-05 Tbc1D8 2.19 5.61E-05 
Sardh -1.24 4.08E-05 Klf9 2.19 4.08E-05 
Slc38A3 -1.24 7.79E-04 Piezo2 2.19 1.61E-05 
Map3K5 -1.24 8.97E-05 Prkca 2.19 2.40E-07 
1700020G17Rik -1.24 4.74E-04 Bhlhe40 2.19 4.62E-06 
Fggy -1.24 9.29E-05 Tmsb4X 2.20 4.00E-05 
Gm42303 -1.23 1.65E-04 Frmd5 2.21 1.22E-06 
Gm16425 -1.23 0.003990649 Vcpkmt 2.21 4.84E-07 
Mfsd7A -1.23 6.48E-05 Nr4A1 2.21 7.11E-06 
Slc16A1 -1.23 0.00246134 Sgtb 2.21 9.99E-07 
Clec2L -1.23 7.06E-04 9330132A10Rik 2.22 0.0010472 
Ahr -1.23 5.31E-04 Flnc 2.22 1.01E-04 
Ift88 -1.23 8.75E-06 Abcb1B 2.22 4.88E-04 




Bc026585 -1.23 4.06E-05 Mtnr1A 2.22 0.007095108 
Gdf1 -1.23 1.14E-04 Tfpi2 2.23 8.06E-05 
Galnt10 -1.23 4.74E-05 Scin 2.23 0.001007151 
Sh3Tc1 -1.23 0.002122786 Gm15425 2.23 0.002529404 
Pick1 -1.23 1.55E-05 Scrn1 2.23 0.005463749 
Ebpl -1.22 1.35E-05 9130017K11Rik 2.24 4.36E-04 
Ankle1 -1.22 3.31E-05 Hmga2 2.24 4.81E-05 
2310001H17Rik -1.22 0.005169347 Cebpb 2.25 3.05E-06 
Bcan -1.22 0.006421506 Scn1B 2.25 7.13E-04 
Cd200 -1.22 2.12E-05 Mob3B 2.25 3.45E-04 
Cyb5R1 -1.22 5.11E-05 Dok1 2.25 2.53E-05 
Ptprt -1.22 2.35E-04 Col17A1 2.25 2.88E-05 
Lect1 -1.22 4.34E-05 Dysf 2.26 3.32E-04 
Il13Ra2 -1.22 6.38E-04 Gm12843 2.26 1.15E-05 
Ctso -1.22 9.29E-05 Trib1 2.27 3.07E-04 
Lhpp -1.21 1.00E-05 Parm1 2.27 3.79E-05 
Spata33 -1.21 7.39E-05 Aplnr 2.27 0.001326376 
Dync2Li1 -1.21 4.34E-05 Gfod1 2.27 2.01E-05 
Angpt2 -1.21 0.002897483 Tmem200B 2.28 3.78E-04 
Dscc1 -1.21 4.55E-05 Gm5294 2.28 2.54E-04 
Fcho1 -1.21 9.93E-05 Basp1 2.28 1.08E-05 
Kdelc2 -1.21 1.11E-04 Grhl3 2.28 0.00704362 
Sgcb -1.21 1.07E-04 Rprm 2.28 3.78E-04 
Esr1 -1.21 4.06E-05 Stx11 2.29 9.39E-04 
Gpr135 -1.21 4.61E-04 Cited1 2.29 0.005175098 
Hlcs -1.21 4.21E-06 Acot4 2.29 0.004609852 
Rapgef4 -1.21 6.13E-05 Bean1 2.29 1.98E-04 
Fgfr4 -1.21 8.28E-04 Gm11655 2.29 0.003329534 
Cables1 -1.20 2.14E-05 Kcnmb4Os1 2.30 9.93E-05 
Slc35F2 -1.20 4.43E-05 Akr1B8 2.30 5.08E-06 
Adamts2 -1.20 8.92E-05 Ppp1R14A 2.30 4.27E-04 
Dhrs7 -1.20 1.39E-04 Gm45892 2.31 1.67E-04 
Myo7A -1.20 6.13E-05 Pcyt1A 2.31 2.37E-06 
Sema3G -1.20 0.001033531 4833422C13Rik 2.32 3.58E-04 
Tnfsf10 -1.20 0.001152183 Tmem100 2.32 2.08E-05 
Ubash3A -1.20 7.52E-04 Adcyap1R1 2.32 8.93E-06 
 Sept4 -1.19 3.44E-05 Gm17087 2.32 9.66E-04 
Chaf1B -1.19 1.62E-04 Trim9 2.33 0.002674948 
Dnase1L1 -1.19 2.99E-05 Slc7A8 2.33 8.67E-07 
Gca -1.19 5.93E-04 Cthrc1 2.33 3.56E-04 
Osbpl1A -1.19 1.64E-05 Lbh 2.34 1.70E-05 




Dap -1.19 3.11E-05 Kcnmb4 2.35 3.15E-05 
9530077C05Rik -1.19 1.81E-04 Cav2 2.35 2.57E-04 
Bst2 -1.19 1.48E-04 Gm16318 2.35 7.19E-04 
Ank3 -1.19 7.99E-05 Gm5106 2.35 9.37E-04 
Rai2 -1.18 2.91E-04 Nrcam 2.36 3.96E-05 
Myo6 -1.18 3.69E-04 Unc79 2.36 2.63E-04 
Cabp1 -1.18 1.85E-04 Cav1 2.37 1.16E-05 
Arhgdig -1.18 0.001363223 Adh1 2.37 3.07E-05 
Khdrbs3 -1.18 6.64E-05 Adamts20 2.38 0.004782395 
Ccdc40 -1.18 9.30E-04 Kcnmb4Os2 2.38 1.05E-05 
Ivns1Abp -1.18 1.55E-04 Pde6H 2.38 0.003116105 
Loxl1 -1.18 4.27E-04 Fam210B 2.39 5.38E-05 
Wfdc10 -1.17 0.003228031 Vldlr 2.39 4.97E-07 
Xxylt1 -1.17 3.46E-05 Itpk1 2.39 1.77E-05 
Nmral1 -1.17 4.20E-05 Entpd1 2.40 5.08E-06 
Jak3 -1.17 1.54E-04 Msx1 2.40 1.76E-05 
Gcdh -1.17 8.58E-06 Robo2 2.40 5.59E-06 
Nipal3 -1.16 1.55E-04 Prrx1 2.41 1.00E-04 
Kcnh7 -1.16 0.001278282 Gm44043 2.41 1.71E-04 
1810062G17Rik -1.16 0.001175 Gm20540 2.41 5.47E-04 
Brca2 -1.16 3.52E-06 Sv2C 2.43 1.64E-05 
Snhg11 -1.16 5.34E-04 Aldh1A3 2.43 1.13E-04 
Slc2A9 -1.16 6.19E-04 Bcl3 2.43 8.56E-05 
Fam3A -1.16 3.89E-05 Gm16559 2.43 1.13E-04 
Tgfb3 -1.16 8.93E-05 Satb2 2.44 4.53E-06 
St3Gal5 -1.16 0.002641644 Smco3 2.44 7.55E-05 
Psmb9 -1.16 8.45E-05 Mmp19 2.44 1.41E-04 
4930550L24Rik -1.16 0.006973818 Slurp1 2.44 2.75E-04 
Fndc9 -1.16 2.71E-04 Gsta2 2.45 8.06E-05 
Slc39A11 -1.16 6.97E-05 Rrad 2.45 6.36E-06 
Tnfsf11 -1.15 0.006525566 Il23A 2.45 3.69E-05 
Etfbkmt -1.15 3.68E-04 9330136K24Rik 2.46 6.22E-06 
Dnah11 -1.15 2.89E-05 Ret 2.46 1.87E-04 
Glt28D2 -1.15 8.12E-04 Sbsn 2.47 1.59E-04 
Fmn1 -1.15 0.00434045 Far1Os 2.47 1.57E-06 
Id3 -1.15 1.56E-05 Rims4 2.47 4.58E-07 
Sft2D2 -1.15 8.93E-06 Krt79 2.48 4.01E-06 
Ankrd24 -1.15 6.57E-06 Cdkn1A 2.48 1.87E-04 
Cryz -1.15 1.66E-05 Gm44981 2.48 0.001122528 
Zkscan2 -1.15 1.74E-04 Klf2 2.48 1.72E-04 
Utrn -1.15 4.22E-06 Gm13889 2.49 4.14E-07 




Zbtb40 -1.15 1.58E-05 Mid1 2.49 1.35E-05 
Ddx60 -1.14 5.66E-04 Aard 2.49 2.09E-06 
Dact2 -1.14 3.52E-04 Fgl2 2.49 1.23E-04 
Rgs7Bp -1.14 2.75E-04 Rgs4 2.50 1.77E-04 
Anxa6 -1.14 1.10E-05 Itga5 2.50 3.83E-06 
Prkag2 -1.14 8.16E-06 L3Mbtl4 2.50 0.008509516 
Alg6 -1.14 4.01E-05 Gpt2 2.51 2.29E-07 
Slc9A5 -1.14 3.22E-04 Hsd17B11 2.51 1.15E-05 
2310040G24Rik -1.14 0.004086668 Far1 2.51 7.00E-08 
Masp1 -1.14 4.58E-04 Klf4 2.51 6.72E-05 
Pmp22 -1.13 9.98E-05 Mical2 2.51 1.16E-05 
Tmem106C -1.13 1.11E-05 C230034O21Rik 2.51 2.08E-04 
Naaladl2 -1.13 0.008898488 Zfp36 2.51 8.29E-04 
Egflam -1.13 0.007759296 Dmd 2.52 1.15E-05 
Dnajb14 -1.13 3.32E-05 Tll1 2.52 4.70E-06 
Hacl1 -1.13 1.48E-05 Lrp8Os2 2.52 4.04E-04 
Fbxo41 -1.13 0.00505215 Itga2 2.52 1.70E-06 
Zeb1 -1.13 1.13E-05 Cldn3 2.53 5.06E-05 
Lgals3Bp -1.13 0.001003305 Synm 2.53 7.76E-06 
Gprasp2 -1.13 1.22E-04 Gm44763 2.53 9.78E-04 
C1Qtnf1 -1.13 4.55E-04 Acsl4 2.53 5.24E-07 
Rph3Al -1.13 1.76E-05 Gm14021 2.53 0.002645975 
Nap1L5 -1.12 5.00E-04 Rufy4 2.53 0.002773969 
Gm16432 -1.12 8.46E-04 Sdc1 2.53 4.45E-06 
1700024F13Rik -1.12 8.36E-04 Twist1 2.55 2.32E-04 
Crb1 -1.12 4.46E-04 Prss30 2.55 6.46E-04 
Omp -1.12 0.002823069 Thsd7A 2.56 8.54E-05 
Kcnb2 -1.12 9.36E-04 Teddm2 2.56 1.76E-05 
Rtn2 -1.12 5.38E-04 Cnr1 2.56 0.002648547 
Tlr5 -1.12 5.55E-04 Rgcc 2.56 9.91E-06 
Gm1673 -1.12 1.62E-04 Them6 2.56 5.24E-05 
Raet1E -1.12 0.001789585 Six4 2.57 2.15E-04 
Mcm8 -1.11 3.61E-04 Egr2 2.58 5.19E-04 
Itga11 -1.11 2.08E-04 Pdzph1 2.58 3.53E-04 
Ppargc1B -1.11 8.20E-04 Phf20L1 2.58 4.45E-07 
Unc119 -1.11 5.88E-05 Pla2G7 2.58 1.46E-04 
Ppp1R3G -1.11 2.41E-04 Gm24224 2.58 0.00116217 
Alms1 -1.11 1.22E-05 St3Gal1 2.59 3.79E-06 
6430573F11Rik -1.11 0.004897859 Apol6 2.59 0.001387809 
Kntc1 -1.11 1.03E-04 Gm45102 2.59 1.49E-04 
Angpt4 -1.11 0.005823352 Sec14L2 2.61 3.07E-04 




Pcbd2 -1.11 2.82E-04 Sh3Gl2 2.62 8.80E-05 
Slfn9 -1.11 2.30E-04 C130089K02Rik 2.62 0.004013595 
5730405O15Rik -1.11 0.001488596 Fblim1 2.62 9.06E-05 
Mpp3 -1.11 2.63E-05 Nxf3 2.63 1.19E-06 
Socs1 -1.11 0.007249503 Peg10 2.64 1.53E-06 
Xrcc2 -1.11 1.07E-04 Ssbp2 2.64 4.65E-06 
Gcnt4 -1.11 1.13E-04 Creb3L1 2.64 3.46E-05 
Spin2C -1.11 4.07E-04 Srgap1 2.64 9.26E-05 
Raver2 -1.11 5.59E-06 Jph2 2.64 7.76E-06 
Rin2 -1.11 1.02E-04 Nt5E 2.64 2.44E-04 
Tbata -1.10 6.70E-04 Fat4 2.65 7.43E-05 
Tmem255B -1.10 0.001212454 Tpd52L1 2.65 1.41E-05 
Map2K6 -1.10 2.22E-04 A830012C17Rik 2.65 3.33E-04 
Tanc1 -1.10 2.77E-05 Wnt2 2.66 6.48E-05 
Sppl3 -1.10 4.34E-05 Srgn 2.66 2.14E-05 
3830406C13Rik -1.10 5.64E-05 Lrrc6 2.67 8.55E-05 
Comp -1.10 0.003537276 Abcb1A 2.67 1.35E-04 
Cfap61 -1.10 0.002355756 Tdrkh 2.67 4.03E-04 
Trappc9 -1.10 6.91E-05 Stk32A 2.69 1.60E-04 
Per3 -1.10 3.46E-05 E030018B13Rik 2.69 0.004173691 
Arsb -1.10 5.95E-05 Grik2 2.69 2.03E-04 
Carhsp1 -1.10 1.10E-05 Glul 2.69 1.04E-06 
Mme -1.10 0.001671519 Nbl1 2.69 1.15E-05 
Nr1D2 -1.09 1.76E-05 Gm42939 2.69 0.00431983 
Tert -1.09 4.81E-05 Ccdc30 2.70 1.22E-05 
Ano4 -1.09 6.50E-04 Fes 2.71 6.55E-04 
C920021L13Rik -1.09 4.96E-04 Adamts4 2.72 2.41E-05 
Scg5 -1.09 0.003625438 Col24A1 2.72 2.44E-06 
1810058I24Rik -1.09 3.09E-05 Gm37019 2.73 0.001997097 
Iqgap3 -1.09 6.98E-05 Gm20089 2.74 0.004963092 
Arhgap27 -1.09 1.13E-04 Bdnf 2.75 1.06E-04 
Arg1 -1.09 0.001605079 Hapln1 2.76 8.50E-05 
P2Ry1 -1.09 2.69E-04 Sema3A 2.77 1.60E-06 
Trim34A -1.09 0.001007151 Thsd7B 2.77 0.001109731 
Tmeff2 -1.09 3.52E-04 Adamts9 2.77 3.06E-06 
H2-M3 -1.09 1.41E-04 Kctd12 2.77 5.48E-07 
Azin2 -1.09 1.31E-04 Gm26778 2.78 9.16E-07 
Il27Ra -1.09 2.79E-04 Srxn1 2.78 1.29E-06 
Arsa -1.09 9.05E-05 Mreg 2.78 1.00E-06 
Agpat5 -1.09 9.88E-05 Etv4 2.79 4.64E-05 
1700112E06Rik -1.09 0.007376284 Lrmp 2.80 2.01E-04 




Slc5A3 -1.08 2.44E-04 Gm43672 2.82 1.61E-05 
Nek8 -1.08 3.65E-05 Hal 2.82 0.004417755 
Chchd6 -1.08 1.52E-04 Frmpd1 2.82 5.48E-05 
4933416I08Rik -1.08 9.97E-04 Tsc22D3 2.83 1.90E-05 
Pbxip1 -1.08 2.14E-05 Cyp4F18 2.86 5.28E-04 
Adam22 -1.08 4.24E-04 Gm28373 2.86 0.001384637 
Nrip1 -1.08 4.44E-04 Gm15737 2.87 3.37E-05 
Prkag2Os1 -1.08 0.00344755 Ncoa7 2.87 6.70E-08 
Slc25A42 -1.08 2.04E-05 Ier3 2.87 8.30E-06 
Gm15663 -1.08 9.46E-04 Plk3 2.88 9.72E-06 
Cbfa2T3 -1.08 1.02E-04 Prune2 2.88 2.38E-05 
Fbxo47 -1.08 4.96E-04 Lynx1 2.88 4.05E-07 
Cln6 -1.07 2.83E-05 Htr1D 2.89 1.03E-05 
Fancd2 -1.07 1.04E-04 Traf3Ip2 2.90 1.51E-05 
Ecm2 -1.07 6.69E-04 Il6Ra 2.90 7.60E-05 
Tmem241 -1.07 5.04E-05 Bin1 2.91 3.29E-07 
Ai464131 -1.07 4.06E-05 Gm45194 2.91 1.11E-05 
Mcm6 -1.07 1.35E-04 Adgrf5 2.91 4.13E-06 
6720489N17Rik -1.07 1.13E-04 Zfp52 2.92 1.86E-07 
Ppp1R26 -1.07 6.57E-05 Dtx1 2.93 2.49E-04 
Lockd -1.07 1.26E-04 Abhd2 2.93 9.74E-08 
Card14 -1.07 3.12E-04 Npr3 2.93 0.002256233 
Kcnn1 -1.07 5.32E-04 Gm11651 2.94 5.78E-05 
Agrn -1.07 7.81E-05 Actn3 2.94 0.001918996 
Prelid2 -1.07 6.92E-04 Tspan11 2.95 2.29E-05 
Slc26A1 -1.07 6.55E-05 Gm14020 2.95 0.002967125 
Gstm7 -1.07 1.75E-05 Nupr1 2.95 6.54E-06 
Igf2R -1.07 0.002428026 Gm5834 2.95 2.24E-04 
Epm2A -1.07 7.57E-04 Pdzrn3 2.96 1.83E-05 
Uevld -1.06 6.67E-05 Sema3E 2.97 4.64E-05 
Catsper2 -1.06 9.60E-05 Col12A1 2.97 1.88E-05 
Grem1 -1.06 0.005802864 Usp43 2.97 5.36E-04 
Abhd14A -1.06 7.53E-06 Cyp4B1 2.98 4.69E-04 
Kitl -1.06 0.009855361 Dok6 2.98 7.67E-04 
Gm15201 -1.06 2.02E-04 Mdga2 2.99 1.25E-05 
Synpo -1.06 2.11E-05 Ahsg 2.99 1.74E-06 
Plbd1 -1.06 2.62E-05 Gm15247 3.00 2.00E-04 
Sned1 -1.06 4.47E-05 Fhl3 3.00 9.52E-05 
C130074G19Rik -1.06 9.94E-05 Nr4A3 3.01 2.75E-05 
Sox12 -1.06 8.92E-05 Ptpn5 3.01 5.49E-05 
Abca7 -1.06 9.96E-06 Chgb 3.02 4.92E-06 




Dnajb13 -1.06 9.97E-05 Cdh17 3.03 1.97E-05 
Mgst3 -1.06 3.69E-05 A330015K06Rik 3.04 1.88E-05 
Cpa2 -1.06 0.009422558 Tac1 3.05 3.86E-05 
Stac -1.06 2.51E-05 Gm8251 3.05 4.63E-05 
Proser2 -1.06 2.15E-04 Ace 3.05 4.99E-06 
Nnt -1.06 9.98E-05 Csf2Rb 3.05 9.52E-05 
Inca1 -1.06 6.50E-04 Rassf9 3.07 1.61E-05 
Vwa8 -1.05 1.85E-05 5430420F09Rik 3.07 0.008320271 
Gja1 -1.05 0.003929781 Nfil3 3.08 2.48E-05 
Tbc1D32 -1.05 1.74E-05 Nsun7 3.09 1.06E-04 
Chid1 -1.05 7.15E-06 Gm15328 3.09 4.85E-05 
Trpc3 -1.05 1.15E-04 Gm16332 3.09 7.59E-04 
Tmem72 -1.05 1.72E-04 Adarb1 3.10 1.19E-06 
Tmem143 -1.05 6.57E-06 Gm17509 3.11 1.55E-05 
Impa2 -1.05 6.02E-05 Cyp11B1 3.12 2.22E-05 
Ccdc159 -1.05 4.43E-04 Ppp1R36 3.13 0.007227887 
Tlcd2 -1.05 5.59E-05 Enpp2 3.13 2.02E-04 
Osbpl5 -1.05 1.75E-05 Gm15726 3.14 1.06E-04 
Nxpe4 -1.05 0.002025125 Gm11870 3.15 1.27E-04 
Dtd1 -1.05 1.40E-04 Adam8 3.15 2.29E-07 
Dym -1.05 1.35E-05 Gldc 3.16 5.71E-04 
A930005H10Rik -1.05 4.46E-04 Rhox5 3.19 1.53E-06 
E130311K13Rik -1.05 2.79E-05 Timp1 3.20 4.14E-06 
Bhlhe41 -1.05 4.71E-04 Bmper 3.20 9.03E-07 
Hmgcs2 -1.05 8.86E-06 Dusp4 3.24 6.74E-05 
Atrnl1 -1.05 1.82E-04 Eno2 3.25 9.96E-06 
Mettl22 -1.05 4.17E-06 St8Sia4 3.27 5.81E-05 
Abhd14B -1.04 5.94E-05 Adam2 3.27 1.99E-04 
Xylb -1.04 4.21E-04 Edn2 3.27 0.006615751 
Gm11747 -1.04 5.60E-04 #N/A 3.27 2.08E-04 
Gstm6 -1.04 6.52E-05 Gm11843 3.28 5.33E-06 
Ccdc125 -1.04 4.58E-05 Sh3Gl3 3.28 1.03E-04 
Ccnd2 -1.04 0.005124334 Npr1 3.29 4.25E-06 
Best1 -1.04 0.002872209 Gm37265 3.29 0.001569914 
Col4A6 -1.04 7.04E-04 M1Ap 3.29 6.67E-04 
Mut -1.04 8.09E-05 Dusp6 3.30 3.02E-06 
Tpk1 -1.04 1.17E-04 5330416C01Rik 3.30 2.15E-05 
Adora1 -1.04 3.83E-05 Gm16048 3.30 3.34E-05 
Tmed3 -1.04 5.82E-05 Unc5D 3.31 0.001361167 
B4Gat1 -1.04 8.16E-05 Cdh6 3.31 0.001605079 
Gpx7 -1.04 1.74E-04 Gm44639 3.32 9.99E-05 




Slfn8 -1.04 0.001145989 Procr 3.32 1.13E-05 
Tmem8B -1.04 1.88E-05 Apcdd1 3.32 1.10E-05 
Txndc16 -1.04 1.43E-04 Adamts3 3.33 9.18E-06 
Gimap8 -1.04 0.004882311 Penk 3.34 9.26E-06 
3632454L22Rik -1.04 0.003929781 Zbtb16 3.35 1.44E-04 
Mybph -1.04 2.76E-04 Emb 3.35 2.76E-06 
Hsd17B1 -1.04 0.002580545 Errfi1 3.38 2.06E-07 
Tlr3 -1.04 8.82E-04 Mpzl2 3.39 2.24E-05 
1110019D14Rik -1.04 7.10E-04 Rab20 3.39 8.56E-05 
Arxes2 -1.03 2.48E-04 Gm26771 3.40 3.05E-05 
Pcca -1.03 3.33E-06 Olfr1250 3.41 1.39E-04 
Gstm4 -1.03 6.96E-04 Etv5 3.41 4.97E-07 
Klc2 -1.03 5.33E-06 Steap1 3.42 4.22E-06 
Au040320 -1.03 9.63E-06 Pxdc1 3.44 4.42E-05 
Nkd2 -1.03 0.004311282 Syne1 3.45 1.02E-05 
Dlec1 -1.03 5.99E-04 Osgin2 3.47 2.06E-07 
Rida -1.03 2.44E-04 Spry3 3.47 1.66E-05 
Hacd4 -1.03 3.25E-05 Nr1H4 3.47 1.27E-04 
Ralb -1.03 4.44E-04 Gm39041 3.48 5.54E-04 
Spint2 -1.03 0.003009829 Fam110C 3.48 7.00E-08 
Med9Os -1.02 0.003227886 Myh13 3.49 0.001496503 
Prkaa2 -1.02 3.64E-04 Clcf1 3.49 4.92E-04 
Msh2 -1.02 1.41E-05 Avil 3.50 1.30E-05 
Mcm3 -1.02 7.52E-04 Sec1 3.51 4.30E-05 
Tmtc2 -1.02 0.001963737 Gm3716 3.51 1.20E-04 
Fgf13 -1.02 0.001543796 Kcnv2 3.52 0.001382912 
Cenpm -1.02 2.24E-04 Mrap 3.53 6.55E-08 
Sgsh -1.02 2.73E-04 Popdc3 3.54 4.32E-06 
Stbd1 -1.02 3.27E-05 Slco1A1 3.55 4.32E-04 
Pcyox1L -1.02 3.80E-05 Tnfrsf12A 3.57 1.69E-06 
Aasdh -1.02 1.38E-05 Dhrs9 3.58 9.20E-05 
Lrp3 -1.02 1.16E-05 Gm10584 3.59 3.54E-05 
Sspo -1.02 0.001139708 Gimap5 3.59 5.59E-04 
Fsbp -1.02 3.42E-04 Sfrp2 3.61 1.66E-05 
Pbld2 -1.02 0.001118867 Cited4 3.62 7.65E-05 
Lyplal1 -1.01 7.84E-05 Gm6614 3.62 3.12E-04 
Tet1 -1.01 3.96E-05 Pcsk5 3.62 6.55E-08 
Trappc6A -1.01 3.01E-05 Zfp365 3.63 3.23E-07 
Tarsl2 -1.01 1.25E-05 S100A3 3.64 0.007824676 
Nupr1L -1.01 0.003350471 Plaur 3.64 1.99E-05 
Foxl2 -1.01 5.18E-05 Rpp25 3.64 1.47E-05 




B230217C12Rik -1.01 7.04E-04 Areg 3.69 0.00222647 
Apoa1Bp -1.01 6.30E-05 Met 3.70 7.21E-05 
Ext1 -1.01 0.002002691 Abi3Bp 3.71 1.61E-07 
Acat1 -1.01 1.23E-04 Zfp949 3.71 8.12E-07 
D930048N14Rik -1.01 1.84E-04 Cldn1 3.72 1.43E-04 
Dirc2 -1.01 5.33E-06 Snap91 3.73 2.40E-05 
Cyp2J6 -1.01 4.73E-04 Tmem37 3.74 1.30E-04 
Zfp950 -1.01 1.15E-04 Dll3 3.74 5.13E-05 
Ppm1K -1.01 3.86E-04 Enpp3 3.75 1.86E-07 
Dnah7B -1.01 9.09E-04 Klrb1C 3.75 1.35E-05 
Mir1901 -1.01 3.69E-04 Vdr 3.77 3.44E-05 
Esrrg -1.00 0.003097381 Fosl1 3.77 0.001255833 
Ephb6 -1.00 9.81E-06 Egln3 3.78 1.42E-05 
Fgfrl1 -1.00 4.21E-04 Lif 3.78 3.69E-04 
Dpp10 -1.00 0.002887231 Olfr1251 3.79 5.23E-05 
Mlxipl -1.00 1.66E-04 Rhox8 3.80 1.09E-05 
Tmem218 -1.00 1.15E-04 Nptx1 3.80 1.67E-04 
Slc6A15 -1.00 0.001647002 Baat 3.82 6.30E-05 
Pccb -1.00 2.53E-05 Pappa2 3.84 7.03E-05 
Col4A3 -1.00 9.66E-04 Fzd1 3.86 7.00E-08 
Amhr2 -1.00 9.60E-04 F3 3.86 8.76E-06 
Ror1 -1.00 0.001042393 Gm19463 3.86 7.00E-08 
Hmgcr 1.00 2.11E-05 Slco2A1 3.87 9.36E-06 
Gse1 1.00 9.55E-04 Creg2 3.91 4.03E-04 
Prss35 1.00 4.58E-05 Igdcc3 3.91 1.48E-05 
Sgms1 1.00 8.58E-06 Hmga1 3.94 1.82E-06 
Chmp4C 1.00 1.85E-04 A730049H05Rik 3.97 4.10E-05 
Cdc42Se1 1.01 2.06E-05 Cxcl5 3.98 3.07E-05 
Cbarp 1.01 1.13E-05 Gm45774 3.98 3.04E-06 
Osbpl6 1.01 1.44E-05 A730020M07Rik 4.00 5.70E-05 
Galnt18 1.01 0.009621887 Gm27820 4.00 2.96E-05 
Rnaseh2A 1.01 9.19E-04 Mt2 4.01 1.59E-06 
Clip3 1.01 0.005157006 Vnn3 4.04 1.51E-05 
Tmem189 1.01 1.93E-05 Dusp2 4.05 0.004792905 
Ahi1 1.01 1.21E-05 Nrg3 4.05 5.82E-05 
Tusc1 1.02 5.82E-05 F2Rl2 4.05 8.82E-04 
Usp53 1.02 4.41E-05 Arl4D 4.06 1.28E-06 
Rassf8 1.02 2.58E-05 Kcne4 4.07 4.77E-04 
Ell2 1.02 8.74E-06 Lox 4.08 6.35E-06 
Rtkn2 1.02 2.16E-05 Pnoc 4.08 2.01E-05 
Epha7 1.02 1.01E-05 Lrrc4C 4.08 1.68E-05 




Chd7 1.03 1.01E-05 Trpa1 4.13 2.06E-04 
Stxbp1 1.03 1.82E-04 Bves 4.15 6.87E-07 
Bc005537 1.03 1.97E-05 Tagln2 4.17 2.83E-08 
Arhgap24 1.03 0.005961878 Star 4.17 1.25E-05 
Pkdcc 1.03 5.08E-04 Il33 4.18 3.33E-04 
Cdkn2D 1.03 0.001395849 Gm45073 4.18 7.76E-05 
Hspa4L 1.03 5.49E-05 Scg2 4.19 2.67E-05 
Me1 1.03 6.27E-06 Hmga1-Rs1 4.19 1.58E-06 
Tnfaip8 1.03 9.03E-04 Il1Rl2 4.19 1.38E-06 
Ppp3Ca 1.03 1.78E-06 Vsig8 4.21 4.42E-05 
Rnase4 1.03 0.003204444 Hhip 4.21 1.04E-06 
Rap1A 1.03 3.91E-06 Efnb2 4.24 4.29E-06 
Btg3 1.03 2.08E-05 Gm26626 4.24 2.48E-05 
Hipk1 1.03 2.10E-04 Runx2Os2 4.25 0.001531121 
Maml2 1.04 9.18E-05 Trbc2 4.27 2.40E-04 
Gm12500 1.04 9.76E-05 Gm19610 4.34 2.13E-05 
Rdh5 1.04 9.36E-04 Rasal1 4.34 5.08E-06 
Baiap2 1.04 1.14E-04 Trac 4.38 1.01E-05 
Leng9 1.04 3.27E-05 Slc7A11 4.38 6.55E-08 
L3Mbtl3 1.04 7.87E-06 Rgs1 4.41 2.70E-04 
Zbtb1 1.04 1.60E-06 Rasef 4.42 3.59E-05 
Lonrf3 1.04 4.29E-05 Runx2 4.42 1.03E-05 
Slc9A3R1 1.04 8.16E-06 Serpinb9B 4.43 9.00E-04 
Tchh 1.04 3.72E-05 Ifi202B 4.43 6.13E-05 
Camk2N1 1.04 3.63E-04 Runx1 4.45 1.86E-07 
Fbxo33 1.04 4.28E-06 Runx2Os1 4.51 0.002864274 
Xpnpep1 1.04 1.69E-04 Esm1 4.53 6.16E-04 
Nyap1 1.05 0.003375358 Gm11714 4.53 5.17E-04 
Pcdh7 1.05 5.12E-05 Gm15482 4.53 1.06E-04 
Pdgfa 1.05 1.53E-04 Fmo2 4.54 1.26E-05 
Col18A1 1.05 2.03E-04 Camp 4.54 4.93E-04 
Zfp516 1.05 2.44E-05 Alcam 4.54 8.06E-08 
Zfp251 1.05 7.27E-06 Gpr83 4.58 3.44E-07 
Amigo2 1.05 3.05E-05 Lrrn3 4.60 2.33E-05 
E130012A19Rik 1.06 3.42E-04 Wnt11 4.60 2.78E-05 
Cars 1.06 3.83E-06 Ly6D 4.67 1.46E-06 
Mob3A 1.06 4.64E-04 Calml3 4.67 1.30E-04 
Smarcd3 1.06 1.99E-05 E230020D15Rik 4.69 2.42E-04 
Kcnt1 1.06 4.92E-04 Pcdh10 4.77 7.00E-08 
Dgka 1.06 0.004087961 Arc 4.77 2.65E-05 
Msn 1.06 4.18E-06 Cntnap5A 4.77 8.48E-06 




Nyx 1.06 1.01E-04 Ptgs1 4.86 3.10E-04 
Nr3C1 1.06 2.52E-06 Tac2 4.87 1.74E-05 
Etl4 1.07 2.67E-04 Svet1 4.89 4.01E-04 
Fbxl22 1.07 3.35E-05 Gm12349 4.89 6.24E-05 
Slc38A4 1.07 3.71E-05 Rnf180 4.90 1.40E-07 
Ttpal 1.07 4.21E-04 Has2Os 4.94 8.48E-06 
Gm7008 1.07 3.79E-04 Cxcr4 4.94 1.40E-07 
Palm2 1.07 0.005045637 Gm13857 4.95 1.93E-05 
Gss 1.07 1.67E-05 Gm43621 4.97 1.67E-04 
Rerg 1.07 7.68E-04 1700027H10Rik 4.98 4.32E-06 
Akr1C18 1.07 0.007721588 Gm45652 4.98 1.69E-04 
Dhcr7 1.07 3.61E-05 Rragd 5.00 6.55E-08 
Tk2 1.08 1.69E-04 Slc10A5 5.02 4.55E-05 
5830432E09Rik 1.08 0.005002862 0610031O16Rik 5.03 8.86E-05 
Vasn 1.08 8.00E-05 Slc22A22 5.06 1.01E-05 
Pdgfd 1.08 6.88E-04 Galnt16 5.06 1.54E-06 
Gm6225 1.08 0.001509433 Asgr1 5.08 1.02E-04 
Snapc1 1.08 1.75E-05 Fabp7 5.10 4.17E-04 
Psat1 1.08 4.57E-06 Dmbt1 5.14 1.22E-05 
Tiparp 1.09 4.95E-06 Tchhl1 5.17 5.22E-04 
Ehbp1L1 1.09 0.001245528 Havcr2 5.19 2.08E-05 
Tiam1 1.09 3.48E-06 Vstm2A 5.20 1.65E-04 
Il20Rb 1.09 0.008741556 Fabp4 5.22 3.49E-04 
Cyb561 1.09 1.02E-04 Akr1B7 5.22 4.71E-06 
Txndc2 1.09 2.90E-04 Kl 5.23 1.54E-04 
Cadm4 1.09 0.003442728 Slc5A7 5.33 9.47E-06 
Icosl 1.09 8.35E-05 Apela 5.34 1.23E-05 
Gcnt2 1.09 0.006747813 Il6 5.35 9.50E-05 
Gm10768 1.09 4.21E-04 Zfp804A 5.36 8.57E-07 
Mex3B 1.09 2.11E-05 Gm42793 5.40 1.50E-04 
Bin3 1.09 8.68E-05 Pthlh 5.41 8.60E-05 
Dner 1.09 0.002924715 Lyve1 5.54 3.07E-05 
Eaf1 1.09 2.18E-05 Sphk1 5.56 4.08E-05 
Rdh10 1.10 1.86E-05 Egr3 5.65 4.32E-06 
Sdcbp 1.10 7.53E-07 Rnd3 5.65 1.06E-06 
Car2 1.10 0.004027136 Gm12648 5.66 4.38E-05 
Bbc3 1.10 0.005768878 A230059L01Rik 5.67 2.02E-05 
Maf 1.10 2.04E-04 Ereg 5.67 3.85E-05 
Tcf24 1.10 3.35E-04 Trank1 5.68 5.28E-06 
Cntnap2 1.10 0.009384629 Rnf125 5.69 1.74E-05 
Nudt4 1.11 9.70E-06 Ptprn 5.73 2.08E-05 




Msantd1 1.11 0.00592378 Gm15767 5.92 5.68E-06 
Ncbp1 1.11 2.01E-05 Msc 5.96 2.30E-05 
Ramp3 1.11 0.006955385 Gm9947 6.08 1.05E-05 
Gm10941 1.11 0.001280177 4930432L08Rik 6.11 5.28E-06 
Wt1 1.12 8.39E-04 Gm28294 6.17 5.58E-05 
Cela1 1.12 0.003376208 Klrb1A 6.18 6.42E-06 
Bloc1S4 1.12 1.35E-04 Lingo4 6.24 6.95E-06 
Epm2Aip1 1.12 1.56E-05 Nmu 6.25 1.41E-05 
Ndrg4 1.12 0.001326376 Aldob 6.29 1.86E-07 
Slc9A3R2 1.12 0.001628078 Pgr 6.35 1.07E-04 
Cecr2 1.12 2.14E-05 Kdm4Dl 6.38 1.08E-06 
Spsb2 1.12 6.49E-05 Gm37498 6.42 4.64E-05 
Gadd45A 1.12 5.98E-04 Adh7 6.45 8.93E-06 
Cntn3 1.12 0.005642239 Gm16485 6.47 0.001371218 
Fam102B 1.12 4.22E-06 Brinp3 6.49 4.59E-05 
Ckb 1.12 4.88E-04 Trdv5 6.50 1.88E-06 
Sesn2 1.13 4.97E-05 Npy 6.53 2.56E-05 
Mir22Hg 1.13 6.06E-06 Ptgs2Os2 6.55 4.53E-06 
Bend7 1.13 1.38E-05 Lepr 6.59 7.00E-08 
Slc7A1 1.13 4.02E-04 Helt 6.61 1.13E-06 
Ednra 1.13 1.42E-05 Btc 6.61 1.55E-06 
Erf 1.13 1.07E-05 Olr1 6.65 1.70E-05 
Nedd9 1.13 1.46E-06 Gm29398 6.78 7.45E-06 
Hdac7 1.13 4.78E-04 Sema4F 6.88 3.70E-05 
F8A 1.13 1.19E-05 Epgn 6.93 6.59E-06 
Map6D1 1.13 6.46E-04 Gm37630 6.94 4.74E-06 
Ank2 1.14 1.77E-04 Retn 6.98 4.57E-06 
Hccs 1.14 3.62E-06 Gm20125 7.03 1.29E-04 
Slc44A1 1.14 3.91E-06 Spp1 7.03 3.83E-06 
Nr2F6 1.14 1.64E-05 Tnfaip6 7.12 1.38E-06 
Jag1 1.14 3.17E-06 Prkg2 7.25 1.04E-06 
Wdfy1 1.14 5.08E-06 Ripply1 7.39 5.13E-07 
Atp2B1 1.14 1.99E-05 Kcnk10 7.42 2.40E-07 
Tle1 1.14 1.51E-05 Ptgs2 7.46 6.74E-07 
Chrna2 1.14 7.47E-04 Krt23 7.65 2.59E-05 
Vps26A 1.14 4.19E-04 Gm38189 8.19 1.88E-06 
Borcs6 1.15 5.28E-05 Gm43434 8.29 1.66E-05 
Pcsk9 1.15 1.09E-04 2010109I03Rik 8.44 1.09E-05 
Fads6 1.15 7.40E-04 Gcg 8.49 8.83E-07 
Bex4 1.15 1.52E-06 Trdc 9.05 6.37E-05 
Tsc22D4 1.15 1.83E-04 Snap25 9.06 1.15E-05 




Inpp5A 1.15 3.32E-05 Ptx3 9.78 2.42E-07 
4932441J04Rik 1.16 3.82E-05 Sprr2G 10.42 3.72E-07 
Lrrc8B 1.16 1.33E-04 Nts 11.47 4.97E-07 
Rev3L 1.16 4.47E-05 Sult1E1 12.68 4.87E-07 





Appendix 8 List of differentially expressed genes in PGRKO vs PGR+/- oviduct identified 
through microarray.  
Genes that had |logFC| ≥ 1 and a p-value cut-off of 0.01 were selected as DEG. LogFC is 
displayed as PGRKO vs PGR+/-.  
Gene logFC p-value Gene logFC p-value 
Itga8 -9.866 1.52E-06 Osr2 -2.38 6.82E-03 
Hmgcs2 -5.812 3.06E-04 Pgr -2.374 9.92E-04 
Maob -5.481 3.37E-04 Galntl2 -2.362 9.41E-04 
Gm106 -4.506 1.46E-03 Pde5a -2.348 5.69E-04 
Zbtb16 -4.326 5.69E-04 Rasl11b -2.338 3.38E-03 
Dpep1 -4.019 4.73E-03 Wfdc1 -2.323 1.55E-03 
Cyp1b1 -3.877 5.85E-03 Slc41a3 -2.31 7.65E-04 
Slc7a8 -3.765 9.12E-03 Ptgfr -2.279 1.32E-02 
Rgs2 -3.644 5.78E-04 Adcy5 -2.272 3.37E-04 
Tcf23 -3.564 9.41E-04 Myocd -2.267 2.86E-03 
Des -3.548 3.37E-04 Cited2 -2.258 1.26E-02 
Arl4d -3.52 1.79E-03 Itgbl1 -2.204 3.37E-04 
Edn3 -3.431 1.15E-03 Adamts9 -2.195 1.38E-02 
Prlr -3.388 1.61E-03 Spock2 -2.19 4.47E-04 
Lrp2 -3.316 6.02E-04 Synpo2 -2.188 1.02E-02 
Adamts1 -3.18 7.65E-04 Ctgf -2.182 1.50E-03 
Kcnj8 -3.149 5.72E-04 Crispld1 -2.177 7.65E-04 
Gria3 -3.145 3.32E-03 Lama1 -2.166 1.48E-02 
Cpxm2 -3.117 4.92E-04 Fgf7 -2.152 8.75E-03 
Ppap2b -2.895 4.47E-04 Tgfbi -2.133 4.73E-04 
Postn -2.865 1.04E-03 Cldn3 -2.128 9.28E-03 
Fxyd4 -2.85 5.46E-04 Hoxa3 -2.128 5.11E-03 
Errfi1 -2.779 4.47E-04 Adamts5 -2.117 9.42E-03 
Sult1a1 -2.708 4.47E-04 Chrdl1 -2.109 1.70E-03 
Tmem204 -2.707 4.65E-03 Aspn -2.093 1.63E-02 
Fkbp5 -2.683 4.53E-03 Hoxa6 -2.088 1.67E-02 
Col12a1 -2.667 9.92E-04 Gpr124 -2.087 2.12E-03 
Abca8a -2.66 7.29E-03 Slc2a4 -2.063 3.58E-03 
Col11a1 -2.642 6.27E-05 Pgm5 -2.05 8.55E-04 
Penk1 -2.64 5.72E-04 Stk17b -2.045 8.04E-03 
Figf -2.629 2.04E-03 Tgfbr3 -2.036 4.73E-04 
Rasd2 -2.533 4.93E-03 Aldh1l1 -2.031 1.85E-03 
Actg2 -2.522 6.27E-05 Timp3 -2.029 5.76E-03 
Klf15 -2.508 9.60E-04 Cdkn1c -2.026 9.47E-04 
Hif3a -2.505 7.65E-04 C7 -2.024 7.54E-03 
Mamdc2 -2.488 9.10E-04 Pi15 -2.014 9.35E-04 
Mapk11 -2.47 7.65E-04 Pln 2.033 3.07E-03 




Pdlim3 -2.426 1.81E-03 Agtr2 2.183 2.60E-03 
Kcnip2 -2.418 3.22E-03 Slc26a4 2.685 5.46E-04 




Appendix 9 List of differentially expressed genes in PGRKO vs PGR+/+ uterus identified 
through microarray.  
Genes that had |logFC| ≥ 1 and a p-value cut-off of 0.01 were selected as DEG. LogFC is 
displayed as PGRKO vs PGR+/+. 
Gene logFC p-value Gene logFC p-value 
Cyp26a1 -9.64 0.00018 Ccng1 -2.24 0.00011 
Lrp2 -5.50 0.00041 Enpp1 -2.24 0.00262 
Npl -5.28 0.00039 Slain1 -2.22 0.00843 
Acot7 -4.88 0.00011 Ctla2a -2.17 0.00207 
Hdc -4.83 0.0002 Etnk1 -2.05 0.00368 
Mthfd2 -4.40 0.00062 Mt2 -2.04 0.00759 
Nfil3 -3.49 0.00345 Tnfrsf21 -2.02 0.00066 
Myd88 -3.13 0.00099 Acss1 -2.01 0.00405 
Pla2g10 -2.92 0.00033 Ptk2b -2.01 0.00217 
Ggct -2.83 9.91E-05 Tiparp -2.00 0.00334 
Pdk3 -2.76 0.00439 Ckmt1 -2.00 0.00922 
Sgk1 -2.73 4.33E-05 Pip5k1b -2.00 0.0026 
Caprin2 -2.53 6.94E-05 Cdh16 2.02 0.00895 
Pdzk1ip1 -2.52 0.00037 Sox7 2.04 0.0005 
Ptgs1 -2.49 0.00237 Emb 2.07 0.00085 
Wnt11 -2.43 0.0052 Mycn 2.10 0.0066 
Alpl -2.43 0.00984 Car8 2.12 0.0075 
Slc25a48 -2.37 5.31E-05 Efnb2 2.18 0.00051 
Cited2 -2.31 0.00276 St6galnac5 2.26 0.00282 
Gars -2.28 0.00705 Gjb2 2.89 0.00385 





Appendix 10 List of antibodies used for immunofluorescence and PLA 







PGR from a human endometrial 







Residues surrounding Tyr541 of 
human PGR 
H3K27ac 
Active Motif 39133 Rabbit 
pAb 








Recombinant CBP specific to the 






Amino acid near the N-terminal of 
human RUNX1 
Santa Cruz Sc-365644 Mouse 
mAb 








Santa Cruz Sc-390715 Mouse 
mAb 







Residue surrounding Asn14 of 
human CBFβ 
c-JUN 
Santa Cruz sc-376488 Mouse 
mAb 
Amino acid 237-273 of mouse c-
JUN 
JUNB 
Santa Cruz sc-8051 Mouse 
mAb 
Amino acid 210-222 of mouse 
JUNB 
JUND 
Santa Cruz sc-271938 Mouse 
mAb 














Appendix 11 RUNX1 ChIP-seq reproducibility and correlation of biological replicates 
for RUNX1 0h, RUNX1 6h and RUNX1 E14.5.  
Sections are divided into RUNX1 0h (A), RUNX1 6h (B) and RUNX1 E14.5 (C). In each 
section: Scatter plot of signal scores, peak ranks and peak count based on estimated IDR for 
RUNX1 ChIP-seq biological replicates (left). Log(signal) and peak rank are displayed as 
replicate 1 vs replicate 2. Peaks with IDR > 0.01 are in red and peaks with IDR ≤ 0.01 are in 
black. Read count frequency of RUNX1 ChIP-seq peaks in replicate 1 and replicate 2 in relation 
to the TSS (middle). Pearson correlation matrix for replicate 1 and replicate 2 (right). The 
colour of matrix squares indicates correlation coefficient, noted in the bar at the bottom. Venn 







































DEG (KO vs 
WT) 
PR_WT1_R1 98646766 101 89.29 219652387 161499585 73.53 48083 11 32389 




PR_WT1_R2 98646766 101               
PR_WT2_R1 86097747 101 89.65 191411670 141827067 74.10       
PR_WT2_R2 86097747 101               
PR_WT3_R1 91499775 101 89.95 205975628 149821093 72.74       
PR_WT3_R2 91499775 101               
PR_WT4_R1 91481539 101 89.56 204544043 150230837 73.45       
PR_WT4_R2 91481539 101               
PR_KO1_R1 85913413 101 90.11 191698835 142028359 74.09       
PR_KO1_R2 85913413 101               
PR_KO2_R1 82837909 101 89.02 186884096 133122561 71.23       
PR_KO2_R2 82837909 101               
PR_KO3_R1 84211516 101 89.63 189420543 136964226 72.31       
PR_KO3_R2 84211516 101               
PR_KO4_R1 87996436 101 88.61 195431490 143504392 73.43       
PR_KO4_R2 87996436 101               
A_WT1_R1 91164449 101 90.66 204596707 150270954 73.45 48113 23 28705 




A_WT1_R2 91164449 101               
A_WT2_R1 88859348 101 88.68 199384188 142744907 71.59       
A_WT2_R2 88859348 101               
A_WT3_R1 88543261 101 91.01 196100419 148333038 75.64       
A_WT3_R2 88543261 101               




A_WT4_R2 87666250 101               
A_KO1_R1 94385408 101 90.5 208570243 157941605 75.73       
A_KO1_R2 94385408 101               
A_KO2_R1 92141186 101 89.95 205324175 151654876 73.86       
A_KO2_R2 92141186 101               
A_KO3_R1 97537594 101 90.33 217188872 161311718 74.27       
A_KO3_R2 97537594 101               
A_KO4_R1 83720240 101 90.49 184923926 140017075 75.72       
A_KO4_R2 83720240 101               
B_WT1_R1 93517712 101 89.52 206903424 154461178 74.65 51771 2 43782 




B_WT1_R2 93517712 101               
B_WT2_R1 94588459 101 90.59 208013215 159246040 76.56       
B_WT2_R2 94588459 101               
B_WT3_R1 87752248 101 89.45 194832357 145127282 74.49       
B_WT3_R2 87752248 101               
B_WT4_R1 88197326 101 89.46 194662277 146128992 75.07       
B_WT4_R2 88197326 101               
B_KO1_R1 90133697 101 87.46 200226516 145259269 72.55       
B_KO1_R2 90133697 101               
B_KO2_R1 88558420 101 89.67 194495485 148225066 76.21       
B_KO2_R2 88558420 101               
B_KO3_R1 95930056 101 87.78 210532927 157098322 74.62       
B_KO3_R2 95930056 101               
B_KO4_R1 92601256 101 86.48 204126836 147926625 72.47       




Appendix 13 List of differentially expressed genes identified in RNA-seq PGRKO vs WT 
granulosa cells identified through RNA-seq.  
Genes that had |logFC| ≥ 1 and an adjusted p-value cut-off of 0.01 were selected as DEG. 
LogFC is displayed as KO vs WT. 
Gene LogFC Adj p-value Gene LogFC Adj p-value 
Lyve1 -4.81 1.27e-121 Armc12 -1.20 0.00344 
Cldn1 -4.05 1.19e-173 4931415c17rik -1.20 0.000283 
Gm34549 -3.90 1.92E-54 Mbnl1 -1.20 9.61E-35 
Cyp2j11/cyp2j8 -3.46 2.9e-49 Gclc -1.19 1.22e-31 
L3mbtl4 -3.37 1.64e-80 Rp23-337k17.1 -1.19 0.000708 
Hsd17b11 -3.31 9.05e-102 Nxf3 -1.19 5.42e-12 
Scara5 -3.26 1.57e-103 Ate1 -1.19 4.05e-22 
Gm12637 -3.19 8.22E-34 Cln5 -1.19 9.97E-21 
Glp2r -3.17 5.18e-164 Rp23-357o17.2 -1.19 0.00498 
Gm33677 -3.12 3.24E-36 Agfg2 -1.18 3.26E-28 
4930467D21Rik -3.11 1.89E-76 Iqck -1.18 1.56E-17 
Kcnv2 -2.96 6.27e-42 Gm43791 -1.18 4.22e-17 
Sctr -2.81 4.7e-25 Loc728392 -1.17 0.000138 
Zic2 -2.74 1.03e-15 Ac134576.3 -1.17 0.00262 
Havcr2 -2.73 1.84e-48 Gm44769 -1.17 0.0000287 
Creg2 -2.72 2.65e-44 Gm45708 -1.17 0.0000659 
Gas7 -2.71 5.6e-144 Trim9 -1.17 3.18e-17 
Tbc1d8 -2.70 5.34e-92 Gm6382 -1.17 1.28e-08 
Ac096777.1 -2.69 2.07e-31 Kcnh6 -1.17 0.00639 
Scg2 -2.67 3.56e-87 Rp23-469k15.2 -1.17 0.00304 
Myh3 -2.65 2.21e-55 Gm10706 -1.17 0.00298 
Sphk1 -2.64 3.27e-53 Gm28516 -1.17 0.00605 
Ppp1r36 -2.63 2.58e-22 Elovl2 -1.16 4.94e-18 
Lingo4 -2.63 4.07e-61 Gm40318 -1.16 0.00599 
Hopxos -2.62 1.1E-24 Stmn4 -1.15 0.0000305 
C10orf71 -2.56 7.34E-28 Dok7 -1.15 6.94E-12 
Rcvrn -2.54 8.06e-25 Entpd7 -1.15 4.92e-25 
Gm38411 -2.54 1.42E-41 Sra1 -1.15 4.82E-21 
Itgb6 -2.54 3.65e-33 Rufy4 -1.15 0.000000127 
Hopx -2.47 4.41e-25 Ac159006.2 -1.15 0.00396 
Vnn3 -2.46 1.52E-50 Xrra1 -1.15 1.75E-12 
Sprr2g -2.45 1.66E-11 4930507D05Rik -1.15 6.55E-08 
A930019D19Rik -2.44 6.5E-62 Gm12926 -1.15 0.000887 
Cited1 -2.44 2.72e-25 Rtbdn -1.15 0.0000235 
Frmpd1os -2.43 9.35E-21 A830008E24Rik -1.14 0.000000021 
Ntn5 -2.43 6.28e-22 1700011b04rik -1.14 0.0076 
Gm33055 -2.40 2.21E-19 Tfcp2l1 -1.14 7.15E-11 




Tmem37 -2.38 1.94e-29 Il6 -1.14 6.26e-08 
Ac118724.1 -2.34 5.58e-38 Kcna5 -1.14 0.00559 
Cdh19 -2.33 8.75e-27 Tcf23 -1.14 0.000316 
Helt -2.33 1.48e-10 Gm12843 -1.14 3.16e-08 
Ralgapa2 -2.33 6.15e-63 Icoslg -1.14 2.07e-16 
Cxcr4 -2.31 2.78e-73 Mir6407 -1.14 0.00868 
Aldob -2.29 3.49e-40 Gm7575 -1.13 0.0000187 
Jcad -2.27 5.76e-43 Albfm1 -1.13 1.62e-11 
Frmpd1 -2.26 5.2e-41 Naa11 -1.13 1.22e-08 
1700040D17Rik -2.24 6.92E-13 Gm15471 -1.13 8.76E-21 
Fzd1 -2.23 2.81e-56 Mir3097 -1.13 0.00679 
Gm8200 -2.22 4.1E-10 Ceacam10 -1.13 0.0000156 
Ac119998.5 -2.21 3.87e-14 Gm15530 -1.13 0.00000157 
Entpd1 -2.20 2.84e-60 Ac113485.1 -1.13 0.00603 
Adam8 -2.19 4.45e-57 Gm14167 -1.12 0.0000248 
Gm11802 -2.19 1.33E-53 Gm18734 -1.12 0.000106 
Gm43545 -2.17 1.84E-47 Xpnpep1 -1.12 8.87E-20 
Rnu2-1 -2.16 1.95e-34 Gm30275 -1.12 3.25e-11 
Rlbp1 -2.15 7.68e-12 Mt3 -1.12 0.000000445 
Ccdc63 -2.15 7.36e-14 A330015k06rik -1.12 3.52e-13 
Gm13583 -2.14 1.58E-27 Olfr1033 -1.12 1.75E-10 
Rp23-390f4.1 -2.14 3.58e-18 Ampd3 -1.11 1.58e-11 
Ac154639.1 -2.13 1.3e-10 Gm44421 -1.11 0.0109 
Kcne4 -2.13 6.28e-22 C2cd4d -1.11 0.000241 
Mir8114 -2.13 2.02E-49 4930522N08Rik -1.10 0.0089 
Gm43401 -2.13 4.37E-22 1010001N08Rik -1.10 3.57E-25 
Myl2 -2.13 6.41e-12 Gm36638 -1.10 0.00135 
Gm3716 -2.11 4.29E-21 Gpr68 -1.10 3.33E-17 
Cd34 -2.10 3.48e-51 A930028n01rik -1.10 0.00000371 
Klf15 -2.10 2.5e-49 Defb45 -1.10 0.0119 
Abcc2 -2.10 3.15e-20 Mir1962 -1.10 0.00829 
Teddm2 -2.09 4.55E-35 Wipf3 -1.10 3.22E-16 
Adh6b -2.08 4.53E-12 4931403E22Rik -1.10 3.57E-15 
Gm37265 -2.08 1.07E-10 Bhmt -1.10 3.67E-08 
Kiaa1217 -2.07 9.97e-59 Papss2 -1.10 4.1e-18 
Rp23-282m20.5 -2.07 2.97e-08 Dclre1b -1.09 3.44e-14 
Gm38691 -2.07 9.72E-31 A530046M15Rik -1.09 0.00498 
Gm33024 -2.05 4.23E-12 Cryab -1.09 0.00000288 
Gm42463 -2.04 5.5E-14 Gm43672 -1.09 0.0000395 
Tsc22d3 -2.03 4.01e-35 Pla2g2f -1.08 0.0151 
Slc7a11 -2.03 4.69e-26 Cep295nl -1.08 3.76e-11 
Gm44079 -2.01 4.67E-39 N-r5s89 -1.08 0.00103 
Gm17590 -2.00 5.35E-35 Serpina5 -1.08 0.00412 
Gm16897 -2.00 7.44E-63 Pgap2 -1.08 2.42E-16 




Actn3 -1.99 1.28E-45 Tle1 -1.07 2.28E-23 
Ai463229 -1.98 1.04e-11 Gm5837 -1.07 0.0000186 
Kl -1.98 1.81e-40 Gm43128 -1.06 0.0148 
Rp23-98c9.5 -1.96 5.68e-27 Prima1 -1.06 0.000103 
Rorc -1.96 5.32e-35 2200002j24rik -1.05 0.00000462 
Mt2 -1.95 2.89E-27 A630009H07Rik -1.05 0.0156 
Gm16638 -1.94 3.94E-39 Hcn4 -1.05 0.00000778 
Adamts1 -1.94 4.95e-35 Pla2g15 -1.05 6.41e-16 
Atp4a -1.93 8.5e-49 Xlr3c  -1.05 0.000421 
Rp23-247p3.3 -1.93 1.25e-28 A430088p11rik -1.05 0.00241 
Hspa2 -1.92 2.38e-23 Rp23-182f9.7 -1.04 0.00000766 
Ankrd55 -1.91 1.17e-17 Syce2 -1.04 1.2e-11 
Gm26638 -1.91 6.83E-12 Gm10635 -1.04 0.00036 
Aloxe3 -1.91 1.61e-16 Rnd3 -1.04 7.03e-13 
Snap25 -1.90 7.34e-51 Cradd -1.04 1.37e-13 
Dcaf4 -1.90 8.05e-40 Rp23-281m13.1 -1.03 0.0042 
4930529N20Rik -1.90 0.0000005 Col27a1 -1.03 1.6E-11 
Gm37342 -1.90 2.06E-19 Add3 -1.03 8.33E-23 
Gm36602 -1.89 2.48E-28 Dusp27 -1.03 0.000621 
Kcnh4 -1.88 6.02e-21 Eldr -1.03 0.00000047 
Pparg -1.88 3.75e-29 Ac122251.2 -1.03 0.000678 
Gm10728 -1.88 2.6E-14 Apcdd1 -1.03 1.05E-10 
Gm44639 -1.87 4.7E-21 Gm28800 -1.03 3.52E-11 
Tnfsf11 -1.85 5.28e-31 Plac8l1 -1.03 0.00252 
Apol6 -1.85 2.67e-29 Unc79 -1.03 1.28e-08 
Pde6h -1.85 2.51e-14 1700049e15rik -1.03 0.0185 
Ripply1 -1.83 1.45E-08 RP23-243B24.4 -1.02 1.38E-18 
Gm20540 -1.81 6.72E-17 E230001N04Rik -1.02 0.000000863 
Cdh13 -1.81 2.21e-35 S100a10 -1.02 1.48e-10 
Rubcnl -1.80 4.02e-31 Clvs2 -1.02 6.92e-09 
Art4 -1.80 2.06e-10 Acsbg2 -1.02 0.00081 
Gm43434 -1.78 2.42E-26 Gm44069 -1.02 0.0191 
Micos10 -1.77 8.71e-26 Gm44284 -1.02 4.16e-11 
Mocs1 -1.77 4.57E-41 Cyp2j7 -1.01 0.0124 
Gm39041 -1.77 2.8E-26 Gm38248 -1.01 0.000000801 
Gm24224 -1.77 1.45E-08 Zyx -1.01 1.33E-13 
Ldhd -1.77 3.33e-33 Gm25043 -1.01 0.00000537 
Efnb2 -1.76 2.48e-33 Apoa1 -1.01 0.00000237 
Maml3 -1.75 1.97e-30 Wdfy2 -1.01 2.03e-19 
Gldc -1.75 4.29e-21 Abtb2 -1.01 1.54e-10 
Gm13068 -1.75 5.25E-21 Mob3b -1.00 4.34E-12 
Zcchc24 -1.74 1.03e-53 C630043f03rik -1.00 0.000364 
Gm37229 -1.74 9.28E-19 Pyroxd2 -1.00 0.00000907 
Gm45073 -1.73 1.37E-10 Ct572985.1 -1.00 0.00000793 




Mapre2 -1.71 1.01E-58 Btc 1.00 0.0000232 
Gm12796 -1.71 1.25E-32 8030423F21Rik 1.01 0.0136 
Gm37832 -1.71 0.000000251 4932441J04Rik 1.01 3E-20 
Tmc3 -1.70 1.69e-22 Gm45352 1.02 0.00000623 
Gk2 -1.70 0.00000537 P2ry14 1.02 2.3e-15 
Egfros -1.70 6.74E-34 Bach2os 1.02 0.00000152 
Sh3gl3 -1.69 5.26e-27 Gm15426 1.03 0.0112 
Trpa1 -1.69 8.83e-16 Gm43775 1.03 6.1e-11 
Gm20089 -1.69 2.01E-22 Vegfc 1.03 0.000000355 
Gm2861 -1.69 0.00000388 Gm42486 1.03 0.00232 
Gm40910 -1.68 0.00000977 Gm43947 1.03 0.0000539 
Kbtbd11 -1.68 1.02e-20 Gm30301 1.04 0.0000966 
Gm31510 -1.67 0.0000147 Kctd8 1.04 0.000000582 
4930524C18Rik -1.66 0.000000521 Gm16033 1.04 1.6E-12 
Rab11fip1 -1.66 3.02e-38 Gm16057 1.04 0.00134 
Bean1 -1.65 1.32e-47 Gm21168 1.04 1.02e-09 
Gm42553 -1.65 0.0000204 Astn1 1.04 0.000000113 
Stard5 -1.65 2.14e-44 Aw551984 1.04 0.000000164 
S100a2 -1.65 2.52e-55 Gm26725 1.04 5.28e-08 
Mb -1.64 2.28e-29 Unc5cl 1.04 0.00602 
Gm37673 -1.64 0.00000456 Fcgbp 1.04 0.0152 
Gm37844 -1.63 3.97E-08 Gm42536 1.04 0.0178 
Gm15475 -1.63 1.77E-21 Rp24-226h19.1 1.04 0.00174 
Hsd17b13 -1.63 1.97e-10 Gm26911 1.04 0.000000012 
Fabp4 -1.63 0.0000157 9330185c12rik 1.05 0.00000108 
Gm42555 -1.63 0.0000299 Gm42676 1.05 0.0157 
A930030B08Rik -1.63 2.83E-09 SIGLEC9 1.05 0.0000851 
Cyp2j15-ps -1.63 0.0000211 1110018n20rik 1.05 0.000787 
Prkg2 -1.62 6.46e-46 Coch 1.05 4.39E-09 
Hnf4a -1.62 0.000000104 Ltf 1.05 0.017 
Gm9748 -1.62 0.000000228 Gm42478 1.05 0.0000492 
Capn6 -1.61 1.92e-13 Gm28096 1.05 0.015 
Sec1 -1.61 6.08E-17 Rpp25 1.05 9.14E-09 
Gm26807 -1.61 3.22E-08 Gm28893 1.05 0.00803 
Gm43621 -1.61 3.2E-16 IGSF10 1.06 2.03E-18 
Hkdc1 -1.60 0.00000167 Fras1 1.06 2.17E-20 
Apol7e  -1.60 6.29E-08 DOK6 1.06 0.0176 
Gm11494 -1.60 0.00000178 Gm17087 1.06 0.000252 
Ces1a -1.59 0.00000847 Rasgrf2 1.06 4.9E-13 
Fyb2 -1.59 4.34e-18 Gm13477 1.06 0.0000309 
Gm43333 -1.59 0.0000251 Cdhr3 1.06 0.00654 
Trdv5 -1.59 1.07E-08 Gm37573 1.07 0.000195 
Gm29183 -1.58 1.31E-17 Gm41192 1.07 1.93E-14 
Gm4275 -1.58 3.64E-11 Ppp1r1a 1.07 0.00228 




Pcdh8 -1.57 1.73e-17 Vmn2r23 1.07 0.0151 
Tac3 -1.57 6.13e-11 5033403h07rik 1.08 0.00000682 
4930452G13Rik -1.57 0.00006 Gm16559 1.08 4.41E-10 
Gm15328 -1.57 4.62E-10 Gm35368 1.08 0.00144 
Pdlim1 -1.57 4.04e-33 Gm20703 1.08 0.000596 
E230020D15Rik -1.57 5.4E-14 Rp23-5h4.2 1.09 0.00994 
Dysf -1.56 5.37e-30 Gm7019 1.09 0.00185 
Defb119 -1.56 1.36e-20 Hba1/hba2 1.09 0.0056 
1810019D21Rik -1.56 1.76E-23 Satb2 1.09 3.47E-20 
Gm15684 -1.56 9.84E-32 Adh1c 1.10 7.33E-10 
Gm26843 -1.55 1.32E-15 9530086O07Rik 1.10 0.00000137 
Hrct1 -1.55 8.06E-08 Ret 1.10 0.00000569 
Aldh3a1 -1.55 8.06e-08 Csf2rb 1.10 4.56E-10 
Gm14319 -1.55 2.82E-08 Dpp6 1.11 3.7E-09 
Gm42435 -1.53 2.71E-08 Rp23-5h4.1 1.11 0.00307 
Ptgs1 -1.53 1.06e-19 Gm12526 1.11 2.85E-09 
4933416M07Rik -1.53 1.96E-11 Ptn 1.11 1.46E-11 
Crispld2 -1.52 3.53e-27 Gm14329 1.11 0.00013 
6030407O03Rik -1.52 6.91E-17 Gm15425 1.11 0.000000204 
Gm45613 -1.51 1.84E-15 Gm20443 1.11 0.0056 
Gstm1 -1.51 3.42e-18 Tmem229a 1.11 0.00634 
Bcl11b -1.51 5.27e-10 9130230l23rik 1.13 0.000000126 
Gm45267 -1.51 2.76E-21 Gmnc 1.13 0.00617 
Gm27884 -1.49 0.000172 Or2h2 1.13 0.00778 
Rnf125 -1.49 2.96E-37 Gm6089 1.13 7.54E-11 
Gm38252 -1.48 0.0000026 Gm42675 1.13 0.000387 
AC147241.1 -1.48 1.82E-16 Gm16072 1.13 0.00897 
PRRT4 -1.48 8.5E-42 Slc22a17 1.13 1.98E-13 
Gm45074 -1.48 0.00000452 Speer4a  1.13 8.22E-08 
Dkfzp434h168 -1.47 1.76e-40 Rp24-349l11.1 1.14 0.0000499 
Gm26833 -1.46 0.000046 Olig3 1.15 0.00101 
Gm10631 -1.46 6.78E-20 Bc049352 1.15 0.00125 
D630033O11Rik -1.46 6.18E-12 Olfr1545-ps1 1.15 0.0076 
Gm37995 -1.46 0.00000606 Or8d1 1.16 0.0000967 
Slc38a4 -1.46 1.27e-17 Gm5144 1.17 0.00317 
Gm37675 -1.45 0.000015 Pla2g7 1.17 7.7E-14 
Dtna -1.45 2.77e-38 Dtx1 1.17 2.92E-15 
Trpc4 -1.45 3.22e-15 Immp2l 1.17 1.81E-17 
Scrn1 -1.44 3.41e-15 Gm42604 1.18 7.76E-09 
Vwce -1.44 8.63e-09 Gm38240 1.19 0.000945 
A330049N07Rik -1.43 0.000000243 Gm35570 1.19 0.00519 
Ac113178.1 -1.43 1.94e-33 Cacna2d3 1.20 9.89E-21 
Serpina3g  -1.43 0.0000824 Arhgef38 1.20 0.00128 
Hgfac -1.42 2.7e-15 Gm18645 1.20 0.000019 




Cyp4f8 -1.42 2.4e-11 Ly6m 1.23 0.000000623 
Gstm5 -1.42 2.38e-17 Edil3 1.24 7.22E-15 
Rp23-156n5.2 -1.42 0.000463 Hla-dob 1.24 0.0000677 
Gm4788 -1.41 1.45E-11 Rsad2 1.24 0.000000741 
Gm25631 -1.41 6.42E-09 Gm21655 1.24 3.76E-11 
Per2 -1.41 5.18e-19 Gm37941 1.25 0.000534 
Gprc5b -1.40 1.27e-24 Mep1a 1.26 8.19E-08 
Slco2a1 -1.40 5.88e-33 Tubb4a 1.26 7.4E-14 
Slc16a6 -1.39 2.97e-26 Gm32364 1.26 1.16E-12 
Gm34776 -1.39 0.0000724 Gm42639 1.29 1.03E-09 
Lpar1 -1.39 1.51e-38 Gm7775 1.30 0.0000494 
Ahsg -1.39 1.08e-10 Ac122355.1 1.30 0.0000017 
Gm10729 -1.39 0.00000701 Ac134249.1 1.30 0.00149 
Glns-ps1 -1.38 0.0000193 Gm42534 1.31 0.00136 
Ca11 -1.38 2.72e-09 Znf804a 1.32 1.16E-11 
Gm12801 -1.38 0.000262 Ky 1.32 0.00000854 
Rasef -1.38 9.82e-20 Rbp4 1.33 3.08E-13 
E130308A19Rik -1.38 7.45E-33 Il25 1.33 0.000888 
Lamc3 -1.38 9.19e-18 Chrna9 1.33 0.00000283 
Esrp2 -1.37 1.07e-18 Gm41031 1.35 1.25E-11 
Ac118724.2 -1.37 0.0000264 Prkcb 1.36 1.09E-20 
Gm3470 -1.37 0.000277 Cyp26b1 1.36 4.08E-26 
Jam3 -1.36 8.74e-38 Dnase2b 1.36 0.000772 
Gm807 -1.36 3.57E-10 Lsamp 1.37 7.48E-17 
Dmd -1.36 4.59e-25 Gm10493 1.37 0.0000196 
Gstm2-ps1 -1.36 0.000000186 Kcnb1 1.38 3.47E-20 
Nipal1 -1.35 1.66e-23 Pgm5 1.38 3.63E-18 
Gm6665 -1.35 8.24E-13 NRG3 1.39 3.44E-13 
Nt5el -1.34 0.000000132 Nrg3os 1.40 3.62E-09 
Gm45463 -1.34 0.000385 Mir-218 1.41 0.000446 
Ac118249.1 -1.34 0.000116 Tmem213 1.41 0.000266 
Gm11384 -1.33 1.44E-09 Lpo 1.41 0.000455 
Slit1 -1.33 0.00000047 Kel 1.42 1.92E-08 
Met -1.33 1.9e-29 Avil 1.42 5.75E-14 
Them6 -1.33 3.92e-13 Brinp3 1.43 9.12E-14 
Gm45266 -1.33 3.43E-09 Slit2 1.44 3.56E-22 
Ppfia2 -1.32 2.1e-09 Olfr1233 1.44 0.000326 
Gm45457 -1.32 3.56E-13 Nsun7 1.44 1.28E-15 
Vnn1 -1.32 0.00128 Gm42640 1.45 2.14E-12 
Edn2 -1.32 4.98e-08 Tac1 1.46 8.13E-13 
Ct030159.2 -1.31 7.29e-12 Gm22513 1.49 1.02E-08 
Vldlr -1.31 3.66e-27 Gm45191 1.49 0.0000034 
Gm14020 -1.31 8.33E-10 C4orf17 1.49 4.41E-15 
Lrp8os3 -1.31 4.69E-11 4930563J15Rik 1.50 3.77E-08 




Gm45615 -1.30 1.14E-10 Uox 1.54 0.0000322 
Arhgap31 -1.30 2.06E-32 Spock3 1.56 5.8E-29 
Gm37068 -1.30 0.00139 Ac122881.1 1.56 5.06E-12 
Cdh18 -1.30 5.78E-08 Gm43426 1.57 6.98E-08 
Gm43298 -1.29 0.00164 Stac2 1.57 6.83E-16 
Ac132133.3 -1.29 1.09E-10 Sprr2f 1.58 1.02E-08 
Sorbs2os -1.29 1.26E-19 4833427F10Rik 1.58 1.02E-22 
Rp24-421p3.9 -1.28 1.23E-21 4933416M06Rik 1.58 1.07E-09 
Rbbp7 -1.28 8.19E-19 Ddit4l 1.61 1.99E-32 
Phf11 -1.28 0.000000003 Ac155634.2 1.63 0.00000297 
Rp24-79i19.5 -1.28 2.01E-21 Spta1 1.63 2.17E-15 
Gm39168 -1.28 0.00143 Npy1r 1.64 2.19E-09 
Vps26a -1.27 2.31E-26 Gm20642 1.64 1.97E-10 
Gm35041 -1.27 0.000000078 Lingo1 1.64 4.02E-34 
Gm29536 -1.27 2.53E-12 Gm15749 1.64 1.5E-26 
Sorbs2 -1.27 2.26E-18 Cmtm5 1.66 0.000000847 
4833404L02Rik -1.27 0.00225 Gm9947 1.68 3.81E-15 
Gm20616 -1.27 0.0000168 Muc4 1.69 0.0000126 
Gm15398 -1.26 0.000000379 Gm7652 1.70 0.00000741 
Gm29053 -1.26 0.000104 Gm37877 1.70 3.79E-08 
Acss3 -1.26 1.27E-10 Egln3 1.71 8.75E-41 
Loc105247277 -1.26 0.00251 4930518C09Rik 1.71 0.000000141 
Pfkfb4 -1.26 1.15E-27 Gm20475 1.75 3.97E-08 
Gm11250 -1.25 0.000000003 Platr22 1.78 7.49E-31 
Gm13441 -1.25 6.33E-11 Mdga2 1.86 4.58E-17 
Ear2  -1.25 0.000000102 Msc 1.87 1.33E-13 
Gm44129 -1.25 6.38E-09 Kcnk10 1.92 6.09E-53 
Gm30606 -1.24 0.0000946 Lrtm1 1.92 1.25E-38 
Mt1 -1.24 8.12E-20 Slitrk2 1.93 5.18E-19 
E130008D07Rik -1.24 0.000515 Gm21049 1.94 1.12E-09 
Rp23-316f10.1 -1.24 0.00276 Lrrn3 1.97 5.39E-28 
Tmem144 -1.24 2.82E-22 Aoc1 1.98 1.47E-08 
Mageb18 -1.23 3.22E-15 Npr3 1.98 7.13E-26 
Al513022.2 -1.23 1.21E-10 Ct025533.1 2.03 4.24E-08 
Reep1 -1.23 1.13E-22 Sprr2b 2.04 4.38E-08 
Trhr2 -1.23 0.00301 Cnr1 2.10 4.55E-35 
Add2 -1.23 7.65E-16 Myh6 2.12 4.52E-11 
Gm16318 -1.22 0.000000423 Clca1 2.23 4.7E-12 
Got1l1 -1.22 0.000936 Chi3l1 2.24 7.9E-11 
Gm44763 -1.22 0.0000004 Gm26771 2.51 7.86E-61 
B4galt6 -1.21 1.2E-15 Sfrp2 2.58 1.17E-58 
Gm27177 -1.21 0.00000239 Sprr2d 2.67 1.16E-13 





Appendix 14 List of differentially expressed genes identified in RNA-seq AKO vs WT 
granulosa cells identified through RNA-seq.  
Genes that had |logFC| ≥ 1 and an adjusted p-value cut-off of 0.01 were selected as DEG. 
LogFC is displayed as KO vs WT. 
Gene LogFC Adj p-value Gene LogFC Adj p-value 
Lyve1 -5.83 0 Sox5os4 -1.21 6.68E-26 
Sprr2g -5.46 1.87E-119 Gm45321 -1.20 0.000817 
Cyp2j11/cyp2j8 -4.40 3.1e-118 Hsd17b13 -1.20 0.00000251 
Zic2 -4.14 1.28e-59 Gm33962 -1.20 2.6E-10 
Hand2 -3.77 7.86e-40 Loxl2 -1.20 5.62E-36 
Cldn1 -3.76 8.62e-155 Sult1a1 -1.20 1.36E-16 
Kcnv2 -3.70 6.09e-121 Sox5os5 -1.19 5.29E-09 
1700040D17Rik -3.70 1.52E-50 Mbnl1 -1.19 5.59E-70 
Cited1 -3.62 2.26e-199 Gm12002 -1.19 1.91E-14 
Myh13 -3.59 3.95e-159 Mt3 -1.19 1.11E-09 
Pla2g2f -3.55 2.55e-39 Cxcl3 -1.19 0.00134 
Fabp4 -3.53 9.66e-102 Cwh43 -1.19 0.00152 
Ppp1r36 -3.34 1.66e-45 Hgfac -1.18 1.9E-14 
L3mbtl4 -3.33 2.65e-139 Dtna -1.18 1.37E-29 
Gm45315 -3.30 1.54E-46 Vnn3 -1.18 2.33E-08 
Kcne4 -3.24 2.19e-131 A730049h05rik -1.18 1.96E-43 
Itga4 -3.22 3.8e-196 Slc17a8 -1.18 3.92E-11 
Sctr -3.22 3.62e-61 Elovl7 -1.18 1.98E-14 
Scg2 -3.00 8.14e-67 Gm3470 -1.17 0.000393 
Ntn5 -2.95 2.82e-85 Dnah3 -1.17 0.00148 
Jcad -2.93 9.59e-257 S1pr3 -1.17 8.64E-26 
Tmem37 -2.82 3.15e-97 Gm43916 -1.17 1.48E-15 
Dusp2 -2.80 2.57e-30 Cfap65 -1.17 0.00203 
Rp23-98c9.5 -2.79 2.12e-122 Gm13266 -1.17 0.00246 
Hand2os1 -2.78 2.77E-28 Dmd -1.17 1.35E-53 
Mt2 -2.78 1.27E-123 Gm36548 -1.17 0.00139 
Havcr2 -2.75 1.52e-80 Tcf23 -1.16 0.00000171 
Sphk1 -2.74 2.03e-92 Gm37513 -1.16 0.000537 
Rp23-357o17.1 -2.73 5.61e-19 Tmc3 -1.16 2.03E-17 
Cdh13 -2.73 7.24e-79 Slc39a4 -1.16 0.000271 
Gm3716 -2.70 6.62E-46 Fes -1.16 1.2E-22 
Ac096777.1 -2.64 1.15e-55 Them6 -1.16 7.53E-18 
Clec2e/clec2h -2.61 4.96e-22 Tle1 -1.16 1.25E-70 
Slco2a1 -2.55 1.31e-162 Gm9847 -1.16 0.000451 
Frmpd1 -2.53 1.72e-116 Smarca2 -1.16 4.62E-54 




Hsd17b11 -2.51 4.54e-133 Gria1 -1.16 0.000052 
Cerkl -2.49 2.22e-70 Gm43557 -1.16 0.000664 
Scn4a -2.47 1.09e-17 Drc7 -1.16 0.00291 
Krtdap -2.46 9.96e-28 Gm17831 -1.15 0.000000153 
Rp24-421p3.9 -2.46 2.82e-112 Sra1 -1.15 2.77E-25 
Sh3gl3 -2.45 3.13e-64 Gm37488 -1.15 4.26E-15 
Gm33024 -2.42 1.79E-27 Pifo -1.15 0.00296 
Gm12637 -2.41 8.4E-29 Lrat -1.15 0.000357 
A930030B08Rik -2.40 2.95E-32 Hspb1 -1.14 1.06E-12 
Fam210b -2.36 5.26e-123 Spock1 -1.14 9.26E-09 
Itgb6 -2.36 9.9e-44 Togaram2 -1.14 0.000212 
N-R5s89 -2.36 4.56E-20 Gm34549 -1.14 0.00155 
Gldc -2.35 4.07e-143 Gm44442 -1.14 0.00000397 
Sec1 -2.33 2.29E-48 Panct2 -1.14 0.00295 
Abcc2 -2.31 6.72e-67 Rp23-247p3.2 -1.13 0.0000205 
E230020D15Rik -2.30 9.5E-92 Hla-dob -1.13 0.00362 
Cyp2j15-ps -2.30 1.19E-14 Igdcc3 -1.13 2.88E-22 
Ces1a -2.30 3.42E-13 Bst1 -1.13 0.0000757 
Gm43298 -2.28 6.24E-16 4930419G24Rik -1.13 0.000000799 
Clec2j -2.27 2.85E-13 Rp1 -1.13 0.00227 
Glp2r -2.24 2.08e-122 Pkdcc -1.13 6.2E-22 
Gm4275 -2.23 6E-38 Tac3 -1.13 0.0000192 
4930452G13Rik -2.22 9.41E-16 Rp23-282m20.5 -1.13 0.00311 
Frmpd1os -2.22 2.66E-21 Slc12a3 -1.13 0.00121 
Tbc1d8 -2.22 2.4e-99 Aldh3a1 -1.13 0.0000771 
Gm45073 -2.21 1.06E-54 2310039L15Rik -1.13 3.04E-11 
2610035F20Rik -2.21 5.5E-11 Sox5os3 -1.12 9.95E-22 
Rp23-390f4.1 -2.21 2.37e-44 Gm30414 -1.12 0.00386 
Gm30771 -2.20 4.61E-13 Ac131329.1 -1.12 0.00149 
Gm12796 -2.19 5.4E-77 Fam83f -1.12 1.34E-09 
Gm13068 -2.15 1.89E-50 Gclc -1.12 1.69E-55 
Gm44988 -2.15 3.99E-10 Mageb18 -1.12 2.18E-19 
Gstm3 -2.13 4.35E-11 Gm15762 -1.12 0.00224 
Pla2r1 -2.12 1.93E-102 Hif3a -1.12 3.36E-11 
Fzd1 -2.10 1.81E-81 Mir6363 -1.12 9.39E-09 
Gm27216 -2.10 2.95E-15 Gfi1 -1.12 0.000928 
Gm18194 -2.10 2.16E-24 3100003L05Rik -1.12 0.00412 
Gm27884 -2.10 2.34E-10 Xlr3c -1.11 0.000186 
Gm36329 -2.09 2E-21 Gm26717 -1.11 0.000313 
4930529N20Rik -2.09 9.99E-12 4930522N08Rik -1.11 0.000878 
Gm12801 -2.08 8.42E-10 Mob3b -1.11 4.4E-17 




Bcl11b -2.07 8.96e-51 Olfr1417 -1.11 0.000887 
Arhgdib -2.07 1.7e-30 Adrb1 -1.10 0.0000175 
Tmprss11b -2.06 1.16E-12 Pygl -1.10 0.0000244 
Helt -2.05 6.32e-12 Vnn1 -1.10 7.35E-30 
Gm45463 -2.05 2.12E-10 Rrm2 -1.10 1.09E-18 
Gm15475 -2.05 4.6E-47 Clic6 -1.10 0.00207 
Zbtb16 -2.04 1.15e-65 Clec2d -1.10 2.07E-29 
Gm15328 -2.04 9.6E-23 Gm12577 -1.09 0.00000788 
Gm39168 -2.03 1.65E-10 Gm43621 -1.09 5.12E-14 
Gstm5 -2.02 2.79e-189 Rpl27-ps2 -1.09 0.000104 
Kcnh4 -2.01 1.14e-31 Speer4cos -1.09 0.00559 
Vwde -2.01 3.72e-59 Mgat4c -1.09 1.91E-14 
1500012K07Rik -2.00 3.34E-09 Rev3l -1.09 1.8E-41 
Gm44079 -2.00 1.4E-78 Pzp -1.09 0.0000735 
Gm37498 -2.00 8.06E-24 Armc4 -1.09 0.000325 
Gas7 -1.99 4.93e-106 Rbp7 -1.09 0.00581 
Rp23-357o17.2 -1.98 8.36e-09 Crispld2 -1.09 4.69E-36 
Vldlr -1.98 5.85e-103 Gm10997 -1.09 0.000000239 
Pde6h -1.98 4.04e-36 Ces1 -1.09 0.00025 
Csgalnact1 -1.97 3.81e-90 C2cd4d -1.08 0.000221 
S100a6 -1.96 3.22e-42 Rny1 -1.08 0.000358 
Gm40910 -1.95 1.92E-13 Marco -1.08 0.00058 
Gm13583 -1.94 6.74E-34 Pex5l -1.08 1.4E-09 
Hopxos -1.94 2.7E-12 Gm37675 -1.08 0.0000518 
Gm8834 -1.94 4.23E-18 Gm15573 -1.08 0.00198 
5830468F06Rik -1.94 1.52E-08 SLC28A3 -1.08 0.000014 
Ca11 -1.94 1.77e-33 Gm20684 -1.08 0.00133 
1700125H03Rik -1.92 1.07E-12 Plet1 -1.08 0.00303 
Pparg -1.91 7.01e-61 Gm26203 -1.07 0.00104 
Gstm2-ps1 -1.90 2.59E-39 Gm38505 -1.07 0.00617 
Cd34 -1.90 1.6e-129 C030005k06rik -1.07 0.000000173 
Bean1 -1.90 1.39e-72 Jam3 -1.07 6.04E-30 
Hopx -1.89 5.44e-22 Cdkl1 -1.07 0.0000617 
Lpar1 -1.89 1.94e-87 Timp2 -1.07 1.12E-45 
Rp23-247p3.3 -1.88 1.97e-37 Atp2b2 -1.07 0.00000101 
Gm20540 -1.88 4.2E-41 Cryab -1.07 0.000000218 
Stmn4 -1.87 1.71e-32 Gm37589 -1.06 3.8E-13 
Ralgapa2 -1.87 4.46e-57 St14 -1.06 4.81E-08 
Mir-434 -1.85 0.00000011 Edn2 -1.06 2.39E-10 
Gm22595 -1.84 0.000000014 Plekhs1 -1.06 0.000593 
Gm11494 -1.84 8.23E-23 Gm43000 -1.06 9.23E-08 




RP23-469K15.2 -1.83 1.12E-10 Naip1 -1.06 0.00731 
Gm33677 -1.83 3.44E-22 Prkab2 -1.06 4.61E-42 
A930019D19Rik -1.83 9.27E-37 Sox17 -1.06 0.00234 
Gm42463 -1.83 3.71E-13 Trpc5os -1.05 3.35E-12 
Gm43545 -1.82 5.14E-54 Ccdc180 -1.05 0.00522 
Slc14a1 -1.82 3.73e-13 Smkr-ps -1.05 4.21E-18 
Gm14319 -1.82 1.56E-18 Mir3092 -1.05 0.000243 
Ai463229 -1.81 1.11e-14 Strc -1.05 0.00736 
Gm16897 -1.81 2.31E-101 Kcnmb1 -1.05 0.0036 
Tnfsf11 -1.81 9.71e-12 Barx2 -1.05 0.000861 
Ldhd -1.81 1.87e-46 Stmnd1 -1.04 0.00728 
Gm17590 -1.79 1.12E-42 6030407O03Rik -1.04 3.4E-14 
1700011B04Rik -1.79 7.77E-09 Gm29183 -1.04 1.33E-09 
Tmem100 -1.79 2.34e-67 Gmnc -1.04 0.00536 
Rnf125 -1.79 6.6E-70 KLF5 -1.04 8.64E-13 
Hkdc1 -1.78 1.99e-11 Gabra1 -1.04 2.12E-12 
Gm44639 -1.77 3.26E-39 Cpn1 -1.04 0.00773 
Gm8233 -1.77 0.000000345 Gm37548 -1.04 0.000357 
Rubcnl -1.76 7.11e-36 4930535l15rik -1.04 0.00545 
Gm11917 -1.76 0.00000027 Plin4 -1.04 8.16E-18 
Gm14085 -1.75 2.88E-26 Sprr2f -1.04 0.0000201 
Cdh5 -1.75 5.91e-43 Smco3 -1.04 0.00115 
Gm45074 -1.74 1.63E-22 Igkc -1.04 0.00404 
Gm38411 -1.72 1.66E-51 1700095J12Rik -1.04 0.0000163 
Npy -1.72 5.43e-26 Cdh18 -1.03 2.32E-13 
Gm10631 -1.72 6.01E-29 Acnat1/Acnat2 -1.03 0.00802 
Slc25a33 -1.71 9.02e-79 Gm43539 -1.03 0.000015 
Mocs1 -1.71 1.42E-78 Ripk4 -1.03 0.00083 
Slc28a2 -1.71 9.63e-31 Gm30211 -1.03 0.0014 
Gm18252 -1.71 1.39E-17 Fbxl5 -1.02 3.22E-50 
Apoa1 -1.70 8.44e-58 Plet1os -1.02 0.00594 
Gm37832 -1.70 0.000000022 Capn8 -1.02 0.000743 
Rras2 -1.70 5.61e-92 Dnai1 -1.02 0.00903 
Kl -1.70 4.92e-62 Gm37651 -1.02 0.00000898 
Rp23-337k17.1 -1.69 5.98e-12 Gm24620 -1.02 0.00104 
Rapgef5 -1.69 1.21e-65 Dpy19l2 -1.02 0.0029 
Gm43401 -1.68 7.9E-43 Ldoc1 -1.02 0.00481 
Cntnap3 -1.68 2.46e-11 Dnah12 -1.02 0.00000032 
1200007C13Rik -1.67 6.96E-13 Gm4032 -1.02 0.0000772 
Gm39041 -1.67 4.29E-29 Gm17970 -1.02 0.00133 
1700073E17Rik -1.66 0.000000373 Cln5 -1.01 2.04E-35 




Hhip -1.64 5.86e-72 Gm19689 -1.01 3.63E-08 
Lmntd1 -1.64 1.08e-19 Gm12364 -1.01 0.00000616 
Ac154639.1 -1.63 2.53e-18 Gm21814 -1.01 6.55E-16 
Stard5 -1.63 7.94e-81 4833423e24rik -1.01 0.00535 
Cys1 -1.63 4.5e-21 Myt1l -1.01 0.000515 
Gm10706 -1.62 2.14E-10 Capsl -1.01 0.00865 
E130008D07Rik -1.61 7.52E-10 Zcchc24 -1.00 5.43E-28 
Xrra1 -1.61 6.33e-31 Fat4 -1.00 2.17E-26 
Gm29682 -1.61 1.01E-24 Sdk1 -1.00 2.28E-10 
Gm15997 -1.60 0.00000198 Acox2 -1.00 0.00877 
Ak3l2-ps -1.60 1.39E-26 Gm40578 1.00 2.13E-08 
Prrt1 -1.60 1.22E-25 Vmn2r88  1.00 0.00445 
Arl4d -1.60 1.17e-32 Gm12860 1.00 0.000123 
Plppr5 -1.59 6.06e-18 Efhd1os 1.01 4.07E-14 
Gm38378 -1.59 0.000000529 Rbm47 1.01 1.2E-25 
Fabp1 -1.59 0.00000809 Cdh10 1.01 2.21E-13 
Ac147241.1 -1.58 0.00000153 Slit2 1.01 1.29E-28 
Gm45266 -1.57 3.3E-14 Gm12349 1.01 0.00131 
Gm37265 -1.57 0.000000691 4933416M06Rik 1.02 1.96E-11 
AC087802.4 -1.57 0.00000748 Gm8773 1.02 0.00438 
Cd33 -1.57 0.00000036 Gm28721 1.02 0.00545 
Gm16318 -1.57 1.76E-15 Epha3 1.02 2.61E-12 
Piwil4 -1.57 3.15e-15 Nme8 1.02 0.000029 
Rasef -1.56 3.03e-28 Cish 1.03 5.67E-12 
Gm45267 -1.56 5.48E-30 Tspan15 1.03 0.0000321 
Add2 -1.56 1.61e-27 Gm26725 1.04 4.37E-14 
Entpd1 -1.56 8.85e-68 Gm16048 1.04 7.35E-11 
Ampd3 -1.55 5.86e-64 1700126h18rik 1.04 0.0000241 
Gm31510 -1.55 0.00000535 Sytl3 1.05 4.74E-13 
Ankrd55 -1.54 3.24e-28 Gm43948 1.05 1.17E-12 
Glns-ps1 -1.54 1.13E-19 Gm29530 1.05 0.00000553 
Gm9748 -1.54 9.18E-15 Plau 1.05 3.49E-17 
Gm18911 -1.54 1.28E-10 Hck 1.05 9.91E-08 
Gcnt1 -1.53 1.16e-16 Gm29480 1.05 0.000000719 
Kbtbd11 -1.53 1.95e-68 Vegfc 1.06 3.2E-13 
Ct572985.1 -1.52 1.96e-14 Gm37679 1.06 1.21E-10 
Tnfrsf21 -1.52 3.46e-53 4930557b06rik 1.06 0.00756 
Fam107a -1.52 0.000000251 Tac1 1.06 4.28E-11 
Bb123696 -1.51 0.000000496 Gm17040 1.06 7.33E-09 
Tmem255a -1.51 1.55e-63 Ptpro 1.07 3.35E-17 
4931431B13Rik -1.51 0.0000335 9530086O07Rik 1.07 0.000000227 




Gm45615 -1.50 4.14E-15 Nsun7 1.07 5.08E-27 
Cblif -1.49 1.26E-08 Loc102633156 1.07 0.00268 
4933416M07Rik -1.49 1.32E-30 Or10v1 1.07 0.00149 
Rmst -1.49 5.63E-19 Kctd19 1.07 0.000603 
Rcvrn -1.49 2.13E-10 Lgi3 1.08 1.28E-31 
Gm24224 -1.48 8.02E-10 Tmprss11e 1.08 0.00187 
Ac132133.2 -1.48 1.74E-13 Gm13780 1.08 1.87E-11 
Ac159006.2 -1.48 0.0000168 Gm17322 1.08 2.3E-11 
Gm28651 -1.47 0.00000126 Npr1 1.08 1.32E-13 
Serpina11 -1.47 0.0000524 Kcnk10 1.08 4.69E-11 
Ccdc63 -1.47 1.18E-17 Arhgap15os 1.09 0.000888 
Tmod1 -1.47 1.04E-62 Slc27a6 1.09 3.75E-24 
Gm11802 -1.46 4.39E-40 Ccl21 1.09 0.00566 
Gm42476 -1.46 0.0000605 Ac120150.1 1.09 0.00174 
Aqp11 -1.46 1.79E-27 Kcnk3 1.10 0.0000852 
Mapre2 -1.45 1.04E-84 Egr4 1.10 0.0000038 
Gm37526 -1.45 0.00000206 Wnt10b 1.10 0.000415 
Pdlim1 -1.45 6.15E-103 Ct010447.1 1.10 0.0000175 
Mt1 -1.45 2.9E-29 Pdzrn3 1.10 2.03E-13 
B020031H02Rik -1.44 0.0000151 Hk2 1.10 1.47E-24 
Plac8l1 -1.44 2.96E-09 Gamt 1.11 5.67E-36 
Mir5619 -1.44 0.0000882 RP23-433C10.1 1.11 0.000236 
Rbbp7 -1.43 2.28E-65 Gm37941 1.11 0.00349 
Gm20616 -1.43 1.52E-08 AC134577.1 1.12 9.86E-19 
Gm36070 -1.43 0.000000469 Tmem178a 1.12 1.74E-14 
Atp4a -1.42 1.43E-25 Gm20475 1.12 0.000197 
Ankrd45 -1.42 0.0000403 Kcnq4 1.13 1.02E-14 
Micos10 -1.42 1.18E-39 Gm17041 1.13 1.55E-14 
Teddm2 -1.41 3.19E-42 Gm43057 1.13 0.000331 
Gm6382 -1.41 2.5E-26 Gm7775 1.13 0.00182 
Mir8114 -1.41 3.5E-45 Nr0b2 1.15 6.84E-09 
Defb119 -1.40 3.84E-27 4930584F24Rik 1.15 0.000102 
Scara5 -1.40 7.73E-36 Gm15917 1.15 1.48E-19 
Kiaa1217 -1.39 4.51E-51 Vsig8 1.16 8.31E-11 
Prkg2 -1.39 7.42E-33 Ackr1 1.17 0.00000252 
Trpc4 -1.39 4.03E-19 Rrad 1.17 2.75E-17 
Ac113178.1 -1.39 1.49E-43 Lsamp 1.17 8.07E-43 
Abhd2 -1.38 2.58E-68 Shank1 1.17 1.4E-17 
Six4 -1.38 9.2E-09 Gm15584 1.18 1.08E-11 
Ifnk -1.38 0.000000622 Gm45589 1.19 0.000983 
F730035M05Rik -1.37 0.00000265 Ppp1r3c 1.19 0.000000038 




Gm11384 -1.37 5.87E-19 Gm44226 1.20 0.0000456 
Actn3 -1.37 1.7E-25 Gm15426 1.20 0.000143 
Gm42435 -1.36 0.000000142 Gm43776 1.20 0.00105 
Serpina1 -1.36 0.000198 Gm32219 1.21 1.42E-09 
Stc2 -1.36 6.99e-22 Gm28053 1.22 1.13E-13 
C1orf87 -1.36 0.000263 Gm12214 1.22 0.000194 
Gm12505 -1.36 0.00000948 Gm6276 1.23 0.000000967 
Cgn -1.35 2.25e-33 Slc22a17 1.23 7.54E-16 
Gm6101 -1.35 0.000273 C11orf86 1.24 0.000582 
Igsf5 -1.35 0.00000354 Bc055402 1.24 0.00116 
Trim9 -1.35 0.0000757 Gfod1 1.25 3.47E-31 
Nrxn3 -1.35 5.09E-14 Sema3d 1.25 2.39E-22 
Aloxe3 -1.34 1.28e-10 Tle2 1.25 1.29E-20 
Gm25788 -1.34 0.000128 Gm37644 1.26 0.000429 
Gm19303 -1.34 0.000169 Gm43947 1.26 1.55E-11 
Gm42555 -1.34 0.0000246 Rgs6 1.26 4.3E-15 
Nipal1 -1.34 2.76e-45 Gm12526 1.26 2.56E-11 
Ryr2 -1.34 1.69e-49 Gm16559 1.26 7.39E-39 
Defb45 -1.34 0.000242 Sh3gl2 1.27 4.41E-22 
Entpd7 -1.33 3.94e-65 Kcnk15 1.28 6.52E-09 
Gm37844 -1.33 3.43E-13 Myh6 1.28 0.0000009 
Pcdh8 -1.33 1.31e-24 Gm8439 1.29 1.28E-18 
Gm15841 -1.33 0.000385 Gm36569 1.30 1.65E-37 
Egfros -1.32 2.31E-25 Csf2rb 1.30 6.21E-13 
Lpar3 -1.32 0.0000013 Map6d1 1.31 3.66E-29 
Gm45199 -1.32 0.000382 Adh1c 1.31 7.85E-47 
Gm44851 -1.32 9.85E-15 4833403J16Rik 1.32 0.0000262 
Gm11250 -1.32 2.01E-26 Plekhg4 1.32 1.2E-14 
Gm9959 -1.32 3.62E-19 Gm9947 1.32 4.95E-09 
Gm21123 -1.31 0.0000224 Atp1a3 1.32 0.000000351 
Zbbx -1.31 0.000266 Gm9899 1.33 2.37E-10 
Slc15a1 -1.31 0.0000378 Lingo1 1.34 6.91E-16 
C630043F03Rik -1.31 1.29E-19 Gm7019 1.34 0.0000098 
Gm36447 -1.30 2.19E-09 Brinp2 1.34 5.97E-17 
Gm37342 -1.30 4.13E-23 Wnt4 1.35 4.83E-33 
Arhgap31 -1.30 2.84e-78 Ly6g6c 1.35 0.0000826 
Cxcl6 -1.30 1.63e-08 Avil 1.36 2.49E-20 
Myl2 -1.30 0.000000304 Astn1 1.36 8.98E-23 
Unc5cl -1.29 0.000000802 Gm20471 1.36 0.00000088 
Parm1 -1.29 6.61e-65 Spock3 1.36 1.03E-46 
Gm10728 -1.29 7.84E-10 4833415N18Rik 1.37 0.000137 




Stxbp6 -1.29 2.83e-31 Nrg3 1.40 4.6E-25 
Hoxd11 -1.29 2.29e-18 Ac155634.2 1.40 0.0000112 
4930523O13Rik -1.29 0.000561 Tbata 1.41 5.66E-14 
4921523L03Rik -1.28 0.000475 Egln3 1.41 8.51E-31 
Gm20089 -1.28 4.13E-23 Gabrb3 1.41 8.14E-24 
Hnf4a -1.27 1.3e-11 Rem1 1.41 2.23E-25 
Gm15901 -1.27 1.78E-11 Ca12 1.43 2.77E-49 
3110080O07Rik -1.27 1.49E-29 Gm44708 1.43 0.0000174 
Cep295nl -1.27 3.17e-25 Lipg 1.44 2.44E-24 
Rhoj -1.27 1.99e-36 Slc29a4 1.45 3.63E-19 
1700019C18Rik -1.27 0.000398 Brinp3 1.46 1.42E-39 
Gm17651 -1.27 3.01E-26 Rpp25 1.47 7.11E-36 
Gm5864 -1.27 0.000000679 Gm36757 1.48 1.17E-12 
A530021J07Rik -1.26 0.00000255 Dtx1 1.49 5E-24 
Pax3 -1.26 0.0000218 Cntnap5b 1.49 2.85E-83 
C10orf53 -1.26 0.000679 Snap91 1.50 2.44E-23 
Ttll2 -1.26 0.000205 Gm21655 1.54 2.02E-27 
Gm15684 -1.26 3.29E-38 Gm37877 1.54 0.000000195 
Gm37229 -1.26 5.42E-41 Gm6089 1.54 8.38E-31 
Gm28793 -1.26 0.000159 Cnr1 1.54 3.92E-23 
Lamc2 -1.26 1.45e-26 Ccrl2 1.55 4.81E-22 
Maml3 -1.25 1.36e-36 Msc 1.55 6.57E-11 
Ear2  -1.25 0.000282 Megf10 1.56 1.77E-18 
Gm15482 -1.25 0.000000131 Cmtm5 1.58 0.000000242 
Apol6 -1.25 3.23E-20 Gm18645 1.59 4.27E-14 
Klf15 -1.24 6.93E-28 Gm16057 1.63 2.34E-08 
Cd5l -1.24 0.000532 Gm9962 1.64 8.54E-13 
Creg2 -1.24 2.02E-13 Tll2 1.65 4.82E-22 
Gm18955 -1.24 0.0011 Nrg3os 1.66 1.07E-41 
Pfkfb3 -1.24 9.8E-39 Kcnb1 1.68 1.84E-34 
Cdh19 -1.24 4.97E-25 Dpp6 1.70 2.26E-33 
Ccdc116 -1.24 3.79E-10 Gm20642 1.70 3.3E-20 
Slco4c1 -1.24 0.0000238 Platr22 1.70 1.49E-30 
Alox12e -1.24 0.000748 4930546K05Rik 1.73 6.98E-25 
Gm23442 -1.24 9.48E-13 Prrx1 1.74 3.03E-27 
A830012C17Rik -1.24 5.4E-20 Il5 1.74 1.81E-21 
Mchr1 -1.23 0.000719 Gm18957 1.74 3.43E-13 
Gm16638 -1.23 7.07E-24 Or8d1 1.75 0.000000027 
Frmpd2 -1.23 0.000483 Gm7557 1.78 7.97E-12 
Fam47e -1.23 0.000402 Lrtm1 1.80 1.14E-16 
Add3 -1.23 3.89E-66 Speer4a  1.81 3.13E-13 




Scrn1 -1.23 3.78e-39 Rprm 1.85 3.05E-21 
Gm2448 -1.23 0.000121 Ptgfr 1.86 2.45E-74 
Gm18997 -1.23 0.00134 Gm43618 1.87 2.17E-49 
Sorbs2os -1.22 1.9E-76 Npr3 1.91 1.4E-37 
Gm38055 -1.22 8.83E-17 Sfrp2 1.93 5.27E-13 
Ppp2r2c -1.22 0.00000139 C4orf17 2.00 1.35E-39 
Klk3 -1.22 0.0012 Olfml2b 2.05 4.41E-60 
Gm43344 -1.22 5.88E-11 Gm15749 2.14 5.01E-17 
Ccdc151 -1.22 0.00093 Ctxn3 2.20 1.31E-40 
Gm9195 -1.22 0.00065 Gm26771 2.22 3.27E-30 
Cyp2j14-ps -1.22 0.00138 Gm16485 2.65 1.15E-53 
Itgb2l -1.21 0.000715 Cyp26b1 2.86 1.31E-88 





Appendix 15 List of differentially expressed genes identified in RNA-seq BKO vs WT 
granulosa cells identified through RNA-seq.  
Genes that had |logFC| ≥ 1 and an adjusted p-value cut-off of 0.01 were selected as DEG. 
LogFC is displayed as KO vs WT. 
Gene LogFC Adj p-value Gene LogFC Adj p-value 
Kcnv2 -1.49 1.21e-21 Ndst3 1.08 9.03E-05 
Cyp2j11/cyp2j8 -1.20 2.15e-13 Ac155634.2 1.08 8.62E-05 
Gm25395 -1.10 0.000018 Elfn1 1.08 3.67E-08 
Hand2 -1.03 8.89e-05 Gm29865 1.08 5.43E-05 
Gm34609 1.00 0.000206 Tmem200a 1.09 5.5E-06 
Cd86 1.00 0.000063 Dgki 1.09 6.47E-06 
St8sia6 1.00 8.12e-05 Gm2164 1.09 7.91E-05 
4930432E11Rik 1.00 0.000269 Dlx6os1 1.09 5.28E-05 
Tspear 1.00 0.000322 Gm38256 1.09 7.75E-05 
C6 1.00 0.000172 Gm43154 1.09 4.36E-05 
Gm11884 1.00 0.000218 Gm11823 1.09 3.52E-05 
Prokr2 1.01 0.000016 Otog 1.10 0.00004 
1700030F04Rik 1.01 0.000312 Gm26815 1.10 6.88E-05 
Rfx4 1.01 0.000095 Kcnq2 1.10 2.57E-05 
A530053G22Rik 1.01 0.000214 Gm46329 1.10 5.95E-05 
Slc22a16 1.01 0.000149 Gm43122 1.11 5.43E-05 
Slc4a10 1.01 0.000303 Ac103362.1 1.11 5.62E-05 
Aoah 1.01 0.000249 Arpp21 1.11 5.28E-05 
Catspere 1.01 0.000279 C12orf42 1.12 4.13E-05 
Gm32884 1.01 0.000253 Crhr2 1.12 4.45E-05 
4932414N04Rik 1.01 0.000292 Ovol2 1.12 2.63E-05 
Dux 1.01 9.21E-05 Gm26713 1.12 4.36E-05 
Siglech 1.01 9.71E-05 4930474H20Rik 1.12 0.00004 
Gm20642 1.01 3.51E-10 Gm37971 1.12 1.26E-05 
Gm46392 1.01 0.000275 Gm29506 1.13 3.29E-05 
Gm7019 1.01 0.00013 Cacng2 1.13 0.000026 
Olfm3 1.01 0.000197 Uox 1.13 3.12E-05 
Soga3 1.02 0.000205 Ct010475.1 1.14 2.97E-05 
Gm35998 1.02 0.000214 Nrg3os 1.15 9.05E-17 
Arhgef38 1.02 0.000241 Skint2 1.15 2.33E-05 
Serpinb3b/serpinb3c 1.02 0.000249 Adra1a 1.16 2.07E-05 
Brinp1 1.02 0.000239 Trpm1 1.16 1.71E-05 
Gm45321 1.02 0.00021 Adamts20 1.16 1.28E-05 
Enthd1 1.03 0.000171 4930435c17rik 1.17 1.23E-05 
Ac163285.1 1.03 0.000232 Fat2 1.17 0.000013 
Cnga3 1.03 9.72e-05 Htr2c 1.17 0.000015 




Lyzl4 1.03 0.000166 Jakmip2 1.18 6.4E-06 
Gm19585 1.03 0.000205 Gm21847 1.19 2.67E-11 
Gm44613 1.03 0.000208 Wdr64 1.19 0.000012 
Ac147639.2 1.03 0.000167 Cd28 1.19 1.46E-06 
Cdhr3 1.03 0.000166 Scn9a 1.19 9.57E-06 
Gm19303 1.04 0.000161 4921533I20Rik 1.20 4.39E-06 
Ac121912.1 1.04 0.000129 Dcdc5 1.20 7.12E-07 
Tacr1 1.04 0.000195 Fam135b 1.20 7.38E-06 
Vmn2r-ps11 1.04 0.000184 Nol4 1.21 5.99E-06 
Dnah6 1.04 6.49e-05 Vmn2r-ps110 1.21 8.35E-06 
Gm28694 1.04 7.04E-05 Gm14280 1.21 5.79E-06 
Wdr49 1.04 0.000126 Vwa3b 1.22 5.49E-06 
Abca15 1.04 0.000136 Gm31698 1.23 4.35E-06 
Gm34184 1.05 5.95E-05 Gm13481 1.23 1.36E-09 
2310002F09Rik 1.05 0.000161 Gm37093 1.24 3.52E-06 
Trpm8 1.05 7.89e-05 Skint5/skint6 1.24 3.68E-06 
Srrm3 1.05 0.000133 Gm15083 1.24 3.65E-06 
Gm30835 1.05 0.00015 Gm10649 1.24 3.52E-06 
Gm16271 1.05 0.000136 Cdh26 1.24 3.01E-06 
Trat1 1.05 0.000155 Macc1 1.25 1.51E-06 
Ptchd1 1.05 0.000147 Dnai1 1.26 1.17E-06 
Cyp2b6 1.05 0.000112 Scn1a 1.28 1.12E-06 
Tmem196 1.05 0.000136 Gm11033 1.28 1.56E-06 
Gad1 1.05 0.000131 Gm13974 1.29 1.17E-06 
Ttll6 1.06 0.000125 Dnah3 1.30 1.58E-08 
Ac060761.1 1.06 0.000134 Wdr63 1.30 1.73E-07 
Gm13598 1.06 6.11E-05 A330069K06Rik 1.30 9.29E-07 
Gm5570 1.06 8.65E-05 Agmo 1.32 6.18E-07 
Vdr 1.06 1.89e-11 Zbbx 1.32 6.93E-07 
Rgs8 1.06 0.000122 4930474g06rik 1.32 5.35E-07 
Gm20752 1.07 0.000109 RP1 1.33 6.38E-08 
Cngb3 1.07 0.000105 Rp1l1 1.38 1.61E-07 
Mlip 1.08 0.000101 3100003l05rik 1.41 4.37E-08 

























Lyve1 -5.83 -4.81 + - Plac8l1 -1.44 -1.03 - - 
Sprr2g -5.46 -2.45 - - Rbbp7 -1.43 -1.28 + + 
Cyp2j11/cyp2j8 -4.40 -3.46 - - Gm20616 -1.43 -1.27 - - 
Zic2 -4.14 -2.74 - + Atp4a -1.42 -1.93 - - 
Cldn1 -3.76 -4.05 + - Micos10 -1.42 -1.77 - - 
Kcnv2 -3.70 -2.96 + + Teddm2 -1.41 -2.09 - - 
1700040D17Rik -3.70 -2.24 - - Gm6382 -1.41 -1.17 - - 
Cited1 -3.62 -2.44 + - Mir8114 -1.41 -2.13 - - 
Pla2g2f -3.55 -1.08 + - Defb119 -1.40 -1.56 - - 
Fabp4 -3.53 -1.63 + - Scara5 -1.40 -3.26 + + 
Ppp1r36 -3.34 -2.63 - - Kiaa1217 -1.39 -2.07 - - 
L3mbtl4 -3.33 -3.37 + + Prkg2 -1.39 -1.62 + + 
Kcne4 -3.24 -2.13 + + Trpc4 -1.39 -1.45 + - 
Sctr -3.22 -2.81 + - Ac113178.1 -1.39 -1.43 - - 
Scg2 -3.00 -2.67 - - Ifnk -1.38 -1.14 + - 
Ntn5 -2.95 -2.43 + + Gm11384 -1.37 -1.33 - - 
Jcad -2.93 -2.27 - + Actn3 -1.37 -1.99 + + 
Tmem37 -2.82 -2.38 + + Gm42435 -1.36 -1.53 - - 
Rp23-98c9.5 -2.79 -1.96 - - Trim9 -1.35 -1.17 + + 
Mt2 -2.78 -1.95 + + Aloxe3 -1.34 -1.91 - + 
Havcr2 -2.75 -2.73 + - Gm42555 -1.34 -1.63 - - 
Sphk1 -2.74 -2.64 + + Nipal1 -1.34 -1.35 - + 
Rp23-357o17.1 -2.73 -1.99 - - Defb45 -1.34 -1.10 - + 
Cdh13 -2.73 -1.81 + - Entpd7 -1.33 -1.15 + + 




Ac096777.1 -2.64 -2.69 - - Pcdh8 -1.33 -1.57 - + 
Slco2a1 -2.55 -1.40 - + Egfros -1.32 -1.70 - - 
Frmpd1 -2.53 -2.26 + - Gm11250 -1.32 -1.25 - - 
Trpa1 -2.52 -1.69 + - C630043F03Rik -1.31 -1.00 - - 
Hsd17b11 -2.51 -3.31 + + Gm37342 -1.30 -1.90 - - 
Rp24-421p3.9 -2.46 -1.28 - - Arhgap31 -1.30 -1.30 - + 
Sh3gl3 -2.45 -1.69 + - Myl2 -1.30 -2.13 - - 
Gm33024 -2.42 -2.05 - - Unc5cl -1.29 1.04 - - 
Gm12637 -2.41 -3.19 - - Gm10728 -1.29 -1.88 - - 
A930030B08Rik -2.40 -1.63 - - SLC7A11 -1.29 -2.03 + + 
Itgb6 -2.36 -2.54 + + Gm20089 -1.28 -1.69 - - 
N-R5s89 -2.36 -1.08 - - Hnf4a -1.27 -1.62 + + 
Gldc -2.35 -1.75 - - Cep295nl -1.27 -1.08 - - 
Sec1 -2.33 -1.61 - - Gm15684 -1.26 -1.56 - - 
Abcc2 -2.31 -2.10 + - Gm37229 -1.26 -1.74 - - 
E230020D15Rik -2.30 -1.57 - - Maml3 -1.25 -1.75 + + 
Cyp2j15-ps -2.30 -1.63 - - Ear2 -1.25 -1.25 - - 
Ces1a -2.30 -1.59 + - Apol6 -1.25 -1.85 + + 
Gm43298 -2.28 -1.29 - - Klf15 -1.24 -2.10 + + 
Glp2r -2.24 -3.17 - - Creg2 -1.24 -2.72 + + 
Gm4275 -2.23 -1.58 - - Cdh19 -1.24 -2.33 + - 
4930452G13Rik -2.22 -1.57 - - Gm16638 -1.23 -1.94 - - 
Frmpd1os -2.22 -2.43 - - Add3 -1.23 -1.03 + + 
Tbc1d8 -2.22 -2.70 + + Scrn1 -1.23 -1.44 + + 
Gm45073 -2.21 -1.73 - - Sorbs2os -1.22 -1.29 - - 
Rp23-390f4.1 -2.21 -2.14 - - Hsd17b13 -1.20 -1.63 - - 
Gm12796 -2.19 -1.71 - - Mbnl1 -1.19 -1.20 + + 
Gm13068 -2.15 -1.75 - - Mt3 -1.19 -1.12 - - 




Gm27884 -2.10 -1.49 - - Dtna -1.18 -1.45 + - 
4930529N20Rik -2.09 -1.90 - - Vnn3 -1.18 -2.46 - - 
Gm12801 -2.08 -1.38 - - Gm3470 -1.17 -1.37 - - 
Efnb2 -2.07 -1.76 + + Dmd -1.17 -1.36 + + 
Bcl11b -2.07 -1.51 + + Tcf23 -1.16 -1.14 - - 
Helt -2.05 -2.33 + - Tmc3 -1.16 -1.70 - - 
Gm45463 -2.05 -1.34 - - Them6 -1.16 -1.33 + - 
Gm15475 -2.05 -1.63 - - Tle1 -1.16 -1.07 + + 
Gm15328 -2.04 -1.57 + - Sra1 -1.15 -1.15 - - 
Gm39168 -2.03 -1.28 - - Gm34549 -1.14 -3.90 - - 
Gstm5 -2.02 -1.42 - - Hla-dob -1.13 1.24 - - 
Kcnh4 -2.01 -1.88 - + Tac3 -1.13 -1.57 - - 
Gm44079 -2.00 -2.01 - - Rp23-282m20.5 -1.13 -2.07 - - 
Gm37498 -2.00 -2.39 - - Aldh3a1 -1.13 -1.55 + - 
Gas7 -1.99 -2.71 + + Gclc -1.12 -1.19 + + 
Rp23-357o17.2 -1.98 -1.19 - - Mageb18 -1.12 -1.23 - - 
Vldlr -1.98 -1.31 + + Xlr3c -1.11 -1.05 - - 
Pde6h -1.98 -1.85 + + 4930522N08Rik -1.11 -1.10 - - 
Gm40910 -1.95 -1.68 - - Mob3b -1.11 -1.00 - - 
Gm13583 -1.94 -2.14 - - Vnn1 -1.10 -1.32 - - 
Hopxos -1.94 -2.62 - - Gm43621 -1.09 -1.61 - - 
Ca11 -1.94 -1.38 - - Crispld2 -1.09 -1.52 + + 
Pparg -1.91 -1.88 + + C2cd4d -1.08 -1.11 - + 
Gstm2-ps1 -1.90 -1.36 - - Gm37675 -1.08 -1.45 - - 
Cd34 -1.90 -2.10 + + Jam3 -1.07 -1.36 + + 
Bean1 -1.90 -1.65 + + Cryab -1.07 -1.09 - - 
Hopx -1.89 -2.47 + + Edn2 -1.06 -1.32 + + 
Lpar1 -1.89 -1.39 - - 6030407O03Rik -1.04 -1.52 - - 




Gm20540 -1.88 -1.81 - - Gmnc -1.04 1.13 - - 
Stmn4 -1.87 -1.15 - + Sprr2f -1.04 1.58 - - 
Ralgapa2 -1.87 -2.33 + + Cdh18 -1.03 -1.30 + - 
Gm11494 -1.84 -1.60 + + Cln5 -1.01 -1.19 - - 
Gm8200 -1.83 -2.22 - - Zcchc24 -1.00 -1.74 + + 
Rp23-469k15.2 -1.83 -1.17 - - Slit2 1.01 1.44 - + 
Gm33677 -1.83 -3.12 - - 4933416M06Rik 1.02 1.58 - - 
A930019D19Rik -1.83 -2.44 - - Gm26725 1.04 1.04 - - 
Gm42463 -1.83 -2.04 - - Vegfc 1.06 1.03 - + 
Gm43545 -1.82 -2.17 - - Tac1 1.06 1.46 - + 
Gm14319 -1.82 -1.55 - - 9530086O07Rik 1.07 1.10 - - 
Ai463229 -1.81 -1.98 - - Gm26911 1.07 1.04 - - 
Gm16897 -1.81 -2.00 + - Nsun7 1.07 1.44 - + 
Tnfsf11 -1.81 -1.85 - - Kcnk10 1.08 1.92 - - 
Ldhd -1.81 -1.77 + + Gm37941 1.11 1.25 - - 
Gm17590 -1.79 -2.00 - - Gm20475 1.12 1.75 - - 
1700011B04Rik -1.79 -1.14 - - Gm7775 1.13 1.30 - - 
Rnf125 -1.79 -1.49 + + Lsamp 1.17 1.37 - - 
Hkdc1 -1.78 -1.60 - - Gm15426 1.20 1.03 - - 
Gm44639 -1.77 -1.87 - - Slc22a17 1.23 1.13 - - 
Rubcnl -1.76 -1.80 + + Gm43947 1.26 1.03 - - 
Gm45074 -1.74 -1.48 - - Gm12526 1.26 1.11 - - 
Gm38411 -1.72 -2.54 - - Gm16559 1.26 1.08 - - 
Gm10631 -1.72 -1.46 - - Myh6 1.28 2.12 - - 
Mocs1 -1.71 -1.77 + - Csf2rb 1.30 1.10 - - 
Apoa1 -1.70 -1.01 - + Adh1c 1.31 1.10 - - 
Gm37832 -1.70 -1.71 - - Gm9947 1.32 1.68 - - 
Kl -1.70 -1.98 + + Lingo1 1.34 1.64 - - 




Gm43401 -1.68 -2.13 - - Avil 1.36 1.42 + + 
Gm39041 -1.67 -1.77 - - Astn1 1.36 1.04 - - 
Gm29536 -1.65 -1.27 - - Spock3 1.36 1.56 - - 
Ac154639.1 -1.63 -2.13 - - Mdga2 1.37 1.86 + - 
Stard5 -1.63 -1.65 + - Nrg3 1.40 1.39 - - 
Gm10706 -1.62 -1.17 - - Ac155634.2 1.40 1.63 - - 
E130008D07Rik -1.61 -1.24 - - Egln3 1.41 1.71 + + 
Xrra1 -1.61 -1.15 - + Brinp3 1.46 1.43 - - 
Ac147241.1 -1.58 -1.48 - - Rpp25 1.47 1.05 + + 
Gm45266 -1.57 -1.33 - - Dtx1 1.49 1.17 - + 
Gm37265 -1.57 -2.08 - - Gm21655 1.54 1.24 - - 
Gm16318 -1.57 -1.22 - - Gm37877 1.54 1.70 - - 
Rasef -1.56 -1.38 - - Gm6089 1.54 1.13 - - 
Gm45267 -1.56 -1.51 - - Cnr1 1.54 2.10 - + 
Add2 -1.56 -1.23 + - Msc 1.55 1.87 - + 
Entpd1 -1.56 -2.20 + + Cmtm5 1.58 1.66 - - 
Ampd3 -1.55 -1.11 + - Gm18645 1.59 1.20 - - 
Gm31510 -1.55 -1.67 - - Gm16057 1.63 1.04 - - 
Ankrd55 -1.54 -1.91 + + Nrg3os 1.66 1.40 - - 
Glns-ps1 -1.54 -1.38 - - Kcnb1 1.68 1.38 - + 
Gm9748 -1.54 -1.62 - - Dpp6 1.70 1.11 - + 
Kbtbd11 -1.53 -1.68 + + Gm20642 1.70 1.64 - - 
Ct572985.1 -1.52 -1.00 - - Platr22 1.70 1.78 - - 
Gm45615 -1.50 -1.30 - - Or8d1 1.75 1.16 - - 
4933416M07Rik -1.49 -1.53 - - Lrtm1 1.80 1.92 + + 
Rcvrn -1.49 -2.54 - - Speer4a 1.81 1.13 - - 
Gm24224 -1.48 -1.77 - - Npr3 1.91 1.98 - - 
Ac159006.2 -1.48 -1.15 - - Sfrp2 1.93 2.58 + + 




Gm11802 -1.46 -2.19 - - Gm15749 2.14 1.64 - - 
Mapre2 -1.45 -1.71 + + Gm26771 2.22 2.51 - - 
Pdlim1 -1.45 -1.57 + + Cyp26b1 2.86 1.36 - + 
Mt1 -1.45 -1.24 + +      
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